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This thesis describes the synthesis and characterisation of a series of new 
homoleptic and heteroleptic [Pd2L4] helicates, synthesised from a series of new 
ligands based on the previously reported 1,4-bis(3-pyridyloxy)benzene ligand. The 
anion exchange process on these homoleptic and heteroleptic helicates was also 
explored. 
Chapter 1 gives a brief introduction into supramolecular chemistry, and the ideas 
behind the self-assembly of homoleptic and heteroleptic architectures with some 
key examples from the literature. Considerations for the binding of ions inside a 
supramolecular architecture are also addressed.  
Chapter 2 discusses the synthesis and characterisation of ligands 1 – 6, where the 
ligands vary in the difference in the sterics of the central group. Chapter 2 then 
moves into detailing the synthesis and characterisation of the homoleptic helicates 
[Pd2(1)4], [Pd2(3)4] and [Pd2(5)4]. The work done shows that varying the sterics of 
the central group of the ligand leads to a preference for some homoleptic cages over 
others. The anion exchange process on the homoleptic helicates [Pd2(1)4], [Pd2(4)4] 
and [Pd2(5)4] with the tetrabutylammonium salts of ClO4-, ReO4- and NO3- is also 
discussed.  
Chapter 3 details the synthesis and characterisation of the dynamic libraries of the 
heteroleptic helicates [Pd2(1)x(3)4-x], [Pd2(1)x(5)4-x] and [Pd2(3)x(5)4-x]. The anion 
exchange process on the heteroleptic helicates [Pd2(1)x(3)4-x], [Pd2(1)x(4)4-x] and 
[Pd2(1)x(5)4-x] with the tetrabutylammonium salts of ClO4- and ReO4- is also 
discussed.  
Chapter 4 details the synthesis and characterisation of the dynamic libraries of the 
heteroleptic tri-ligand helicates [Pd2(1)x(2)y(3)z], [Pd2(1)x(3)y(6)z], 
[Pd2(1)x(4)y(5)z], [Pd2(2)x(3)y(6)z] and [Pd2(3)x(5)y(6)z]. 
Appendix 2 and 3 contain details on the synthesis and characterisation, and anion 
exchange processes for the other homoleptic and heteroleptic helicates synthesised 
from ligands 1 – 6. The experimental information for chapters 2, 3 and 4 are in 
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br                        Broad 
CDCl3                  Deuterated chloroform 
CD3NO2              Deuterated nitromethane 
CH3NO2              Nitromethane 
COSY                   Correlated SpectroscopY 
CuAAC                Copper(I) – catalysed azide – alkyne cycloaddition 
d                           Doublet (NMR) 
dddd                   Doublet of doublet of doublet of doublets (NMR) 
DCM                    Dichloromethane 
DFT                     Density functional theory 
DMAc                  Dimethylacetamide 
DMAP                  4 – dimethylaminopyridine 
DMF                     Dimethylformamide 
DMSO                  Dimethyl sulfoxide 
d6 – DMSO          Deuterated dimethyl sulfoxide 
DOSY                    Diffusion – Ordered SpectroscopY 
EA                         Elemental analysis 
en                         Ethylenediamine 
eq.                        Equivalents 
ESI – TOF MS     Electrospray ionisation time – of – flight mass spectrometry 
EtOAc                   Ethyl acetate 
Et2O                     Diethyl ether 
HR – ESI MS      High resolution electrospray ionisation mass spectrometry 
i – Pr2O               Diisopropyl ether 
m                          Multiplet 
Me                        Methyl 
MeCN                  Acetonitrile 
NaOH                  Sodium hydroxide 
v 
 
NMR                    Nuclear Magnetic Resonance 
pet. ether           Petroleum ether (40 – 60 oC) 
ppm                    Parts per million 
Py                        Pyridine 
ROESY               Rotating frame Overhause Effect SpectroscopY 
s                          Singlet (NMR) 
STEM                 Scanning Transmission Electron Microscope 
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1.1 Supramolecular Chemistry  
 
Supramolecular chemistry, as defined by Lehn, one of the field’s pioneers in 1987, is 
“chemistry beyond the molecule”.1 If looking for a simple description of 
supramolecular chemistry, it is the chemistry of taking molecular “building-blocks” 
and using them to design/create larger molecular architectures that have desirable 
qualities. For example, structures which can bind guests inside a cavity, or 
structures which can act as sensors. It is also defined as the chemistry of tailor-
shaped intermolecular interactions in which information is stored in the form of 
structural peculiarities.2 
Most interesting is that these supramolecular architectures are assembled 
spontaneously in solution, which is driven by formation of noncovalent interactions 
between the building blocks. This self-assembly process is widely used in nature,3-6 
for example, base paring (which is seen in RNA and DNA) and secondary 
polypeptide interactions. Both of these interactions rely on hydrogen bonding, and 
this has been widely used by supramolecular chemists.7 Nature exploits 
noncovalent interactions for the construction of various cell components, for 
example, ribosomes and chromosomes use mostly hydrogen bonding with 
covalently formed peptide bonds to form specific structures.8 The self-assembly 
process also eliminates the need for lengthy multi-step synthesis of these structures 
which generally leads to low yields of such products.9 
Over the past few decades, metallosupramolecular chemistry, which utilises 
interactions between metals and organic ligands to create well defined, discrete 
architectures has bloomed, with a number of architectures from groups including 
those of Lehn,10 Fujita,11 Nitschke12 and Crowley.13 Utilising metals allows for 
geometries which are not possible with normal organic supramolecular 
architectures.8 Common metals used in these self-assemblies include those of Zn(II), 
Fe(II), Hg(II), Co(III), Cu(I, II), Ru(II), Pt(II) and Pd(II).14 Common coordination 
geometries include that of square planar (Pd(II)) and  octahedral (Co(II)) which 
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allow for the creation of large supramolecular architectures, for example, helicates, 
metallocrowns, polyhedra and cages.15-16 The use of metals also introduces 
interesting physical properties into the molecules as they can possess magnetic, 
biological and photophysical properties.17 These metal – ligand interactions are a 
key part of these architectures as they are highly directional and can be used in place 
of many weak interactions to direct their formation.4, 8 The metal used is generally 
able to form labile coordinative bonds which leads to self-correction of the kinetic 
products to eventually lead to the thermodynamic product. For example, Pd(II) – 
N(pyridine) metal – ligand bonds are widely used for self-assembled architectures 







Figure 1.1 An example of a supramolecular architecture, a double-walled knotted 





1.2 Supramolecular Cages 
 
 
Models of self-assembly 
 
There are two main models used to describe the self-assembly of 
metallosupramolecular architectures; the “molecular library” and the “symmetry 
interaction” model.14 The molecular library model (or ligand directed model), 
popularised by Fujita11 and Stang,8 describes the assembly of 
metallosupramolecular architectures which utilises rigid, highly directional multi-
branched bis-monodentate (non-chelating) ligands and partially coordinatively 
unsaturated metal units. This leads to the formation of geometric shapes or 
polyhedra.8, 14 Utilising this model, the construction of almost any macrocyclic 
system which contains a transition metal can be achieved by looking at the 
appropriate angles between the binding sites on the donor (ligand) and metal 
(acceptor).8 For example, Fujita reported in 1990 the formation of a square-shaped 
macrocycle utilising four cis-protected metal units with 90o angles and four rigid 
bidentate linear ligands (180o), commonly known as the Fujita square.19 For 2-
dimensional architectures, one of the building blocks must contain two binding 
sites, for 3-dimensional architectures, there must be one containing three binding 
sites.8 A table of possible 2-dimensional architectures is shown in Figure 1.2, and a 






Figure 1.2 Possible 2-dimensional structures which can be formed from building 
blocks with only two binding sites.  
 
 
The symmetry interaction model, popularised by Saalfrank20, Lehn10 and Raymond4, 
describes the predictive design strategy to form clusters from utilising multi-
branched ligands and metal units8, 14. This leads to increased preorganization of the 
architectures and stronger binding due to the chelate effect, which is not possible 
using single monodentate ligands. Depending on the coordination of the metal unit 
used, the resulting architecture can either be neutral or charged depending on the 
nature of ligand used.8 
The method followed for the construction of the metallosupramolecular 
architectures described in this thesis fall under the “molecular library” category as 
bis-monodentate ligands and unprotected metal units are utilised in construction. 
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In particular, we utilise square-planar palladium(II) and pyridine-based bidentate 
ligands. These building blocks have been extensively used for the construction of 
self-assembled architectures, as facilitated by favourable kinetic lability and the 
thermodynamic stability of the palladium(II) – ligand interactions.14 Depending on 
the nature of the palladium(II) used, two or four coordination sites are available for 
the ligand to bind to. To access only two coordination sites, the palladium(II) metal 
is typically cis-protecting using a suitable bidentate chelating ligand, for example 
ethylenediamine (en).14 The majority of palladium(II)-based self-assembled 
complexes are of high symmetry, composed of only one type of ligand and the 
chosen metal component, and are termed “homoleptic”. These high symmetry 
homoleptic complexes have been used in a wide range of applications, for example; 




1.3 Homoleptic Cages 
 
Homoleptic cage self-assembly 
 
An architecture that utilises one type of ligand is defined as being homoleptic. The 
strategy for the formation of homoleptic metallosupramolecular architectures is 
quite straight forward, mixing the metal component and chosen ligand together 
produces a highly symmetric homoleptic complex. The reliability of this approach 
has led to a wide range of compounds. These cage-like structures are of interest as 
they possess an internal cavity to encapsulate guest molecules. For example, anions 
can be selectively bound by electrostatic interactions and by hydrogen bonding, 
depending on the nature of the cage structure.25 Many different metal building 
blocks have been used in the production of metallosupramolecular architectures, 
however this thesis will focus mostly on those employing square-planar coordinated 
metals to produce cages of the form [M2L4]. Many of the ligands used in the 
mentioned examples of self-assembled cages utilise pyridine-based ligands, 
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however other nitrogen containing ligands can be utilised. For example; 
imidazole,26-27 triazole,28 and benzimidazole based ligands have been used.29  
An early example of a cage-like architecture comes from Fujita in 2001.30 They were 
able to form a [M2L4] cage that was shown to bind NO3- inside its cavity. The cage 
was formed by utilising palladium(II) metal building blocks and a rigid organic 
ligand containing two pyridine donors (Figure 1.3). The cage was formed from a 1:2 
ratio of metal : ligand in DMSO with heating at 90o, and was then precipitated out 
using diethyl ether. It was determined that the cage-like structure exhibits 
remarkable thermodynamic stability due to only the cage forming when a limited 
amounts of palladium(II) is available, also the structure is formed when there is an 
excess of palladium(II). The NO3- anion was shown to be bound inside the cavity by 
electrostatic interactions between the palladium metals and the oxygen atoms of the 
nitrate anion. A similar cage to this was prepared by Chand in 2006, where the 
palladium(II) building blocks were replaced for platinum(II) instead and was shown 






Figure 1.3. [Pd2L4] cage utilising rigid ligands, Fujita 2001.  
 
 
From 2003-2004, Puddephatt investigated a series of palladium(II)-based 
metallocages using bis(amidopyridine) ligands.32-33 The bis(amidopyridine) ligand 
used could adopt three different conformations; 1) where both NH groups point into 
the cavity, 2) where one NH and CO group point into, and 3) where both CO groups 
point into the cavity (Figure 1.4). The reaction of [PdCl2(NCPh)2] with the ligand in 
a 1:2 ratio in chloroform formed the cage with all ligands in the 1st conformation, the 
same reaction conditions in benzonitrile/DMF with silver trifluoroacetate yielded 
the cage with all ligands in the 2nd conformation.  A homoleptic cage where the 
ligands are in the 3rd conformation was unable to form. The metallocage where the 
ligands are in the 1st conformation encapsulates two chloride anions inside the 
cavity, however the other cage was shown to be able to encapsulate two alkali metal 
cations (Na+ or K+) where each are coordinated to two of the inward CO groups. 
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Therefore, depending on the conformation of the ligand, specific host-guest 




Figure 1.4. Formation of different [Pd2L4] metallocages, hydrogen atoms and 




Yoshizawa reported that introducing an atropisomeric axis into a bent bispyridine 
ligand led to the formation of a complex mixture of atropisomeric [Pd2L4] cages.34 
By synthesising a bispyridine ligand with a 1,4-napthylene-embedded in it, this 
leads to three possible atropisomers of the ligand due to the hindered rotation 
around the phenyl – naphthyl bonds. When this ligand is mixed with the metal ions, 
it leads to the possibility of 42 different isomers of the [Pd2L4] cage. 1H NMR of the 
mixture showed complicated and broadened signals, and 1H DOSY data revealed 
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that these signals all had the same diffusion coefficient, indicating the existence of 
an isomeric mixture of cages present. ESI – TOF MS analysis of the mixture also 
confirmed that only one species was present, which was the [Pd2L4] cage. With the 





Figure 1.5. Guest – induced convergence with C60 on a mixture of atropisomeric 
[Pd2L4] cages to form a single atropisomer. 
 
 
Metallocages utilising functionalised ligands 
 
The self-assembly of a metallocage with the ability to bind large guest molecules up 
to diameters of 1 nm was reported by Yoshizawa.35 By utilising anthracene units, 
they were able to produce a ligand which contained large aromatic panels which are 
used to create the aromatic shell of the metallocage. This aromatic shell is ideal for 
the encapsulation of neutral molecules in aqueous media due to the hydrophobic 
cavity, and the long hydrophilic pendant chains which come off the metallocage. The 
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metallocage was produced by mixing AgNO3 : Pd(II) : ligand in a 2:1:2 ratio in d6 – 
DMSO at 100oC, and X-ray crystallography showed  that there are one water, seven 
methanol’s and one NO3- molecule located inside the cavity (Figure 1.6). 
Encapsulation studies36 have shown that the metallocage can encapsulate medium-
sized spherical guests ([2,2]-paracyclophane), planar guests (1-methylpyrene), but 




Figure 1.6. Formation of a metallocage which can bind large guests within its 
cavity. Shown is the formation of the NO3- binding metallocage, and with addition 
of planar guest 1-methylpyrene (magenta) the cage selectively binds two 
molecules of the guest.  
 
 
Most self-assembled metallocages use rigid ligands which contain organic linkers, 
these linkers can be carefully chosen to add different functionalities to the resulting 
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metallocage without interfering with the assembly process.25 Crowley was able to 
produce a palladium(II) metallocage which was shown to bind the cancer 
chemotherapy drug cisplatin inside the cavity, by mixing the palladium(II) source 
and the tripyridyl ligand in a 1:2 mixture in acetonitrile.24 In the structure of the 
metallocage, the central pyridyl ring is involved in hydrogen bonding to disordered 
solvent molecules inside the cage’s cavity. Most interesting about this metallocage, 
is that it can be disassembled/reassembled depending on what has been added to 









When competitive ligands (L), such as DMAP or Cl- are added, the metallocage is 
disassembled into free ligand and the corresponding [Pd2(L)4]2+/-. Reassembly is 
possible with the removal of the competing ligands using acid (protonation of 
DMAP) or silver cations (to form insoluble AgCl). When cisplatin is coordinated 
inside the cavity, the same stimuli-responsive disassembly/reassembly is also 
observed. 
Crowley also did studies on whether the addition of an exo-functional group to the 
ligand backbone could add extra functionality to the metallocage.37 The exo-
functional group added to the ligand was that of a 1,2,3-triazole unit. The triazole 
ligand is easy to synthesise and functionalise using the Cu(I)-catalyzed 1,3-
cycloaddition of organic azides with terminal alkynes (the CuAAC reaction).28, 38-39 
Crowley utilises 1,4-substituted 1,2,3-triazole ligand types instead of polypyridyl 
ligands, since triazole ligand types are inexpensive to produce and take less time 
than the synthesis of polypyridyl ligands. By changing the substituents on the 1,2,3-
triazole unit, functionality could be added to the ligand. The group produced three 
different exo-functionalised ligands, a phenyl, a ferrocene and a caffeine substituted 
ligand. Ferrocene has been attached to a number of metallosupramolecular 
architectures, with the goal of producing electrochemically active systems.37 
However, the addition of the ferrocene substituent to the ligand had no effect on the 
redox processes in the free ligand state, or when coordinated to palladium(II) in the 
metallocage.   Overall all three of the exo-functionalised ligands had no effect on the 
self-assembly process or the binding of cisplatin of the metallocages. 
Hooley showed the formation of a self-assembled metallocage which can control the 
guest binding by utilising two-component recognition.40 The resulting cage has a 
“paddle-wheel” structure, and was formed from the 1:2 mixture of palladium(II) : 
bis(pyridine)-based ligand in d6 – DMSO (Figure 1.8). The metallocage is stable in 
air at room temperature for months, and was shown to have binding affinity 
towards neutral molecules such as benzonitrile and 1,4-difluorobenzene. Binding of 
neutral guests is difficult due to competition with the binding of solvent molecules 
by the metallocage. Other studies carried out by Hooley41-42 include looking at 
adding endo-functionality to the ligand back-bone, which is used to produce similar 
palladium(II) self-assembled clusters. An example of an endo-functionalised ligand 
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and its corresponding cluster from Hooley is shown in the assembly-dependent 
integrative self-sorting sub-chapter.   
 
 
Figure 1.8. Formation of metallocage, hydrogen atoms and solvent molecules have 
been omitted for clarity. 
 
 
Clever showed the self-assembly of a metallocage where a guest can be 
bound/released by utilising a ligand which changes conformation with a certain 
wavelength of light.43 The ligand of choice is bis(pyridyl)-based and is also based on 
a dithienylethene(DTE) photoswitch, when in white light the ligand is in its open-
ring form (black ligand) and if in UV light (365 nm) it is in the closed-ring form (blue 
ligand). This is also true for the metallocage which is formed from a 1:2 reaction of 
Pd(II):ligand in acetonitrile, the open-ring form of the cage can be converted back to 
the closed-ring cage with irradiation of UV light (Figure 1.9). The guest in question 
is that of B12F122-, which is large and spherical and can be encapsulated in the open-




Figure 1.9. Conversion between different conformations of ligands/metallocages 
with irradiation specific wavelengths of light. Anions, solvent molecules and 
hydrogen atoms have been omitted for clarity. 
 
 
In 2019 Liu created a metallocage which is also photoswitchable but utilises an 
azobenzene-based bis(pyridyl) ligand instead of the dithienylethene based ligand.44 
When irradiated with UV light, the azo-ligand goes from the trans isomer to the cis 
isomer which causes the self-assembled trans metallocage to disassemble due to the 
ligand no longer being in the right conformation for assembly (Figure 1.10). These 
types of metallocages discussed above could potentially be used in drug delivery due 





Figure 1.10. Assembly/disassembly of a trans metallocage using irradiation of UV 





An interesting subclass of metallocages is that of helical structures. The term 
“helicate” was first introduced by Lehn in 1987, which he defined as a metal complex 
which contains two or more metals bridged by one or more ligand strands.45  
M2L4 helicates and M2L4 cages are similar, the only difference between them is how 
the ligands are bound within the structure. This can be explained by measuring the 
azimuthal angle of the structure.46 The azimuthal angle (θ) is defined as the angle 
formed between the two donors of the bis-monodentate bridging ligand, therefore 
giving an estimate of the degree of twisting (Figure 1.11). To qualify as a helicate, 
the measured azimuthal angle of the ligands must be non-zero. If the measured angle 
is zero, therefore there is no degree of twisting of the ligands, and therefore it cannot 





Figure 1.11. Visual depiction of the azimuthal angle θ in M2L4 cages. Only one of 
the four ligands is depicted for clarity. From left to right, normal M2L4 cage (θ = 0o), 
right handed (P) helicate and left handed (M) helicate (θ ≠ 0o). 
 
 
The difference between M2L4 helicate systems and others from the works of 
Crowley,13, 24, 47-48 Clever,3, 16, 49-51 and others25, 36, 46, 52 is the fact that it is highly 
dynamic, due to the use of a non-rigid ligand. These other M2L4 systems utilise 
ligands which are rigid, and therefore produce cavities which are largely static and 
cannot adjust their size. Therefore, any selectivity shown by these cages is based 
solely on how well the size of the guest matches the cavity of the host. 
Lehn produced a double-stranded [M2L2] and a double-stranded [M3L2] helicate, 
where the Cu(I) metals are wrapped around by the two oligobipyridine ligands. 
Helicates are interesting as they are chiral, therefore there are two possible 
enantiomers of the helicates structure. One where the structure is twisted to the 
right (P) and the other where it is twisted to the left (M). Helicates of the form [M2L4] 
are more interesting as due to their arrangement, they can allow for a reasonable 
sized and potentially chiral cavity for host-guest chemistry. There have only been a 
few reports of such quadruple-stranded helicates utilising palladium(II) as the 
metal building block. 
The self-assembly of a palladium(II) quadruply stranded metallohelicate was 
reported by Chand in 2010,53 where the ligand used is N,N’-bis(3-
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pyridylformyl)piperazine. The metallohelicate was produced from mixing Pd(II) : 
ligand in a 1:2 ratio in MeCN at room temperature and is shown to bind a NO3- anion 
in its cavity, which has an azimuthal angle of 45o (Figure 1.12 A). Another 
metallohelicate was produced by Chand in 2012 utilising the ligand N,N’-(pyridine-
2,6-diyl)dinicotinamide  with mixing in DMSO at room temperature in a 1:2 
palladium(II) : ligand ratio for 48 hours.46 The resulting helicate was shown to bind 
3 NO3- anions inside its cavity and both enantiomers were shown in the X-ray crystal 




Figure 1.12. A) Metallohelicate encapsulating one NO3- anion within its cavity. 
Helicate displays twisting to the right (P). B) Metallohelicate encapsulating three 
NO3- anions within its cavity. Only the (P) enantiomer of the helicate is displayed. 




Crowley has reported that 1,4-substituted 1,2,3-triazole ligands are a good pyridine 
substitute for the self-assembly of palladium(II) metallohelicates.39 A 
metallohelicate was formed from the mixing 1:2 palladium(II) : ligand in 
acetonitrile, and then isolated by slow vapour diffusion with diethyl ether.28 A single 
crystal of the metallocage showed that both enantiomers were present with a helical 
pitch of 90o (Figure 1.13). The cavity formed is too small to encapsulate guests, but 
is stable due to a number of face to face π-π stacking interactions54 between the 




Figure 1.13. Formation of two enantiomers of a metallohelicate from a 1,4-
substituted 1,2,3-triazole ligand. Left structure is twisted to the left (M), right 








An architecture utilising more than one type of ligand is defined as being 
heteroleptic. However, as more types of ligands are added, the strategy for 
formation of a single heteroleptic product becomes more complicated. There are 
many examples of discrete heteroleptic self-assembled architectures from various 
metal components such as Zn(II), Fe(II), Cu(II), Ru(II) and Pt(II) from the groups of 
Lehn, Fujita, Zheng, Stang, Schmittel, Nitschke and others.14 However, heteroleptic 
palladium(II) complexes have been less explored. This is due to the possibility of 
uncontrolled statistical mixtures of kinetic products in the initial stage; therefore, 
clever strategies are required to construct targeted heteroleptic complexes.6, 55 Early 
examples of multicomponent selective self-assembly are shown by Lehn56 and 
Sauvage,57 where they used different topologies of a rigid macrocycle containing a 
1,10-phenathroline derivative to guide the selective self-assembly of 
multicomponent pseudorotaxanes.58 Another technique which has been used to 
selectively construct multicomponent self-assemblies utilises steric constraints as 
shown in examples by Schmittel,59 Fujita60 and Kobayashi.61  
Another technique utilized to minimise the degree of self-sorting is by using cis-
protected metal centres, which limits the coordination sites of a square-planar metal 
from four down to two. This has been shown in an example from Stang and Zhen, 
where heteroleptic prisms have been constructed through charge-separation 
between adjacent carboxylate/pyridine donors.58 Fujita also uses this approach of 
using cis-protected metal units to produce prism shaped architectures.60 There are 
several reviews62-64 which focus on understanding this phenomenon of integrative 
self-sorting to produce a particular heteroleptic architecture, and approaches that 
facilitate the assembly of these are being developed.6  
The construction of a single hollow metallosupramolecular heteroleptic cage from 
naked metal ions and more than one type of ligand is not straightforward.6 Using the 
[M2L4] framework as an example, there are three different scenarios which can 
occur when the naked metal ion is mixed with two different ligands; 1 – Statistical 
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mixtures, 2 – Narcissistic self-sorting, and 3 – Integrative self-sorting.6 Systems 
which are fully-dynamic require a deeper understanding of the underlying self-
assembly principles, compared with the traditional two-component homoleptic 








Statistical mixtures (Path 1) generally occur in the absence of favourable 
interactions between ligands L and L’ and produce entries which follow the form of 
[M2LnL’4-n] where n = 0 – 4. An example of this has been demonstrated by Ogata and 
Yuasa in 2020, where utilising chiral groups on imidazole-based ditopic ligands 
leads to self-recognising behaviour depending on what chirality the two groups are 
in.65 They showed that when ligand 1 (R,R), 2 (R,S) and palladium (II) are mixed in 
a 1:1:0.5 ratio, a statistical mixture of [Pd2L4]4+ cages are formed (Figure 1.15). The 
ratios of the cages produced follow a Boltzmann distribution, and that of Pascal’s 
triangle.66-67 From the Boltzmann distribution, the expected ratio of cages produced 
are as follows; 1 of [Pd2(1)4]2+, 4 of [Pd2(1)3(2)]2+, 6 of [Pd2(1)2(2)2]2+ (2 trans, 4 cis), 




Figure 1.15. Statistical mixture of [Pd2L4]4+ cages formed from the mixing of chiral 
ligands 1 and 2. 
 
 
Narcissistic self-sorting (Path 2) is seen in examples where there is a significant 
energetic penalty which arises from the combination of ligands L and L’, which is 
generally due to differences in ligand shape and size between them. Therefore, in 
these mixtures only [M2L4] and [M2L’4] homoleptic cages are seen. An example of 
narcissistic sorting has also been shown by Ogata and Yuasa, where a different 




Figure 1.16. Narcissistic self-sorting to form two homoleptic [Pd2L4] cages from 
the mixing of chiral ligands 1 and 3. 
 
 
Narcissistic self-sorting was only achieved for the ditopic ligands which had the 
chiral groups in the R,R and R,S configuration, whereas a combination of ligands in 
the conformations R,R (1) and S,S (3) gave a near statistical mixture (Figure 1.14) 
(Path 1).  
Thirdly, integrative self-sorting (Path 3) to give a single heteroleptic product, for 
example, [M2L3L’], is often driven by significant enthalpic factors which originate 
from the combination of L and L’ ligands. If kinetically allowed, mixtures of pre-
assembled homoleptic cages can undergo ligand shuffling to follow scenario 1 or 3, 








Assembly-dependent integrative self-sorting 
 
The following section outlines strategies that use different assembly-driven 
techniques to force integrative self-sorting.  
The Hooley group in 2011 showed that they could control the formation of a 
heteroleptic [Pd2L3L’]4+ cage by the introduction of a bulky endohedral group to 
their bis-monodentate ligand (Figure 1.17).41 When 3 equivalents of the 
bis(pyridine) ligand 1 are mixed with 1 equivalent of the bulkier endohedral ligand 
2 and 2 equivalents of palladium (II), integrative self-sorting occurs to mainly 
produce the heteroleptic [Pd(1)3(2)]4+ cage and some narcissistic self-sorting 
occurs to form the homoleptic [Pd(1)4]4+ cage. Only the [Pd(1)3(2)]4+ cage is 
produced containing ligand 2, which is due to the fact that the NHCOCF3 is large 
enough to fill the empty cavity within the cage. Because of this, it is impossible for 
another 2 ligand to be used in the assembly of the heteroleptic cage as the two 
endohedral groups will bang into each other. Therefore, this experiment 
demonstrates that filling the empty space within the cage with endohedral steric 





Figure 1.17. Example of integrative self-sorting of a [PdL3L’]4+ cage controlled by 
the endohedral steric bulk of ligand 2. 
 
 
Templating effects can also be used for the integrative self-assembly of heteroleptic 
cages, if the formation of the heteroleptic cage relies on two ligands with similar 
dimensions and/or donor groups, the fine energetic balance between the possible 
products can be controlled by the incorporation of a guest as a template.6 An 
example from Albrecht in 1999 saw that the binding of different alkali cation guests 
inside the cavity of their Ti(IV) triple helicates could regulate the outcome of self-
sorting.68 They showed that with the addition of Na+, the system drives to a 
narcissistic mixture of the two homoleptic helicates, however when Li+ is added to 
the system, this drives it to a mixture containing both homoleptic species and the 
heteroleptic species. Yoshizawa in 2015 showed that fullerene C60 acts as a good 
guest template with their anthracene-functionalised cages.52 In the absence of the 
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C60 guest, the 1:1 mixture of the two homoleptic cages was found to spontaneously 
rearrange into a statistical mixture of cages, but when C60 was introduced this drove 
the system to the integrative self-sorting heteroleptic product, [C60 @ Pd2(1)2(2)2] 
(Figure 1.18). The use of force-field calculations suggested that the cis isomer to be 
the most energetically favoured due to the favourable host-guest interactions with 




Figure 1.18. The process of integrative self-sorting of homoleptic [Pd2L4] cages to 
form one heteroleptic [Pd2L2L’2] cage. As shown, integrative self-sorting to form 
one heteroleptic cage only occurs in the present of a template; fullerene C60. In the 
absence of the template, a statistical mixture (Path 1) is formed. 
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Another strategy for the integrative self-assembly of metallosupramolecular 
architectures is by using geometric principles to design cage assemblies of desired 
shapes and sizes. This strategy has been termed “edge-directed”self-assembly, 
which has been pioneered by Stang.5, 69 As the name suggests, certain building blocks 
with defined angles/geometries are used to define the edges of the desired 
structure. In this strategy the angles present between reactive sites on the building 
blocks used are retained in the final product, and closely match the ideal values for 
the wanted structure.69 The only problem with this approach is that usually one of 
the organic components is irreversibly attached to a metal centre, which results in a 
non-dynamic system with straight-forward design criteria.6 However, in dynamic 
heteroleptic systems, it becomes difficult to control integrative self-sorting due to 
the possibility of ligand exchange in energetically similar structures.  
Clever and co-workers have developed a strategy to force integrative self-sorting. 
They explored the use of geometrically designed ligands to steer the formation of 
the heteroleptic product.49 This was done by utilising “banana ligands” which 
possess different bend angles, one with an angle of 120o (1) and the other 60o (2). It 
was found that when heating a 1:1:1 mixture of the two ligands with palladium(II), 
one distinct heteroleptic species was produced, [Pd2(1)2(2)2]4+ (Figure 1.19).  
 
 
Figure 1.19. Integrative self-sorting to form one heteroleptic species by utilising 
ligands of different geometries. 
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They also investigated whether the heteroleptic species is the thermodynamic 
minimum of a mixture of the respective homoleptic species. When the homoleptic 
species are mixed in a ratio of 2:1 (60o: 120o), there is a very slow conversion of the 
species to form the heteroleptic one if heated consecutively at 70oC for 12 days 
(Figure 1.20). However, if the 120o ligand is added to the 60o homoleptic species, 
fast conversion at room temperature occurs to form the heteroleptic species (Figure 
1.21). They based these differences on the difference in strain between the 





Figure 1.20. Slow ligand shuffling from a mixture of the two homoleptic 





Figure 1.21. Fast ligand shuffling from a mixture of homoleptic [Pd2(1)4]4+ and 2 
to form the heteroleptic structure at room temperature.  
 
 
The group undertook further studies on complementary geometries of ligands by 
introducing a third ligand, with a bend angle of 75o.50 They managed to form two 
new heteroleptic architectures depending on which combination of ligands was 
used, for example mixing the 75o and 120o ligands which have similar backbones 
with palladium(II) led to the formation of the 2:2 cis heteroleptic species. At the 
time, this represented the first heteroleptic cage exclusively formed from simple 
pyridine donors, which demonstrated that geometric factors are more dominant in 
this system than specific donor combinations.6 This heteroleptic species can also be 






Figure 1.22. Pathways to form the heteroleptic species; A) mixing both 75o and 
120o ligand in a 1:1:2 ratio with palladium(II), B) mixing the homoleptic species in 
a 2:1 ratio of 75o : 120o. 
 
 
When mixing the 75o ligand with the 60o ligand in a 1:1:1 mixture with palladium(II), 
a heteroleptic architecture was formed where the 60o ligand was locked in an anti-
conformation rather than the normal syn-conformation. It was found that the 
architecture was that of a trans-[Pd2(anti-60o)2(75o)2] cage which resembled a 




Figure 1.23. Formation of the heteroleptic species from a mixture of the 75o and 
60o ligands. The crystal structure shows the “doubly-bridged figure-eight” 
topology of the species. 
 
Clever showed that with the addition of a competing ligand (120o) to the trans-
[Pd2(anti-60o)2(75o)2] cage, the cage could be transformed to the cis-
[Pd2(60o)2(120o)2] cage. The cis 75o : 120o cage can also be converted to the cis-
[Pd2(60o)2(120o)2] cage with addition of the competing 60o ligand (Figure 1.24). 
Therefore they were able to show that there was a degree of morphological control 
within this system, and they explained the process being driven by the ideal shape 




Figure 1.24. Interconversion of heteroleptic species depending on which 
competing ligand is added. 
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Coordination-dependent integrative self-sorting 
 
Complementary to the above examples of assembly-dependent integrative self-
sorting, coordination-dependency can also be used to drive the integrative self-
sorting of heteroleptic architectures. One main approach to achieve this is by 
utilising secondary interactions to drive the formation of the heteroleptic 
architecture. 
Utilising secondary interactions can also direct the integrative self-sorting of 
heteroleptic cage formation. Crowley showed in 2016 that they were able to cleanly 
form a 2:2 heteroleptic cage from the addition of an electron-rich amino-substituted 
tripyridyl (2A-tripy) ligand to a mixture of a [Pd2(tripy)4]4+ cage, whereas when the 
other amino derivative ligand (3A-tripy) was added to the cage mixture it resulted 
in complete displacement of the tripy ligands of the cage to form [Pd2(3A-tripy)4]4+ 







Figure 1.25. Clean formation of a 2:2 heteroleptic cage from utilising favourable 
hydrogen-bonding interactions between amino protons of 2A-tripy and 
neighbouring acidic protons of tripy. Heteroleptic cage formation does not occur 




The formation of the [Pd2(2A-tripy)2(tripy)2]4+ cage architecture was confirmed 
using 1H, DOSY and ROESY NMR experiments, as well as HR – ESI MS. The formation 
of this cage species was determined to be driven by favourable hydrogen-bonding 
interactions between the amino protons of 2A-tripy and the acidic α-protons of the 
adjacent tripy which stabilise the mixed cage. DFT calculations that were performed 
indicated that the cis-isomer is energetically more favourable than the trans-isomer 
which would be due to the favourable hydrogen-bonding interaction above. The DFT 
calculations suggested that the homoleptic [Pd2(2A-tripy)4]4+ is the thermodynamic 
product of the reaction as it has a lower stabilisation energy than the cis-isomer. 
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However, the homoleptic cage could not be obtained from heating the cis-isomer 
with 2 eq of 2A-tripy, or from leaving the mixture sitting for 40 days. This suggested 
that the cis-isomer is a highly metastable kinetic product, and that the species is 
kinetically trapped in this configuration. The heteroleptic cis-isomer could not be 
obtained from heating a 1:1 mixture of the homoleptic cages, or from a 1:1:1 mixture 
of the components which suggests that a specific pre-organization conformation is 
necessary to access the heteroleptic cage species.6 
 
 
1.5 Considerations for ion binding 
 
To design a supramolecular architecture which selectively binds a particular ion, a 
number of factors need to be considered. These factors include size and electronic 
compatibility between the ion and host, solvent interactions, host pre-organisation 
(leads to a rigid structure of the host), enthalpic/entropic contributions to the 
interaction, cation and host free energies of solvation, and binding kinetics. Perhaps, 
the most important factor out of these is the size-fit relationship between the ion 
and the host cavity: if the guest is too big for the host, no binding can occur. However 
solvation energies and the pre-organisation of the host also play a very important 
part in ion binding.  
 
 
Size and Electronic compatibility 
 
The key to a host being able to encapsulate an ion is the size-fit relationship between 
the ion and the cavity. This is directly related to the ionic radii of the ion and the 
apparent size of the cavity. This was first discussed by Christensen in 1971, 
regarding the binding on an ion with a synthetic macrocycle.70 In terms of ion size, 
anions tend to be larger than cations due to generally being polyatomic, whereas 
cations are generally monoatomic. Cations are mostly spherical in shape, whereas 
anions can exist in many different shapes, including spherical, trigonal planar and 
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Na+ 0.102 F- 0.126 
K+ 0.138 Cl- 0.172 
Li+ 0.076 Br- 0.188 
Ag+ 0.115 I- 0.210 
La3+ 0.103 BF4- 0.232 
Lu3+ 0.086 ClO4- 0.240 
Mg2+ 0.072 ReO4- 0.260 
aFrom ref. 70, bfrom ref. 71 
 
 
The electronics between the ion and cavity must also complement each other to 
achieve ion binding. Factors that contribute to the electronic compatibility between 
the ion and cavity include electrostatics, polarity, H–bonding, potential hardness 
versus softness, and Lewis acids/bases. For example, a cavity which is electron 
deficient has great electronic compatibility with anions due to the attraction of the 
charges, but has weak electronic compatibility with cations. 
 
 
Solvent interactions  
 
To ensure that a host can encapsulate an ion, solvent interactions need to be 
considered. There is competition between the incoming ion and solvent molecules 
for binding within the host, since the solvent molecules are in a large excess. To 
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ensure that binding of the ion can occur, the solvent molecules must effectively be 
removed from around the ion, and in some cases from the host cavity. In water, 
hydration enthalpies of the ions indicate how easy it is to remove water molecules 
surrounding the ion. In general, as ion size increases, hydration enthalpies tend to 
decrease, indicating that it is easier to remove the water molecules surrounding the 
ion. Hydration enthalpies of some common cations and anions is shown in Table 
1.2.72-74 From comparing the hydration enthalpies for the common cations and 
anions, there is no real difference in the energy required to remove the water 
molecules surrounding the ion in question.  
 
 












Na+ -415 -446 F- -510 
K+ -330 -368 Cl- -365 
Li+ -530 - Br- -335 
Ag+ -480 -543 I- -290 
Mg2+ -1945 - BF4- -225 
- - - ClO4- -245 
- - - ReO4- -360 
- - - NO3- -310 
aFrom ref. 71, bfrom ref. 72, cfrom ref. 73. 
 
However, in different solvents, the energy required to remove the solvent molecules 
from around the ion depends on how much the ion likes that solvent. The solvation 
enthalpies of some common cations in DMSO are shown in Table 1.2. Comparing 
these values to that of the hydration enthalpies for the same cations, they are similar. 
Therefore, while experimental data for the solvation of anions in DMSO is not 
reported in the literature, it can be assumed that the solvation enthalpies of the 
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common anions in DMSO should also mirror that seen for the hydration enthalpies. 
Interestingly, even though it is enthalpically unfavoured to remove solvent 
molecules surrounding the ion, it is entropically favoured due to the release of 





Favourable intermolecular interactions between the host cavity and the ion also 
contribute to the ability for a host to encapsulate an ion. Some common 
intermolecular interactions used to help the host cavity encapsulate anions are 
those of electrostatic, H-bonding and anion – π interactions, and the energies 
associated with these are summarised in Table 1.3.75-76 With the addition of groups 
to the host which can facilitate these intermolecular interactions between the host 
cavity and ion, this can lead to the preferred binding of one ion over another species 
present. For example, by designing a host which has an overall electron deficient 




Table 1.3. Common intermolecular interactions and their associated strengths. 
Intermolecular Interaction Interaction Strength (kJ mol-1) 
Electrostatica 100 -350  
H-bondinga 4 - 60 
Anion – πb 20 - 70 
aFrom ref. 74, bfrom ref. 75. 
 
An example of a host utilising intermolecular interactions to encapsulate an anion 
was reported by Beer, where incorporating amide or urea groups into the host 
facilitates H-bonding between the host and anion (Figure 1.26).77 Beer synthesised 
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two different macrocycles, where one contains amide groups and the other urea 
groups. It was shown that swapping the amide groups for urea led to an increase in 
the binding of anions which matched the compatibility between the H-bond donor 









Figure 1.26. Structure of the macrocycle host containing amide groups to facilitate 
H-bonding between host cavity and anions.77 Hydrogen atoms and solvent 










1.6 Previous work 
 
In 1998, McMorran and Steel reported the first coordinatively saturated, quadruply 
stranded [Pd2L4] helicate, utilising a 1,4-bis(3-pyridyloxy)benzene ligand.78 At the 
time this research was published, only single-, double- and triple-stranded helicates 
had been widely explored.79 There was also only one other example of a quadruply 
stranded helicate which had been reported a year earlier.80 This helicate utilised 
metal – metal bonds with ancillary ligands bound to the octahedral metal centres, to 
form a linear pentanuclear complex, which was helical. However, according to the 
definition of Piguet et al.,79 this complex falls under the category of being 
unsaturated.78 
The 1,4-bis(3-pyridyloxy)benzene (1) ligand was prepared by the reaction of 3-
hydroxypyridine with 1,4-dibromobenzene in the presence of potassium carbonate 
and copper bronze (17 % yield).81  Reaction of the ligand with either [PdCl2(PPh3)2] 
or [PdI2(py)2] in the presence of silver triflate yielded dimeric Pd2(1)2 complexes 
(2,3), respectively. The formation of these complexes was confirmed by EA, MS and 
NMR data. Diffusion of diethyl ether into an acetonitrile solution of the dimeric 
complex (3) and ammonium hexafluorophosphate yielded the [Pd2(1)4] helicate 





Figure 1.27. Reaction scheme for the formation of the first coordinatively 
saturated, quadruply stranded helicate showing the encapsulation of a PF6- anion. 




The X-ray crystal structure of the [Pd2(1)4] helicate showed that each square-planar 
palladium(II) atom coordinated to one pyridine donor of each of the four bridging 
ligands, which led to a cage like structure that encapsulated a well-ordered PF6- 
anion (Figure 1.28). There were three PF6- anions and two acetonitrile anions 
located outside of the cavity in the crystal structure. The size of the cavity formed by 
the [Pd2(1)4] helicate is defined by the palladium(II) – palladium(II) distance 
(8.8402(8) Å), and the distances between the centroids of each parallel benzene ring 
(8.849(7) Å and 8.925(7) Å), which gave a value of 92.0 Å3. The helical pitch, which 
is the height of one complete helix turn, is defined by the approximate 45o angle 
(41.5o) subtended by each ligand about the helical axis, and was found to be 76.7 Å.  
Due to the nature of the helicate’s structure, the planes of all the pyridine rings are 
approximately orthogonal to the planes of the linking benzene rings. Within the X-
ray crystal structure, the two axial F atoms of the encapsulated PF6- anion were 
shown to weakly coordinate to the palladium(II) atoms, which was the first example 
of an usually non-coordinating anion acting as a bridge between two metal atoms. 
The four remaining F atoms reside between the faces of each of the four benzene 
rings. According to the definition by Piguet et al.,79 the [Pd2L4] helicate could be 
classified as a coordinatively saturated, quadruply stranded helicate, since both 
palladium(II) ions are fully coordinated to the four ligand strands, which wrap 
themselves around the palladium(II) ions.78 This was the first example of such 
helicate, and there have been a small number of reports of other quadruply stranded 
helicates formed in the last two decades.28, 47, 82-83 
 
 
Figure 1.28. X-ray crystal structure of [PF6- ⊂ Pd2(1)4]3+.78 
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It was also reported that the cage structure is maintained in solution when crystals 
of the [Pd2(1)4] helicate are dissolved in DMSO. The resulting 1H NMR spectrum is 
consistent with the X-ray structure. The number of peaks in the spectrum match that 
of a single ligand environment as there are five distinct signals which match the five 
different proton environments in 1. The singlet at δ 6.93 ppm is due to the phenyl 
spacer protons of 1 (16H) and shows that the phenyl spacer protons are all in the 
same chemical environment since a singlet is observed (Figure 1.29). The 19F NMR 
also supports this claim of PF6- encapsulation as it shows two peaks in a 1:3 ratio, 
consistent with one PF6- anion bound inside the cavity and three on the outside. The 
anion is essentially tumbling within the cavity, rather than being locked in one 
orientation (static) as shown by the X-ray structure of the solid state. The MS data 
supports the claim that the PF6- is bound within the cavity since the major peak 
matches the calculated peak for [PF6-⊂Pd2(1)4]3+. 
 
Figure 1.29. 1H NMR of [PF6-⊂Pd2(1)4]3+ in d6 – DMSO at 298 K.84 The spectrum 
shows that only one ligand environment is present as the number of signals 




At the time of publication, only one other example of anion encapsulation had been 
reported. Lehn reported that a chloride anion could be encapsulated by a circular 
[(Fe5L5)Cl]9+ double helicate,  where L was a tris-bipyridine ligand.85 However, the 
quadruply stranded [Pd2L4] helicate was the first to show encapsulation of a 
polyatomic anion by a helicate, and was also the second example of an X-ray crystal 
structure containing the encapsulation of a PF6- anion of any species.78 
McMorran and Steel performed numerous experiments to determine whether the 
encapsulated PF6- anion could be exchanged for other anions, and therefore be used 
as a selective host for anions. In 2019, they reported how the quadruply stranded 
helicate could be used for selective anion recognition.84 Since the 1,4-bis(3-
pyridyloxy)benzene (1) ligand is non-rigid (flexible), it allows for the [Pd2(1)4] 
helicate to dynamically change the dimensions of its cavity in response to the size of 
the guest.  
Anion exchange experiments were performed using 1H NMR as a quantitative 
measure of anion selectivity of the [Pd2(1)4] helicate. The anions used in these anion 
exchange experiments were the tetrahedral anions BF4-, ClO4-, ReO4- and octahedral 
PF6-. Preparation of helicates [BF4- ⊂ Pd2(1)4]3+ and [ClO4- ⊂ Pd2(1)4]3+ for the anion 
exchange experiments were achieved following the method outlined previously.78 
The formation of these helicates was confirmed by EA, MS, NMR and X-ray data.  
The characteristic peaks in the 1H NMR data for [BF4- ⊂ Pd2(1)4]3+ and [ClO4- ⊂ 
Pd2(1)4]3+ in d6 – DMSO closely match that seen for the [PF6- ⊂ Pd2(1)4]3+ helicate. 
The same characteristic pattern of peaks is seen for the 3-substituted pyridine ring, 
and also a singlet for the four protons on the phenyl ring. The consistencies in the 
1H NMR suggested that if the new cages are adopting the same helical structure as 
reported for [PF6- ⊂ Pd2(1)4]3+, then the two helical forms (P and M) must be 
interconverting rapidly on the NMR timescale. If the two forms were not rapidly 
interconverting, then the pairs of protons on the central phenyl ring would be 
inequivalent, leading to more signals observed in the 1H NMR spectra. An example 
of slow interconversion of helical forms is seen in the [NO3- ⊂ Pd2L4]3+ helicate, 
produced by Sun and Zhou.86 McMorran and Steel also reported a new method for 
the formation of [BF4- ⊂ Pd2(1)4]3+. The helicate was reported to be formed by the 
reaction of [Pd(MeCN)4](BF4)2 with two equivalents of 1 in d6 – DMSO at room 
43 
 
temperature, where initially the 1H NMR of the solution showed a number of species 
present, however after 3 hours only signals corresponding to the helicate were 
observed. 
The 1H NMR spectra of the helicates in d6 – DMSO do not change over time, but when 
a different anion to that which is encapsulated is added, the size of the initial cage 
peaks decrease depending on the degree of exchange between the added and 
encapsulated anion. For example, when two equivalents of ClO4- are added to a 
solution of [BF4- ⊂ Pd2(1)4]3+, the size of the characteristic [BF4- ⊂ Pd2(1)4]3+ cage 
peaks (blue triangles) begin to decrease as new peaks appear (pink triangles) 
(Figure 1.30). These new peaks appear to match that of a pure sample of [ClO4- ⊂ 
Pd2(1)4]3+. Interestingly, three characteristic peaks of the [ClO4- ⊂ Pd2(1)4]3+ cage 
are shifted compared to those observed for the [BF4- ⊂ Pd2(1)4]3+ cage. These 
characteristic peak shifts are assigned to the H2’ protons (which point into the 
cavity), H6’ protons (which point towards the neighbouring ligand), and the H2,3,5,6 
protons (central phenyl ring forms the wall of the cavity). Importantly, it is observed 
that these characteristic peaks do not gradually shift in position upon addition of a 
second anion, as observed in most anion binding studies where the exchange 
process is fast on the NMR timescale. Since the peak positions observed do not shift 
at all, it was inferred that both the [ClO4- ⊂ Pd2(1)4]3+ and [BF4- ⊂ Pd2(1)4]3+ helicates 







Figure 1.30. Reaction of [BF4- ⊂ Pd2(1)4]3+ with two equivalents of ClO4- in d6 – 
DMSO at 298 K, followed by 1H NMR.84 Blue triangles represent characteristic 
peaks of [BF4- ⊂ Pd2(1)4]3+ and pink triangles represent characteristic peaks of 
[ClO4- ⊂ Pd2(1)4]3+. 
 
 
Since the interchanging of the two helicates was slow on the NMR timescale, 
McMorran and Steel were able to use the peak integrals in the final spectrum to 
easily estimate the competition constant (Kcomp) for replacement of BF4- with ClO4-, 
of 5.2 by using Equation (1). The competition constants for the tetrahedral anions 
BF4-, ReO4-, ClO4- and the octahedral PF6- anion were determined for each of the three 
different helicate mixtures following the same procedure, and are summarised in 




Equation (1): [BF4- ⊂ Pd2(1)4]3+ + [ClO4-] ⇌ [ClO4- ⊂ Pd2(1)4]3+ + [BF4-]  
 
Table 1.4. Summary of calculated equilibrium competition constants from anion 
exchange experiments on each of the three helicate solutions. 
 
Anions [BF4- ⊂ Pd2(1)4]3+ 
Kcomp 
[ClO4- ⊂ Pd2(1)4]3+ 
Kcomp 
[PF6- ⊂ Pd2(1)4]3+ 
Kcomp 
BF4- - 0.18 560 
ClO4- 5.2 - 2350 
ReO4- 0.16 0.04 50 
PF6- <0.01 <0.01 - 
 
 
From analysing the competition constants for each of the anion exchange reactions 
with different [X- ⊂ Pd2(1)4]3+ helicates, it was shown that the helicate prefers the 
smaller tetrahedral anions over the larger octahedral PF6- anion. Of the tetrahedral 
anions, the helicate is shown to show preference of encapsulation in the order of 
ClO4- > BF4- > ReO4-. The preference for encapsulation is interesting since ClO4- is 
slightly bigger than that of BF4- and smaller than the ReO4- anion.  
The 1H NMR data of the three different anion encapsulated helicates and their 
exchange reaction data suggested that they must have similar structures. This was 
confirmed by the X-ray crystal structures obtained of [BF4- ⊂ Pd2(1)4]3+ and [ClO4- ⊂ 
Pd2(1)4]3+ (Figure 1.31). A crystal structure of [I- ⊂ Pd2(1)4]3+ was also obtained 






Figure 1.31. X-ray crystal structures (from left to right) of [PF6-⊂Pd2(1)4]3+,78 
[ClO4-⊂Pd2(1)4]3+, [BF4-⊂Pd2(1)4]3+ and [I-⊂Pd2(1)4]3+.84 Hydrogen atoms and 
solvent molecules have been omitted for clarity. 
 
 
The three obtained crystal structures of [ClO4- ⊂ Pd2(1)4]3+, [BF4- ⊂ Pd2(1)4]3+ and 
[I- ⊂ Pd2(1)4]3+ clearly showed that they shared a similar helical structure shown by 
the crystal structure of [PF6- ⊂ Pd2(1)4]3+.78 Comparing the four crystal structures, 
the overall size and shape of the helicates change in response to the encapsulated 
anion. From PF6- to ClO4- to BF4- to I-, the size of the encapsulated anion decreases, 
and so does the palladium(II) – palladium(II) distance within the helicate. The 
decrease in the palladium(II) – palladium(II) distance is achieved by a combination 
of changes in the torsional angles about the single bonds within the ligands. This in 
turn leads to a large increase in azimuthal angle of the ligands, and therefore a 
decrease of the helical pitch of the cage.  
Calculations of the volume of the cavity showed that as the conformation of the 
helicate changes, the volume also changes. However, the percentage filling of the 
encapsulated anion within the cavity remains relatively constant (between 69 – 78 
%). Comparison of these values with that of the proposed ideal of 55 % from Rebek 
showed that these values are slightly larger, however Rebek’s ideal percentage 
filling value was based on a host-guest interaction which was mainly dipole – dipole 
in nature.87 McMorran and Steel suggested that the larger percentage filling values 
were most likely due to the attractive interactions between the anion and 
palladium(II) cations within the helicate, and thus must be the main driving force 
for anion encapsulation. However, the anion exchange mechanism for the [Pd2(1)4] 
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helicate is still unclear, and why the helicate prefers to bind ClO4- over PF6- and other 
tetrahedral anions. 
In 2019, Hiraoka reported a detailed study on the formation of the NO3- 
encapsulated [Pd2(1)4] helicate.88 They reported that in the absence of a template 
anion which is small enough to fit inside the [Pd2(1)4] cage, a kinetically trapped 
micrometre-sized 2 – D sheet is formed. However, when the NO3- template anion is 
present the thermodynamic product, [NO3- ⊂ Pd2(1)4]3+ is formed.  
The formation of the micrometre-sized sheet from the reaction of [Pd(3-
Clpy)4](OTf)2 (3-Clpy is 3-chloropyridine) and ligand 1 in CD3NO2 at 298 K was 
supported by STEM measurements on the reaction mixture (Figure 1.32 A). The 
OTf- encapsulated cage was reported to have formed after one day, but with a small 
yield of only 6.3 %. This suggested that OTf- was not a good templating anion, which 
is consistent with the findings from McMorran and Steel.78 Addition of smaller 
anions (BF4-, ClO4- and PF6-) was shown to convert the sheet into the corresponding 
encapsulated cage, where the addition of smaller anions resulted in increases of the 




Figure 1.32. A) Formation of a kinetically trapped micrometre-sized sheet from 
the reaction of [Pd(Py)4](OTf)2 with 1 in CD3NO2 at 298 K. B) Formation of the 
thermodynamically stable [NO3- ⊂ Pd2(1)4]3+ cage from the addition of NO3- to the 




Hiraoka also reported that NO3- is more strongly bound within the [Pd2(1)4] cage 
than ClO4- reported by McMorran and Steel.88 It was also shown that the addition of 
NO3- considerably accelerated the conversion of the kinetic sheet product to the 
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thermodynamic [NO3- ⊂ Pd2(1)4]3+ cage. The reaction of ligand 1, [Pd(Py)4](OTf)2 
and n-Bu4NNO3 in CD3NO2 formed only [NO3- ⊂ Pd2(1)4]3+, there was no evidence of 
formation  of the sheet. The 1H NMR spectrum of the mixture showed characteristic 
peaks due to the NO3- encapsulated cage at 5 minutes, and after one day it was 
reported that the cage had been formed in a 79 % yield. A crystal structure of the 
[NO3- ⊂ Pd2(1)4]3+ cage was obtained from slow diffusion of i-Pr2O into a cage 
solution in CH3NO2 for 10 days, and it was noted that the structure is similar to that 




Figure 1.33. X-ray crystal structures (from left to right) of [I- ⊂ Pd2(1)4]3+ 
(McMorran and Steel)84 and [NO3- ⊂ Pd2(1)4]3+ (Hiraoka).88 Hydrogen atoms and 
solvent molecules have been omitted for clarity. 
 
 
The cage was found to be strongly twisted with a twist angle of 84.6o, and a 
palladium(II) – palladium(II) distance of 7.167 Å. These values closely match those 
obtained for [I- ⊂ Pd2(1)4] of 84.8o and 7.442 Å, respectively. The encapsulated NO3- 
anion is shown to be disordered between two sites, and lies on the plane 
perpendicular to the helix of the cage. They also reported that the shortest distance 
between the pyridine proton pointing into the cavity and the oxygen atoms of NO3- 
was 2.33 Å, which suggests that there must be a hydrogen bonding interaction 
occurring between the cage and anion. This therefore suggests that hydrogen 
bonding is used to help stabilise the encapsulated guest. Similar distances between 
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the pyridine proton and the oxygen atoms of the anion are observed in the crystal 
structure of [ClO4- ⊂ Pd2(1)4]3+, which therefore might explain the binding affinity 
of ClO4- over BF4- for the helicate. The central phenyl linker protons signal is also 
observed further downfield for the [NO3- ⊂ Pd2(1)4]3+ helicate compared to that of 
the signal for the [ClO4- ⊂ Pd2(1)4]3+ helicate. 
Hiraoka suggested that this helicate prefers smaller anions due to how the helicate 
dynamically changes with encapsulation of an anion. To accommodate the anion, the 
cage will adjust itself by changing the twist angle/palladium(II)-palladium(II) 
distance of the cage to fit the anion. When the helicate decreases its palladium(II)-
palladium(II) distance, the twist angle of the cage increases, which in turn leads to 
the electron-rich aromatic walls of the cage to be slightly separated from each other. 
This leads to the reduction in electrostatic repulsion between the walls of the cage 
and the encapsulated anion, therefore there is no anion – π interaction between the 
helicate and encapsulated anion. 
Results of McMorran and Steel, and Hiraoka suggest that the anion binding ability of 
the [Pd2L4] cages depend on the ability of the helicate to change shape in response 
to anion size, and that the electronic interactions between the anion and the walls 
of the cavity are important. 
To build on these ideas, we have studied five new ligands, based on the 1,4-bis(3-
pyridoxyl)benzene ligand backbone to use for the formation of the coordinatively 
saturated, quadruply stranded helicate. The five new ligands produced utilise 
groups which change the electronics and sterics of the original 1,4-bis(3-
pyridoxyl)benzene ligand. The benzene ring of the 1,4-bis(3-pyridoxyl)benzene 
ligand has been replaced with either naphthalene, anthracene, 2,5-difluorobenzene, 








Figure 1.34. Chemical structures of 1,4-bis(3-pyridyloxy)benzene derivatives 
(from top to bottom, left to right) 1,4-bis(3-pyridyloxy)benzene (1), 1,4-bis(3-
pyridyloxy)naphthalene (2), 9,10-bis(3-pyridyloxy)anthracene (3),89 1,4-bis(3-
pyridyloxy)-2,5-difluorobenzene (4), 1,4-bis(3-pyridyloxy)-2,5-dimethylbenzene 
(5) and 1,4-bis(3-pyridyloxy)tetramethylbenzene (6). 
 
 
These ligands were synthesised to investigate how they affect the electronics of the 
cavity, the overall dimensions of the cavity/compactness of the helicate, and 
therefore the anion selectivity of the helicate. A space-filling model of the smallest 
helicate reported by McMorran and Steel,84 [I- ⊂ Pd2(1)4]3+ shows how the size of 
the central spacer of the ligand contributes to the compactness of the helicate 






Figure 1.35. Space-filling model of [I- ⊂ Pd2(1)4]3+ showing the compactness of the 
helicate. Hydrogen atoms and solvent molecules have been omitted for clarity. 
 
 
Comparing ligands 1 – 3, they differ in the number of aromatic rings on the central 
spacer. This should lead to the formation of helicates with differing cavity 
dimensions due to how close the ligands can come together. With changes in cavity 
dimensions/compactness, the anion selectivity of the respective helicates may also 
change. The same argument can be made for ligands 5 – 6, due to the bulky nature 
of the methyl groups attached to the central spacer. The bulkiness of the attached 
methyl groups to the central spacer should limit how close each of the ligands can 
come together (Figure 1.35). Due to this limitation, the compactness/dimensions 
of the cavity, and therefore the anion selectivity of the respective helicates should 
differ from each other, and from the [Pd2(1)4] helicate.  
It is proposed that the anion – π interactions between the walls of the cavity and the 
encapsulated anion could be a potential factor contributing to how well certain 
anions are bound inside the helicates’ cavity. However, McMorran and Steel mention 
nothing about anion – π binding between the encapsulated anion and the walls of 
the cavity, and Hiraoka suggests that anion – π interactions are not possible between 
the encapsulated anion and the walls of the cavity due to the distance between them. 
Comparing the electronics of ligands 1 – 3, with the increasing number of aromatic 
rings, the electronic properties of the ligand should also increase. This increase in 
the number of π – electrons should lead to the cavity being more electron rich. Due 
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to this, the anion – π interaction, assuming there is one, would be diminished due to 
unfavourable electrostatic repulsion. This could lead to a change in the anion 
selectivity for each of the respective helicates. However, comparing ligands 4 and 5, 
the electronics of the π – system should differ due to the properties of the functional 
groups. F is electron withdrawing and therefore will leave the π – system electron 
deficient, whereas methyl groups are electron donating and will make the π – system 
electron rich. Therefore, it is expected that the possible anion – π interaction in 
[Pd2(4)4] should be enhanced and the interaction in [Pd2(5)4] should be diminished, 
therefore they should differ in anion selectivity. Ligand 6 should diminish the anion 
– π interaction even more than ligand 5 due to the presence of four methyl groups 
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Chapter 2 – Homoleptic [Pd2L4] helicates 
 
 
2.1 Synthesis of Ligands 
 
Synthesis of 1,4-bis(3-pyridyloxy)benzene (1) 
 
The synthesis of the bidentate ligand 1,4-bis(3-pyridyloxy)benzene (1), originally 
reported by McMorran and Steel,1 was low yielding and so we initially explored 
alternative ways to make the ligand, these are summarised in Table 2.1. Ligand 1 
was synthesised from the reaction of two equivalents of 3-hydroxypyridine and one 
equivalent of 1,4-dibromobenzene in dry DMAc, under reflux and argon (Reaction 
13, Figure 2.1). However, this reaction only yielded 8 %. Comparing this yield to the 
experimental yield reported of 17 %,1 a percentage yield of 8 % is considered 
reasonable. Since then, this reaction has improved to produce 1 in a yield of 21 %. 





Figure 2.1. Synthesis of ligand 1 from 3-hydroxypyridine and 1,4-dibromobenzene 
in dry DMAc, under reflux at 170 oC. 
 
 
The synthesis of 1 involves the deprotonation of the hydroxyl group of 3-
hydroxypyridine and then a substitution reaction occurs with 1,4-dibromobenzene 
to form the ligand. All of the reactions involving hydroquinone (or a protected 
hydroquinone, Reaction 3) as the hydroxyl group source resulted in no formation 
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of 1, whereas using 3-hydroxypyridine as the source yielded 1 (Reaction 10 and 
Reaction 13). The difference in the reactivities between hydroquinone and 3-
hydroxypyridine can be explained by the difference in pKa of the two reactants. The 
experimental pKa value for 3-hydroxypyridine is 4.80,2 and for hydroquinone the 
value is 9.96.3 Deprotonation of the hydroxyl group on 3-hydroxypyridine is more 
favourable than that of hydroquinone, which supports why 1 is not synthesised 






































































































































































































Note that all reactions were carried out with Cu0 (8 mol %), a adapted from Saari et 
al,4  b adapted from Lipshutz et al.5 
 
 
Another possibility for why the formation of 1 occurs using 3-hydroxypyridine over 
hydroquinone is due to how many sites need to be deprotonated. There is only one 
hydroxyl group on 3-hydroxypyridine compared to two on hydroquinone.  
For the second part of the mechanism, the hydroxide anion must displace the 
bromine atoms on 1,4-dibromobenzene to form 1. The reaction mechanism goes by 
an Ullmann condensation to form the ether linkages in 1, where a cross-coupling 
reaction is believed to occur between Cu and the two starting reactants.6 The full 
mechanistic details of the Cu catalysed condensation are not yet fully understood, 
however, it is widely believed that the Cu catalyst is in the form of Cu(I).6-8 Most 
Ullman condensation reactions require a supporting ligand which coordinates to the 
Cu source. The mechanisms for the Cu catalysed Ullmann condensation can be 
divided into 4 main classes; aromatic nucleophilic substitution where Cu(I) π-
coordinates to the aromatic ring of the aryl-halide to make it more susceptible to 
substitution, single electron transfer which involves the redox couple Cu(I)/Cu(II), 
metathesis mechanisms which leads to a 4-membered cyclic transition state 
involving coordination of ‘Cu’ to the halogen of the aryl-halide, and mechanisms 
involving oxidative addition-reductive elimination cycle with Cu(III) intermediates.6 
Without the presence of a supporting ligand, it is believed that the condensation 
reaction goes via copper-catalysed arylation of nucleophiles. There are two possible 
pathways; Path A consists of oxidative addition of ‘Cu’ to the aryl-halide and then 
nucleophilic substitution of the nucleophile (deprotonated 3-hydroxypyridine) to 
form [Cu]ArNu which then can form the desired product ArNu and release ‘Cu’, in 
Path B nucleophilic substitution to ‘Cu’ occurs before the oxidative addition of ArX 









For the reaction to form 1, the electronegativity and therefore bond strength of the 
aryl-halide bond must have an influence on the reactivity of the reaction. 
Comparison of all the reactions that used 1,4-diiodobenzene as the aryl halide, the 
majority were not able to synthesise 1. Reaction 6 and Reaction 9 produced the 
half-ligand of 1, where only one side of the 1,4-diiodobenzene had formed an ether 
linkage to 3-hydroxypyridine. However, when 1,4-dibromobenzene is used instead 
as the aryl halide, the reaction produces 1. It is unclear as to why this is the case, 
since the bromine – carbon bond is a stronger bond than that of the iodine – carbon 
bond, and therefore it is harder to displace the bromine atoms than the iodine atoms. 
Reaction 3 and Reaction 11 utilised a different approach to try and form 1 by using 
protecting groups on one of the reaction sites. However, Reaction 3 yielded no 
product formation and Reaction 11 resulted in an explosion of the microwave 
vessel.  
The 1H NMR spectrum of the synthesised ligand 1 (Figure 2.3) was consistent with 
the data reported by McMorran and Steel,1 and the parent ion signal observed in the 
HR – ESI MS of 1 (Figure 2.4) is consistent with the calculated m/z value for the       
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[1 + H+]+ ion (265.09786 and 265.09715, respectively). The EA data of 1 was found 
to also be consistent with the value reported for 1 by McMorran and Steel. An X-ray 







Figure 2.3. 1H NMR (400 MHz, CDCl3) of 1,4-bis(3-pyridyloxy)benzene (1) 




Figure 2.4. HR – ESI MS (DCM) of 1,4-bis(3-pyridyloxy)benzene (1) showing the 
observed parent ion and the calculated parent ion for [1 + H+]+. 
 
 
Figure 2.5. X-ray crystal structure of 1,4-bis(3-pyridyloxy)benzene (1).9 
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Synthesis of 1,4-bis(3-pyridyloxy)naphthalene (2) 
 
The synthesis of 1,4-bis(3-pyridyloxy)naphthalene (2) followed the synthesis of 1, 
where the 1,4-dibromobenzene precursor was replaced with 1,4-
dibromonaphthalene to yield 2 under similar conditions, with a percentage yield of 
32 % (Figure 2.6). The reaction was performed in a slight excess of 3-
hydroxypyridine (2.3 equivalents) to 1,4-dibromonaphthalene (1 equivalent), and 




Figure 2.6. Synthesis of ligand 2 from 3-hydroxypyridine and 1,4-
dibromonaphthalene in dry DMAc, under reflux at 170 oC. 
 
 
In this case the reaction gave the product as a sticky brown oil instead of a solid. 
After isolating ligand 2, it was placed in a desiccator overnight to dry. When the 
ligand was removed from the desiccator, the ligand was a dry powder. However, 
after 5 minutes exposed to the air, the ligand became a sticky oil again. This apparent 
hydroscopicity prevented good EA from being obtained. 
The 1H NMR spectrum of 2 was determined to be consistent with the proposed 
structure. The observed peak shifts for 2 were similar to that of 1 but shifted further 
downfield due to the replacement of benzene with naphthalene (Figure 2.7). The 
parent ion observed in the HR – ESI MS of 2 (Figure 2.8) is consistent with the 
calculated m/z value for [2 + H+]+ ion (315.11147 and 315.11280, respectively). 
There is also another peak observed in the HR – ESI MS for [2 + Na]+ which is 










Figure 2.7. 1H NMR (400 MHz, CDCl3) of 1,4-bis(3-pyridyloxy)naphthalene (2) 





Figure 2.8. HR – ESI MS (DCM) of 1,4-bis(3-pyridyloxy)naphthalene (2) showing 
the observed parent ion and the calculated parent ion for [2 + H+]+ and [2 + Na]+. 
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Synthesis of 9,10-bis(3-pyridyloxy)anthracene (3) 
 
The 9,10-bis(3-pyridyloxy)anthracene ligand was acquired from the group, as it had 
already been previously made and reported.10 The synthesis of 3 is similar to that of 
1, where the 1,4-dibromobenzene precursor is replaced with 9,10-




Figure 2.9. Synthesis of ligand 3 from 3-hydroxypyridine and 9,10-
dibromoanthracene in DMAc, under reflux at 170 oC. 
 
 
The 1H NMR spectrum of 3 is similar to that of 1 and 2, but contains different 
splitting patterns of the signals due to the nature of the anthracene spacer (Figure 


















Figure 2.10. 1H NMR (400 MHz, CDCl3) of synthesised 9,10-bis(3-







Figure 2.11. HR – ESI MS (DCM) of 9,10-bis(3-pyridyloxy)anthracene (3) showing 
the observed parent ion and the calculated parent ion for [3 + H+]+ and [3 + Na]+. 
 
 
Synthesis of 1,4-bis(3-pyridyloxy)2,5-difluorobenzene (4) 
 
The synthesis of 1,4-bis(3-pyridyloxy)2,5-difluorobenzene (4) was based on the 
synthesis of 1, where the 1,4-dibromobenzene precursor was replaced with 1,4-
diiodotetrafluorobenzene to yield 4 under the same conditions, with a percentage 





Figure 2.12. Synthesis of ligand 4 from 3-hydroxypyridine and 1,4-
diiodotetrafluorobenzene in DMAc, under reflux at 170 oC. 
 
 
The reaction of 3-hydroxypyridine with 1,4-diiodotetrafluorobenzene was expected 
to form the 1,4-bis(3-pyridyloxy)tetrafluorobenzene ligand (4tet, Figure 2.13), 
however the 1H NMR and HR – ESI MS data suggested that this was not the product 
formed (Figure 2.14 and 2.15, respectively). In the 1H NMR spectrum, there was a 
triplet observed at δ 7.00 ppm which is similar to the chemical shift observed for the 
central ring protons of 1 and 2. Therefore, this suggested that the ligand formed 
must have at least one proton of the central ring, therefore it cannot be the 4tet 
ligand. Also a triplet is observed in the 19F NMR spectrum of 4 (Figure 2.16), which 
has a matching J value (8.5 Hz) to the triplet observed in the 1H NMR spectrum. The 
HR – ESI MS spectrum of 4 also supported that at least one proton on the central 
ring, as the parent ion was determined to have the formula of [4tet -2F + 3H]+ ( m/z 
observed, 301.07663; calculated, 301.07103). Therefore, sometime during the 
formation of 4, two fluorine atoms on the central ring have been removed and 
replaced with two protons, yielding a ligand containing only two fluorine atoms, 
instead of four. The removal of fluorine atoms during a reaction is quite uncommon, 













Figure 2.14. 1H NMR (400 MHz, CDCl3) of 1,4-bis(3-pyridyloxy)2,5-











Figure 2.15. HR – ESI MS (DCM) of 1,4-bis(3-pyridyloxy)2,5-difluorobenzene (4) 










There are three possible structures for 4, depending on the positioning of the 
fluorine atoms. The structure of 4 can either be that of 4, (4A) or (4B) (Figure 2.17). 
The 1H and 19F NMR spectra (Figure 2.14 and 2.16, respectively) of 4 suggest that 
the ligand formed contains a C2 axis, since only one fluorine signal is observed in the 
19F NMR spectrum, and other than the pyridine signals, there is only one aromatic 
proton signal observed in the 1H NMR spectrum. Therefore, this rules out that the 
structure is 4B, as it does not contain a C2 axis and therefore both pyridine rings are 
different. It was then determined that the structure of 4 was indeed the proposed 
structure from comparison of 1H NMR data with that reported for the similar 
structures 1,4-diacetoxy-2,5-difluorobenzene and 1,4-diacetoxy-2,3-
difluorobenzene.13 From this data, the chemical shift, multiplicity and coupling 
constant of 4 closely matched that of 1,4-diacetoxy-2,5-difluorobenzene (δ 7.02 
ppm, t, JH-F = 8.3 Hz), and didn’t match that of 1,4-diacetoxy-2,3-difluorobenzene (δ 




Figure 2.17. Three possible structures of 4; 4, 4A and 4B. 
 
 
To try and determine whether the structure of 4 is in fact what we had proposed, or 
if the structure was 4A, an investigation into the structure of the half-product was 
performed. The half-product was isolated from the first fraction off the column. A 
HR – ESI MS was performed on the half-product to determine how many fluorine 
atoms are present in the structure (Figure 2.19). It was determined that the 
observed parent ion of the half-product had a chemical formula of C11H6F3NO, since 
this matched the calculated pattern for [C11H6F3NO + H]+. A 1H NMR and 19F NMR 
spectrum was also run on the half-product to determine if it had structural 
similarities to that observed in 4 (Figure 2.20 and 2.21).  
The 1H NMR spectrum showed that the half-product was structurally similar to that 
of 4, since the aromatic protons of the half-product have a similar chemical shift to 
that observed in 4. However, the spectrum of the half-product suggested that there 
were two inequivalent protons on the benzene ring, compared to two equivalent 
protons observed in 4. The splitting patterns of the two proton signals on the 
benzene ring are also different to that observed for the proton signal on the benzene 
ring of 4. A 1H – 1H COSY spectrum of the half-product confirmed that the two proton 
signals are not coupled to each other, therefore the suspected structure should have 
the two protons of the benzene not next to each other (Figure 2.22). The only 
coupled proton signals are those on the pyridine ring, which is expected. From the 
nature of the starting material, one iodine atom must have been replaced with a 
proton, so to enable a space between protons, the other proton must have replaced 
one of the fluorine atoms closest to the ether linkage. Therefore the only structure 
of the half-product which satisfies the data gathered from HR – ESI MS, 1H NMR and 










Figure 2.19. HR – ESI MS (DCM) of half-product of 4 showing the observed parent 













Figure 2.22. 1H- 1H COSY NMR (400 MHz, CDCl3) of the half-product of 4 showing 
proton coupling.  
 
 
The 19F NMR spectrum of the half-product also confirmed that the structure 
contained three fluorine atoms, since three signals are observed compared to only 
one signal in the spectrum of 4. However, the observed splitting of the fluorine 
signals are more complicated than that observed in 4, which would be due to 
coupling between each of the fluorine atoms and also the two protons. The multiplet 
at δ -131.06 ppm was determined to be that of F1 (the one closest to the ether 
linkage), due to the fact that it is close in chemical shift to the fluorine shift observed 
in 4 (δ -131.22 ppm). It was more difficult to assign the other two fluorine signals 
due to the complicated splitting patterns, however since the multiplet at δ -137.57 
ppm has a similar splitting pattern as F1, it was assumed this signal must be due to 
F2. Therefore, the last signal must be due to F3 at δ -139.01 ppm (dddd), which is the 
one situated between two protons as it is the most shielded. The splitting pattern of 
the signal suggests that F3 must be split by three different neighbours which are 
inequivalent. This matches the position of F3 as the signal must be split by the two 
neighbouring protons, and the fluorine trans to it, which is F1.  
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Synthesis of 1,4-bis(3-pyridyloxy)-2,5-dimethylbenzene (5) 
 
The synthesis of 1,4-bis(3-pyridyloxy)-2,5-dimethylbenzene (5) was based on the 
synthesis of 1, where the 1,4-dibromobenzene precursor was replaced with 1,4-
diiodo-2,5-dimethylbenzene to yield 5 under the same conditions, with a percentage 




 Figure 2.23. Synthesis of ligand 5 from 3-hydroxypyridine and 1,4-diiodo-
2,5-dimethylbenzene in DMAc, under reflux at 170 oC. 
 
 
The 1H NMR spectrum of 5 is consistent with the proposed structure of the ligand 
and contains similar chemical shifts for the aromatic pyridine protons to ligands 1-
2, and 4 (Figure 2.24). There is a singlet proton signal at δ 6.83 ppm which is 
consistent with an aromatic proton on the central spacer, when compared to the 
chemical shifts of this proton in the other synthesised ligands. The chemical shift for 
the methyl groups is observed upfield at δ 2.13 ppm. The HR – ESI MS of 5 is also 
consistent with the proposed structure of the ligand since the parent ion in the 
spectrum matches the calculated m/z value for [5 + H]+ (293.12731 and 293.12900, 














Figure 2.24. 1H NMR (400 MHz, CDCl3) of 1,4-bis(3-pyridyloxy)2,5-





Figure 2.25. HR – ESI MS (DCM) of 1,4-bis(3-pyridyloxy)2,5-dimethylbenzene (5) 
showing the observed parent ions and the calculated parent ions for [5 + H+]+ and 
[5 + Na]+. 
 
 
Synthesis of 1,4-bis(3-pyridyloxy)tetramethylbenzene (6) 
 
The synthesis of 1,4-bis(3-pyridyloxy)tetramethylbenzene (6) was based on the 
synthesis of 1, where the 1,4-dibromobenzene precursor was replaced with 1,4-
diiodotetramethylbenzene to yield 6 under the same conditions, with a percentage 






Figure 2.26. Synthesis of ligand 6 from 3-hydroxypyridine and 1,4-
diiodotetramethylbenzene in DMAc, under reflux at 170 oC. 
 
 
The 1H NMR spectrum of 6 is consistent with the proposed structure as it contains 
similar characteristic chemical shifts to that of 5, with the exception of no H3 proton 
(Figure 2.27). The chemical shifts of the aromatic protons of the pyridine ring are 
also consistent with all the synthesised ligands. The HR – ESI MS of 6 also supported 
the proposed structure as the observed parent ions matched the m/z values 
calculated for [6 + H]+ and [6 + Na]+(321.15095 and 321.15975, 343.14087 and 



















Figure 2.27. 1H NMR (400 MHz, CDCl3) of 1,4-bis(3-





Figure 2.28. HR – ESI MS (DCM) of 1,4-bis(3-pyridyloxy)tetramethylbenzene (6) 
showing the observed parent ions and the calculated parent ions for [6 + H+]+ and 
[6 + Na]+. 
 
 
2.2 Synthesis of [Pd2L4] helicates 
 
Homoleptic helicates of [Pd2(L)4]3+ were synthesised from the mixing of a 
palladium(II) metal source with one of the ligands 1 – 6 synthesised earlier. From 
herein we will discuss the synthesised helicates [Pd2(1)4]3+, [Pd2(3)4]3+ and 
[Pd2(5)4]3+. The other helicates synthesised, [Pd2(2)4]3+, [Pd2(4)4]3+ and [Pd2(6)4]3+ 




Synthesis of [Pd2(1)4] helicate 
 
The [Pd2(1)4]3+ helicate was synthesised from the mixing of 
tetrakis(acetonitrile)palladium(II) tetrafluoroborate ([Pd(MeCN)4](BF4)2) and 1 in 
a 1 : 2 ratio in d6 – DMSO at room temperature (Figure 2.29). The mixture was left 
for three days to equilibrate, and then sent for HR – ESI MS, 1H NMR and 19F NMR 
analysis. This method is different to that reported by McMorran and Steel, as they 




Figure 2.29. Synthesis of BF4- encapsulated [Pd2(1)4] helicate from the mixture of 
[Pd(MeCN)4](BF4)2 and 1 in d6 – DMSO at room temperature. 
 
 
The HR – ESI MS of the mixture supports the formation of the BF4- encapsulated 
helicate (Figure 2.30). The calculated m/z value for the [BF4- ⊂ Pd2(1)4]3+ helicate 
matched one of the main signals observed in the mixture (452.39054 and 
452.39047, respectively). The isotope patterns of both the calculated and observed 
signals matched, supporting that the [BF4- ⊂ Pd2(1)4]3+ helicate had likely formed. 
Two other signals were present in the spectrum of the mixture, one at 696.06998 
corresponding to a [Pd2(1)4BF4Cl]2+ helicate and the other at 1479.14395 
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corresponding to a [Pd2(1)4(BF4)2Cl]+ helicate. The Cl- anions are likely to have been 




Figure 2.30. HR – ESI MS (d6 – DMSO) of synthesised [BF4- ⊂ Pd2(1)4]3+ showing 
the observed parent ion and isotope pattern and the calculated parent ion and 
isotope pattern for [C64H48N8O8Pd2BF4]3+.  
 
 
The 1H NMR spectrum of the mixture supports the formation of the helicate with an 
encapsulated BF4- anion due to the observed differences in the aromatic proton 
chemical shifts, when compared to the spectrum of the pure ligand 1 (Figure 2.31). 
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The H2’ proton is shifted the furthest downfield which suggests that it must be 
interacting strongly with the encapsulated BF4- anion within the helicate. This 
downfield shift is significant since this proton points directly into the cavity of the 
helicate. The H6’ proton is also shifted downfield but not to the same extent as H2’. 
Both the H4’ and H5’ protons are shifted downfield and no longer overlap with each 
other, this shift is suggested to be caused by either the interaction between the 
pyridine protons on neighbouring 1 ligands, or due to the change in electronics of 
the pyridine ring when it is coordinated to palladium(II). The protons on the central 
benzene linker of the ligands are shifted upfield relative to the observed chemical 
shift of the pure ligand 1, which infers that these protons are more shielded. This 
shielding is suggested to be due to the anion – π interaction between the benzene 
ring electrons and that of the encapsulated BF4- anion.15 Comparison of the 1H NMR 
data with that reported by McMorran and Steel for [BF4- ⊂ Pd2(1)4]3+ supports that 




Figure 2.31. 1H NMR (400 MHz, d6 – DMSO) of synthesised [BF4- ⊂ Pd2(1)4]3+ 




The 19F NMR spectrum of the mixture also supports the formation of the BF4- 
encapsulated helicate (Figure 2.32). The spectrum shows two distinct signals for 
each BF4-, which are split in a 1:4 ratio. The splitting of these two signals is caused 
by the difference in the natural abundance of the NMR active nuclei, 10B and 11B, 
which is roughly 20% : 80%.  
The larger of the two signals present in the spectrum has a chemical shift of δ -
148.29 ppm and the smaller one has a chemical shift of δ -148.89 ppm. The 
integrations of these two signal shows that the larger one is three times larger than 
the smaller signal. The chemical shift of pure [Pd(MeCN)4](BF4)2 in d6 – DMSO was 
found to have one signal present in the 19F NMR spectrum, which matches the 
chemical shift of larger signal observed at δ -148.29 ppm. Since the helicate can only 
encapsulated one BF4- anion, there must be three BF4- anions outside the cavity to 
neutralise the +3 charge on the helicate. Therefore, the larger of the two signals must 
be due to the BF4- anions on the outside of the cavity whereas the smaller signal 
must be due to the encapsulated BF4- anion. This is similar to what was reported by 
McMorran and Steel for the PF6- encapsulated helicate, as the two signals for PF6- are 
observed in a 3.00:1.00 ratio in the 19F NMR spectrum.1 Therefore, on the NMR 
timescale the exchange of BF4- in and out of the cage is slow since two separate 




Figure 2.32. 19F NMR (376 MHz, d6 – DMSO) of synthesised [BF4- ⊂ Pd2(1)4]3+ 
showing fluorine assignment. 
 
 
A 19F DOSY spectrum was also performed on the mixture to determine the diffusion 
coefficients of both the free and [BF4- ⊂ helicate] anions (Figure 2.33). The diffusion 
coefficient for the free BF4- anion signal was recorded as (4.91 ± 0.01) x 10-10 m2 s-1, 
whereas the signal for the encapsulated BF4- anion was recorded as (1.34 ± 0.04) x 
10-10 m2 s-1. This supports that the signal at δ -148.89 ppm is that of [BF4- ⊂ 
Pd2(1)4]3+ since it diffuses slower through d6 – DMSO than that of the free BF4- signal, 





Figure 2.33. 19F DOSY (470 MHz, d6 – DMSO) of synthesised [BF4- ⊂ Pd2(1)4]3+ 
showing diffusion coefficients of free and encapsulated BF4-. 
 
 
Attempted synthesis of [Pd2(3)4] helicate 
 
The [Pd2(3)4]3+ helicate was attempted to be synthesised from the mixing of 
[Pd(MeCN)4](BF4)2 and 3 in a 1 : 2 ratio in d6 – DMSO at room temperature. The 
mixture was left for three days to equilibrate, and then sent for HR – ESI MS, 1H NMR 
and 19F NMR analysis. 
The HR – ESI MS spectrum of the mixture showed no formation of the [BF4- ⊂ 
Pd2(3)4]3+ helicate, or any other possible cage species (Figure 2.34). The calculated 
m/z for [BF4- ⊂ Pd2(3)4]3+ occurs at 579.43320, however there is no peak observed 
in the spectrum of the mixture at this value. The major ion in the spectrum was that 
of [3 + H]+ at m/z 365.12729, which suggests that the ligand does not like to form 
the [BF4- ⊂ Pd2(3)4]3+ helicate. This might be due to the fact that the anthracene 
95 
 
linker is too bulky to allow the ligands to come close together to form the [BF4- ⊂ 
Pd2(3)4]3+ helicate. 
 
Figure 2.34. HR – ESI MS (d6 – DMSO) of [Pd2(MeCN)4](BF4)2 : 3 mixture showing 




The 1H NMR spectrum of the mixture was hard to assign due to the complexity of 
the aromatic proton signals (Figure 2.35). The majority of the signals in the 
spectrum are very sharp and have similar chemical shifts to that of the pure ligand, 
3. The signals for the mixture all fall in the range of δ 8.7 – 7.1 ppm, whereas the 
signals for 3 fall in the range of δ 8.5 – 7.0 ppm. This suggests that there is no 
formation of the [BF4- ⊂ Pd2(3)4]3+ helicate, otherwise the aromatic proton signals 
of the mixture should have shifted to a higher chemical shift as seen in the spectra 




Figure 2.35. 1H NMR (400 MHz, d6 – DMSO) of [Pd2(MeCN)4](BF4)2 : 3 mixture 
showing aromatic proton signals. 
 
The 19F NMR spectrum of the mixture also suggested that the [BF4- ⊂ Pd2(3)4]3+ 
helicate has not been formed (Figure 2.36). There is only one signal observed in the 
spectrum at a chemical shift of δ -148.23 ppm, which is due to free BF4-. 
 
 
Figure 2.36. 19F NMR (376 MHz, d6 – DMSO) of [Pd2(MeCN)4](BF4)2 : 3 mixture 
showing fluorine assignment. 
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Synthesis of [Pd2(5)4] helicate 
 
The [Pd2(5)4]3+ helicate was synthesised from the mixing of [Pd(MeCN)4](BF4)2 and 
5 in a 1 : 2 ratio in d6 – DMSO at room temperature. The mixture was left for three 
days to equilibrate, and then sent for HR – ESI MS, 1H NMR and 19F NMR analysis. 
The HR – ESI MS of the mixture supports the formation of the BF4- encapsulated 
helicate (Figure 2.37). The calculated m/z value for the [BF4- ⊂ Pd2(5)4]3+ helicate 
matched one of the main signals observed in the mixture (489.76571 and 
489.76602, respectively). The isotope patterns of both the calculated and observed 
signals matched, supporting that the [BF4- ⊂ Pd2(5)4]3+ helicate had likely formed. 
Two other signals were present in the spectrum of the mixture, one at m/z value 
778.15015 corresponding to a [Pd2(5)4(BF4)2]2+ helicate, and the other at m/z value 
1642.30490 corresponding to a [Pd2(5)4(BF4)3]+ helicate.  
 
 
Figure 2.37. HR – ESI MS (d6 – DMSO) of synthesised [BF4- ⊂ Pd2(5)4]3+ showing 
the observed parent ion and isotope pattern and the calculated parent ion and 
isotope pattern for [C72H64N8O8Pd2BF4]3+.  
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The aromatic proton signals present in the 1H NMR spectrum of the mixture were 
hard to assign due to their complexity (Figure 2.38). Some of the signals are sharp, 
whereas others are quite broad. The peaks are different to what is observed for the 
pure ligand 5, which suggests that there is no free ligand present in the mixture. This 
is supported by the HR – ESI MS of the mixture as there was no peak observed in the 
spectrum for [C18H16N2O2 + H]+. The sharper signals suggest that there is fast 
interconversion of P and M helical forms of the helicate on the NMR timescale, 
whereas the broader signals suggest slow interconversion of P and M helical forms 




Figure 2.38. 1H NMR (400 MHz, d6 – DMSO) of synthesised [BF4- ⊂ Pd2(5)4]3+ 
showing aromatic proton signals. 
 
 
The 19F NMR spectrum of the mixture contained signals for free BF4- and [BF4- ⊂ 
Pd2(5)4]3+, where the larger signal at δ -148.26 is assigned to be that of free BF4- 
(Figure 2.39). However, instead of only seeing one signal slightly upfield from the 
BF4- signal as observed for [BF4- ⊂ Pd2(1)4]3+ and [BF4- ⊂ Pd2(2)4]3+, three different 
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signals are observed. All three signals are assumed to be due to [BF4- ⊂ Pd2(5)4]3+ 
helicates, since they all have same splitting pattern as observed for free BF4- signal. 
The three signals of [BF4- ⊂ Pd2(5)4]3+ are observed at δ -148.64 (A), -148.93 (B) 




Figure 2.39. 19F NMR (376 MHz, d6 – DMSO) of synthesised [BF4- ⊂ Pd2(5)4]3+ 
showing fluorine assignment. 
 
 
Due to the nature of ligand 5, when the ligands coordinate to palladium(II) to form 
[BF4- ⊂ Pd2(5)4]3+, different relative dispositions of the ligand substituents in the 
helicates are possible. These differences in the relative dispositions of the ligand 
substituents are referred to as atropisomers.16-17 This occurs because ligand 5 has 
the methyl groups in a 2,5- configuration, so when coordination occurs the ligand 
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can either have the methyl groups pointing “up” or “down” (Figure 2.40). Since all 
the atropisomers experience the same electronic environment, the slight difference 
in chemical shifts between the atropisomers cannot be due to the electronics of the 
cavity. It is more likely that the slight difference in chemical shift is related to the 
difference in cavity sizes due to the subtle differences in the dispositions of the 




Figure 2.40. Possible helicate conformations for a ligand with 2,5-substituted 




Comparing the chemical shifts of the [BF4- ⊂ Pd2(5)4]3+ helicates with the [BF4- ⊂ 
Pd2(1)4]3+, [BF4- ⊂ Pd2(2)4]3+, and [BF4- ⊂ Pd2(4)4]3+ helicates, it was found that 
atropisomer A is the most deshielded of all the atropisomers synthesised. It is even 
more deshielded than the [BF4- ⊂ Pd2(1)4]3+ helicate (δ -148.89 ppm). Atropisomer 
B was found to be more shielded than the [BF4- ⊂ Pd2(1)4]3+ helicate, but more 
deshielded than the [BF4- ⊂ Pd2(2)4]3+ (δ -150.24 ppm) and atropisomers A and D 
of [BF4- ⊂ Pd2(4)4]3+. The most deshielded atropisomer, C, was found to be more 
deshielded than the [BF4- ⊂ Pd2(1)4]3+ and [BF4- ⊂ Pd2(4)4]3+ helicates, but more 
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shielded than the [BF4- ⊂ Pd2(2)4]3+ helicate. This suggests that the subtle difference 
in cavity sizes of atropisomers A, B and C causes a large difference in how well the 
encapsulated BF4- is shielded/deshielded from the external magnetic field. 
The ratio of the free BF4- signal to the three new signals is 9.00:1.00, which suggests 
that not all of the ligand in the mixture was used to form the [BF4- ⊂ Pd2(5)4]3+ 
helicates, since the ratio is not exactly 3:1. However, there was no indication in the 
HR – ESI MS of the mixture that there was free ligand present. Therefore, it is likely 
that there are other products forming in the mixture which weren’t detected in the 
HR – ESI MS and 1H NMR, for example, oligomers.  
The [BF4- ⊂ Pd2(5)4]3+ mixture was then heated to see if changes in the intensity of 
the free BF4- and [BF4- ⊂ Pd2(5)4]3+ signals occur (Figure 2.41). The ratio of free BF4- 
to encapsulated BF4- was found to slightly decrease from 9.00:1.00 to 8.84:1.00 after 
heating the mixture at 80 oC for 22 hours. This decrease in the ratio suggests that 
heating the sample causes the production of more [BF4- ⊂ Pd2(5)4]3+ helicates. 
Interesting to note is that atropisomer C is larger than the two other atropisomer 
signals in the heated sample, whereas before heating, the signal for atropisomer C 
was smaller than the other two signals. This suggest that with heating the more 
thermodynamically stable atropisomer is produced more, therefore atropisomer C 







Figure 2.41. 19F NMR (376 MHz, d6 – DMSO) of synthesised [BF4- ⊂ Pd2(5)4]3+ after 
heating showing fluorine assignment. 
 
 
A 19F DOSY spectrum was also performed on the mixture to determine the diffusion 
coefficients of both the free BF4- and [BF4- ⊂ helicate] signals (Figure 2.42). The 
diffusion coefficient for the free BF4- anion signal was recorded as (4.78 ± 0.03) x 10-
10 m2 s-1, whereas the signals for each of the encapsulated BF4- helicates were 
recorded as (from A to C); (1.22 ± 0.04) x 10-10 m2 s-1, (1.18 ± 0.06) x 10-10 m2 s-1 and 
(1.18 ± 0.06) x 10-10 m2 s-1. This information supports the view that the smaller 
signals are that of the atropisomers of [BF4- ⊂ Pd2(5)4]3+ since they diffuse slower 
through d6 – DMSO than that of the free BF4- signal. The DOSY also confirms that all 
three encapsulated BF4- diffusion coefficients overlap, therefore they must be 






Figure 2.42. 19F DOSY (470 MHz, d6 – DMSO) of synthesised [BF4- ⊂ Pd2(5)4]3+ 
showing diffusion coefficients of free and encapsulated BF4-. 
 
 
2.3 Anion exchange on [Pd2L4] helicates 
 
McMorran and Steel reported that the [Pd2(1)4] helicate was able to selectively bind 
anions within its internal cavity due to its dynamic nature. Because of the helicate’s 
dynamic nature, it allowed for the size of the internal cavity to be tuned to match the 
size of the encapsulated anion by adjusting its helical pitch.  
To build on this, the anion exchange process in the [Pd2(1)4], [Pd2(2)4], [Pd2(4)4], 
and [Pd2(5)4] helicates was investigated by adding the tetrabutylammonium salts of 
perchlorate (TBAClO4), perrhenate (TBAReO4), and nitrate (TBANO3) to solutions of 
each helicate. The anion exchange process was investigated to see if it actually 
happens like observed in [Pd2(1)4],14 and if the new helicates show any preferences 
for the selective binding of one anion over another. Since the helicates only differ by 
the different central linker of the ligand used, they should all possess a similar 
dynamic nature as reported for the [Pd2(1)4] helicate. HR – ESI MS and 19F NMR 
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analysis were chosen to follow the anion exchange process for each helicate, due to 
the simplicity of the spectra. 
From herein, we will focus the discussion of the anion exchange process in the 
[Pd2(1)4], [Pd2(4)4] and [Pd2(5)4] helicates. The anion exchange process in the 
[Pd2(2)4] helicate is discussed in Appendix 2. 
 
 
Anion exchange on [Pd2(1)4] 
 
Addition of tetrabutylammonium perchlorate  
 
16 equivalents of tetrabutylammonium perchlorate (TBAClO4) were added to a 
solution of [BF4- ⊂ Pd2(1)4]3+ in d6 – DMSO. The mixture was then left overnight to 
equilibrate, and was analysed by HR – ESI MS and 19F NMR. The 1H NMR spectrum 
was run on the mixture, however analysis of the anion exchange process of ClO4- for 
BF4- in the [BF4- ⊂ Pd2(1)4]3+ helicate by 1H NMR has already been reported by 
McMorran and Steel.14 
The HR – ESI MS of the mixture confirms that anion exchange on the [BF4- ⊂ 
Pd2(1)4]3+ helicate has occurred with addition of TBAClO4 (Figure 2.43). The major 
3+ ion observed is due to the [ClO4- ⊂ Pd2(1)4]3+ helicate, which occurs at an m/z of 
456.37164. This value matches that of the calculated m/z and isotope pattern for 
[C64H48N8O8Pd2ClO4]3+ (456.37193). The minor 3+ ion signal is due to the [BF4- ⊂ 
Pd2(1)4]3+ helicate, which occurs at a m/z of 452.39021, and matches the signal 
observed in the HR – ESI MS of pure [BF4- ⊂ Pd2(1)4]3+ (Figure 2.30). The ratio of 
the heights of the [BF4- ⊂ Pd2(1)4]3+ signal to the [ClO4- ⊂ Pd2(1)4]3+ signal is 27:82, 
which suggests that the helicate prefers to bind ClO4- over BF4- inside its internal 
cavity. 
 The biggest signal observed in the spectrum is a 1+ ion at an m/z of 242.28360, 
which corresponds to the TBA+ cation. This signal is the largest due to the fact that 
the amount of TBAClO4 added was four times the amount of the [BF4- ⊂ Pd2(1)4]3+ 
helicate present in solution. Similar to what was observed in the HR – ESI MS of the 
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[BF4- ⊂ Pd2(1)4]3+ helicate, there are several other smaller signals in the spectrum of  
4 TBAClO4 : [BF4- ⊂ Pd2(1)4]3+ corresponding to 2+ helicate species. There are five 
2+ helicate signals observed in the spectrum corresponding to [Pd2(1)4(BF4)(Cl)]2+, 
[Pd2(1)4(ClO4)(Cl)]2+, [Pd2(1)4(ClO4)(NO3)]2+, [Pd2(1)4(BF4)(ClO4)]2+ and 





Figure 2.43. HR – ESI MS (d6 – DMSO) of [BF4- ⊂ Pd2(1)4]3+ after addition of 16 
equivalents of TBAClO4, showing observed signals for both [BF4- ⊂ Pd2(1)4]3+ and 
[ClO4- ⊂ Pd2(1)4]3+ helicates. 
 
 
The 19F NMR of the mixture supports the formation of [ClO4- ⊂ Pd2(1)4]3+ from the 
anion exchange of BF4- for ClO4- in [BF4- ⊂ Pd2(1)4]3+ (Figure 2.44).  19F NMR was 
chosen for following the anion exchange process due to the fact that only the signals 
corresponding to free BF4- and encapsulated BF4- are observed, and therefore 
changes in the amount of free and encapsulated BF4- are easier to follow. The signal 
at δ -148.83 ppm corresponds to the [BF4- ⊂ Pd2(1)4]3+ helicate, as it has a similar 




Figure 2.44. 19F NMR (376 MHz, d6 – DMSO) of the reaction of [BF4- ⊂ Pd2(1)4]3+ 
with 16 equivalents of TBAClO4 showing fluorine assignment. 
 
 
Comparing the spectra of the pure [BF4- ⊂ Pd2(1)4]3+ solution and that of the [BF4- ⊂ 
Pd2(1)4]3+ solution with 16 equivalents of TBAClO4, the ratio of free BF4- to 
encapsulated BF4- is increased. This suggests that ClO4- has exchanged with the 
encapsulated BF4- to form the [ClO4- ⊂ Pd2(1)4]3+ helicate and release BF4-. The ratio 
of the free BF4- signal to the encapsulated BF4- signal is 32.00:1.00, whereas the ratio 
of the free BF4- signal to the encapsulated BF4- signal for the reactant solution was 
3.00:1.00. This suggests that the anion exchange of ClO4- for BF4- to form the [ClO4- 
⊂ Pd2(1)4]3+ helicate is favoured, and that the helicate prefers to bind ClO4- over 
BF4- inside its internal cavity. 
The differences in the 19F NMR spectra of the pure [BF4- ⊂ Pd2(1)4]3+ solution and 
the solution with 16 equivalents of ClO4- can be used as a quantitative measure of 
the anion selectivity of the [Pd2(1)4] helicate. Differences in the 1H NMR spectra have 
been utilised by McMorran and Steel to demonstrate the selectivity of ClO4- over BF4- 
107 
 
for the [Pd2(1)4] helicate. It was reported that the free ClO4- anions were exchanging 
with the encapsulated BF4- anions in a process which is slow on the NMR timescale, 
since the characteristic signals in the 1H NMR for both the [ClO4- ⊂ Pd2(1)4]3+ and 
[BF4- ⊂ Pd2(1)4]3+ helicates did not gradually shift over time with the addition of 
ClO4- anions.14 Therefore, it is safe to assume that this slow exchange of ClO4- anions 
with the encapsulated BF4- anions is also slow on the 19F NMR timescale.  
To determine the anion selectivity of ClO4- over BF4- for the [Pd2(1)4] helicate, the 
method used by McMorran and Steel was adapted to utilise changes observed in the 
19F NMR and HR – ESI MS, instead of the 1H NMR. From measuring the difference 
between the initial integration of the [BF4- ⊂ Pd2(1)4]3+ helicate and the final 
integration of the [BF4- ⊂ Pd2(1)4]3+ helicate in the 19F NMR, and assuming that 
concentration overall of [Pd2(1)4] helicates remained constant, the equilibrium 
values for [BF4- ⊂ Pd2(1)4]3+, [ClO4- ⊂ Pd2(1)4]3+, [BF4-] and [ClO4-] can be 
determined. With these concentrations determined, the competition constant Kcomp 
for the replacement of BF4- for ClO4- can be calculated by using Equation 1, and 
therefore the selectivity of the helicate can be determined. 
 
Equation (1): [BF4- ⊂ Pd2(1)4]3+ + [X-] ⇌ [X- ⊂ Pd2(1)4]3+ + [BF4-]  
 
The ratio in the initial spectrum of free BF4- to [BF4- ⊂ Pd2(1)4]3+ is 3:1, therefore the 
initial [BF4-] and [BF4- ⊂ Pd2(1)4]3+ can be determined.  At equilibrium, [ClO4- ⊂ 
Pd2(1)4]3+ can be determined from the change in the integration of the initial [BF4- 
⊂ Pd2(1)4]3+ signal and final [BF4- ⊂ Pd2(1)4]3+ signal, assuming that the change in 
the integration of the [BF4- ⊂ Pd2(1)4]3+ signal is due to only the formation of the 
new [ClO4- ⊂ Pd2(1)4]3+ helicate. Therefore, [ClO4-] at equilibrium must be equal to 
the initial concentration of TBAClO4 added to the mixture, minus the [ClO4- ⊂ 
Pd2(1)4]3+ helicate at equilibrium. [BF4- ⊂ Pd2(1)4]3+ at equilibrium is equal to the 
final integral of the [BF4- ⊂ Pd2(1)4]3+ signal, and [BF4-] is equal to the initial 
concentration of free BF4- determined from the initial integral of free BF4-, plus the 
[ClO4- ⊂ Pd2(1)4]3+ helicate, assuming that all the BF4- replaced by ClO4- goes back 
into the solution. The worked calculations to determine [BF4- ⊂ Pd2(1)4]3+e, [ClO4- ⊂ 
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Pd2(1)4]3+e, [BF4-]e, and [ClO4-]e and the calculated values are summarised in 
Appendix 2, Table A2.1.  
The Kcomp for the replacement of BF4- for ClO4- can also be calculated using the 
relative heights of the [BF4- ⊂ Pd2(1)4]3+ and [ClO4- ⊂ Pd2(1)4]3+ helicates observed 
in the HR – ESI MS. The same assumptions were made as for the calculation of Kcomp 
from the 19F NMR data, where the total heights of the [BF4- ⊂ Pd2(1)4]3+ and [ClO4- ⊂ 
Pd2(1)4]3+ helicates must equal the initial concentration of [BF4- ⊂ Pd2(1)4]3+ before 
the addition of ClO4-. The worked calculations to determine [BF4- ⊂ Pd2(1)4]3+e, 
[ClO4- ⊂ Pd2(1)4]3+e, [BF4-]e, and [ClO4-]e and the calculated values are summarised 
in Appendix 2, Table A2.2. 
Using the values calculated above, the competition constant Kcomp for the 
replacement of BF4- for ClO4- using Equation 1 was calculated to be 4.52 from the 
19F NMR data, and 1.70 from the HR – ESI MS data. The value determined from the 
19F NMR data is in agreement with that reported by McMorran and Steel of 5.2.14 
Comparing the value determined from the 19F NMR data with that determined from 
the HR – ESI MS data of 1.70, they both support that the [ClO4- ⊂ Pd2(1)4]3+ helicate 
is favoured over the [BF4- ⊂ Pd2(1)4]3+ helicate.  
 
 
Addition of tetrabutylammonium perrhenate  
 
16 equivalents of tetrabutylammonium perrhenate (TBAReO4) were added to a 
solution of [BF4- ⊂ Pd2(1)4]3+ in d6 – DMSO. The mixture was then left overnight to 
equilibrate, and was analysed by HR – ESI MS and 19F NMR. 
The HR – ESI MS of the mixture confirms that anion exchange on the [BF4- ⊂ 
Pd2(1)4]3+ helicate has occurred with addition of TBAReO4 (Figure 2.45). The major 
3+ ion observed is due to the [BF4- ⊂ Pd2(1)4]3+ helicate, which occurs at an m/z of 
452.39024. The minor 3+ ion signal is due to the [ReO4- ⊂ Pd2(1)4]3+ helicate, which 
occurs at a m/z of 506.36689, and matches the calculated m/z and isotope pattern 
for [C64H48N8O8Pd2ReO4]3+ of 506.36738. The ratio of the heights of the [BF4- ⊂ 
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Pd2(1)4]3+ signal to the [ReO4- ⊂ Pd2(1)4]3+ signal is 8:1, which suggests that the 
helicate prefers to bind BF4- over ReO4- inside its internal cavity. 
Similar to what was observed in the HR – ESI MS of the [BF4- ⊂ Pd2(1)4]3+ helicate 
with the addition of ClO4-, there are several other smaller signals in the spectrum of 
4 TBAReO4 : [BF4- ⊂ Pd2(1)4]3+ corresponding to 2+ helicate species. There are four 
2+ helicate signals observed in the spectrum corresponding to [Pd2(1)4(BF4)(Cl)]2+, 
[Pd2(1)4(BF4)2]2+, [Pd2(1)4(ReO4)(Cl)]2+, and [Pd2(1)4(BF4)(ReO4)]2+ (m/z 




Figure 2.45. HR – ESI MS (d6 – DMSO) of [BF4- ⊂ Pd2(1)4]3+ after addition of 16 
equivalents of TBAReO4, showing observed signals for both [BF4- ⊂ Pd2(1)4]3+ and 
[ReO4- ⊂ Pd2(1)4]3+ helicates. 
 
 
The 19F NMR of the mixture supports the formation of [ReO4- ⊂ Pd2(1)4]3+ from the 
anion exchange of BF4- for ReO4- in [BF4- ⊂ Pd2(1)4]3+ (Figure 2.46).  The signal at δ 
-148.83 ppm corresponds to the [BF4- ⊂ Pd2(1)4]3+ helicate, as it has a similar 






Figure 2.46. 19F NMR (376 MHz, d6 – DMSO) of the reaction of [BF4- ⊂ Pd2(1)4]3+ 
with 16 equivalents of TBAReO4 showing fluorine assignment. 
 
 
Comparing the spectra of the pure [BF4- ⊂ Pd2(1)4]3+ solution and that of the [BF4- ⊂ 
Pd2(1)4]3+ solution with 16 equivalents of TBAReO4, the ratio of free BF4- to 
encapsulated BF4- is slightly increased. This suggests that ReO4- has exchanged with 
the encapsulated BF4- to form the [ReO4- ⊂ Pd2(1)4]3+ helicate and release BF4-. The 
ratio of the free BF4- signal to the encapsulated BF4- signal is 6.00:1.00, whereas the 
ratio of the free BF4- signal to the encapsulated BF4- signal for the reactant solution 
was 3.00:1.00. This suggests that the anion exchange of ReO4- for BF4- to form the 
[ReO4- ⊂ Pd2(1)4]3+ helicate is not as favoured as the exchange on ClO4-. 
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The competition constant Kcomp for the replacement of BF4- for ReO4- was calculated 
from the 19F NMR and HR – ESI MS data following the same procedure for the 
replacement of BF4- for ClO4-, and the results are summarised in Appendix 2, Table 
A2.3 and A2.4. From utilising Equation 1, the competition constants Kcomp for the 
replacement of BF4- for ReO4- was determined to be 0.20 from the 19F NMR data and 
0.052 from the HR – ESI MS data. The value determined from the 19F NMR data is in 
agreement with that reported by McMorran and Steel of 0.16. Comparing the value 
determined from the 19F NMR data with that determined from the HR – ESI MS data 
of 0.052, they both support that the [BF4- ⊂ Pd2(1)4]3+ helicate is favoured over the 
[ReO4- ⊂ Pd2(1)4]3+ helicate.  
 
 
Addition of tetrabutylammonium nitrate 
 
16 equivalents of tetrabutylammonium nitrate (TBANO3) were added to a solution 
of [BF4- ⊂ Pd2(1)4]3+ in d6 – DMSO. The mixture was then left overnight to 
equilibrate, and was analysed by HR – ESI MS and 19F NMR. 
The HR – ESI MS of the mixture confirms that anion exchange on the [BF4- ⊂ 
Pd2(1)4]3+ helicate has occurred with addition of TBANO3 (Figure 2.47). The first 3+ 
ion observed is due to the [NO3- ⊂ Pd2(1)4]3+ helicate, which occurs at an m/z of 
444.05156. This value matches that of the calculated m/z and isotope pattern for 
[C64H48N8O8Pd2NO3]3+ (444.05191). The second 3+ ion signal is due to the [BF4- ⊂ 
Pd2(1)4]3+ helicate, which occurs at a m/z of 452.39020. The ratio of the heights of 
the [BF4- ⊂ Pd2(1)4]3+ signal to the [NO3- ⊂ Pd2(1)4]3+ signal is 1:1, which suggests 
that both helicates exist in equal amounts. From this, the HR – ESI MS spectrum 
suggests that the helicate has no preference over the binding of either NO3- or 
BF4- inside its internal cavity. 
Similar to what was observed in the HR – ESI MS of the [BF4- ⊂ Pd2(1)4]3+ helicate 
with the addition of ClO4-, there are several other smaller signals in the spectrum of  
4 TBANO3 : [BF4- ⊂ Pd2(1)4]3+ corresponding to 2+ helicate species. There are four 
2+ helicate signals observed in the spectrum corresponding to [Pd2(1)4(NO3)(Cl)]2+, 
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[Pd2(1)4(BF4)(Cl)]2+, [Pd2(1)4(NO3)(BF4)]2+, and [Pd2(1)4(BF4)2]2+ (m/z 683.56118, 




Figure 2.47. HR – ESI MS (d6 – DMSO) of [BF4- ⊂ Pd2(1)4]3+ after addition of 16 
equivalents of TBANO3, showing observed signals for both [BF4- ⊂ Pd2(1)4]3+ and 
[NO3- ⊂ Pd2(1)4]3+ helicates. 
 
 
The 19F NMR of the mixture supports the formation of [NO3- ⊂ Pd2(1)4]3+ from the 
anion exchange of BF4- for NO3- in [BF4- ⊂ Pd2(1)4]3+ (Figure 2.48). The signal at δ -
148.82 ppm corresponds to the [BF4- ⊂ Pd2(1)4]3+ helicate, as it has a similar 





Figure 2.48. 19F NMR (376 MHz, d6 – DMSO) of the reaction of [BF4- ⊂ Pd2(1)4]3+ 
with 16 equivalents of TBANO3 showing fluorine assignment. 
 
 
Comparing the spectra of the pure [BF4- ⊂ Pd2(1)4]3+ solution and that of the [BF4- ⊂ 
Pd2(1)4]3+ solution with 16 equivalents of TBANO3, the ratio of free BF4- to 
encapsulated BF4- is greatly increased. This suggests that NO3- has exchanged with 
the encapsulated BF4- to form the [NO3- ⊂ Pd2(1)4]3+ helicate and release BF4-. The 
ratio of the free BF4- signal to the encapsulated BF4- signal is 490:1.00, whereas the 
ratio of the free BF4- signal to the encapsulated BF4- signal for the reactant solution 
was 3.00:1.00. This suggests that the anion exchange of NO3- for BF4- to form the 
[NO3- ⊂ Pd2(1)4]3+ helicate is highly favoured, and that the helicate prefers to bind 




The competition constant Kcomp for the replacement of BF4- for NO3- was calculated 
from the 19F NMR and HR – ESI MS data following the same procedure for the 
replacement of BF4- for ClO4-, and the results are summarised in Appendix 2, Table 
A2.5 and A2.6. From utilising Equation 1, the competition constants Kcomp for the 
replacement of BF4- for NO3- was determined to be 33.14 from the 19F NMR data and 
0.45 from the HR – ESI MS data. Comparing the value determined from the 19F NMR 
data with that determined from the HR – ESI MS data of 0.052, they are not in 
agreement with each other. The HR – ESI MS data suggests that the helicate prefers 
to slightly bind BF4- over NO3-, whereas the 19F NMR data suggests that the helicate 
prefers to bind NO3- over BF4- to a high degree. From this disagreement in values, 
there must be another process occurring with NO3- which causes the breakdown of 
the [BF4- ⊂ Pd2(1)4]3+ helicate to release a large amount of free BF4-. 
 
 
Anion exchange on [Pd2(4)4] 
 
Addition of tetrabutylammonium perchlorate 
 
16 equivalents of tetrabutylammonium perchlorate (TBAClO4) were added to a 
solution of [BF4- ⊂ Pd2(4)4]3+ in d6 – DMSO. The mixture was then left overnight to 
equilibrate, and was analysed by HR – ESI MS and 19F NMR. 
The HR – ESI MS of the mixture confirms that anion exchange on the [BF4- ⊂ 
Pd2(4)4]3+ helicate has occurred with addition of TBAClO4 (Figure 2.49). The major 
3+ ion observed is due to the [ClO4- ⊂ Pd2(4)4]3+ helicate, which occurs at an m/z of 
504.34323. This value matches that of the calculated m/z and isotope pattern for 
[C64H40F8N8O8Pd2ClO4]3+ (504.34680). The minor 3+ ion signal is due to the [BF4- ⊂ 
Pd2(4)4]3+ helicate, which occurs at a m/z of 500.36169. The ratio of the heights of 
the [BF4- ⊂ Pd2(4)4]3+ signal to the [ClO4- ⊂ Pd2(4)4]3+ signal is 15:78, which suggests 
that the helicate prefers to bind ClO4- over BF4- inside its internal cavity. 
Similar to what was observed in the HR – ESI MS of the [BF4- ⊂ Pd2(1)4]3+ helicate 
with the addition of ClO4-, there are several other smaller signals in the spectrum of 
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4 TBAClO4 : [BF4- ⊂ Pd2(4)4]3+ corresponding to 2+ helicate species. There are four 
2+ helicate signals observed in the spectrum corresponding to [Pd2(4)4(BF4)(Cl)]2+, 
[Pd2(4)4(ClO4)(Cl)], [Pd2(4)4(BF4)2]2+, and [Pd2(4)4(ClO4)2]2+ (m/z 768.02697, 




Figure 2.49. HR – ESI MS (d6 – DMSO) of [BF4- ⊂ Pd2(4)4]3+ after addition of 16 
equivalents of TBAClO4, showing observed signals for both [BF4- ⊂ Pd2(4)4]3+ and 
[ClO4- ⊂ Pd2(4)4]3+ helicates. 
 
 
The 19F NMR of the mixture supports the formation of [ClO4- ⊂ Pd2(4)4]3+ from the 
anion exchange of BF4- for ClO4- in [BF4- ⊂ Pd2(4)4]3+ (Figure 2.50).  The fluorine 
signals due to the fluorine atoms of 4 in [BF4- ⊂ Pd2(4)4]3+ are observed at δ -127.23, 
-133.23, and -134.25, respectively. The intensity of the signals due to the fluorine 
atoms of 4 in [BF4- ⊂ Pd2(4)4]3+ are unchanged with the addition of ClO4-. Changes 
in the intensity of the free BF4- and encapsulated BF4- signals indicate that exchange 
of encapsulated BF4- for ClO4- has occurred. The signals at δ -149.07 (A), -149.18 (B), 
-149.24 (C), and -149.48 (D) ppm correspond to the atropisomers of the [BF4- ⊂ 
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Pd2(4)4]3+ helicate, as it has a similar chemical shift and splitting pattern as the 




Figure 2.50. 19F NMR (376 MHz, d6 – DMSO) of the reaction of [BF4- ⊂ Pd2(4)4]3+ 
with 16 equivalents of TBAClO4 showing fluorine assignment. 
 
 
Comparing the spectra of the pure [BF4- ⊂ Pd2(4)4]3+ solution and that of the [BF4- ⊂ 
Pd2(4)4]3+ solution with 16 equivalents of TBAClO4, the ratio of free BF4- to 
encapsulated BF4- is increased. This suggests that ClO4- has exchanged with the 
encapsulated BF4- to form the [ClO4- ⊂ Pd2(4)4]3+ helicates and release BF4-. The ratio 
of the free BF4- signal to the encapsulated BF4- signals is 53.00:1.00, whereas the 
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ratio of the free BF4- signal to the encapsulated BF4- signal for the reactant solution 
was 5.00:1.00. This suggests that the anion exchange of ClO4- for BF4- to form the 
[ClO4- ⊂ Pd2(4)4]3+ helicates is favoured, and that the helicates likely prefer to bind 
ClO4- over BF4- inside its internal cavity.  
The average competition constant Kcomp across all atropisomers for the replacement 
of BF4- for ClO4- was calculated from the 19F NMR and HR – ESI MS data following the 
same procedure for the replacement of BF4- for ClO4- for [BF4- ⊂ Pd2(1)4]3+. Since the 
initial ratio of free BF4- to encapsulated BF4- is 4.57:1.00 instead of 3.00:1.00, this 
needed to be accounted for in the calculations. The calculated values of [BF4- ⊂ 
Pd2(4)4]e, [ClO4- ⊂ Pd2(4)4]e, [BF4-]e, and [ClO4-]e , and the starting concentrations of 
BF4- and [BF4- ⊂ Pd2(4)4] are summarised in Appendix 2, Table A2.7 and A2.8.  
From utilising Equation 1, the average competition constant Kcomp across all 
atropisomers for the replacement of BF4- for ClO4- was determined to be 8.87 from 
the 19F NMR data and 4.09 from the HR – ESI MS data. Comparing the value 
calculated of 8.87 to the value calculated for the replacement of BF4- for ClO4- of 4.52 
for the [Pd2(1)4] helicate, the [Pd2(4)4] atropisomers on average prefer to bind ClO4- 
over BF4- twice as much as the [Pd2(1)4] helicate prefers to bind ClO4-. Comparing 
the value determined from the 19F NMR data with that determined from the HR – 
ESI MS data of 4.09, they both support that the [ClO4- ⊂ Pd2(4)4]3+ helicates are 
favoured over the [BF4- ⊂ Pd2(4)4]3+ helicates, and therefore [Pd2(4)4] selectively 
binds ClO4- over BF4-. 
 
 
Addition of tetrabutylammonium perrhenate 
 
16 equivalents of tetrabutylammonium perrhenate (TBAReO4) were added to a 
solution of [BF4- ⊂ Pd2(4)4]3+ in d6 – DMSO. The mixture was then left overnight to 
equilibrate, and was analysed by HR – ESI MS and 19F NMR. 
The HR – ESI MS of the mixture confirms that anion exchange on the [BF4- ⊂ 
Pd2(4)4]3+ helicate has occurred with addition of TBAReO4 (Figure 2.51). The major 
3+ ion observed is due to the [BF4- ⊂ Pd2(4)4]3+ helicate, which occurs at an m/z of 
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500.36201. The minor 3+ ion signal is due to the [ReO4- ⊂ Pd2(4)4]3+ helicate, which 
occurs at a m/z of 555.00522, and matches the calculated m/z and isotope pattern 
for [C64H40F8N8O8Pd2ReO4]3+ of 555.00910. The ratio of the heights of the [BF4- ⊂ 
Pd2(4)4]3+ signal to the [ReO4- ⊂ Pd2(4)4]3+ signal is 18:1, which suggests that the 
helicate prefers to bind BF4- over ReO4- inside its internal cavity. 
Similar to what was observed in the HR – ESI MS of the [BF4- ⊂ Pd2(4)4]3+ helicate 
with the addition of ClO4-, there are several other smaller signals in the spectrum of 
4 TBAReO4 : [BF4- ⊂ Pd2(4)4]3+ corresponding to 2+ helicate species. There are six 
2+ helicate signals observed in the spectrum corresponding to [Pd2(4)4(BF4)(Cl)]2+, 
[Pd2(4)4(BF4)(NO3)]2+, [Pd2(4)4(BF4)2]2+, [Pd2(4)4(Cl)(ReO4)]2+, 
[Pd2(4)4(BF4)(ReO4)]2+, and [Pd2(4)4(ReO4)2]2+ (m/z 768.02730, 781.53692, 




Figure 2.51. HR – ESI MS (d6 – DMSO) of [BF4- ⊂ Pd2(4)4]3+ after addition of 16 
equivalents of TBAReO4, showing observed signals for both [BF4- ⊂ Pd2(4)4]3+ and 
[ReO4- ⊂ Pd2(4)4]3+ helicates. 
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The 19F NMR of the mixture supports the formation of [ReO4- ⊂ Pd2(4)4]3+ from the 
anion exchange of BF4- for ReO4- in [BF4- ⊂ Pd2(4)4]3+ (Figure 2.52).  The fluorine 
signals due to the fluorine atoms of 4 in [BF4- ⊂ Pd2(4)4]3+ are observed at δ -127.00, 
-133.18, and -134.40, respectively. The intensity of the signals due to the fluorine 
atoms of 4 in [BF4- ⊂ Pd2(4)4]3+ are unchanged with the addition of ReO4-. Changes 
in the intensity of the free BF4- and encapsulated BF4- signals indicate that exchange 
of encapsulated BF4- for ReO4- has occurred. The signals at δ -149.05 (A), -149.16 
(B), -149.22 (C), and -149.45 (D) ppm correspond to the atropisomers of the [BF4- 
⊂ Pd2(4)4]3+ helicate, as it has a similar chemical shift and splitting pattern as the 




Figure 2.52. 19F NMR (376 MHz, d6 – DMSO) of the reaction of [BF4- ⊂ Pd2(4)4]3+ 
with 16 equivalents of TBAReO4 showing fluorine assignment. 
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Comparing the spectra of the pure [BF4- ⊂ Pd2(4)4]3+ solution and that of the [BF4- ⊂ 
Pd2(4)4]3+ solution with 16 equivalents of TBAReO4, the ratio of free BF4- to 
encapsulated BF4- is slightly decreased. The ratio of the free BF4- signal to the 
encapsulated BF4- signal is 4.00:1.00, whereas the ratio of the free BF4- signal to the 
encapsulated BF4- signal for the reactant solution was 5.00:1.00. This slight decrease 
in the ratio of free BF4- to encapsulated BF4- can be contributed to the accuracy of 
the measurements, as there is no possible way for more [BF4- ⊂ Pd2(4)4]3+ helicates 
to be formed with the addition of ReO4-. Therefore, it is likely that there is no change 
in the ratio, which would mean that no anion exchange has occurred. 
The average competition constant Kcomp across all atropisomers for the replacement 
of BF4- for ReO4- was calculated from the 19F NMR and HR – ESI MS data following 
the same procedure for the replacement of BF4- for ClO4- for [BF4- ⊂ Pd2(4)4]3+. The 
calculated values of [BF4- ⊂ Pd2(4)4]e, [ReO4- ⊂ Pd2(4)4]e, [BF4-]e, and [ReO4-]e , and 
the starting concentrations of BF4- and [BF4- ⊂ Pd2(4)4] are summarised in 
Appendix 2, Table A2.9 and A2.10.  
From utilising Equation 1, the average competition constant Kcomp across all 
atropisomers for the replacement of BF4- for ReO4- was determined to be 0.095 from 
the 19F NMR data and 0.032 from the HR – ESI MS data. Comparing the value 
calculated of 0.095 to the value calculated for the replacement of BF4- for ReO4- of 
0.20 for the [Pd2(1)4] helicate, the [Pd2(4)4] atropisomers on average prefer to bind 
BF4- over ReO4- twice as much as the [Pd2(1)4] helicate prefers to bind BF4-. 
Comparing the value determined from the 19F NMR data with that determined from 
the HR – ESI MS data of 0.032, they both support that the [BF4- ⊂ Pd2(4)4]3+ helicates 
are favoured over the [ReO4- ⊂ Pd2(4)4]3+ helicates, and therefore that [Pd2(4)4] 








Anion exchange on [Pd2(5)4] 
 
Addition of tetrabutylammonium perchlorate  
 
16 equivalents of tetrabutylammonium perchlorate (TBAClO4) were added to a 
solution of [BF4- ⊂ Pd2(5)4]3+ in d6 – DMSO. The mixture was then left overnight to 
equilibrate, and was analysed by HR – ESI MS and 19F NMR. 
The HR – ESI MS of the mixture confirms that anion exchange on the [BF4- ⊂ 
Pd2(5)4]3+ helicate has occurred with addition of TBAClO4 (Figure 2.53). The major 
3+ ion observed is due to the [ClO4- ⊂ Pd2(5)4]3+ helicate, which occurs at an m/z of 
493.74687. This value matches that of the calculated m/z and isotope pattern for 
[C72H64N8O8Pd2ClO4]3+ (493.74709). The minor 3+ ion signal is due to the [BF4- ⊂ 
Pd2(5)4]3+ helicate, which occurs at a m/z of 489.76550, and matches the signal 
observed in the HR – ESI MS of the reactant solution (Figure 2.37). The ratio of the 
heights of the [BF4- ⊂ Pd2(5)4]3+ signal to the [ClO4- ⊂ Pd2(5)4]3+ signal is 55:71, 
which suggests that the helicate prefers to bind ClO4- over BF4- inside its internal 
cavity. 
Similar to what was observed in the HR – ESI MS of the [BF4- ⊂ Pd2(1)4]3+ helicate 
with the addition of ClO4-, there are several other smaller signals in the spectrum of 
4 TBAClO4 : [BF4- ⊂ Pd2(5)4]3+ corresponding to 2+ helicate species. There are four 
2+ helicate signals observed in the spectrum corresponding to [Pd2(5)4(BF4)(Cl)]2+, 
[Pd2(5)4(ClO4)(Cl)], [Pd2(5)4(ClO4)(BF4)]2+, and [Pd2(5)4(ClO4)2]2+ (m/z 752.13210, 





Figure 2.53. HR – ESI MS (d6 – DMSO) of [BF4- ⊂ Pd2(5)4]3+ after addition of 16 
equivalents of TBAClO4, showing observed signals for both [BF4- ⊂ Pd2(5)4]3+ and 
[ClO4- ⊂ Pd2(5)4]3+ helicates. 
 
 
The 19F NMR of the mixture supports the formation of [ClO4- ⊂ Pd2(5)4]3+ from the 
anion exchange of BF4- for ClO4- in [BF4- ⊂ Pd2(5)4]3+ (Figure 2.54). The signals at δ 
-148.61 (A), -148.90 (B), and -149.88 (C) ppm correspond to the atropisomers of 
the [BF4- ⊂ Pd2(5)4]3+ helicate, as it has a similar chemical shift and splitting pattern 





Figure 2.54. 19F NMR (376 MHz, d6 – DMSO) of the reaction of [BF4- ⊂ Pd2(5)4]3+ 
with 16 equivalents of TBAClO4 showing fluorine assignment. 
 
 
Comparing the spectra of the reactant solution and that of the [BF4- ⊂ Pd2(5)4]3+ 
solution with 16 equivalents of TBAClO4, the ratio of free BF4- to encapsulated BF4- 
is slightly increased. This suggests that ClO4- has exchanged with the encapsulated 
BF4- to form the [ClO4- ⊂ Pd2(5)4]3+ helicates and release BF4-. The ratio of the free 
BF4- signal to the encapsulated BF4- signal is 12.00:1.00, whereas the ratio of the free 
BF4- signal to the encapsulated BF4- signal for the reactant solution was 9.00:1.00. 
This suggests that the anion exchange of ClO4- for BF4- to form the [ClO4- ⊂ Pd2(5)4]3+ 
helicates is favoured, and that the helicates likely prefer to bind ClO4- over 
BF4- inside its internal cavity.  
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The competition constant Kcomp for the replacement of BF4- for ClO4- for each 
atropisomer and the average competition constant over all atropisomers were 
calculated from the 19F NMR and HR – ESI MS data following the same procedure for 
the replacement of BF4- for ClO4- for [BF4- ⊂ Pd2(1)4]3+. Since the initial ratio of free 
BF4- to encapsulated BF4- is 9.00:1.00 instead of 3.00:1.00, this needed to be 
accounted for in the calculations. The Kcomp for the replacement of BF4- for ClO4- for 
each of the three atropisomers can be determined due to the signals being well 
defined. To determine the individual values of [BF4- ⊂ Pd2(5)4]e and [ClO4- ⊂ 
Pd2(5)4]e for each atropisomer, the changes in the intensity of the signal before and 
after the addition of ClO4- were determined. A worked example for the calculation of 
[BF4- ⊂ Pd2(5)4]i, [BF4- ⊂ Pd2(5)4]e and [ClO4- ⊂ Pd2(5)4]e for the first atropisomer is 
shown in Appendix 1. The calculated values of [BF4- ⊂ Pd2(5)4]e, [ClO4- ⊂ Pd2(5)4]e, 
[BF4-]e, and [ClO4-]e , and the starting concentrations of BF4- and [BF4- ⊂ Pd2(5)4] 
overall, and for each individual atropisomer are summarised in Appendix 2, Tables 
A2.11 – A2.15. 
From utilising Equation 1, the competition constant Kcomp determined from the 19F 
NMR data for the replacement of BF4- for ClO4- for atropisomers A, B and C, and the 
average Kcomp over all atropisomers were determined to be 0.43, 0.43, 1.93 and 0.80, 
respectively. Comparing the average Kcomp value to the one determined for the 
replacement of BF4- for ClO4- of 4.52 for the [Pd2(1)4] helicate, the atropisomers of 
[Pd2(5)4] on average prefer to bind BF4- over ClO4-. However, looking at the Kcomp 
values determined for each atropisomer, atropisomers A and B have the same value, 
whereas atropisomer C has a value which is four times bigger than that of A and B. 
This suggests that atropisomers A and B prefer to bind BF4- over ClO4-, and 
atropisomer C prefers the opposite. Comparing the average competition constant 
over all atropisomers determined from the 19F NMR data of 0.80 with that 
determined from the HR – ESI MS data of 1.73, they disagree with each other. The 
19F NMR data suggests that on average the atropisomers of [Pd2(5)4] prefer to bind 
BF4- over ClO4-, whereas the HR – ESI MS data suggest that the atropisomers prefer 





Addition of tetrabutylammonium perrhenate  
 
16 equivalents of tetrabutylammonium perrhenate (TBAReO4) were added to a 
solution of [BF4- ⊂ Pd2(5)4]3+ in d6 – DMSO. The mixture was then left overnight to 
equilibrate, and was analysed by HR – ESI MS and 19F NMR. 
The HR – ESI MS of the mixture confirms that anion exchange on the [BF4- ⊂ 
Pd2(5)4]3+ helicate has occurred with addition of TBAReO4 (Figure 2.55). The major 
3+ ion observed is due to the [BF4- ⊂ Pd2(5)4]3+ helicate, which occurs at an m/z of 
489.76213. The minor 3+ ion signal is due to the [ReO4- ⊂ Pd2(5)4]3+ helicate, which 
occurs at a m/z of 544.40542, and matches the calculated m/z and isotope pattern 
for [C72H64N8O8Pd2ReO4]3+ of 544.40940. The 1+ ion which occurs at a m/z of 
571.56864 corresponds to [(TBA)2(BF4)]+. The ratio of the heights of the [BF4- ⊂ 
Pd2(5)4]3+ signal to the [ReO4- ⊂ Pd2(5)4]3+ signal is 81:38, which suggests that the 
helicate prefers to bind BF4- over ReO4- inside its internal cavity.  
Similar to what was observed in the HR – ESI MS of the [BF4- ⊂ Pd2(5)4]3+ helicate 
with the addition of ClO4-, there are several other smaller signals in the spectrum of 
4 TBAReO4 : [BF4- ⊂ Pd2(5)4]3+ corresponding to 2+ helicate species. There are five 
2+ helicate signals observed in the spectrum corresponding to [Pd2(5)4(BF4)(Cl)]2+, 
[Pd2(5)4(BF4)2]2+, [Pd2(5)4(ReO4)(Cl)]2+, [Pd2(5)4(BF4)(ReO4)]2+, and 






Figure 2.55. HR – ESI MS (d6 – DMSO) of [BF4- ⊂ Pd2(5)4]3+ after addition of 16 
equivalents of TBAReO4, showing observed signals for both [BF4- ⊂ Pd2(5)4]3+ and 
[ReO4- ⊂ Pd2(5)4]3+ helicates. 
 
 
The 19F NMR of the mixture supports the formation of [ReO4- ⊂ Pd2(5)4]3+ from the 
anion exchange of BF4- for ReO4- in [BF4- ⊂ Pd2(5)4]3+ (Figure 2.56). The signals at 
δ -148.62 (A), -148.90 (B), and -149.88 (C) ppm correspond to the atropisomers of 
the [BF4- ⊂ Pd2(5)4]3+ helicate, as it has a similar chemical shift and splitting pattern 




Figure 2.56. 19F NMR (376 MHz, d6 – DMSO) of the reaction of [BF4- ⊂ Pd2(5)4]3+ 
with 16 equivalents of TBAReO4 showing fluorine assignment. 
 
 
Comparing the spectra of the reactant solution and that of the [BF4- ⊂ Pd2(5)4]3+ 
solution with 16 equivalents of TBAReO4, the ratio of free BF4- to encapsulated BF4- 
is increased. This suggests that ReO4- has exchanged with the encapsulated BF4- to 
form the [ReO4- ⊂ Pd2(5)4]3+ helicates and release BF4-. The ratio of the free BF4- 
signal to the encapsulated BF4- signal is 20.00:1.00, whereas the ratio of the free BF4- 
signal to the encapsulated BF4- signal for the reactant solution was 9.00:1.00. This 
ratio is greater than that observed for [BF4- ⊂ Pd2(5)4]3+ with the addition of ClO4- 
(12.00:1.00). This suggests that the anion exchange of ReO4- for BF4- to form the 
[ReO4- ⊂ Pd2(5)4]3+ helicates is favoured over the anion exchange of ClO4- for BF4-. 
Interesting to note is that the intensity of atropisomer C appears to be larger than 
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that of atropisomers A and B signals with the addition of ReO4-, however with the 
addition of ClO4-, the intensity of atropisomer C is smaller than that of atropisomers 
A and B (Figure 2.54). 
The competition constant Kcomp for the replacement of BF4- for ReO4- for each 
atropisomer and the average competition constant over all atropisomers were 
calculated from the 19F NMR and HR – ESI MS data following the same procedure for 
the replacement of BF4- for ClO4- for [BF4- ⊂ Pd2(5)4]3+. The calculated values of [BF4- 
⊂ Pd2(5)4]e, [ReO4- ⊂ Pd2(5)4]e, [BF4-]e, and [ReO4-]e , and the starting concentrations 
of BF4- and [BF4- ⊂ Pd2(5)4] overall, and for each individual atropisomer are 
summarised in Appendix 2, Tables A2.16 – A2.20.  
From utilising Equation 1, the competition constant Kcomp determined from the 19F 
NMR data for the replacement of BF4- for ReO4- for atropisomers A, B and C, and the 
average Kcomp over all atropisomers were determined to be 1.12, 0.56, <0.00001 and 
0.56, respectively. Comparing the average Kcomp value to the one determined for the 
replacement of BF4- for ReO4- of 0.20 for the [Pd2(1)4] helicate, the atropisomers of 
[Pd2(5)4] on average prefer to bind ReO4- over BF4- with respect to the [Pd2(1)4] 
helicate. However, the Kcomp value suggest that on average, the [Pd2(5)4] 
atropisomers prefer to bind BF4- over ReO4-. Interesting to note is that all three 
atropisomers have different Kcomp values. Atropisomer A prefers to bind ReO4- over 
BF4-, whereas atropisomer B prefers to bind BF4- over ReO4-. Atropisomer C prefers 
to only bind BF4- since the intensity of the signal did not change with the addition of 
ReO4-. Comparing the average competition constant over all atropisomers 
determined from the 19F NMR data of 0.56 with that determined from the HR – ESI 
MS data of 0.52, they are in agreement with each other. Both the 19F NMR and HR – 
ESI MS data suggests that on average, the atropisomers of [Pd2(5)4] prefer to bind 







Addition of tetrabutylammonium nitrate 
 
16 equivalents of tetrabutylammonium nitrate (TBANO3) were added to a solution 
of [BF4- ⊂ Pd2(5)4]3+ in d6 – DMSO. The mixture was then left overnight to 
equilibrate, and was analysed by HR – ESI MS and 19F NMR. 
The HR – ESI MS of the mixture confirms that anion exchange on the [BF4- ⊂ 
Pd2(5)4]3+ helicate has occurred with addition of TBANO3 (Figure 2.57). The first 3+ 
ion observed is due to the [NO3- ⊂ Pd2(5)4]3+ helicate, which occurs at an m/z of 
481.42685. This value matches that of the calculated m/z and isotope pattern for 
[C72H64N8O8Pd2NO3]3+ (481.42707). The second 3+ ion signal is due to the [BF4- ⊂ 
Pd2(5)4]3+ helicate, which occurs at a m/z of 489.76529. The ratio of the heights of 
the [BF4- ⊂ Pd2(5)4]3+ signal to the [NO3- ⊂ Pd2(5)4]3+ signal is 111:49, which 
suggests that the helicate prefers to bind BF4- over NO3- inside its internal cavity. 
There is a small signal in the spectrum corresponding to [5 + H]+ at a m/z of 
293.12810. 
Similar to what was observed in the HR – ESI MS of the [BF4- ⊂ Pd2(5)4]3+ helicate 
with the addition of ClO4-, there are several other smaller signals in the spectrum of 
4 TBANO3 : [BF4- ⊂ Pd2(5)4]3+ corresponding to 2+ helicate species. There are four 
2+ helicate signals observed in the spectrum corresponding to [Pd2(5)4(NO3)(Cl)]2+, 
[Pd2(5)4(BF4)(Cl)]2+, [Pd2(5)4(NO3)(BF4)]2+, and [Pd2(5)4(BF4)2]2+ (m/z 739.62468, 





Figure 2.57. HR – ESI MS (d6 – DMSO) of [BF4- ⊂ Pd2(5)4]3+ after addition of 16 
equivalents of TBANO3, showing observed signals for both [BF4- ⊂ Pd2(5)4]3+ and 
[NO3- ⊂ Pd2(5)4]3+ helicates. 
 
 
The 19F NMR of the mixture supports the formation of [NO3- ⊂ Pd2(5)4]3+ from the 
anion exchange of BF4- for NO3- in [BF4- ⊂ Pd2(5)4]3+ (Figure 2.58). The signals at δ 
-148.61 (A), -148.91 (B), and -149.89 (C) ppm correspond to the atropisomers of 
the [BF4- ⊂ Pd2(5)4]3+ helicates, as it has a similar chemical shift and splitting pattern 




Figure 2.58. 19F NMR (376 MHz, d6 – DMSO) of the reaction of [BF4- ⊂ Pd2(5)4]3+ 
with 16 equivalents of TBANO3 showing fluorine assignment. 
 
 
Comparing the spectra of the reactant solution and that of the [BF4- ⊂ Pd2(5)4]3+ 
solution with 16 equivalents of TBANO3, the ratio of free BF4- to encapsulated BF4- 
is greatly increased. This suggests that NO3- has exchanged with the encapsulated 
BF4- to form the [NO3- ⊂ Pd2(5)4]3+ helicates and release BF4-. The ratio of the free 
BF4- signal to the encapsulated BF4- signal is 37.00:1.00, whereas the ratio of the free 
BF4- signal to the encapsulated BF4- signal for the reactant solution was 9.00:1.00. 
This ratio is greater than that observed for [BF4- ⊂ Pd2(5)4]3+ with the addition of 
ClO4- (11.84:1.00) and ReO4- (20.00:1.00). This suggests that the anion exchange of 
NO3- for BF4- to form the [NO3- ⊂ Pd2(5)4]3+ helicates is favoured. However, this 
increase in the ratio of free BF4- to encapsulated BF4- might also be due to the 
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breakdown of the [BF4- ⊂ Pd2(5)4]3+ helicates to release BF4- since some free ligand 
5 is observed in the HR – ESI MS of the mixture. 
The competition constant Kcomp for the replacement of BF4- for NO3- for each 
atropisomer and the average competition constant over all atropisomers were 
calculated from the 19F NMR and HR – ESI MS data following the same procedure for 
the replacement of BF4- for ClO4- for [BF4- ⊂ Pd2(5)4]3+. The calculated values of [BF4- 
⊂ Pd2(5)4]e, [NO3- ⊂ Pd2(5)4]e, [BF4-]e, and [NO3-]e , and the starting concentrations 
of BF4- and [BF4- ⊂ Pd2(5)4] overall, and for each individual atropisomer are 
summarised in Appendix 2, Tables A2.21 – A2.25.  
From utilising Equation 1, the competition constant Kcomp determined from the 19F 
NMR data for the replacement of BF4- for NO3- for atropisomers A, B and C, and the 
average Kcomp over all atropisomers were determined to be 5.71, 7.35, 20.55 and 
8.96, respectively. Comparing the average Kcomp value to the one determined for the 
replacement of BF4- for NO3- of 33.14 for the [Pd2(1)4] helicate, the atropisomers of 
[Pd2(5)4] on average prefer to bind BF4- over NO3- with respect to the [Pd2(1)4] 
helicate. However, the Kcomp value suggest that on average, the [Pd2(5)4] 
atropisomers prefer to bind NO3- over BF4-. Interesting to note is that all three 
atropisomers have different Kcomp values. All three atropisomers prefer to bind NO3- 
over BF4-, where atropisomer C strongly prefers to bind NO3-, followed by 
atropisomer B and then atropisomer A. Comparing the average competition 
constant over all atropisomers determined from the 19F NMR data of 8.96 with that 
determined from the HR – ESI MS data of 0.53, they are not in agreement with each 
other. The HR – ESI MS data suggests that the helicate prefers to slightly bind BF4- 
over NO3-, whereas the 19F NMR data suggests that the helicate prefers to bind 
NO3- over BF4-. From this disagreement in values, there must be another process 
occurring with NO3- which causes the breakdown of the [BF4- ⊂ Pd2(5)4]3+ helicates 








It has been determined that by changing the electronics and bulkiness of ligand 1, 
by producing ligands 2 – 6, the electronic properties of the helicate and the anion 
selectivity of the helicate can be tuned. 
The 19F NMR chemical shifts of the encapsulated BF4- signal for each of the 
synthesised helicates, [BF4- ⊂ Pd2(1)4]3+, [BF4- ⊂ Pd2(2)4]3+, [BF4- ⊂ Pd2(4)4]3+, and 
[BF4- ⊂ Pd2(5)4]3+ are summarised in Table 2.2.  
 
 
Table 2.2. 19F NMR chemical shifts for the encapsulated BF4- signal for each 
synthesised helicate. 
Helicate 19F NMR Chemical Shift (δ, ppm) 
[BF4- ⊂ Pd2(1)4]3+ -148.89 
[BF4- ⊂ Pd2(2)4]3+ -150.24 
[BF4- ⊂ Pd2(4)4]3+  A -149.09 
- B -149.20 
- C -149.26 
- D -149.50 
[BF4- ⊂ Pd2(5)4]3+  A -148.64 
- B -148.93 
- C -149.90 
 
 
There seems to be a relationship between the electronics of the ligands used to 
synthesise the helicates and the chemical shift of the encapsulated BF4- signals. The 
chemical shift of the encapsulated BF4- signal is dependent on the electronics of the 
internal cavity of the helicate, the more electron deficient the cavity is, the more 
deshielded the BF4- signal will be, and vice versa. In terms of electronic effects, ligand 
2 should is the most electron donating, followed by ligand 5, then ligand 1, and the 
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most electron withdrawing is ligand 4. Since 2 is the most electron donating group 
out of the ligands incorporated into helicates, the cavity of the [BF4- ⊂ Pd2(2)4]3+ 
helicate should shield the encapsulated BF4- anion the most. Ligand 5 contains two 
methyl groups which donate electron density onto the central phenyl ring, and 
therefore the [BF4- ⊂ Pd2(5)4]3+ signals should have the second most shielded 
signals. Ligand 4 contains two fluorine atoms attached to the central phenyl ring, 
which pulls electron density away from the ring. Therefore, the [BF4- ⊂ Pd2(4)4]3+ 
helicates should have the most deshielded signals. 
From most shielded encapsulated BF4- signal to most deshielded, the helicates go in 
the order of [BF4- ⊂ Pd2(2)4]3+ > [BF4- ⊂ Pd2(5)4]3+ C > [BF4- ⊂ Pd2(4)4]3+ D > [BF4- 
⊂ Pd2(4)4]3+ C > [BF4- ⊂ Pd2(4)4]3+ B > [BF4- ⊂ Pd2(4)4]3+ A > [BF4- ⊂ Pd2(5)4]3+ B > 
[BF4- ⊂ Pd2(1)4]3+ > [BF4- ⊂ Pd2(5)4]3+ A. This trend in the most shielded signal to 
the most deshielded signal is not what was expected for the helicates synthesised. 
The atropisomers of [BF4- ⊂ Pd2(4)4]3+ should be the most deshielded signals, 
however they are all more shielded than that of the [BF4- ⊂ Pd2(1)4]3+ signal. The 
observed chemical shifts of the atropisomers of [BF4- ⊂ Pd2(5)4]3+ is also not what 
was expected. The signal for atropisomer C is the second most shielded signal, 
whereas the signals for atropisomers A and B signals are highly deshielded. 
Interestingly, atropisomer A is the most deshielded signal out of all of the helicates.  
If the observed BF4- chemical shifts of the helicates were only dependent on the 
electronic properties of their cavities, then all the atropisomers of both [BF4- ⊂ 
Pd2(4)4] and [BF4- ⊂ Pd2(5)4]3+ should have the same observed chemical shift. 
However, this is not the case. There must be something else going on apart from the 
electronics of the cavity that causes these slight differences in the observed chemical 
shifts for each atropisomer. This could possibly be due to the subtle differences in 
the dispositions of the ligand substituents of the [BF4- ⊂ Pd2(4)4] and [BF4- ⊂ 
Pd2(5)4]3+ helicates, which could cause slight differences in the cavity sizes of each 
atropisomer, however more investigation is needed to see if this is the case.  
A summary of the diffusion coefficients for the free BF4- and encapsulated BF4- 
signals determined from 19F DOSY analysis on the each of the helicate mixtures is 
shown in Table 2.3. The diffusion coefficients give information on how fast the 
species diffuses through the medium (d6 – DMSO), so in general the bigger the 
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diffusion coefficient, the faster the species diffuses. The speed at which the species 
diffuses through the medium is related to the apparent size of the species, therefore 
if the species is diffusing fast through the medium, the apparent size of the species 
is small. The largest diffusion coefficients belong to the free BF4- signals is each of 
the helicate mixtures, which is consistent with the smaller size of free BF4-. It is 
important to note that DMSO is not a good solvent for DOSY NMR as it is too viscous, 
it is better to use a solvent that is less viscous to allow for the species to easily diffuse 
through the solvent. However, DMSO is the only solvent that these helicates will 
form in, so therefore the results are not as good as they would be if they were 
performed in a less viscous solvent.  
 
 
Table 2.3. 19F DOSY diffusion coefficients for free BF4- and encapsulated BF4- 
signals for each synthesised helicate. 
 
Helicate 
Free BF4-  
( x10-10 m2 s-1) 
Encapsulated BF4- 
( x10-10 m2 s-1) 
[BF4- ⊂ Pd2(1)4]3+ 4.91 ± 0.01 1.34 ± 0.04 
[BF4- ⊂ Pd2(2)4]3+ 5.53 ± 0.04 1.53 ± 0.05 
[BF4- ⊂ Pd2(4)4]3+  A 5.02 ± 0.02 0.83 ± 0.04 
- B - 0.95 ± 0.02 
- C - 1.13 ± 0.01 
- D - 0.82 ± 0.03 
[BF4- ⊂ Pd2(5)4]3+  A 4.78 ± 0.03 1.22 ± 0.04 
- B - 1.18 ± 0.06 
- C - 1.18 ± 0.06 
 
 
It was expected that diffusion coefficients of the encapsulated BF4- signals for each 
of the helicates should follow a pattern which reflects the molecular weight of the 
helicates, however this is not observed. The diffusion coefficients should follow the 
order [BF4- ⊂ Pd2(2)4]3+ < [BF4- ⊂ Pd2(4)4]3+ < [BF4- ⊂ Pd2(5)4]3+ < [BF4- ⊂ Pd2(1)4]3+, 
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where [BF4- ⊂ Pd2(2)4]3+ has the smallest diffusion coefficient. However, the order 
observed is [BF4- ⊂ Pd2(4)4]3+ D < [BF4- ⊂ Pd2(4)4]3+ A < [BF4- ⊂ Pd2(4)4]3+ B < [BF4- 
⊂ Pd2(4)4]3+ C < [BF4- ⊂ Pd2(5)4]3+ B = [BF4- ⊂ Pd2(5)4]3+ C < [BF4- ⊂ Pd2(5)4]3+ A < 
[BF4- ⊂ Pd2(1)4]3+ < [BF4- ⊂ Pd2(2)4]3+. The fact that the [BF4- ⊂ Pd2(2)4]3+ has the 
largest diffusion coefficient is interesting as it is the heaviest helicate in terms of 
molecular weight, and should have the smallest diffusion coefficient. This suggests 
that the [BF4- ⊂ Pd2(2)4]3+ helicate must be more compact than the other helicates. 
As expected, the diffusion coefficients for the encapsulated BF4- signals of the 
atropisomers of [BF4- ⊂ Pd2(4)4]3+ are consistent with each other, suggesting that 
they all have a similar apparent size. The same consistency is observed for the 
encapsulated BF4- signals of the atropisomers of [BF4- ⊂ Pd2(5)4]3+.  
A summary of the calculated Kcomp values determined from the 19F NMR and HR – 
ESI MS data for each of the anion exchange solutions is shown in Table 2.4. 
Comparing the Kcomp values determined from the 19F NMR and HR – ESI MS data for 
each anion exchange process shows that there is a slight correlation between the 
heights of the signals observed in the MS and the change observed in the 
corresponding 19F NMR spectrum.  
 
 
Table 2.4. Calculated Kcomp values determined from 19F NMR and HR – ESI MS data 

























0.052 33.14 0.45 
[BF4- ⊂ Pd2(4)4]3+  8.87 4.09 0.095 0.032 - - 






For the [BF4- ⊂ Pd2(1)4]3+ solution with ClO4-, both Kcomp values determined from the 
19F NMR and HR – ESI MS data are in agreement with each other, and support that 
the [Pd2(1)4] helicate prefers to bind ClO4- over BF4- inside its internal cavity. This 
agreement in values is also shown with the addition of ReO4-, which supports that 
the [Pd2(1)4] helicate prefers to bind BF4- over ReO4- inside its internal cavity. With 
the addition of NO3-, the Kcomp values determined from the 19F NMR and HR – ESI MS 
data are not in agreement with each other. The Kcomp value determined from the 19F 
NMR is 33.14, whereas the value determined from the HR – ESI MS is 0.45. The NMR 
data suggests that the [Pd2(1)4] helicate greatly prefers to bind NO3- over BF4- inside 
its internal cavity, however the MS data suggests that this is not the case.  
For the [BF4- ⊂ Pd2(4)4]3+ solution with ClO4-, both Kcomp values determined from the 
19F NMR and HR – ESI MS data are in agreement with each other, and support that 
on average the atropisomers of [Pd2(4)4] prefer to bind ClO4- over BF4- inside its 
internal cavity. This agreement in values is also shown with the addition of ReO4-, 
which supports that on average the atropisomers of [Pd2(4)4] prefer to bind BF4- 
over ReO4- inside its internal cavity.  
For the [BF4- ⊂ Pd2(5)4]3+ solution with ClO4-, the Kcomp values determined from the 
19F NMR and HR – ESI MS data they disagree with each other. The average Kcomp 
value which is determined over all atropisomers in the 19F NMR suggests that on 
average the atropisomers of [Pd2(5)4] prefer to bind BF4- over ClO4- inside its 
internal cavity. However, the value determined from the MS data suggests that the 
atropisomers prefer to bind ClO4- over BF4-. Looking at the individual Kcomp values 
determined for each atropisomer, atropisomers A (0.43) and B (0.43) prefer to bind 
BF4- over ClO4- and atropisomer C (1.93) prefers the opposite. Comparing these 
values, atropisomer C prefers to bind ClO4- over BF4- four times more than A and B, 
which might contribute as to why the [ClO4- ⊂ Pd2(5)4]3+ helicate is the most 
abundant in the HR – ESI MS spectrum.  
However, for the [BF4- ⊂ Pd2(5)4]3+ solution with ReO4-, both Kcomp values 
determined from the 19F NMR and HR – ESI MS data are in agreement with each 
other, and support that on average the atropisomers of [Pd2(5)4] prefer to bind BF4- 
over ReO4- inside its internal cavity. Looking at the individual Kcomp values 
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determined for each atropisomer, atropisomer A (1.12) prefers to bind ReO4- over 
BF4- and atropisomers B (0.56) and C (<0.01) prefer the opposite.   
For the [BF4- ⊂ Pd2(5)4]3+ solution with NO3-, the Kcomp values determined from the 
19F NMR and HR – ESI MS data they disagree with each other. The average Kcomp 
value which is determined over all atropisomers in the 19F NMR suggests that on 
average the atropisomers of [Pd2(5)4] prefer to bind NO3- over BF4- inside its 
internal cavity. However, the value determined from the MS data suggests that the 
atropisomers prefer to bind BF4- over NO3-. Looking at the individual Kcomp values 
determined for each atropisomer, they all prefer to bind NO3- over BF4-. Atropisomer 
C (20.55) prefers to bind NO3- the most, followed by atropisomers B (7.35) and C 
(5.71). These values do not reflect what is observed in the HR – ESI MS spectrum of 
[BF4- ⊂ Pd2(5)4]3+, therefore suggesting that something else is occurring in the 
equilibrium mixture which is unknown. 
From the comparison of the calculated Kcomp values determined from the 19F NMR 
and HR – ESI MS data for each of the anion exchange processes, it is clear that there 
is a slight correlation between the heights of the signals in the MS spectrum and the 
corresponding equilibrium constant determined from the NMR spectrum. The only 
time the calculated Kcomp values do not agree with each other is when the anion in 
question is NO3-. This supports the earlier claim that the NO3- anion is most likely 
pulling the [Pd2(L)4] helicate apart to release BF4- anions.  
Comparison of the Kcomp values calculated from the 19F NMR data for the anion 
exchange process on each of the helicate solutions shows that there is a possible 
correlation between the electronics of the internal cavity and the anion binding 
preference. For the addition of ClO4-, the Kcomp goes from 4.52 for the [BF4- ⊂ 
Pd2(1)4]3+ helicate to 8.87 for the [BF4- ⊂ Pd2(4)4]3+ helicate. This suggests that 
adding electron withdrawing groups (F) to the central phenyl spacer of ligand 1 
doubles the binding preference of ClO4- over BF4- inside the internal cavity of the 
helicate. However, the addition of electron donating groups (Me) to the central 
phenyl spacer of ligand 1 decreases the binding preference of ClO4- over BF4- by a 
factor of five (4.52 versus 0.80).  
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The opposite is observed for the addition of ReO4-, the Kcomp goes from 0.20 for the 
[BF4- ⊂ Pd2(1)4]3+ helicate to 0.095 for the [BF4- ⊂ Pd2(4)4]3+ helicate. This suggests 
that adding electron withdrawing groups (F) to the central phenyl spacer of ligand 
1 halves the binding preference of ReO4- over BF4- inside the internal cavity of the 
helicate. However, the addition of electron donating groups (Me) to the central 
phenyl spacer of ligand 1 increases the binding preference of ReO4- over BF4- by a 
factor of three (0.20 versus 0.56). 
From the comparison of the Kcomp values for the addition of ClO4- or ReO4- to the 
different helicate mixtures, the addition of electron withdrawing groups increases 
the binding preference for ClO4- but decreases the binding preference for ReO4-. The 
opposite of this is observed for the addition of electron donating groups, where the 
binding preference for ClO4- decreases whereas the binding preference for 
ReO4- increases. Therefore, the addition of electron withdrawing groups configures 
the electronics of the cavity to accommodate the smaller ClO4- anion, and leads to a 
cavity unable to accommodate the larger ReO4- anion. However, the addition of 
electron donating groups configures the electronics of the cavity to accommodate 
the larger ReO4- anion, and leads to the cavity being unable to accommodate the 
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Heteroleptic [Pd2LxL’4-x] helicates are less explored than homoleptic [Pd2L4] 
helicates due to the fact as more ligands are added, the strategy for the rational 
formation of a single heteroleptic product becomes more complicated.1-2 There are 
many examples of heteroleptic [M2LxL’4-x] complexes,3 however heteroleptic 
palladium(II) complexes have been less explored. This is due to the possibility of 
uncontrolled statistical mixtures of thermodynamic products; therefore, clever 
strategies are required to construct targeted heteroleptic complexes.  
There are three different scenarios which can occur when a naked metal ion is mixed 
with two different ligands; 1 – Statistical mixtures, 2 – Narcissistic self-sorting, and 
3 – Integrative self-sorting (Figure 1.14).1 For a statistical mixture, the amount of 
[Pd2LxL’4-x] cages formed follows a Boltzmann distribution curve, where the amount 
formed is related to the number of different ways the heteroleptic cage can form. 
For narcissistic self-sorting, no heteroleptic [Pd2LxL’4-x] cages are formed and only 
homoleptic [Pd2L4] and [Pd2L’4] cages are observed. For integrative self-sorting, 
only one heteroleptic cage is formed over the other possibilities, for example, 
[Pd2L2L’2].  
Heteroleptic supramolecular architectures are interesting as they lead to 
architectures with reduced symmetry compared to that of homoleptic architectures. 
An example of this was reported by Clever, by utilising “banana ligands” which 
possess different bend angles. Mixing these ligands with palladium(II) led to 
integrative self-sorting to form the [Pd2L2L’2] cage, where the cage binds two 
different ligands with different bend angles, leading to a reduced symmetry cage 
(Figure 1.19).4 This occurs as the homoleptic [Pd2L4] cage is too strained with the 
bend angle of L, and the homoleptic [Pd2L’4] cage is more of a box-like structure with 
the bend angle of L’. Therefore, mixing the two ligands together with palladium(II) 
leads to the clean assembly of a cis – [Pd2L2L’2] cage as the bend angles of L and L’ 
complement each other.  
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Utilising different ligands to form heteroleptic [Pd2LxL’4-x] cages, can lead to fine 
tuning of the cages capabilities. For example, introducing ligands with different 
functional properties can lead a heteroleptic cage with desirable traits not accessible 
by a homoleptic cage.  
To build on the research carried out in Chapter 2, combinations of ligands 1 – 6 
were mixed together with palladium(II) to produce libraries of heteroleptic 
[Pd2LxL4-x] helicates. These libraries were investigated to see if the combination of 
two or more different ligands leads to further fine tuning of the electronics of the 
helicates, and the anion selectivity of the helicates. Investigations were also made to 
see if there was a possibility of tuning the combination of ligands used to form a 
single caged species. By utilising ligands with bulky substituents attached to the 
central phenyl spacer, this should lead to the limitation of some heteroleptic species 
due to steric interactions between neighbouring ligands. 
From herein we will discuss the synthesised heteroleptic helicates [Pd2(1)x(3)4-x]3+, 
[Pd2(1)x(5)4-x]3+ and [Pd2(3)x(5)4-x]3+. The other heteroleptic helicates synthesised 
are discussed in Appendix 3. 
 
 
3.2 Synthesis of [Pd2(L)x(L’)4-x] helicates 
 
 
Synthesis of [Pd2(1)x(3)4-x] helicates 
 
[Pd2(1)x(3)4-x]3+ helicates were synthesised from the mixing of [Pd(MeCN)4](BF4)2, 
1, and 3 in a 2 : 2 : 2 ratio in d6 – DMSO at room temperature. The mixture was left 
for three days to equilibrate, and then sent for HR – ESI MS and 19F NMR analysis. 
The HR – ESI MS of the mixture supports the formation of a mixture of [BF4- ⊂ 
Pd2(1)x(3)4-x]3+ helicates (Figure 3.1). There are four main 3+ signals observed at 
m/z 452.38982, 485.73368, 519.07747, and 552.42127. The isotope patterns and 
m/z of the observed signals match that calculated for the heteroleptic species [BF4- 
⊂ Pd2(1)4]3+, [BF4- ⊂ Pd2(1)3(3)]3+, [BF4- ⊂ Pd2(1)2(3)2]3+, and [BF4- ⊂ Pd2(1)(3)3]3+. 
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There is no signal observed for [BF4- ⊂ Pd2(3)4]3+, as the helicate is too sterically 
hindered to form (Chapter 2). 
There were several other signals corresponding to 2+ and 1+ helicate species 
present in the spectrum of the mixture. The three largest 2+ signals observed at m/z 
696.06968, 746.08537, and 796.10111 correspond to the heteroleptic species 
[Pd2(1)4(BF4)(Cl)]2+, [Pd2(1)3(3)(BF4)(Cl)]2+, and [Pd2(1)2(3)2(BF4)(Cl)]2+, 
respectively.  
Heating of the mixture at 80 oC overnight resulted in the intensity of the [BF4- ⊂ 
Pd2(1)4]3+ helicate decreasing, and the intensities of the [BF4- ⊂ Pd2(1)3(3)]3+, [BF4- 
⊂ Pd2(1)2(3)2]3+, and [BF4- ⊂ Pd2(1)(3)3]3+ helicates increasing (Figure 3.2). This 
suggests that heating the mixture leads to the increased formation of the 
thermodynamic products, whereas before heating the kinetic products dominate. 
Ratios of the HR – ESI MS heights before and after heating with respect to the [BF4- 
⊂ Pd2(1)4]3+ height are summarised in Table 3.1. This difference in the intensities 





















Figure 3.1. HR – ESI MS (d6 – DMSO) of synthesised [BF4- ⊂ Pd2(1)x(3)4-x]3+ 





Figure 3.2. HR – ESI MS (d6 – DMSO) of synthesised [BF4- ⊂ Pd2(1)x(3)4-x]3+ 
helicates after heating at 80 oC overnight showing the observed m/z and isotope 
pattern for each helicate. 
 
Table 3.1. Normalised ratios of the HR – ESI MS heights before and after heating 
with respect to the [BF4- ⊂ Pd2(1)4]3+ height. 
 








Initial 1.00 13.00 19.60 0.80 
After Heating 1.00 48.00 141.00 21.00 
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The 19F NMR of the mixture supports the formation of mixed [BF4- ⊂ Pd2(1)x(3)4-x]3+ 
helicates as the spectrum is different to the spectra of [BF4- ⊂ Pd2(1)4]3+ and [BF4- ⊂ 
Pd2(3)4]3+ mixtures (Figure 3.3). Other than the signal for the free BF4-, there are 
five signals observed in the spectrum at δ -148.89, -149.85 (A), -150.07 (B), -150.25 
(C), and -150.80 (D) ppm, and are due to the [BF4- ⊂ helicate]3+ species. Comparing 
the spectrum that of [BF4- ⊂ Pd2(1)4]3+, the signal at δ – 148.89 ppm is likely that of 
the [BF4- ⊂ Pd2(1)4]3+ helicate. The other four signals are due to the different 
heteroleptic [BF4- ⊂ Pd2(1)x(3)4-x]3+ helicates present. The ratio of free BF4- signal to 
the encapsulated BF4- signals is 3.00:1.00, which shows that all of the ligand is 




Figure 3.3. 19F NMR (376 MHz, d6 – DMSO) of mixed [BF4- ⊂ Pd2(1)x(3)4-x]3+ 




The 19F NMR of the mixture after heating shows an increase in signal intensities for 
signals B and C, and a decrease in the signal intensities of [BF4- ⊂ Pd2(1)4]3+ and 
signal A (Figure 3.4). This reflects what was observed in the HR – ESI MS of the 
heated mixture, as the intensities of all the helicates mostly increase apart from the 
[BF4- ⊂ Pd2(1)4]3+ signal. The ratio of the free BF4- signal to encapsulated BF4- signals 
slightly decreases to 2.00:1.00 after heating. This slight decrease can be contributed 






Figure 3.4. 19F NMR (376 MHz, d6 – DMSO) of mixed [BF4- ⊂ Pd2(1)x(3)4-x]3+ 






A 19F DOSY spectrum was also performed on a more concentrated solution of [BF4- 
⊂ Pd2(1)x(3)4-x]3+ (double the original concentration) to determine the diffusion 
coefficients of both free BF4- and [BF4- ⊂ helicate]3+ signals (Figure 3.5). The 
diffusion coefficient for the free BF4- anion signal was recorded as (3.30 ± 0.1) x 10-
10 m2 s-1, whereas the diffusion coefficients of signals A, B, C and D were recorded as 
(1.56 ± 0.1) x 10-10 m2 s-1, (1.09 ± 0.2) x 10-10 m2 s-1, (1.34 ± 0.1) x 10-10 m2 s-1, and 
(1.28 ± 0.05) x 10-10 m2 s-1, respectively.  
The diffusion coefficient for the [BF4- ⊂ Pd2(1)4]3+ helicate could not be measured as 
it was not observed in the more concentrated solution. The diffusion coefficient for 
signal A suggests that it has the smallest apparent size, which means that it is likely 
the [BF4- ⊂ Pd2(1)3(3)]3+ helicate. The diffusion coefficient for signal B suggests it 
has the largest apparent size, which means that it is likely the [BF4- ⊂ Pd2(1)(3)3]3+ 
helicate. The diffusion coefficients for signals C and D are close to each other and are 
in between the values for signals A and B. This suggests that C and D are likely that 
of the cis/trans [BF4- ⊂ Pd2(1)2(3)2]3+ helicates. Since the intensity of signal D is 
greater than that of signal C, it is likely the D is the trans helicate and C is likely the 
cis helicate.   
 
 
Figure 3.5. 19F DOSY (470 MHz, d6 – DMSO) of mixed [BF4- ⊂ Pd2(1)x(3)4-x]3+ 




It was investigated whether changing the ratio of ligands 1 : 3 added to the mixture 
would influence the speciation of the heteroleptic [BF4- ⊂ Pd2(1)x(3)4-x]3+ helicates 
formed. Two different mixtures were produced, one where the helicates were 
synthesised from the mixing of [Pd(MeCN)4](BF4)2, 1, and 3 in a 2 : 3 : 1 ratio in d6 – 
DMSO at room temperature, and the other synthesised from the mixing of 
[Pd(MeCN)4](BF4)2, 1, and 3 in a 2 : 1 : 3 ratio in d6 – DMSO at room temperature. 
The mixtures were left for three days to equilibrate, and were then sent for 19F NMR 
analysis. 
The 19F NMR of the 2 : 3 : 1 mixture (red) shows the formation of helicates [BF4- ⊂ 
Pd2(1)4]3+, A, C and D, whereas the 2 : 1 : 3 mixture (blue) shows the formation of 
helicates A, B, C and D (Figure 3.6). Comparing the two spectra, the intensities of 
the signals differ, for the red spectrum the intensities of the signals go in the order 
of A > D = [BF4- ⊂ Pd2(1)4]3+ > C, and for the blue spectrum they go in the order of D 









Figure 3.6. 19F NMR (376 MHz, d6 – DMSO) of mixed [BF4- ⊂ Pd2(1)x(3)4-x]3+ 
helicates showing fluorine assignment. Red is the 2 : 3 : 1 mixture of Pd(II) : 1 : 3, 
and blue is the 2 : 1 : 3 mixture. 
 
 
Since the assignment of the signals has been determined earlier from 19F DOSY, the 
difference in the speciation can be rationalised. When more of ligand 1 is added than 
ligand 3, more of the [BF4- ⊂ Pd2(1)3(3)]3+ helicate is formed than the trans [BF4- ⊂ 
Pd2(1)2(3)2]3+ and [BF4- ⊂ Pd2(1)4(3)]3+ helicates which are formed in the same 
amount. Only a very tiny amount of the cis [BF4- ⊂ Pd2(1)2(3)2]3+ helicate is formed, 
and the [BF4- ⊂ Pd2(1)(3)3]3+ helicate is not formed at all. This suggests that when 
the two ligands are mixed together, the least sterically hindered helicate that 
incorporates both ligands is formed the most, then the second least sterically 
hindered helicate (trans) and the homoleptic [BF4- ⊂ Pd2(1)4]3+ helicate are formed 
in equal amounts.  
However, when more of ligand 3 is added than ligand 1, more of the trans [BF4- ⊂ 
Pd2(1)2(3)2]3+ helicate is formed than the [BF4- ⊂ Pd2(1)3(3)]3+ helicate, which is 
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formed more than the cis [BF4- ⊂ Pd2(1)2(3)2]3+ helicate, which is formed more than 
the [BF4- ⊂ Pd2(1)(3)3]3+ helicate. The least sterically hindered of all the helicates, 
[BF4- ⊂ Pd2(1)4]3+ is not formed. This suggests that when the two ligands are mixed 
together, the least sterically hindered helicate which incorporates most of the ligand 
in excess of the other is formed the most. Then the [BF4- ⊂ Pd2(1)3(3)]3+ helicate 
which is the least sterically hindered is formed over that of the more sterically 
hindered cis helicate, even though the trans helicate is formed the most. A small 
amount of the most sterically hindered [BF4- ⊂ Pd2(1)(3)3]3+ helicate is formed over 
the formation of the least sterically hindered [BF4- ⊂ Pd2(1)4]3+, which suggests that 
it is more favourable to form the helicate which incorporates both ligands over the 
one which contains only ligand 1. 
From these two experiments, it is clear that changing the ratio of ligands 1 : 3 added 
to the mixture influences the speciation of the heteroleptic [BF4- ⊂ Pd2(1)x(3)4-x]3+ 
helicates formed. It also supports that the trans helicate is preferably formed over 
this cis helicate. 
 
 
Synthesis of [Pd2(1)x(5)4-x] helicates 
 
 
[Pd2(1)x(5)4-x]3+ helicates were synthesised from the mixing of [Pd(MeCN)4](BF4)2, 
1, and 5 in a 2 : 2 : 2 ratio in d6 – DMSO at room temperature. The mixture was left 
for three days to equilibrate, and then sent for HR – ESI MS and 19F NMR analysis. 
The HR – ESI MS of the mixture supports the formation of a mixture of [BF4- ⊂ 
Pd2(1)x(5)4-x]3+ helicates (Figure 3.7). There are five main 3+ signals observed at 
m/z 452.39038, 461.73418, 471.07781, 480.42143, and 489.76503. The isotope 
patterns and m/z of the observed signals match that calculated for the heteroleptic 
species [BF4- ⊂ Pd2(1)4]3+, [BF4- ⊂ Pd2(1)3(5)]3+, [BF4- ⊂ Pd2(1)2(5)2]3+, [BF4- ⊂ 
Pd2(1)(5)3]3+, and [BF4- ⊂ Pd2(5)4]3+. There were no signals corresponding to 2+ or 
1+ helicate species. The ratios of the HR – ESI MS heights with respect to the [BF4- ⊂ 




Figure 3.7. HR – ESI MS (d6 – DMSO) of synthesised [BF4- ⊂ Pd2(1)x(5)4-x]3+ 
helicates showing the observed m/z and isotope pattern for each helicate. 
 
 
Table 3.2. Normalised ratios of the HR – ESI MS heights with respect to the [BF4- ⊂ 
Pd2(1)4]3+ height. 
 










Initial 1.00 11.86 10.86 5.71 1.43 
 
 
The 19F NMR of the mixture supports the formation of mixed [BF4- ⊂ Pd2(1)x(5)4-x]3+ 
helicates as the spectrum is different to the spectra of [BF4- ⊂ Pd2(1)4]3+ and [BF4- ⊂ 
Pd2(5)4]3+ mixtures (Figure 3.8). Other than the signal for the free BF4-, there are 
nine signals observed in the spectrum at δ -148.65 (A), -148.79 (D), -148.84 ([BF4- 
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⊂ Pd2(1)4]3+ + B), -148.90 ([BF4- ⊂ Pd2(1)4]3+ + B), -149.01 (E), -149.13 (F), -149.28 




Figure 3.8. 19F NMR (376 MHz, d6 – DMSO) of mixed [BF4- ⊂ Pd2(1)x(5)4-x]3+ 
helicates showing fluorine assignment. 
 
 
Comparing the spectrum with the spectrum of [BF4- ⊂ Pd2(5)4]3+, signals A, B, and C 
are likely those of the different atropisomers of [BF4- ⊂ Pd2(5)4]3+, and comparing 
the spectrum with that of [BF4- ⊂ Pd2(1)4]3+, the signals at δ – 148.84  and -148.90 
ppm are likely due to that of the [BF4- ⊂ Pd2(1)4]3+ helicate and atropisomer B, as 
the signals overlap. The signals, D, E, F, G, and H are due to the different heteroleptic 
[BF4- ⊂ Pd2(1)x(5)4-x]3+ helicates present. Comparison of the intensities of the 
encapsulated BF4- signals in the [BF4- ⊂ Pd2(5)4]3+ spectrum and the [BF4- ⊂ 
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Pd2(1)x(5)4-x]3+ spectrum, signals A and C have both decreased which suggests that 
the ratio of [BF4- ⊂ Pd2(5)4]3+ atropisomers has changed.  The ratio of free BF4- signal 
to the encapsulated BF4- signals is 4.00:1.00, which suggests that not all of the 
ligands have been incorporated into helicates. 
The 19F NMR of the mixture after heating shows a decrease in signal intensities for 
signal A, and no change in the intensities of the other signals. The ratio of the free 
BF4- signal to encapsulated BF4- signals slightly increases to 5.01:1.00 after heating, 
which suggests that more free ligand is present after heating.  
A 19F DOSY spectrum was also performed to determine the diffusion coefficients of 
both free BF4- and [BF4- ⊂ helicate]3+ signals (Figure 3.9). The diffusion coefficient 
for the free BF4- anion signal was recorded as (4.73 ± 0.2) x 10-10 m2 s-1, whereas the 
signals for the encapsulated BF4- anions of D, B + [BF4- ⊂ Pd2(1)4]3+, and F were 
recorded as (1.22 ± 0.2) x 10-10 m2 s-1, (1.32 ± 0.2) x 10-10 m2 s-1, (1.30 ± 0.2) x 10-10 
m2 s-1, and (1.21 ± 0.2) x 10-10 m2 s-1, respectively. The diffusion coefficients for 
signals A, C, E, G and H could not be measured due to the weakness of the signals. 
The diffusion coefficient for the free BF4- signal is consistent with what was observed 
for free BF4- in the other mixtures, and the diffusion coefficient for the encapsulated 
BF4- signal of [BF4- ⊂ Pd2(1)4]3+ is also consistent with what was observed for the 
pure solution of [BF4- ⊂ Pd2(1)4]3+. (1.34 ± 0.04 x 10-10 m2 s-1). Comparison of the 
diffusion coefficients for D and F with the values for signals A, B, and C in the pure 
[BF4- ⊂ Pd2(5)4]3+ mixture, the apparent sizes are of the helicates in both cases are 







Figure 3.9. 19F DOSY (470 MHz, d6 – DMSO) of mixed [BF4- ⊂ Pd2(1)x(5)4-x]3+ 
helicates showing diffusion coefficients of free and encapsulated BF4-. 
 
 
Synthesis of [Pd2(3)x(5)4-x] helicates 
 
 
[Pd2(3)x(5)4-x]3+ helicates were synthesised from the mixing of [Pd(MeCN)4](BF4)2, 
3, and 5 in a 2 : 2 : 2 ratio in d6 – DMSO at room temperature. The mixture was left 
for three days to equilibrate, and then sent for HR – ESI MS and 19F NMR analysis. 
The HR – ESI MS of the mixture supports the formation of a mixture of [BF4- ⊂ 
Pd2(3)x(5)4-x]3+ helicates (Figure 3.10). There are three main 3+ signals observed 
at m/z 489.76413, 513.76438, and 537.76453. The isotope patterns and m/z of the 
observed signals match that calculated for the heteroleptic species [BF4- ⊂ 
Pd2(5)4]3+, [BF4- ⊂ Pd2(3)(5)3]3+, and [BF4- ⊂ Pd2(3)2(5)2]3+. There are no signals 
observed for the homoleptic [BF4- ⊂ Pd2(3)4]3+ helicate and the heteroleptic [BF4- ⊂ 
Pd2(3)3(5)]3+ helicate. 
There were other signals corresponding to 2+ and 1+ helicate species present in the 
spectrum of the mixture. The two 2+ signals observed at m/z 788.13127 and 
824.13126 correspond to the heteroleptic species [Pd2(3)(5)3(BF4)(Cl)]2+ and 
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[Pd2(3)2(5)2(BF4)(Cl)]2+, respectively. The ratios of the HR – ESI MS heights with 




Figure 3.10. HR – ESI MS (d6 – DMSO) of synthesised [BF4- ⊂ Pd2(3)x(5)4-x]3+ 





Table 3.3. Normalised ratios of the HR – ESI MS heights with respect to the [BF4- ⊂ 
Pd2(5)4]3+ height. 
 
 [BF4- ⊂ Pd2(5)4]3+ [BF4- ⊂ Pd2(3)(5)3]3+ [BF4- ⊂ Pd2(3)2(5)2]3+ 
Initial 1.00 10.33 11.33 
 
 
The 19F NMR of the mixture supports the formation of mixed [BF4- ⊂ Pd2(3)x(5)4-x]3+ 
helicates as the spectrum is different to the spectra of [BF4- ⊂ Pd2(3)4]3+ and [BF4- ⊂ 
Pd2(5)4]3+ mixtures (Figure 3.11). Other than the signal for the free BF4-, there are 
12 signals observed in the spectrum at δ -148.57 (D), -148.67 (A + E), -148.83 (F), -
148.91 (G), -148.96 (B + H), -149.10 (I), -149.25 (J), -149.41 (K), -149.89 (C), -







Figure 3.11. 19F NMR (376 MHz, d6 – DMSO) of mixed [BF4- ⊂ Pd2(3)x(5)4-x]3+ 
helicates showing fluorine assignment. 
 
 
Comparing the spectrum with that of [BF4- ⊂ Pd2(5)4]3+, signals A, B, and C are likely 
due to the different atropisomers of [BF4- ⊂ Pd2(5)4]3+. However, they are hard to 
assign due to the overlapping of new signals due to the heteroleptic [BF4- ⊂ 
Pd2(3)x(5)4-x]3+ helicates (signals E and H). Signals D, F, G, and I - N are due to the 
new formed [BF4- ⊂ Pd2(3)x(5)4-x]3+ helicates. Due to the fact there are different 
atropisomers of the [BF4- ⊂ Pd2(5)4]3+ helicate, the heteroleptic [BF4- ⊂ Pd2(3)x(5)4-
x]3+ helicates can also have different atropisomers. This leads to a large number of 
signals observed in the 19F NMR, and therefore makes the assignment of the signals 
impossible. The ratio of free BF4- signal to the encapsulated BF4- signals is 8.00:1.00, 
which suggests that not all of the ligands have been incorporated into helicates. 
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The 19F NMR of the mixture after heating shows a decrease in signal intensities for 
signals D, A + E, F, G, B + H, I, C and M, and an increase in the signal intensities for 
signals J, L and N. There are also three new signals which have appeared at δ -150.38 
(O), -151.36 (P), and -151.50 (Q) ppm (Figure 3.12). These new signals could be 
due to either atropisomers of the [BF4- ⊂ Pd2(3)(5)3]3+ and [BF4- ⊂ Pd2(3)2(5)2]3+, 
or due to the formation of the [BF4- ⊂ Pd2(3)3(5)]3+ helicate, or a combination of the 
two. The sample was submitted for HR – ESI MS, however due to machine failure the 
sample could not be analysed.  
 
 
Figure 3.12. 19F NMR (376 MHz, d6 – DMSO) of mixed [BF4- ⊂ Pd2(3)x(5)4-x]3+ 
helicates after heating, showing fluorine assignment. 
 
 
A 19F DOSY spectrum was also performed to determine the diffusion coefficients of 
both free BF4- and [BF4- ⊂ helicate]3+ signals (Figure 3.13). The diffusion coefficient 
for the free BF4- anion signal was recorded as (5.22 ± 0.02) x 10-10 m2 s-1, whereas 
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the diffusion coefficients for signals F - G, B + H, J – K, C, and L were recorded as 
(1.57 ± 0.1) x 10-10 m2 s-1, (1.53 ± 0.1) x 10-10 m2 s-1, (1.93 ± 0.07) x 10-10 m2 s-1, (1.63 
± 0.03) x 10-10 m2 s-1, (1.82 ± 0.03) x 10-10 m2 s-1, (1.66 ± 0.02) x 10-10 m2 s-1, and 
(1.79 ± 0.02) x 10-10 m2 s-1,  respectively.  
The diffusion coefficients for signals D, A + E, I, M, and N could not be measured due 
to the weakness of the signals. The diffusion coefficient for the free BF4- signal is 
consistent with what was observed for free BF4- in the other mixtures. Comparing 
the diffusion coefficients for signals B + H and C with the diffusion coefficients of B 
and C from the [BF4- ⊂ Pd2(5)4]3+ mixture, the values are not in agreement with each 
other. In the [BF4- ⊂ Pd2(5)4]3+ mixture, the diffusion coefficient for both signal B 
and C was determined to be 1.18 ± 0.06 x 10-10 m2 s-1, whereas in this mixture the 
value for the signal B + H was determined to be 1.93 ± 0.07 x 10-10 m2 s-1, and C was 
determined to be 1.66 ± 0.02 x 10-10 m2 s-1. Comparing the signals to each other, the 
measured values for signals F and G are similar, so are the values for signals for J 
and C. The values for signals B + H, K, and L are also similar to each other. This 
suggests that the similar signals belong to different atropisomers of the same mixed 
helicate. Due to the complexity of the signals and the possibility of atropisomers, the 






Figure 3.13. 19F DOSY (470 MHz, d6 – DMSO) of mixed [BF4- ⊂ Pd2(3)x(5)4-x]3+ 
helicates showing diffusion coefficients of free and encapsulated BF4-. 
 
 
3.3 Synthesis of heteroleptic [Pd2(L)x(L’)4-x] helicates by ligand 
exchange on homoleptic [Pd2(L)4] helicates 
 
 
It was investigated whether heteroleptic helicates could be synthesised by adding 
free ligand to an existing solution of a homoleptic helicate, as described in Figure 
3.14. This was performed by adding ligand 3 to a solution of [BF4- ⊂ Pd2(1)4]3+, and 






Figure 3.14. Possible formation of heteroleptic [BF4- ⊂ Pd2(1)x(3)4-x]3+ helicates 
from the addition of ligand 3 to a solution of [BF4- ⊂ Pd2(1)4]3+. 
 
 
Synthesis of [Pd2(1)x(3)4-x] by ligand exchange on [Pd2(1)4] 
 
[Pd2(1)4]3+ helicate was synthesised from the mixing of [Pd(MeCN)4](BF4)2 and 1 in 
a 1 : 2 ratio in d6 – DMSO at room temperature. The mixture was left for three days 
to equilibrate, and then sent for 19F NMR analysis. Ligand 3 (1 eq.) was then added 
to the solution of [Pd2(1)4]3+ in d6 – DMSO at room temperature. The mixture was 
left again for three days to equilibrate, and then sent for 19F NMR analysis. 
A stack plot of the initial 19F NMR spectrum and the spectrum after the addition of 
ligand 3 is shown in Figure 3.15. The initial 19F NMR spectrum shows two signals 
at δ -148.28 and -148.88 ppm corresponding to free BF4- and the [BF4- ⊂ Pd2(1)4]3+ 
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helicate, respectively, and the ratio of the free BF4- signal to the encapsulated BF4- 
signal is 4.00:1.00, which suggests that not all of the ligands have been incorporated 
into helicates. After the addition of ligand 3, three new signals appeared at δ -149.84 
(A), -150.25 (C) and -150.80 (D) ppm, and are due to the [BF4- ⊂ Pd2(1)3(3)]3+, cis 
[BF4- ⊂ Pd2(1)2(3)2]3+, and trans [BF4- ⊂ Pd2(1)2(3)2]3+ helicates, respectively. The 
assignment of signals A, C and D were able to be determined as the match the 
chemical shift and splitting pattern observed of the respective signals in the 19F NMR 
spectrum of [BF4- ⊂ Pd2(1)x(3)4-x]3+. Interestingly, the [BF4- ⊂ Pd2(1)(3)3]3+ helicate 
is not produced from the mixing of ligand 3 with the solution of [BF4- ⊂ Pd2(1)4]3+. 
After the addition of ligand 3, the ratio of the free BF4- signal to the encapsulated 
BF4- signal was 3.00:1.00, which suggests that all of the ligands have been 
incorporated into helicates. Comparing this spectrum with the other spectra of 
synthesised [Pd2(1)x(3)4-x]3+ helicates, the intensities observed closely resemble 
that observed for the 2 : 3 : 1 mixture of Pd(II) : 1 : 3. Therefore, the same speciation 
of [Pd2(1)x(3)4-x]3+ helicates can be produced by either mixing the ligands in a 2 : 3 : 








Figure 3.15. 19F NMR (376 MHz, d6 – DMSO) stack plot of initial [BF4- ⊂ Pd2(1)4]3+ 




Synthesis of [Pd2(1)x(3)4-x] by ligand exchange on a mixture of Palladium(II) : 
3 
 
The palladium(II) : 3 mixture was synthesised from the mixing of 
[Pd(MeCN)4](BF4)2 and 3 in a 1 : 2 ratio in d6 – DMSO at room temperature. The 
mixture was left for three days to equilibrate, and then sent for 19F NMR analysis. 
Ligand 1 (1 eq.) was then added to the mixture of palladium (II) : 3  in d6 – DMSO at 
room temperature. The mixture was left again for three days to equilibrate, and then 
sent for 19F NMR analysis. 
A stack plot of the initial 19F NMR spectrum and the spectrum after the addition of 
ligand 3 is shown in Figure 3.16. The initial 19F NMR spectrum shows one signal at 
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δ -148.27 ppm corresponding to free BF4-, no signal is observed for the [BF4- ⊂ 
Pd2(3)4]3+ helicate as it is unable to form due to sterics. After the addition of ligand 
1, four new signals appeared at δ -148.93, -149.89 (A), -150.12 (B), -150.29 (C), and 
-150.84 (D) ppm, which are due to the [BF4- ⊂ Pd2(1)3(3)]3+, [BF4- ⊂ Pd2(1)(3)3]3+, 
cis [BF4- ⊂ Pd2(1)2(3)2]3+, and trans [BF4- ⊂ Pd2(1)2(3)2]3+ helicates, respectively. 
The assignment of signals A, B, C and D were able to be determined as the match the 
chemical shift and splitting pattern observed of the respective signals in the 19F NMR 
spectrum of [BF4- ⊂ Pd2(1)x(3)4-x]3+.   
After the addition of ligand 1, the ratio of the free BF4- signal to the encapsulated 
BF4- signal was 6.00:1.00, which suggests that not all of the ligands have been 
incorporated into helicates. Comparing this spectrum with the other spectra of 
synthesised [Pd2(1)x(3)4-x]3+ helicates, the intensities observed closely resemble 
that observed for the 2 : 3 : 1 mixture of Pd(II) : 1 : 3, and also that of the ligand 
exchange of 3 on [BF4- ⊂ Pd2(1)4]3+. Therefore, the same speciation of [Pd2(1)x(3)4-
x]3+ helicates can be produced by either mixing the ligands in a 2 : 3 : 1 mixture, by 
the addition of 1 equivalent of 3 to an existing solution of [BF4- ⊂ Pd2(1)4]3+, or by 





Figure 3.16. 19F NMR (376 MHz, d6 – DMSO) stack plot of initial palladium(II) : 3 




3.4 Anion exchange on [Pd2(1)x(L)4-x] helicates 
 
 
Similar to Chapter II, the anion exchange process was investigated on the libraries 
of synthesised [BF4- ⊂ Pd2(1)x(L)4-x]3+ helicates by adding the tetrabutylammonium 
salts of perchlorate (TBAClO4), perrhenate (TBAReO4), and nitrate (TBANO3). The 
anion exchange process was investigated to see if the heteroleptic helicates of 
[BF4- ⊂ Pd2(1)x(L)4-x]3+ would show preferences for binding of one anion over 
another, differently perhaps to what is observed for the homoleptic helicates. HR – 
ESI MS and 19F NMR analyses were chosen to follow the anion exchange process for 
each helicate library. 
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From herein, we will focus the discussion on the anion exchange processes for ClO4- 
and ReO4- in the [Pd2(1)x(3)4-x], [Pd2(1)x(4)4-x] and [Pd2(1)x(5)4-x] helicate mixtures. 
The anion exchange processes for NO3- in each helicate mixture, and the anion 
exchange processes for the [Pd2(1)x(2)4-x] and [Pd2(1)x(6)4-x] helicate mixtures are 
discussed in Appendix 3. 
 
 
Anion exchange on [Pd2(1)x(3)4-x] 
 
Addition of tetrabutylammonium perchlorate 
 
16 equivalents of tetrabutylammonium perchlorate (TBAClO4) were added to a 
solution of [BF4- ⊂ Pd2(1)4(3)4-x]3+ in d6 – DMSO. The mixture was then left for two 
days to equilibrate, and then analysed by HR – ESI MS and 19F NMR. 
The HR – ESI MS of the mixture confirms that anion exchange on the [BF4- ⊂ 
Pd2(1)4(3)4-x]3+ helicates has occurred with the addition of TBAClO4 (Figure 3.17). 
There are four main 3+ signals observed which match the m/z values calculated for 
the heteroleptic species [BF4- ⊂ Pd2(1)3(3)]3+, [ClO4- ⊂ Pd2(1)3(3)]3+, [BF4- ⊂ 






Figure 3.17. HR – ESI MS (d6 – DMSO) of [BF4- ⊂ Pd2(1)x(3)4-x]3+ after addition of 
16 equivalents of TBAClO4, showing observed signals for BF4- and 
ClO4- encapsulated helicates. 
 
 
Comparison with the initial MS spectrum of the [BF4- ⊂ Pd2(1)4(3)4-x]3+ solution,  
after the addition of 16 equivalents of ClO4- to the solution, some helicates are no 
longer observed: initially signals are observed for the [BF4- ⊂ Pd2(1)4]3+, [BF4- ⊂ 
Pd2(1)2(3)]3+, [BF4- ⊂ Pd2(1)2(3)2]3+, and [BF4- ⊂ Pd2(1)(3)3]3+ helicates. However, 
after the addition of ClO4-, only the [BF4- ⊂ Pd2(1)3(3)]3+ and [BF4- ⊂ Pd2(1)2(3)2]3+ 
helicates and the corresponding ClO4- encapsulated helicates are observed. This 
suggests that when ClO4- is added, the equilibrium mixture of [BF4- ⊂ Pd2(1)4(3)4-
x]3+ helicates rearranges to produce more of the helicates which prefer to 
encapsulate ClO4-. The relative heights of the [BF4- ⊂ Pd2(1)x(3)4-x]3+ helicates also 
differ between the initial spectrum and the spectrum after the addition of ClO4-. 
Before the addition, the [BF4- ⊂ Pd2(1)2(3)2]3+ signal is larger than the [BF4- ⊂ 
Pd2(1)3(3)]3+ signal, however after the addition the [BF4- ⊂ Pd2(1)3(3)]3+ signal is 
now larger than the [BF4- ⊂ Pd2(1)2(3)2]3+ signal. 
The ratio of heights of the [BF4- ⊂ Pd2(1)3(3)]3+ signal to the [ClO4- ⊂ Pd2(1)3(3)]3+ 
signal is 4:3, whereas the ratio of heights of the [BF4- ⊂ Pd2(1)2(3)2]3+ signal to the 
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[ClO4- ⊂ Pd2(1)2(3)2]3+ is 16:7. From this, the HR – ESI MS spectrum suggests that 
the [BF4- ⊂ Pd2(1)4(3)4-x]3+ helicates prefer to bind BF4- over ClO4-. 
The 19F NMR spectrum of the mixture supports the formation of ClO4- encapsulated 
helicates from the anion exchange of BF4- for ClO4- in [BF4- ⊂ Pd2(1)x(3)4-x]3+ (Figure 
3.18). Comparing this spectrum to the spectrum of the initial [BF4- ⊂ Pd2(1)x(3)4-
x]3+ solution, only the signals of A, C and D are observed: there is no signal observed 
for B or the [BF4- ⊂ Pd2(1)4]3+ helicate. The ratio of the free BF4- signal to the 
encapsulated BF4- signals also increases from 3.00:1.00 to 15.00:1.00, after the 
addition of 16 equivalents of ClO4-. This suggests that there is more free BF4- in the 
solution after the addition of ClO4-, which is due to the anion exchange of ClO4- for 




Figure 3.18. 19F NMR (470 MHz, d6 – DMSO) of the reaction of [BF4- ⊂ Pd2(1)x(3)4-




Addition of tetrabutylammonium perrhenate  
 
16 equivalents of tetrabutylammonium perrhenate (TBAReO4) were added to a 
solution of [BF4- ⊂ Pd2(1)x(3)4-x]3+ in d6 – DMSO. The mixture was then left for two 
days to equilibrate, and then analysed by HR – ESI MS and 19F NMR. 
The HR – ESI MS of the mixture confirms that anion exchange on the [BF4- ⊂ 
Pd2(1)4(3)4-x]3+ helicates has occurred with the addition of TBAReO4 (Figure 3.19). 
There are six main 3+ signals observed which match the m/z values calculated for 
the heteroleptic species [BF4- ⊂ Pd2(1)3(3)]3+, [ReO4- ⊂ Pd2(1)3(3)]3+, [BF4- ⊂ 




Figure 3.19. HR – ESI MS (d6 – DMSO) of [BF4- ⊂ Pd2(1)x(3)4-x]3+ after addition of 
16 equivalents of TBAReO4, showing observed signals for BF4- and 
ReO4- encapsulated helicates. 
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Comparison with the initial MS spectrum of the [BF4- ⊂ Pd2(1)x(3)4-x]3+ solution,  
after the addition of 16 equivalents of ClO4- to the solution, some helicates are no 
longer observed: initially signals are observed for the [BF4- ⊂ Pd2(1)4]3+, [BF4- ⊂ 
Pd2(1)2(3)]3+, [BF4- ⊂ Pd2(1)2(3)2]3+, and [BF4- ⊂ Pd2(1)(3)3]3+ helicates. However, 
after the addition of ReO4-, only the [BF4- ⊂ Pd2(1)3(3)]3+, [BF4- ⊂ Pd2(1)2(3)2]3+ and 
[BF4- ⊂ Pd2(1)(3)3]3+ helicates and the corresponding ReO4- encapsulated helicates 
are observed. This suggests that when ReO4- is added, the equilibrium mixture of 
[BF4- ⊂ Pd2(1)x(3)4-x]3+ helicates also rearranges to produce more of the helicates 
which prefer to encapsulate ReO4-. The relative heights of the                                          
[BF4- ⊂ Pd2(1)x(3)4-x]3+ helicates remain the same after the addition of ReO4-. 
The ratio of heights of the [BF4- ⊂ Pd2(1)x(3)4-x]3+ signals to the corresponding 
[ReO4- ⊂ Pd2(1)x(3)4-x]3+ signals are summarised in Table 3.4. For each helicate, the 
peak corresponding to the BF4- encapsulated helicate is larger than that of the 




Table 3.4. Ratio of MS heights of BF4- encapsulated helicates to corresponding 
ReO4- helicates. 
 [Pd2(1)3(3)]3+ [Pd2(1)2(3)2]3+ [Pd2(1)(3)3]3+ 
Ratio of BF4- : ReO4- 7:2 12:1 5:1 
 
 
The 19F NMR spectrum of the mixture supports the formation of ReO4- encapsulated 
helicates from the anion exchange of BF4- for ReO4- in [BF4- ⊂ Pd2(1)x(3)4-x]3+ 
(Figure 3.20). Comparing this spectrum to the spectrum of the initial [BF4- ⊂ 
Pd2(1)x(3)4-x]3+ solution, only the signals of A, B, C and D are observed: there is no 
signal observed for the [BF4- ⊂ Pd2(1)4]3+ helicate. The ratio of the free BF4- signal to 
the encapsulated BF4- signals also increases from 3.00:1.00 to 6.00:1.00, after the 
addition of 16 equivalents of ReO4-. This suggests that there is more free BF4- in the 
173 
 
solution after the addition of ReO4-, which is due to the anion exchange of ReO4- for 





Figure 3.20. 19F NMR (470 MHz, d6 – DMSO) of the reaction of [BF4- ⊂ Pd2(1)x(3)4-
x]3+ with 16 equivalents of TBAReO4 showing fluorine assignment. 
 
 
Anion exchange on [Pd2(1)x(4)4-x] 
 
Addition of tetrabutylammonium perchlorate 
 
16 equivalents of tetrabutylammonium perchlorate (TBAClO4) were added to a 
solution of [BF4- ⊂ Pd2(1)x(4)4-x]3+ in d6 – DMSO. The mixture was then left for two 
days to equilibrate, and then analysed by HR – ESI MS and 19F NMR. 
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The HR – ESI MS of the mixture confirms that anion exchange on the [BF4- ⊂ 
Pd2(1)x(4)4-x]3+ helicates has occurred with the addition of TBAClO4 (Figure 3.21). 
There are five main 3+ signals observed which match the m/z values calculated for 
the heteroleptic species [ClO4- ⊂ Pd2(1)4]3+, [ClO4- ⊂ Pd2(1)3(4)]3+, [ClO4- ⊂ 
Pd2(1)2(4)2]3+, [ClO4- ⊂ Pd2(1)(4)3]3+ and [ClO4- ⊂ Pd2(4)4]3+. There are no signals 
observed for the BF4- encapsulated [Pd2(1)x(4)4-x]3+ helicates. Interestingly, the 
speciation of [ClO4- ⊂ Pd2(1)x(4)4-x]3+ helicates is similar to that observed for the 




Figure 3.21. HR – ESI MS (d6 – DMSO) of [BF4- ⊂ Pd2(1)x(4)4-x]3+ after addition of 




The 19F NMR spectrum of the mixture supports the formation of ClO4- encapsulated 
helicates from the anion exchange of BF4- for ClO4- in [BF4- ⊂ Pd2(1)x(4)4-x]3+ (Figure 
3.22). Comparing this spectrum to that of the initial [BF4- ⊂ Pd2(1)x(4)4-x]3+ solution, 
there are no signals observed for BF4- encapsulated helicates. This suggests that 
175 
 
ClO4- has fully exchanged with the encapsulated BF4- helicates to form the [ClO4- ⊂ 




Figure 3.22. 19F NMR (470 MHz, d6 – DMSO) of the reaction of                                




Addition of tetrabutylammonium perrhenate  
 
16 equivalents of tetrabutylammonium perrhenate (TBAReO4) were added to a 
solution of [BF4- ⊂ Pd2(1)x(4)4-x]3+ in d6 – DMSO. The mixture was then left for two 
days to equilibrate, and then analysed by HR – ESI MS and 19F NMR. 
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The HR – ESI MS of the mixture confirms that anion exchange on the [BF4- ⊂ 
Pd2(1)x(4)4-x]3+ helicates has not occurred with the addition of TBAReO4 (Figure 
3.23). There are four main 3+ signals observed which match the m/z values 
calculated for the heteroleptic species [BF4- ⊂ Pd2(1)3(4)]3+, [BF4- ⊂ Pd2(1)2(4)2]3+, 
[BF4- ⊂ Pd2(1)(4)3]3+ and [BF4- ⊂ Pd2(4)4]3+. Interestingly, after the addition of ReO4-
, the relative heights of the [BF4- ⊂ Pd2(1)x(4)4-x]3+ observed in the MS are slightly 
different to what is observed in the initial spectrum. Before the addition the order 
of heights was 2:2 > 3:1 > 1:3 > 4:0 = 0:4, after addition the order of heights was 2:2 




Figure 3.23. HR – ESI MS (d6 – DMSO) of [BF4- ⊂ Pd2(1)x(4)4-x]3+ after addition of 




The 19F NMR spectrum of the mixture supports that the formation of 
ReO4- encapsulated helicates from the anion exchange of BF4- for ReO4- in [BF4- ⊂ 
Pd2(1)x(4)4-x]3+ has not occurred (Figure 3.24). Comparing this spectrum to the 
spectrum of the initial [BF4- ⊂ Pd2(1)x(4)4-x]3+ solution, all of the signals for the BF4- 
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encapsulated helicates are observed, including a small amount of the [BF4- ⊂ 
Pd2(1)4]3+ helicate, even though it is not observed in the HR – ESI MS of the mixture. 
The ratio of the free BF4- signal to the encapsulated BF4- signals also slightly 
increases from 4.00:1.00 to 5.00:1.00, after the addition of 16 equivalents of ReO4-. 
This slight increase is most likely due to the error within the measurement of the 






Figure 3.24. 19F NMR (470 MHz, d6 – DMSO) of the reaction of                                







Anion exchange on [Pd2(1)x(5)4-x] 
 
Addition of tetrabutylammonium perchlorate 
 
16 equivalents of tetrabutylammonium perchlorate (TBAClO4) were added to a 
solution of [BF4- ⊂ Pd2(1)x(5)4-x]3+ in d6 – DMSO. The mixture was then left for two 
days to equilibrate, and then analysed by HR – ESI MS and 19F NMR. 
The HR – ESI MS of the mixture confirms that anion exchange on the [BF4- ⊂ 
Pd2(1)x(5)4-x]3+ helicates has occurred with the addition of TBAClO4 (Figure 3.25). 
There are five main 3+ signals observed which match the m/z values calculated for 
the heteroleptic species [BF4- ⊂ Pd2(1)3(5)]3+, [ClO4- ⊂ Pd2(1)3(5)]3+, [BF4- ⊂ 
Pd2(1)2(5)2]3+, [ClO4- ⊂ Pd2(1)2(5)2]3+ and [ClO4- ⊂ Pd2(1)(5)3]3+. This suggests that 
when ClO4- is added, the equilibrium mixture of [BF4- ⊂ Pd2(1)x(5)4-x]3+ helicates 
rearranges to produce more of the helicates which prefer to encapsulate ClO4-. The 
ratio of heights of the [BF4- ⊂ Pd2(1)x(5)4-x]3+ signals to the corresponding [ClO4- ⊂ 
Pd2(1)x(5)4-x]3+ signals are summarised in Table 3.5. For each helicate, the ClO4- 
encapsulated helicate is larger than that of the corresponding BF4- helicate, 







Figure 3.25. HR – ESI MS (d6 – DMSO) of [BF4- ⊂ Pd2(1)x(5)4-x]3+ after addition of 
16 equivalents of TBAClO4, showing observed signals for BF4- and 
ClO4- encapsulated helicates. 
 
 
Table 3.5. Ratio of MS heights of BF4- encapsulated helicates to corresponding 
ClO4- helicates. 
 [Pd2(1)3(5)]3+ [Pd2(1)2(5)2]3+ 
Ratio of BF4- : ClO4- 8:63 3:68 
 
 
The 19F NMR spectrum of the mixture supports the formation of ClO4- encapsulated 
helicates from the anion exchange of BF4- for ClO4- in [BF4- ⊂ Pd2(1)x(5)4-x]3+ (Figure 
3.26). Comparing this spectrum to that of the initial [BF4- ⊂ Pd2(1)x(5)4-x]3+ solution, 
only signals D and B are observed. The ratio of the free BF4- signal to the 
encapsulated BF4- signals also increases from 4.00:1.00 to 143:1.00, after the 
addition of 16 equivalents of ClO4-. This suggests that there is more free BF4- in the 
solution after the addition of ClO4-, which is due to the anion exchange of ClO4- for 
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Figure 3.26. 19F NMR (470 MHz, d6 – DMSO) of the reaction of                                




Addition of tetrabutylammonium perrhenate  
 
16 equivalents of tetrabutylammonium perrhenate (TBAReO4) were added to a 
solution of [BF4- ⊂ Pd2(1)x(5)4-x]3+ in d6 – DMSO. The mixture was then left for two 
days to equilibrate, and then analysed by HR – ESI MS and 19F NMR. 
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The HR – ESI MS of the mixture confirms that anion exchange on the [BF4- ⊂ 
Pd2(1)x(5)4-x]3+ helicates has occurred with the addition of TBAReO4 (Figure 3.27). 
There are four main 3+ signals observed which match the m/z values calculated for 
the heteroleptic species [BF4- ⊂ Pd2(1)3(5)]3+, [ReO4- ⊂ Pd2(1)3(5)]3+, [BF4- ⊂ 
Pd2(1)2(5)2]3+ and [ReO4- ⊂ Pd2(1)2(5)2]3+. This suggests that when ReO4- is added, 
the equilibrium mixture of [BF4- ⊂ Pd2(1)x(5)4-x]3+ helicates rearranges to produce 
more of the helicates which prefer to encapsulate ReO4-. The 1+ ion which occurs at 
a m/z of 571.53799 corresponds to [(TBA)2BF4]+. The ratio of heights of the [BF4- ⊂ 
Pd2(1)x(5)4-x]3+ signals to the corresponding [ReO4- ⊂ Pd2(1)x(5)4-x]3+ signals are 
summarised in Table 3.6. For each helicate, the BF4- encapsulated helicate is larger 
than that of the corresponding ReO4- helicate, indicating that the helicates prefer to 







Figure 3.27. HR – ESI MS (d6 – DMSO) of [BF4- ⊂ Pd2(1)x(5)4-x]3+ after addition of 
16 equivalents of TBAReO4, showing observed signals for BF4- and 
ReO4- encapsulated helicates. 
 
 
Table 3.6. Ratio of MS heights of BF4- encapsulated helicates to corresponding 
ReO4- helicates. 
 [Pd2(1)3(5)]3+ [Pd2(1)2(5)2]3+ 





The 19F NMR spectrum of the mixture supports the formation of ReO4- encapsulated 
helicates from the anion exchange of BF4- for ReO4- in [BF4- ⊂ Pd2(1)x(5)4-x]3+ 
(Figure 3.28). Comparing this spectrum to that of the initial [BF4- ⊂ Pd2(1)x(5)4-x]3+ 
solution, only signals D, B and E are observed. The ratio of the free BF4- signal to the 
encapsulated BF4- signals also increases from 4.00:1.00 to 16.00:1.00, after the 
addition of 16 equivalents of ReO4-. This suggests that there is more free BF4- in the 
solution after the addition of ReO4-, which is due to the anion exchange of ReO4- for 




Figure 3.28. 19F NMR (470 MHz, d6 – DMSO) of the reaction of                                








It has been shown that by mixing different combinations of ligands 1 – 6, the 
speciation of the resulting dynamic libraries [Pd2LxL’4-x] can be altered. This in turn 
leads to further fine tuning of the electronics of the helicate’s cavity and therefore 
the potential ability of the cage to act as a host of anions. 
A histogram of the relative HR – ESI MS heights for each species in the synthesised 
[BF4- ⊂ Pd2LxL’4-x]3+ mixtures is shown in Figure 3.29. Comparing the dynamic 
libraries for [BF4- ⊂ Pd2(1)x(L)4-x]3+, as the bulkiness of ligand L is increased, the 
number of helicates observed and the overall speciation of helicates changes. For 
[BF4- ⊂ Pd2(1)x(2)4-x]3+, all five possible heteroleptic helicates are observed, 
however when ligand 2 is exchanged for ligand 3, all helicates are observed apart 
from [BF4- ⊂ Pd2(3)4]3+. When ligand 2 is exchanged for ligand 6, only three helicates 
are observed; [BF4- ⊂ Pd2(1)4]3+, [BF4- ⊂ Pd2(1)3(6)]3+ and [BF4- ⊂ Pd2(1)2(6)2]3+. 
This indicates that ligand 6 is bulkier than ligand 3, which is in turn bulkier than 
ligand 2 since less of the larger possible helicates are observed. The relative 
abundance of helicates observed also differs between the three mixtures, in [BF4- ⊂ 
Pd2(1)x(2)4-x]3+ the most abundant helicate is that of [BF4- ⊂ Pd2(1)2(2)2]3+, in [BF4- 
⊂ Pd2(1)x(3)4-x]3+ the most abundant is [BF4- ⊂ Pd2(1)2(3)2]3+, and in [BF4- ⊂ 









Figure 3.29. HR – ESI MS heights (mol %) for each species in the synthesised [BF4- 
⊂ Pd2LxL’4-x]3+ mixtures. Note: [BF4- ⊂ Pd2(2)x(6)4-x]3+ and [BF4- ⊂ Pd2(4)x(5)4-x]3+ 
are not shown due to overlap of signals in the spectra, and [BF4- ⊂ Pd2(3)x(6)4-x]3+ 
is not shown due to no formation of helicates. 
 
 
Comparing mixtures [BF4- ⊂ Pd2(1)x(4)4-x]3+ and [BF4- ⊂ Pd2(1)x(5)4-x]3+, all possible 
helicates are observed, however the relative abundances differ. The relative heights 
of the species in [BF4- ⊂ Pd2(1)x(4)4-x]3+ follow more of a Boltzmann distribution, 
whereas the most abundant species observed in [BF4- ⊂ Pd2(1)x(5)4-x]3+ is that of 
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[BF4- ⊂ Pd2(1)3(5)]3+. From this it suggests that ligand 5 is likely larger than that of 
ligand 4, since there is more of an abundance of smaller sized helicates observed in 
[BF4- ⊂ Pd2(1)x(5)4-x]3+ than [BF4- ⊂ Pd2(1)x(4)4-x]3+.  
From comparing the speciation observed in the [BF4- ⊂ Pd2LxL’4-x]3+ mixtures, the 
relative size of the ligands has been determined. Ligand 6 is the largest, and the size 
of the ligands in order from largest to smallest follow the order of 6 > 3 > 2 > 5 > 4 
> 1. Interestingly, the smallest possible ligand in the [BF4- ⊂ Pd2(1)x(4)4-x]3+ 
mixtures, [BF4- ⊂ Pd2(1)4]3+, is not the most abundant. Therefore, this suggests that 
it is more energetically favourable to incorporate as many of the two different 
ligands into heteroleptic helicates instead of forming the stable homoleptic 
helicates. The steric bulk of the ligands drives the speciation observed in the 
dynamic libraries. Similar observations have been reported by Clever where 
increasing the steric bulk of the ligand backbone leads to complete integrative self-
sorting to produce one heteroleptic product.5 
The same size conclusions can be made by comparison of the dynamic libraries for 
the [BF4- ⊂ Pd2(2)x(L)4-x]3+, [BF4- ⊂ Pd2(3)x(L)4-x]3+, [BF4- ⊂ Pd2(4)x(L)4-x]3+ and the 
[BF4- ⊂ Pd2(5)x(L)4-x]3+ mixtures. 
Comparing mixtures [BF4- ⊂ Pd2(3)x(4)4-x]3+ and [BF4- ⊂ Pd2(3)x(5)4-x]3+ highlights 
the differences in the size of ligand 4 and 5. For [BF4- ⊂ Pd2(3)x(4)4-x]3+, only the 3 : 
1, 2 : 2 and 1 : 3 helicates are observed, and for [BF4- ⊂ Pd2(3)x(5)4-x]3+, only the 2 : 
2, 1 : 3 and 0 : 4 helicates are observed. More of the helicates which incorporate 
ligand 3 are observed in the MS of [BF4- ⊂ Pd2(3)x(4)4-x]3+, whereas for [BF4- ⊂ 
Pd2(3)x(5)4-x]3+ less of the helicates which incorporate ligand 3 are observed. This 
supports the claim that ligand 4 is smaller than ligand 5, as ligand 4 is small enough 
to form the sterically demanding [BF4- ⊂ Pd2(3)3(4)]3+ helicate, whereas ligand 5 
cannot form the sterically demanding [BF4- ⊂ Pd2(3)3(5)]3+ helicate. Comparing 
mixtures [BF4- ⊂ Pd2(4)x(6)4-x]3+ and [BF4- ⊂ Pd2(5)x(6)4-x]3+ also highlight that 
ligand 4 is smaller than ligand 5. The most abundant species observed in the MS 
spectrum of [BF4- ⊂ Pd2(4)x(6)4-x]3+ is that of [BF4- ⊂ Pd2(4)3(6)]3+, whereas the 




From comparing these results to the three possible scenarios which can occur when 
a naked metal ion is mixed with two different ligands, only a select few of the 
dynamic libraries can be categorised into these scenarios. The dynamic libraries of 
[BF4- ⊂ Pd2(1)x(2)4-x]3+, [BF4- ⊂ Pd2(1)x(4)4-x]3+, [BF4- ⊂ Pd2(1)x(5)4-x]3+, [BF4- ⊂ 
Pd2(2)x(4)4-x]3+ and [BF4- ⊂ Pd2(2)x(5)4-x]3+ all roughly seem to form statistical 
mixtures of helicates. None of the dynamic libraries display narcissistic self-sorting 
to exclusively form homoleptic helicates, and none display integrative self-sorting 
to exclusively form one heteroleptic helicate.5  
The rest of the dynamic libraries seem to undergo partial integrative self-sorting to 
form more than one heteroleptic helicate, which seems to be influenced by the 
relative sizes of the two ligands employed in the mixtures. Therefore, there should 
be another sub-class under the integrative self-sorting scenario to account for these 
observations. 
It has also been determined that with the addition of a competing anion to the 
[Pd2LxL’4-x] dynamic libraries, the speciation of the resulting heteroleptic helicates 
can be further tuned by the exchange of BF4- for the competing anion. 
A stacked histogram of relative observed HR – ESI MS heights of the initial [BF4- ⊂ 
Pd2(1)x(L)4-x]3+ heights, and the observed [ClO4- ⊂ Pd2(1)x(L)4-x]3+ heights and 
[ReO4- ⊂ Pd2(1)x(L)4-x]3+ heights after the addition of 16 equivalents of TBAClO4 or 
TBAReO4 is shown in Figure 3.30. Comparing the observed heights of the BF4- and 
ClO4- encapsulated helicates for [Pd2(1)x(3)4-x]3+, the speciation of the heteroleptic 
helicates differ. For the [ClO4- ⊂ Pd2(1)x(3)4-x]3+ mixture, the most abundant species 
is that of the 1 : 3 species, whereas for [BF4- ⊂ Pd2(1)x(3)4-x]3+ the most abundant 
species is that of the 2 : 2 species. The speciation of [ReO4- ⊂ Pd2(1)x(3)4-x]3+ 
helicates closely resembles that observed for [BF4- ⊂ Pd2(1)x(3)4-x]3+, apart from the 




Figure 3.30. HR – ESI MS heights (mol %) for each species in synthesised [BF4- ⊂ 
Pd2(1)x(L)4-x]3+ mixtures. From top to bottom; initial [BF4- ⊂ Pd2(1)x(L)4-x]3+ 
helicates, [ClO4- ⊂ Pd2(1)x(L)4-x]3+ after addition of ClO4-, [ReO4- ⊂ Pd2(1)x(L)4-x]3+ 




For [BF4- ⊂ Pd2(1)x(4)4-x]3+, after the addition of ClO4- the speciation of [ClO4- ⊂ 
Pd2(1)x(4)4-x]3+ remains mostly the same as that observed for [BF4- ⊂ Pd2(1)x(4)4-
x]3+. The main difference is that the 2 : 2 and 1 : 3 helicates have the same abundance, 
and that the 0 : 4 helicate is more abundant than the 4 : 0 helicate. However, the 
addition of ReO4- to [BF4- ⊂ Pd2(1)x(4)4-x]3+ leads to no [ReO4- ⊂ Pd2(1)x(4)4-x]3+ 
helicates being observed. 
For [BF4- ⊂ Pd2(1)x(5)4-x]3+, after the addition of ClO4- the speciation of [ClO4- ⊂ 
Pd2(1)x(5)4-x]3+ differs to that observed for [BF4- ⊂ Pd2(1)x(5)4-x]3+. For [ClO4- ⊂ 
Pd2(1)x(5)4-x]3+, the most abundant species is that of the 2 : 2 helicate, whereas for 
[BF4- ⊂ Pd2(1)x(5)4-x]3+ the most abundant species is that of the 3 : 1 helicate. 
Another difference is the fact that the 4 : 0 and 0 : 4 ClO4- helicates are not observed 
in the MS. For [ReO4- ⊂ Pd2(1)x(5)4-x]3+, the most abundant species is that of the 2 : 
2 helicate, which matches the speciation observed for [BF4- ⊂ Pd2(1)x(5)4-x]3+, 
however the 4 : 0, 1 : 3 and 0 : 4 ReO4- helicates are not observed in the MS.  
For [BF4- ⊂ Pd2(1)x(6)4-x]3+, after the addition of both ClO4- and ReO4-, the speciation 
of [ClO4- ⊂ Pd2(1)x(6)4-x]3+ and [ReO4- ⊂ Pd2(1)x(6)4-x]3+ helicates observed closely 
resembles that observed for [BF4- ⊂ Pd2(1)x(6)4-x]3+. The only difference is that the 
4 : 0 helicate is not observed in the speciation of [ReO4- ⊂ Pd2(1)x(6)4-x]3+ helicates. 
From comparing the speciation observed for the [BF4- ⊂ Pd2(1)x(L)4-x]3+, [ClO4- ⊂ 
Pd2(1)x(L)4-x]3+ and [ReO4- ⊂ Pd2(1)x(L)4-x]3+ helicates, it is evident that the addition 
of a competing anion can further tune the speciation of heteroleptic helicates 
observed. It was found that the addition of ClO4- was more suited for the fine tuning 
as it led to an overall difference in the speciation of heteroleptic helicates observed, 










In conclusion, the mixing of different combinations of ligands 1 – 6 to produce 
dynamic libraries of [BF4- ⊂ Pd2(L)x(L’)4-x]3+ leads to differences in the speciation of 
helicates observed. These differences in speciation gives an indication of the relative 
sizes of ligands 1 – 6. As the size of the ligands used in the preparation of the [BF4- 
⊂ Pd2(L)x(L’)4-x]3+ mixtures increases, the resulting number of heteroleptic helicates 
observed decreases due to the steric interactions between neighbouring ligands of 
the helicate. For example in the mixture of [BF4- ⊂ Pd2(1)x(6)4-x]3+, no 1 : 3 or 0 : 4 
helicates are observed due to steric interactions between neighbouring 6 ligands. 
For [BF4- ⊂ Pd2(1)x(3)4-x]3+, only the 0 : 4 helicate is not observed due to steric 
interactions between neighbouring 3 ligands. Therefore, the conclusion can be 
drawn that ligand 6’s relative size is larger than that of ligand 3. From comparison 
of all [BF4- ⊂ Pd2(L)x(L’)4-x]3+ mixtures, it was determined that the relative size of 










It has become common practise to use density functional theory (DFT) calculations 
to better understand the lowest energy structures in an equilibrium mixture of 
heteroleptic species. Attempts were made to use DFT to calculate the lowest energy 
structures in these equilibrium mixtures by following strategies used by the likes of 
Preston6 and Crowley,7 however the results were inconclusive. This is most likely 
due to the increased flexibility of the ligands employed in the heteroleptic mixtures, 
compared to the rigid ligands used by Preston and Crowley. 
The addition of a competing anion to a prepared solution of [BF4- ⊂ Pd2(1)x(L)4-x]3+ 
leads to the further tuning of the speciation of the helicates observed for each 
mixture. For example, for [BF4- ⊂ Pd2(1)x(3)4-x]3+ the most abundant helicate 
observed is [BF4- ⊂ Pd2(1)2(3)2]3+, however after the addition of ClO4-, the [ClO4- ⊂ 
Pd2(1)3(3)]3+ helicate is the most abundant helicate observed. After the addition of 
ReO4- to the prepared solution, the most abundant helicate observed is [ReO4- ⊂ 
Pd2(1)2(3)2]3+. A similar observation is also made for the addition of a competing 
anion to a prepared solution of [BF4- ⊂ Pd2(1)x(5)4-x]3+. Therefore, the conclusion 
can be drawn that the addition of ClO4- to a prepared solution of                                          
[BF4- ⊂ Pd2(1)x(L)4-x]3+ leads to a change in the speciation of helicates observed, 
however the addition of ReO4- does not lead to a change in the observed speciation 
of helicates observed.  
From the anion exchange experiments on prepared solutions of                                          
[BF4- ⊂ Pd2(1)x(L)4-x]3+, it is evident that increasing the size of the competing anion 
has an effect on the overall speciation of helicates observed, leading to an increased 
amplification of helicates which are better suited for the binding of the incoming 
anion. For example, after the addition of ClO4- to the solution of                                            
[BF4- ⊂ Pd2(1)x(3)4-x]3+, only the [ClO4- ⊂ Pd2(1)3(3)]3+ and [ClO4- ⊂ Pd2(1)2(3)2]3+ 
helicates are observed, where the abundance of [ClO4- ⊂ Pd2(1)3(3)]3+ is greater 
than that of [ClO4- ⊂ Pd2(1)2(3)2]3+. However after the addition of ReO4- to the 
prepared solution, only the [ReO4- ⊂ Pd2(1)3(3)]3+, [ReO4- ⊂ Pd2(1)2(3)2]3+ and 
[ReO4- ⊂ Pd2(1)(3)3]3+ helicates are observed, where the abundance of [ReO4- ⊂ 
Pd2(1)2(3)2]3+ > [ReO4- ⊂ Pd2(1)3(3)]3+ > [ReO4- ⊂ Pd2(1)(3)3]3+. Since ClO4- is 
smaller than ReO4-, it is expected that the helicates with the smaller cavity size, 3 : 1 
and 2 : 2 are the only helicates observed to bind ClO4- as they contain the right sized 
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cavity to bind ClO4-, but too small to bind ReO4-. However ReO4- is larger than ClO4-, 
therefore it is expected that more of the 2 : 2 and some of the 1 : 3 helicates are 
observed to bind ReO4-, as the cavity would be large enough to accommodate the 
size of ReO4-, but too large for ClO4-. 
The same observation is also made for the addition of a competing anion to a 
prepared solution of [BF4- ⊂ Pd2(1)x(5)4-x]3+. After the addition of ClO4- to the 
solution of [BF4- ⊂ Pd2(1)x(5)4-x]3+, only the [ClO4- ⊂ Pd2(1)3(5)]3+, [ClO4- ⊂ 
Pd2(1)2(5)2]3+ and [ClO4- ⊂ Pd2(1)(5)3]3+ helicates are observed, where the 
abundance of [ClO4- ⊂ Pd2(1)2(5)2]3+ > [ClO4- ⊂ Pd2(1)3(5)]3+ > [ClO4- ⊂ 
Pd2(1)(5)3]3+. However, after the addition of ReO4- to the prepared solution, only the 
[ReO4- ⊂ Pd2(1)3(5)]3+ and [ReO4- ⊂ Pd2(1)2(5)2]3+ helicates are observed, where 
the abundance of [ReO4- ⊂ Pd2(1)3(5)]3+ is greater than that of [ReO4- ⊂ 
Pd2(1)2(5)2]3+. Since ClO4- is smaller than ReO4-, it is expected that more of the 
helicates containing more of ligand 5 than 1 will be produced to bind ClO4- as they 
have the right sized cavity to accommodate the size of ClO4-. However, the 1 : 3 
helicate is not observed to bind ReO4- suggesting that the 1 : 3 helicates cavity is too 
small to accommodate the size of ReO4-, therefore the helicates with more of ligand 
1 than 5 bind ReO4- more.  
From these results, it has been shown that the dynamic libraries seem to undergo 
partial integrative self-sorting to form more than one heteroleptic helicate, which 
seems to be influenced by the relative sizes of the two ligands employed in the 
mixtures. It has also been shown that adding a competing anion to a prepared 
solution of [BF4- ⊂ Pd2(1)x(L)4-x]3+ leads to an increase in the slight integrative self-
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To build further on the mixed heteroleptic [Pd2L4] helicates synthesised earlier, it 
was investigated whether it was possible to synthesise “tri-ligand” helicates which 
contained three different ligands, denoted L, L’, and L’’. There is only one reported 
method of the synthesis of a tri-ligand [Pd2(L)x(L’)y(L’’)y]4+ architecture.1 It was 
shown that the tri-ligand [Pd2(L)x(L’)y(L’’)y]4+ architecture was able to be generated 
in an equilibrium mixture from the ligand exchange reaction on the cis/trans 
heteroleptic [Pd2(L)2(L’)2]4+ cage with a competing ligand, L’’ (Figure 4.1). All three 
ligands contain the similar tripyridyl backbone, where the ligands differ with 
different substituents on the pyridine rings which interact with palladium (II). 
In contrast, we investigated whether a tri-ligand [Pd2(L)x(L’)y(L’’)y] helicate could 



















Figure 4.1. Synthesis of an equilibrium mixture containing a tri-ligand 
[Pd2(L)x(L’)y(L’’)y]4+ architecture from the ligand exchange reaction of ligand L’’ 





4.2 Synthesis of [Pd2(L)x(L’)y(L’’)z]3+ helicates 
 





The [Pd2(1)x(2)y(3)z]3+ helicates were synthesised by mixing [Pd(MeCN)4](BF4)2, 1, 
2 and 3 in a 2 : 2 : 2 : 2 ratio in d6 – DMSO at room temperature. The mixture was left 
for three days to equilibrate, and then sent for 19F NMR and 1H NMR analysis. The 
mixture was then heated at 80 oC overnight, and then sent for 19F NMR and HR – ESI 
MS analysis to ensure all thermodynamic products had been formed. 
A stack plot of the 19F NMR spectra of the [Pd2(1)x(2)y(3)z]3+ mixture (F), the heated 
mixture (G), as well as the spectra of [BF4- ⊂ Pd2(1)4]3+ (A), [BF4- ⊂ Pd2(2)4]3+ (B), 
[BF4- ⊂ Pd2(1)x(2)4-x]3+ (C), [BF4- ⊂ Pd2(1)x(3)4-x]3+ (D), and [BF4- ⊂ Pd2(2)x(3)4-x]3+ 
(E) supports the formation of tri-ligand [Pd2(1)x(2)y(3)z]3+ helicates (Figure 4.2), 
as there are two new [BF4- ⊂ helicate]3+ signals observed at δ -149.88 (a) and -
150.11 (b) ppm. The ratio of the free BF4- signal to the [BF4- ⊂ helicate]3+ signals is 
5.00:1.00, which suggests that not all palladium(II) is incorporated into cages. After 
heating, the ratio of free BF4- to encapsulated BF4- decreased to 4.00:1.00, which 









Figure 4.2. 19F NMR (376 MHz, d6 – DMSO) stack plot of homoleptic and heteroleptic 
mixtures showing tri-ligand helicate assignment. A; [BF4- ⊂ Pd2(1)4]3+, B; [BF4- ⊂ 
Pd2(2)4]3+, C; [BF4- ⊂ Pd2(1)x(2)4-x]3+, D; [BF4- ⊂ Pd2(1)x(3)4-x]3+, E; [BF4- ⊂ 




The 1H NMR spectrum of the mixture gave no support on whether all the ligands are 
incorporated into helicates due to its complexity (Figure 4.3). There is a mixture of 
large sharp signals and smaller signals observed, however comparing this to the 1H 
NMR spectra of the individual ligands, it is hard to determine if there is free ligand 
present in the mixture. To determine the identity of what tri-ligand 




Figure 4.3. 1H NMR (400 MHz, d6 – DMSO) of synthesised [BF4- ⊂ 
Pd2(1)x(2)y(3)z]3+, showing proton signals. 
 
 
The HR – ESI MS of the mixture suggests the formation of tri-ligand [BF4- ⊂ 
Pd2(1)x(2)y(3)z]3+ helicates (Figure 4.4). There are seven main 3+ signals which 
match that calculated for the heteroleptic species [BF4- ⊂ Pd2(1)4]3+, [BF4- ⊂ 
Pd2(1)3(2)]3+, [BF4- ⊂ Pd2(1)2(2)2]3+ or [BF4- ⊂ Pd2(1)3(3)]3+, [BF4- ⊂ Pd2(1)(2)3]3+ 
or [BF4- ⊂ Pd2(1)2(2)(3)]3+, [BF4- ⊂ Pd2(1)2(3)2]3+ or [BF4- ⊂ Pd2(2)4]3+ or [BF4- ⊂ 
Pd2(1)(2)2(3)]3+, [BF4- ⊂ Pd2(2)3(3)]3+ or [BF4- ⊂ Pd2(1)(2)(3)2]3+, and [BF4- ⊂ 
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Pd2(1)(3)3]3+ or [BF4- ⊂ Pd2(2)2(3)2]3+. There are no signals observed for [BF4- ⊂ 
Pd2(3)4]3+ or [BF4- ⊂ Pd2(2)(3)3]3+. Since ligands 1 – 3 only differ by one phenyl 
group, most of the signals observed in the HR – ESI MS have the same m/z signal as 
each other. This makes it difficult to determine what tri-ligand heteroleptic helicates 
are present in the mixture. 
As observed for the other heteroleptic species, there were several other signals 
corresponding to 2+ and 1+ helicate species present in the spectrum of the mixture. 
However, as mentioned above it is hard to determine what helicate has contributed 




Figure 4.4. HR – ESI MS (d6 – DMSO) of synthesised [BF4- ⊂ Pd2(1)x(2)y(3)z]3+ 









The [Pd2(1)x(3)y(6)z]3+ helicates were synthesised from the mixing of 
[Pd(MeCN)4](BF4)2, 1, 3 and 6 in a 2 : 2 : 2 : 2 ratio in d6 – DMSO at room temperature. 
The mixture was left for three days to equilibrate, and then sent for 19F NMR 
analysis. The mixture was then heated at 80 oC overnight, and then sent for HR – ESI 
MS and 19F NMR analysis to ensure all thermodynamic products had been formed. 
A stack plot of the 19F NMR spectra of the [Pd2(1)x(3)y(6)z]3+ mixture (D), the heated 
mixture (E), as well as the spectra of [BF4- ⊂ Pd2(1)4]3+ (A), [BF4- ⊂ Pd2(1)x(3)4-x]3+ 
(B), and [BF4- ⊂ Pd2(1)x(6)4-x]3+ (C) supports the formation of tri-ligand 
[Pd2(1)x(2)y(3)z]3+ helicates (Figure 4.5), as there are two new [BF4- ⊂ helicate]3+ 
signals observed at δ -149.56 (b) and -149.92 (a) ppm. The ratio of the free BF4- 
signal to the [BF4- ⊂ helicate]3+ signals is 6.00:1.00, which suggests that not all 
palladium(II) is incorporated into cages. After heating, the ratio of free BF4- to 
encapsulated BF4- decreased to 5.00:1.00, which suggests that still not all 
palladium(II) is incorporated into the new tri-ligand helicates. To determine the 
identity of what tri-ligand [Pd2(1)x(2)y(3)z]3+ helicates are present in the mixture, 





Figure 4.5. 19F NMR (376 MHz, d6 – DMSO) stack plot of homoleptic and heteroleptic 
mixtures showing tri-ligand helicate assignment. A; [BF4- ⊂ Pd2(1)4]3+, B; [BF4- ⊂ 
Pd2(1)x(3)4-x]3+, C; [BF4- ⊂ Pd2(1)x(6)4-x]3+, D; [BF4- ⊂ Pd2(1)x(3)y(6)z]3+, E; heated 
[BF4- ⊂ Pd2(1)x(3)y(6)z]3+. 
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The HR – ESI MS of the mixture supports the formation of tri-ligand [BF4- ⊂ 
Pd2(1)x(3)y(6)z]3+ helicates (Figure 4.6). There are eight main 3+ signals which 
match that calculated for the heteroleptic species [BF4- ⊂ Pd2(1)4]3+, [BF4- ⊂ 
Pd2(1)3(6)]3+, [BF4- ⊂ Pd2(1)3(3)]3+, [BF4- ⊂ Pd2(1)2(6)2]3+, [BF4- ⊂ Pd2(1)2(3)(6)]3+, 
[BF4- ⊂ Pd2(1)2(3)2]3+, [BF4- ⊂ Pd2(1)(3)2(6)]3+, and [BF4- ⊂ Pd2(1)(3)3]3+. There are 
no signals observed for [BF4- ⊂ Pd2(1)(6)3]3+, [BF4- ⊂ Pd2(3)4]3+, [BF4- ⊂ Pd2(6)4]3+, 
[BF4- ⊂ Pd2(3)3(6)]3+, [BF4- ⊂ Pd2(3)2(6)2]3+, [BF4- ⊂ Pd2(3)(6)3]3+, or [BF4- ⊂ 
Pd2(1)(3)(6)2]3+helicates, due to the bulkiness of both ligands 3 and 6 as seen 
previously.  
From the 19F NMR and HR – ESI MS data, the two new signals observed in the 19F 
NMR spectrum of [BF4- ⊂ Pd2(1)x(3)y(6)z]3+ are due to that of the tri-ligand helicates 
[BF4- ⊂ Pd2(1)2(3)(6)]3+ and [BF4- ⊂ Pd2(1)(3)2(6)]3+, where [BF4- ⊂ 
Pd2(1)(3)2(6)]3+ is the largest signal observed in the MS. To determine which signal 
is due to which helicate, a 19F NMR DOSY was performed as they should have 
different diffusion coefficients. However, due to the large number of signals present 
in the 19F NMR spectrum and the fact that the signals are weak, the DOSY gave no 
information on the diffusion coefficients of the tri-ligand helicates. Since heating the 
mixture forms new signal b, it is likely that this tri-ligand helicate is a 
thermodynamic product, and therefore is likely to be the more sterically hindered 
[BF4- ⊂ Pd2(1)(3)2(6)]3+ helicate. 
There were other signals corresponding to 2+ and 1+ helicate species present in the 
spectrum of the mixture. The seven 2+ signals observed which correspond to the 
heteroleptic species [Pd2(1)3(6)(BF4)(Cl)]2+, [Pd2(1)3(3)(BF4)(Cl)]2+, 
[Pd2(1)2(6)2(BF4)(Cl)]2+, [Pd2(1)2(3)(6)(BF4)(Cl)]2+, [Pd2(1)2(3)2(BF4)(Cl)]2+, 















Figure 4.6. HR – ESI MS (d6 – DMSO) of synthesised [BF4- ⊂ Pd2(1)x(3)y(6)z]3+ 
















The [Pd2(1)x(4)y(5)z]3+ helicates were synthesised from the mixing of 
[Pd(MeCN)4](BF4)2, 1, 4 and 5 in a 2 : 2 : 2 : 2 ratio in d6 – DMSO at room temperature. 
The mixture was left for three days to equilibrate, and then sent for 19F NMR 
analysis. The mixture was then heated at 80 oC overnight, and then sent for HR – ESI 
MS and 19F NMR analysis to ensure all thermodynamic products had been formed. 
A stack plot of the 19F NMR spectra of the [Pd2(1)x(4)y(5)z]3+ mixture (G), the heated 
mixture (H), as well as the spectra of [BF4- ⊂ Pd2(1)4]3+ (A), [BF4- ⊂ Pd2(4)4]3+ (B), 
[BF4- ⊂ Pd2(5)4]3+ (C), [BF4- ⊂ Pd2(1)x(4)4-x]3+ (D), [BF4- ⊂ Pd2(1)x(5)4-x]3+ (E), and 
[BF4- ⊂ Pd2(4)x(5)4-x]3+ (F) supports the formation of a tri-ligand [Pd2(1)x(4)y(5)z]3+ 
helicate (Figure 4.7), as there is one new [BF4- ⊂ helicate]3+ signal observed at δ – 
148.97 (a) ppm. Due to the overlap of signals in the spectrum, it is hard to determine 
if there are more new peaks present. The ratio of the free BF4- signal to the [BF4- ⊂ 
helicate]3+ signals is 5.00:1.00, which suggests that not all palladium(II) is 
incorporated into cages. After heating, the ratio of free BF4- to encapsulated 
BF4- stays consistent at 5.00:1.00, which suggests that still not all palladium(II) is 
incorporated into the new tri-ligand helicates. To determine the identity of the tri-
ligand [Pd2(1)x(4)y(5)z]3+ helicate present in the mixture, or if there are any more 





Figure 4.7. 19F NMR (376 MHz, d6 – DMSO) stack plot of homoleptic and heteroleptic 
mixtures showing tri-ligand helicate assignment. A; [BF4- ⊂ Pd2(1)4]3+, B; [BF4- ⊂ 
Pd2(4)4]3+, C; [BF4- ⊂ Pd2(5)4]3+, D; [BF4- ⊂ Pd2(1)x(4)4-x]3+, E; [BF4- ⊂ Pd2(1)x(5)4-




The HR – ESI MS of the mixture supports the formation of tri-ligand [BF4- ⊂ 
Pd2(1)x(4)y(5)z]3+ helicates (Figure 4.8). There are 14 main 3+ signals which 
overlap with each other and match that calculated for the heteroleptic species [BF4- 
⊂ Pd2(1)4]3+, [BF4- ⊂ Pd2(1)3(5)]3+, [BF4- ⊂ Pd2(1)3(4)]3+, [BF4- ⊂ Pd2(1)2(5)2]3+, 
[BF4- ⊂ Pd2(1)2(4)(5)]3+, [BF4- ⊂ Pd2(1)2(4)2]3+, [BF4- ⊂ Pd2(1)(5)3]3+, [BF4- ⊂ 
Pd2(1)(4)(5)2]3+, [BF4- ⊂ Pd2(1)(4)2(5)]3+, [BF4- ⊂ Pd2(1)(4)3]3+, [BF4- ⊂ Pd2(5)4]3+, 
[BF4- ⊂ Pd2(4)(5)3]3+, [BF4- ⊂ Pd2(4)2(5)2]3+, and [BF4- ⊂ Pd2(4)3(5)]3+. There is no 
signal observed for the [BF4- ⊂ Pd2(4)4]3+ helicate. 
The HR – ESI MS suggests that all three possible tri-ligand helicates are present in 
the mixture, however only one new signal is observed in the 19F NMR spectrum. 
Therefore, it is likely that two of the tri-ligand helicate signals are overlapped by the 
signals of the other heteroleptic helicates present in the mixture. Since the largest 
signal observed in the HR – ESI MS is that of the [BF4- ⊂ Pd2(1)2(4)(5)]3+ helicate, it 
is most likely that signal a corresponds to this helicate as it is the most abundant.  
There were other signals corresponding to 2+ and 1+ helicate species present in the 
spectrum of the mixture. The 12 2+ signals observed correspond to the heteroleptic 
species [Pd2(1)4(BF4)(Cl)]2+, [Pd2(1)3(5)(BF4)(Cl)]2+, [Pd2(1)3(4)2(BF4)(Cl)]2+, 
[Pd2(1)2(5)2(BF4)(Cl)]2+, [Pd2(1)2(4)(5)(BF4)(Cl)]2+, [Pd2(1)2(4)2(BF4)(Cl)]2+, 
[Pd2(1)(5)3(BF4)(Cl)]2+, [Pd2(1)(4)(5)2(BF4)(Cl)]2+, [Pd2(1)(4)2(5)(BF4)(Cl)]2+, 




















Figure 4.8. HR – ESI MS (d6 – DMSO) of synthesised [BF4- ⊂ Pd2(1)x(4)y(5)z]3+ 
















The [Pd2(2)x(3)y(6)z]3+ helicates were synthesised from the mixing of 
[Pd(MeCN)4](BF4)2, 2, 3 and 6 in a 2 : 2 : 2 : 2 ratio in d6 – DMSO at room temperature. 
The mixture was left for three days to equilibrate, and then sent for 19F NMR 
analysis. The mixture was then heated at 80 oC overnight, and then sent for HR – ESI 
MS and 19F NMR analysis to ensure all thermodynamic products had been formed. 
A stack plot of the 19F NMR spectra of the [Pd2(2)x(3)y(6)z]3+ mixture (D), the heated 
mixture (E), as well as the spectra of [BF4- ⊂ Pd2(2)4]3+ (A), [BF4- ⊂ Pd2(2)x(3)4-x]3+ 
(B), and [BF4- ⊂ Pd2(2)x(6)4-x]3+ (C) supports the formation of tri-ligand 
[Pd2(2)x(3)y(6)z]3+ helicates (Figure 4.9), as there are three new [BF4- ⊂ helicate]3+ 
signals observed at δ – 149.04 (a), -151.02 (b), and -148.98 (c) ppm. The ratio of the 
free BF4- signal to the [BF4- ⊂ helicate]3+ signals is 7.00:1.00, which suggests that not 
all palladium(II) is incorporated into cages. After heating, the ratio of free BF4- to 
encapsulated BF4- decreases to 6.00:1.00, which suggests that still not all 
palladium(II) is incorporated into the new tri-ligand helicates. To determine the 
identity of the tri-ligand [Pd2(2)x(3)y(6)z]3+ helicates present in the mixture, HR – 






Figure 4.9. 19F NMR (376 MHz, d6 – DMSO) stack plot of homoleptic and heteroleptic 
mixtures showing tri-ligand helicate assignment. A; [BF4- ⊂ Pd2(2)4]3+, B; [BF4- ⊂ 
Pd2(2)x(3)4-x]3+, C; [BF4- ⊂ Pd2(2)x(6)4-x]3+, D; [BF4- ⊂ Pd2(2)x(3)y(6)z]3+, E; heated 




The HR – ESI MS of the mixture supports the formation of tri-ligand [BF4- ⊂ 
Pd2(2)x(3)y(6)z]3+ helicates (Figure 4.10). There are seven main 3+ signals which 
match that calculated for the heteroleptic species [BF4- ⊂ Pd2(2)4]3+, [BF4- ⊂ 
Pd2(2)3(6)]3+, [BF4- ⊂ Pd2(2)3(3)]3+, [BF4- ⊂ Pd2(2)2(3)(6)]3+, [BF4- ⊂ Pd2(2)2(3)2]3+, 
[BF4- ⊂ Pd2(2)(3)2(6)]3+, and [BF4- ⊂ Pd2(2)(3)3]3+. There are no signals observed for 
[BF4- ⊂ Pd2(2)2(6)2]3+, [BF4- ⊂ Pd2(2)(6)3]3+, [BF4- ⊂ Pd2(3)3(6)]3+, [BF4- ⊂ 
Pd2(3)2(6)2]3+, [BF4- ⊂ Pd2(3)(6)3]3+, [BF4- ⊂ Pd2(3)4]3+, [BF4- ⊂ Pd2(6)4]3+, or [BF4- 
⊂ Pd2(2)(3)(6)2]3+helicates, due to the steric constraints of the ligands.  
From the 19F NMR and HR – ESI MS data, the three new signals observed in the 19F 
NMR spectrum of [BF4- ⊂ Pd2(2)x(3)y(6)z]3+ are due to that of the tri-ligand helicates 
[BF4- ⊂ Pd2(2)2(3)(6)]3+ and [BF4- ⊂ Pd2(2)(3)2(6)]3+. Since three new signals are 
observed in the 19F NMR of the mixture, and the MS suggest only two possible tri-
ligand helicates are present, it is likely that the third signal is an atropisomer of the 
[BF4- ⊂ Pd2(2)2(3)(6)]3+ helicate. However, there is no way to determine which 
signal in the NMR belongs to which tri-ligand helicate. 
There were other signals corresponding to 2+ and 1+ helicate species present in the 
spectrum of the mixture. The seven 2+ signals observed which correspond to the 
heteroleptic species [Pd2(2)4(BF4)(Cl)]2+, [Pd2(2)3(6)(BF4)(Cl)]2+, 
[Pd2(2)3(3)(BF4)(Cl)]2+, [Pd2(2)2(3)(6)(BF4)(Cl)]2+, [Pd2(2)2(3)2(BF4)(Cl)]2+, 



















Figure 4.10. HR – ESI MS (d6 – DMSO) of the 2 : 2 : 2 : 2 mixture of palladium (II) : 















The [Pd2(3)x(5)y(6)z]3+ helicates were synthesised from the mixing of 
[Pd(MeCN)4](BF4)2, 3, 5 and 6 in a 2 : 2 : 2 : 2 ratio in d6 – DMSO at room temperature. 
The mixture was left for three days to equilibrate, and then sent for 19F NMR 
analysis. The mixture was then heated at 80 oC overnight, and then sent for 19F NMR 
and HR – ESI MS analysis to ensure all thermodynamic products had been formed. 
A stack plot of the 19F NMR spectra of the [Pd2(3)x(5)y(6)z]3+ mixture (D), the heated 
mixture (E), as well as the spectra of [BF4- ⊂ Pd2(5)4]3+ (A), [BF4- ⊂ Pd2(3)x(5)4-x]3+ 
(B), and [BF4- ⊂ Pd2(5)x(6)4-x]3+ (C) supports the formation of tri-ligand 
[Pd2(3)x(5)y(6)z]3+ helicates (Figure 4.11), as there are seven new [BF4- ⊂ 
helicate]3+ signals observed at δ – 150.99 (a), -150.33 (b), -150.38 (c), -150.84 (d), -
151.16 (e), -151.37 (f), and -151.30 (g) ppm. The larger number of new signals 
observed are possibly due to the different atropisomers of the [BF4- ⊂ 
Pd2(3)(5)2(6)]3+ helicate, as seen in previous helicates containing ligand 5. 
Interesting to note is that with heating, the signals at δ -148.65, -148.93 and -150.99 
ppm disappear, and new signals appear. The ratio of the free BF4- signal to the [BF4- 
⊂ helicate]3+ signals is 18.00:1.00, which suggests that not all palladium(II) is 
incorporated into cages. After heating, the ratio of free BF4- to encapsulated 
BF4- decreases to 8.00:1.00, which suggests that still not all palladium(II) is 
incorporated into the new tri-ligand helicates. To determine the identity of the tri-





Figure 4.11. 19F NMR (376 MHz, d6 – DMSO) stack plot of homoleptic and 
heteroleptic mixtures showing tri-ligand helicate assignment. A; [BF4- ⊂ Pd2(5)4]3+, 
B; [BF4- ⊂ Pd2(3)x(5)4-x]3+, C; heated [BF4- ⊂ Pd2(5)x(6)4-x]3+, D; [BF4- ⊂ 




The HR – ESI MS of the mixture supports the formation of tri-ligand [BF4- ⊂ 
Pd2(3)x(5)y(6)z]3+ helicates (Figure 4.12). There are nine main 3+ signals which 
match that calculated for the heteroleptic species [BF4- ⊂ Pd2(5)4]3+, [BF4- ⊂ 
Pd2(5)3(6)]3+, [BF4- ⊂ Pd2(5)2(6)2]3+, [BF4- ⊂ Pd2(3)(5)3]3+, [BF4- ⊂ Pd2(3)(5)2(6)]3+, 
[BF4- ⊂ Pd2(3)(5)(6)2]3+, [BF4- ⊂ Pd2(3)2(5)2]3+, [BF4- ⊂ Pd2(3)2(5)(6)]3+, and [BF4- ⊂ 
Pd2(3)3(5)]3+. There are no signals observed for [BF4- ⊂ Pd2(3)4]3+, [BF4- ⊂ 
Pd2(3)3(6)]3+, [BF4- ⊂ Pd2(3)2(6)2]3+, [BF4- ⊂ Pd2(3)(6)3]3+, [BF4- ⊂ Pd2(5)(6)3]3+, or 
[BF4- ⊂ Pd2(6)4]3+helicates, due to the steric constraints of the ligands.  
From the 19F NMR and HR – ESI MS data, the seven new signals observed in the 19F 
NMR spectrum of [BF4- ⊂ Pd2(3)x(5)y(6)z]3+ are due to that of the tri-ligand helicates 
[BF4- ⊂ Pd2(3)2(5)(6)]3+, [BF4- ⊂ Pd2(3)(5)2(6)]3+ and [BF4- ⊂ Pd2(3)(5)(6)2]3+. Since 
seven new signals are observed in the 19F NMR of the mixture, and the MS suggest 
only two possible tri-ligand helicates are present, it is likely that most of the signals 
are due to the atropisomers of the [BF4- ⊂ Pd2(3)(5)2(6)]3+ helicate. However, there 
is no way to determine which signal in the NMR belongs to which tri-ligand helicate. 
There were other signals corresponding to 2+ and 1+ helicate species present in the 
spectrum of the mixture. The seven 2+ signals observed correspond to the 
heteroleptic species [Pd2(5)3(6)(BF4)(Cl)]2+, [Pd2(5)2(6)2(BF4)(Cl)]2+, 
[Pd2(3)(5)3(BF4)(Cl)]2+, [Pd2(3)(5)2(6)(BF4)(Cl)]2+, [Pd2(3)2(5)2(BF4)(Cl)]2+, 



















Figure 4.12. HR – ESI MS (d6 – DMSO) of the 2 : 2 : 2 : 2 mixture of palladium (II) : 













It has been determined that mixing different combinations of three different ligands 
chosen from ligands 1 – 6 in a 2 : 2 : 2 : 2 ratio with palladium (II) leads to the 
formation of tri-ligand [Pd2(L)x(L’)y(L’’)y] helicates. It was also determined that the 
number of tri-ligand helicates observed for a certain mixture of ligands was 
dependent on the size compatibility of the ligands chosen. 
For the mixture of palladium(II) : 1 : 2 : 3, the MS of the mixture suggests that all 
three possible tri-ligand helicates are produced. However, since each ligand only 
differs by one benzene unit, the m/z signal for the tri-ligands are the same as the 
m/z signal for some of the [Pd2(L)x(L’)4-x] helicates.  
For the mixture of palladium(II) : 1 : 4 : 5, all three possible tri-ligand helicates are 
observed in the MS of the mixture. The [BF4- ⊂ Pd2(1)2(4)(5)]3+ helicate is the most 
abundant species observed in the MS, closely followed by the [BF4- ⊂ 
Pd2(1)(4)2(5)]3+ helicate. The [BF4- ⊂ Pd2(1)(4)(5)2]3+ helicate is the least abundant 
of the three tri-ligand helicates. In Chapter 3, the relative sizes of ligands 1 – 6 were 
determined, where 5 > 4 > 1. Since ligand 5 is larger than ligand 1 and 4, it is least 
likely that two 5 ligands would be able to easily form a tri-ligand helicate species 
compared to two 4 ligands or two 1 ligands due to the increase in steric interactions 
between neighbouring ligands. 
For the mixture of palladium(II) : 3 : 5 : 6, all three possible tri-ligand helicates are 
observed in the MS of the mixture. However, for the mixtures of palladium(II) : 1 : 3 
: 6 and palladium(II) : 2 : 3 : 6, the tri-ligand helicate containing two 6 ligands signal 
is not observed. The observations for how many tri-ligand helicates are observed 
for each of the three mixtures can be explained by the relative size of the ligands 
used. All three mixtures use ligands 3 and 6, which were determined as the two 
largest ligands out of ligands 1 – 6. Therefore, comparing the relative sizes of 1, 2 
and 5 should explain why the number of tri-ligand helicates are observed.  
For palladium(II) : 3 : 5 : 6, the [BF4- ⊂ Pd2(3)(5)2(6)]3+ helicate is the most 
abundant tri-ligand helicate, followed by [BF4- ⊂ Pd2(3)2(5)(6)]3+ and then [BF4- ⊂ 
Pd2(3)(5)(6)2]3+. The [BF4- ⊂ Pd2(3)(5)(6)2]3+ helicate is the smallest signal 
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observed in the MS of the mixture, suggesting that having a ligand containing two 
ligands of 6 is not favourable, which is due to the fact that 6 has the largest relative 
size out of ligands 1- 6. Therefore, this helicate has the largest steric interactions 
between neighbouring ligands. The [BF4- ⊂ Pd2(3)(5)2(6)]3+ helicate is the more 
abundant than the [BF4- ⊂ Pd2(3)2(5)(6)]3+ helicate, since the relative size of ligand 
5 is smaller than that of ligand 3. 
For palladium(II) : 2 : 3 : 6, the [BF4- ⊂ Pd2(2)2(3)(6)]3+ helicate is the most 
abundant tri-ligand helicate compared to [BF4- ⊂ Pd2(2)(3)2(6)]3+, and the [BF4- ⊂ 
Pd2(2)(3)(6)2]3+ helicate is not observed in the MS of the mixture. Since the relative 
size of ligand 2 is smaller than that of ligand 3, it is easier to fit two of ligand 2 beside 
ligands 3 and 6 compared to fitting two of ligand 3 beside ligands 2 and 6. It is 
harder to fit two of ligand 6 beside ligands 2 and 3, due to the bulkiness of ligand 6. 
This would cause an increase in the steric interactions between neighbouring 
ligands in the helicate, which is therefore why it is not observed in the MS of the 
mixture. Since ligand 2 is much larger than ligand 5, it is harder to form the tri-ligand 
[BF4- ⊂ Pd2(2)(3)(6)2]3+ helicate compared to the tri-ligand [BF4- ⊂ Pd2(3)(5)(6)2]3+ 
helicates, due to the increase in steric interactions between the neighbouring 
ligands. 
For palladium(II) : 1 : 3 : 6, the [BF4- ⊂ Pd2(1)2(3)(6)]3+ helicate is the most 
abundant tri-ligand helicate compared to [BF4- ⊂ Pd2(1)(3)2(6)]3+, and the [BF4- ⊂ 
Pd2(1)(3)(6)2]3+ helicate is not observed in the MS of the mixture. Since the relative 
size of ligand 1 is smaller than that of ligand 3, it is easier to fit two of ligand 1 beside 
ligands 3 and 6 compared to fitting two of ligand 3 beside ligands 1 and 6. It is 
harder to fit two of ligand 6 beside ligands 1 and 3, due to the bulkiness of ligand 6. 
This would cause an increase in the steric interactions between neighbouring 
ligands in the helicate, which is therefore why it is not observed in the MS of the 
mixture. However, the relative size of ligand 5 was determined to be larger than 
ligand 6, but the [BF4- ⊂ Pd2(3)(5)(6)2]3+ helicate is observed but the [BF4- ⊂ 
Pd2(1)(3)(6)2]3+ is not. This suggests that there might be another factor that 




4.4 Conclusions  
 
In conclusion, the number of tri-ligand species observed for a mixture of three 
different ligands was found to depend on the size compatibility of the ligands 
employed. In general, the tri-ligand species which is formed in the greatest amount 
is the one that contains two ligands of the ligand with the smallest relative size to 
the other ligands employed in the mixture. 
For example for the mixture of palladium(II) : 1 : 4 : 5, all three possible tri-ligand 
species are observed, where the [BF4- ⊂ Pd2(1)2(4)(5)]3+ helicate is the most 
abundant, followed by [BF4- ⊂ Pd2(1)(4)2(5)]3+ and then [BF4- ⊂ Pd2(1)(4)(5)2]3+. 
All three possible tri-ligand species are observed as ligands 1, 4, and 5 have the 
smallest relative sizes of ligands 1 – 6. Since all three ligands are relatively small, the 
size compatibility between them is great, and therefore all three tri-ligand species 
can form. 
For the mixture of palladium(II) : 2 : 3 : 6, only two of the three possible tri-ligand 
species are observed, where the [BF4- ⊂ Pd2(2)2(3)(6)]3+ helicate more abundant 
than the [BF4- ⊂ Pd2(2)(3)2(6)]3+ helicate. The [BF4- ⊂ Pd2(2)(3)(6)2]3+ helicate is 
not observed in the mixture. Only two of the three possible tri-ligand species are 
observed as ligands 2, 3 and 6 have the largest relative sizes of ligands 1 – 6. Since 
all three ligands are relatively large, the size compatibility between them is poor, 
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A1.1 General experimental information 
 
Unless otherwise stated, all reagents were purchased from commercial sources and 
used without further purification. All solvents were laboratory reagent grade, and 
petroleum ether refers to the fraction of petrol boiling in the range of 40 – 60 oC. 1H 
(1D or 2D) and 19F NMR spectra were recorded on either a Varian 400 MHz (400 
MHz for 1H and 376 MHz for 19F) or a Varian 500 MHz spectrometer (470 MHz for 
19F) at 298 K. All chemical shifts are reported relative to the residual CDCl3 or d6 – 
DMSO solvent peaks (CDCl3: 1H δ 7.26 ppm; d6 – DMSO:  1H δ 2.50 ppm), or to the 
internal standard of TBAPF6 in d6 – DMSO (19F), according to the δ scale. Chemical 
shifts are rounded to 0.01 ppm, and coupling constants rounded to 0.1 Hz. 
Resonances were assigned as follows: chemical shift (number of protons, 
multiplicity, coupling constant(s), assigned proton(s)). Multiplicity abbreviations 
are reported by the following conventions: s (singlet), d (doublet), t (triplet), m 
(multiplet) and br (broad). High resolution electrospray ionisation mass spectra 
(HR – ESI MS) were collected on a Shimadzu LCMS – 9030 mass spectrometer. 
Microanalyses were performed at the Campbell Microanalytical Laboratory at the 
University of Otago. 
Unless otherwise stated, assignment of 19F NMR BF4- chemical shifts and diffusion 






A2.1 Synthesis of [Pd2(L)4] helicates 
 
 
Synthesis of [Pd2(2)4] helicate 
 
The [Pd2(2)4]3+ helicate was synthesised from the mixing of [Pd(MeCN)4](BF4)2 and 
2 in a 1 : 2 ratio in d6 – DMSO at room temperature. The mixture was left for three 
days to equilibrate, and then sent for HR – ESI MS, 1H NMR and 19F NMR analysis. 
The HR – ESI MS of the mixture supports the formation of the BF4- encapsulated 
helicate. The calculated m/z value for the [BF4- ⊂ Pd2(2)4]3+ helicate matched one of 
the main signals observed in the mixture (519.07827 and 519.07604, respectively). 
The isotope patterns of both the calculated and observed signals matched, 
supporting that the [BF4- ⊂ Pd2(2)4]3+ helicate had likely formed (Figure A2.1). Two 
other signals were present in the spectrum of the mixture, one at m/z value 
796.09870 corresponding to a [Pd2(2)4(BF4)Cl]2+ helicate and the other at m/z value 
1679.20080 corresponding to a [Pd2(2)4(BF4)2Cl]+ helicate. A small amount of 2 was 
also observed in the spectrum at 315.1109, which matches the calculated value for 




Figure A2.1. HR – ESI MS (d6 – DMSO) of synthesised [BF4- ⊂ Pd2(2)4]3+ showing 
the observed parent ion and isotope pattern and the calculated parent ion and 
isotope pattern for [C80H56N8O8Pd2BF4]3+.  
 
 
The 1H NMR of the mixture was complicated due to the broadness of the signals for 
the aromatic protons, which is different to the sharp signals observed in the 
spectrum of pure ligand 2 (Figure A2.2). This is different to what is observed with 
the spectrum of pure ligand 1 and the spectrum of [BF4- ⊂ Pd2(1)4]3+ as these both 
have sharp signals, and therefore were easier to assign due to the rapid 
interconversion of M and P helical forms on the NMR timescale. The broadness of 
the aromatic signals for [BF4- ⊂ Pd2(2)4]3+ suggests that the M and P helical forms 





Figure A2.2. 1H NMR (400 MHz, d6 – DMSO) of synthesised [BF4- ⊂ Pd2(2)4]3+ 
showing broad aromatic proton signals. 
 
 
The 19F NMR of the mixture was easier to analyse since only two signals are 
observed in the spectrum (Figure A2.3).  The larger of the two signals is similar to 
that observed for free BF4- in the [BF4- ⊂ Pd2(1)4]3+ spectrum, and is observed at the 
same chemical shift of δ -148.29 ppm. The second signal is smaller and broader than 
the signal observed for [BF4- ⊂ Pd2(1)4]3+, and is observed more upfield at δ -150.24 
ppm. This signal is likely to be due to the [BF4- ⊂ Pd2(2)4]3+ helicate.  The ratio of the 
free BF4- signal to this new signal is 4.00:1.00, which suggests that there is four times 
the amount of free BF4- in the mixture than of the [BF4- ⊂ Pd2(2)4]3+ helicate present. 
The ratio of the two signals suggests that not all of the ligand in the mixture was 
used to form the [BF4- ⊂ Pd2(2)4]3+ helicate, since the ratio is not exactly 3:1. This 







Figure A2.3. 19F NMR (376 MHz, d6 – DMSO) of synthesised [BF4- ⊂ Pd2(2)4]3+ 
showing fluorine assignment. 
 
 
A 19F DOSY spectrum was also performed on the mixture to determine the diffusion 
coefficients of both the free and [BF4- ⊂ helicate] anions (Figure A2.4). The diffusion 
coefficient for the free BF4- anion signal was recorded as (5.53 ± 0.04) x 10-10 m2 s-1, 
whereas the signal for the encapsulated BF4- anion was recorded as (1.53 ± 0.05) x 
10-10 m2 s-1. This information supports that the smaller signal is that of [BF4- ⊂ 





Figure A2.4. 19F DOSY (470 MHz, d6 – DMSO) of synthesised [BF4- ⊂ Pd2(2)4]3+ 
showing diffusion coefficients of free and encapsulated BF4-. 
 
 
Synthesis of [Pd2(4)4] helicate 
 
The [Pd2(4)4]3+ helicate was synthesised from the mixing of [Pd(MeCN)4](BF4)2 and 
4 in a 1 : 2 ratio in d6 – DMSO at room temperature. The mixture was left for three 
days to equilibrate, and then sent for HR – ESI MS, 1H NMR and 19F NMR analysis. 
The HR – ESI MS of the mixture supports the formation of the BF4- encapsulated 
helicate (Figure A2.5). The calculated m/z value for the [BF4- ⊂ Pd2(4)4]3+ helicate 
matched one of the main signals observed in the mixture (500.36541 and 
500.36459, respectively). The isotope patterns of both the calculated and observed 
signals matched, supporting that the [BF4- ⊂ Pd2(4)4]3+ helicate had likely formed. 
Three other signals were present in the spectrum of the mixture, one at m/z value 
768.03073 corresponding to a [Pd2(4)4(BF4)(Cl)]2+ helicate, one at m/z value 
794.04838 corresponding to a [Pd2(4)4(BF4)2]2+ helicate, and the other at m/z value 
1674.10024 corresponding to a [Pd2(4)4(BF4)3]+ helicate. A small amount of 4 was 
also observed in the spectrum at m/z value 301.07714, which matches the 





Figure A2.5. HR – ESI MS (d6 – DMSO) of synthesised [BF4- ⊂ Pd2(4)4]3+ showing 
the observed parent ion and isotope pattern and the calculated parent ion and 
isotope pattern for [C64H40F8N8O8Pd2BF4]3+.  
 
 
The aromatic proton signals present in the 1H NMR spectrum of the mixture were 
hard to assign due to their complexity (Figure A2.6). Some of the signals are sharp, 
whereas others are quite broad. The broader signals are most likely due to the slow 




Figure A2.6. 1H NMR (400 MHz, d6 – DMSO) of synthesised [BF4- ⊂ Pd2(4)4]3+ 
showing aromatic proton signals. 
 
 
The 19F NMR spectrum of the mixture shows fluorine signals from the fluorine atoms 
of [BF4- ⊂ Pd2(4)4]3+, from other products and from free and encapsulated BF4- 
(Figure A2.7). The fluorine signal at δ -127.09 ppm is likely due to the fluorine 
atoms of 4 in [BF4- ⊂ Pd2(4)4]3+ since the signal is similar to that observed for the 
pure ligand, 4 and has been shifted downfield. This downfield shift of the signal is 
typical for coordination to a metal ion, and is observed in the 1H NMR spectrum of 
[BF4- ⊂ Pd2(1)4]3+. However, there is no signal observed at δ -131.23 ppm which 
suggests that there is no free ligand present in the mixture. The other two signals 
observed at δ -133.28 and -134.43 ppm are most likely to be that of other products 
which could be present in the mixture as they are shifted upfield relative to the 
signal for pure ligand 4.  
The other signals present in the 19F NMR spectrum are assigned to free BF4- and [BF4- 
⊂Pd2(4)4]3+, where the larger signal at δ -148.25 is assigned to free BF4-. However, 
instead of only seeing one signal slightly upfield from the BF4- signal as observed for 
[BF4- ⊂ Pd2(1)4]3+ and [BF4- ⊂ Pd2(2)4]3+, four different signals are observed. Three 
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of the signals are slightly overlapping, and the other signal is sharp. All four of the 
signals are assumed to be due to [BF4- ⊂ Pd2(4)4]3+ helicates, since all the signals 
have the same splitting pattern observed for free BF4-. The four signals of [BF4- ⊂ 





Figure A2.7. 19F NMR (376 MHz, d6 – DMSO) of synthesised [BF4- ⊂ Pd2(4)4]3+ 
showing fluorine assignment. 
 
 
Due to the nature of ligand 4, when the ligands coordinate to palladium(II) to form 
[BF4- ⊂ Pd2(4)4]3+, different relative dispositions of the ligand substituents in the 
helicates are possible. These differences in the relative dispositions of the ligand 
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substituents are referred to as atropisomers. This occurs because ligand 4 has the 
fluorine atoms in a 2,5- configuration, so when coordination occurs the ligand can 
either have the fluorine atoms pointing “up” or “down”, as seen for [BF4- ⊂ 
Pd2(5)4]3+. Since all the atropisomers experience the same electronic environment, 
the slight difference in chemical shifts between the atropisomers cannot be due to 
the electronics of the cavity. It is more likely that the slight difference in chemical 
shift is related to the difference in cavity sizes due to the subtle differences in the 
dispositions of the ligand substituents of [BF4- ⊂ Pd2(4)2]3+. 
However, there is no way to distinguish which atropisomer of the [BF4- ⊂ Pd2(4)4]3+ 
helicate is responsible for which encapsulated BF4- helicate signal. The chemical 
shifts of the [BF4- ⊂ Pd2(4)4]3+ helicates are further upfield than that of the [BF4- ⊂ 
Pd2(1)4]3+ helicate (δ -148.89 ppm), but are downfield to that of the [BF4- ⊂ 
Pd2(2)4]3+ helicate (δ – 150.24 ppm). The ratio of the free BF4- signal to the four new 
signals is 5.00:1.00, which suggests that not all of the ligand in the mixture was used 
to form the [BF4- ⊂ Pd2(4)4]3+ helicates, since the ratio is not exactly 3:1.  
A 19F DOSY spectrum was also performed on the mixture to determine the diffusion 
coefficients of both the free and [BF4- ⊂ helicate]3+ anions (Figure A2.8). The 
diffusion coefficient for the free BF4- anion signal was recorded as (5.02 ± 0.02) x 10-
10 m2 s-1, whereas the signals for each of the encapsulated BF4- helicates were 
recorded as (from A to D); (0.83 ± 0.04) x 10-10 m2 s-1, (0.95 ± 0.02) x 10-10 m2 s-1, 
(1.13 ± 0.01) x 10-10 m2 s-1 and (0.82 ± 0.03) x 10-10 m2 s-1. This information supports 
that the smaller signals are that of the atropisomers [BF4- ⊂ Pd2(4)4]3+ helicates 
since they diffuse slower through d6 – DMSO than that of the free BF4- signal. Two of 
the diffusion coefficients for the [BF4- ⊂ Pd2(4)4]3+ atropisomers overlap suggesting 
that they are similar in size, however the other two diffusion coefficients do not 





Figure A2.8. 19F DOSY (470 MHz, d6 – DMSO) of synthesised [BF4- ⊂ Pd2(4)4]3+ 
showing diffusion coefficients of free and encapsulated BF4-. 
 
 
Attempted synthesis of [Pd2(6)4] helicate 
 
The [Pd2(6)4]3+ helicate was attempted to be synthesised from the mixing of 
[Pd(MeCN)4](BF4)2 and 6 in a 1 : 2 ratio in d6 – DMSO at room temperature. After 
three hours, the mixture had turned into a jelly-like substance. The mixture was left 
for three days to equilibrate, and then sent for HR – ESI MS, 1H NMR and 19F NMR 
analysis.  
The HR – ESI MS of the mixture showed a number of different signals, but none 
matched that of the [BF4- ⊂ Pd2(6)4]3+ helicate (Figure A2.9). The calculated m/z for 
[BF4- ⊂ Pd2(6)4]3+ occurs at 520.80808, however there is no signal observed in the 
spectrum of the mixture at this value. This supports that the [BF4- ⊂ Pd2(6)4]3+ 
helicate has unlikely formed. The formation of a jelly-like substance suggests that a 
polymer-sheet of palladium(II) and 6 has formed, which is similar to what is 
reported to occur to a mixture of palladium(II) and 1 in the absence of a templating 
ion.1 The major signal observed in the spectrum occurs at m/z 242.28390 and is a 
1+ ion, however it is uncertain if this is due to a polymer or oligomer of palladium(II) 
231 
 
and 6. There is a small signal observed which is due to [6 + H]+ at m/z 321.15941, 
which suggests that not all of the ligand is used in the reaction. 
 
 
Figure A2.9. HR – ESI MS (d6 – DMSO) of [Pd2(MeCN)4](BF4)2 : 6 mixture showing 




The 1H NMR spectrum of the mixture is hard to analyse due to the broadness of the 
aromatic proton signals (Figure A2.10). The spectrum gives no information on 
whether there is free ligand 6 present, or if there is coordination of 6 to 
palladium(II). This resulting spectrum might be due to the fact that the mixture was 




Figure A2.10. 1H NMR (400 MHz, d6 – DMSO) of [Pd2(MeCN)4](BF4)2 : 6 mixture 
showing aromatic proton signals. 
 
The 19F NMR spectrum of the mixture also suggested that the [BF4- ⊂ Pd2(6)4]3+ 
helicate has not been formed (Figure A2.11). There is only one signal observed in 




Figure A2.11. 19F NMR (376 MHz, d6 – DMSO) of [Pd2(MeCN)4](BF4)2 : 6 mixture 
showing fluorine assignment. 
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From the HR – ESI MS, 1H NMR and 19F NMR data, it is clear that the [BF4- ⊂ 
Pd2(6)4]3+ helicate has not formed.  This might be due to the fact that the 
tetramethylbenzene linker is too bulky to allow the ligands to come close together 
to form the [Pd2(6)4]3+ helicate, as seen for ligand 3. Also, the mixture formed a jelly-
like substance, whereas all the other mixtures which formed the corresponding 
helicates were solutions. It is unclear as to why this mixture formed a jelly-like 
substance, whereas the 1:2 [Pd(MeCN)4](BF4)2 : 3 mixture formed a solution. This 
could be due to the difference in size between anthracene and tetramethylbenzene, 
where the tetramethylbenzene group on 6 is too big to form the [Pd2(6)4]3+ helicate, 
but is small enough to form a polymer-sheet. 
Two equivalents of 4-dimethylaminopyridine (DMAP) was added to the 1:2 
[Pd2(MeCN)4](BF4)2 : 6 mixture to see if this could break up the jelly-like substance. 
DMAP has a similar structure to the pyridine rings on 6 and contains a 4-
dimethylamino group, this causes it to form stronger bonds with palladium(II) and 
therefore displaces the ligands coordinated to palladium(II). As soon as the DMAP 
was added to the mixture, the jelly-like substance dissolved. 
The HR – ESI MS spectrum of the mixture contained signals corresponding to 
products containing different combinations of DMAP, 6 and palladium(II). However, 
there was still no signal present corresponding to the [BF4- ⊂ Pd2(6)4]3+ helicate. The 
1H NMR spectrum of the mixture showed a mixture of sharp and broad signals after 
the addition of DMAP, but assignment of the signals was still too difficult to achieve. 
Some of the signals have been moved to a higher chemical shift which is suggestive 
of coordination of the ligand to palladium(II), which supports what was observed in 
the HR – ESI MS of the mixture. The 19F NMR spectrum of the mixture still shows 
only one signal, however the signal has shifted slightly downfield to a chemical shift 







A2.2 Anion exchange of [Pd2(L)4] helicates 
 
 
Attempted anion exchange on [Pd2(2)4] 
 
Addition of tetrabutylammonium perchlorate 
 
16 equivalents of tetrabutylammonium perchlorate (TBAClO4) were added to a 
solution of [BF4- ⊂ Pd2(2)4]3+ in d6 – DMSO. The mixture was then left overnight to 
equilibrate, and was analysed by 19F NMR. 
A couple of minutes after the addition of ClO4- to the [Pd2(2)4] helicate, a white 
precipitate started to form in the solution. When the solution was analysed after 
being left overnight, the amount of the white precipitate produced had increased. 
HR – ESI MS analysis on the mixture was not performed due to the formation of the 
white precipitate. 
The 19F NMR of the mixture suggests that there is not much of the [BF4- ⊂ Pd2(2)4]3+ 
present in the mixture after the addition of ClO4-, since the signal has decreased 
significantly (Figure A2.12). The ratio of free BF4- to encapsulated BF4- has 
increased significantly from 4.00:1.00 to 88.00:1.00 after the addition of ClO4-, which 
suggests that the precipitate which is formed after the addition of ClO4- is likely to 
be a combination of oligomers of 2, anions and palladium(II), causing the decrease 





Figure A2.12. 19F NMR (376 MHz, d6 – DMSO) of the reaction of [BF4- ⊂ Pd2(2)4]3+ 
with 16 equivalents of TBAClO4 showing fluorine assignment. 
 
 
To determine if the formation of the precipitate was a one-off occurrence, 16 
equivalents of TBAClO4 were added to a fresh solution of [BF4- ⊂ Pd2(2)4]3+ in d6 – 
DMSO. The mixture was then left overnight to equilibrate, and was analysed by 19F 
NMR. Again, a couple of minutes after the addition of ClO4-, the white precipitate 
formed in the solution. The precipitate was isolated from the mixture, and then 
washed with water and acetone. The precipitate was then placed in a desiccator 
overnight to dry out. The elemental analysis on the precipitate determined that the 
percentages of C, H and N led to an empirical formula which is consistent with the 
chemical formula of 2, so confirming that the ligand remains intact and that the 





Addition of tetrabutylammonium perrhenate  
 
16 equivalents of tetrabutylammonium perchlorate (TBAReO4) were added to a 
solution of [BF4- ⊂ Pd2(2)4]3+ in d6 – DMSO. The mixture was then left overnight to 
equilibrate, and was analysed by 19F NMR. 
A couple of minutes after the addition of ReO4- to the [Pd2(2)4] helicate, a white 
precipitate started to form in the solution. When the solution was analysed after 
being left overnight, the amount of the white precipitate produced had increased. 
HR – ESI MS analysis on the mixture was not preformed due to the formation of the 
white precipitate, as it was not soluble. The amount of precipitate formed after the 
addition of ReO4- was significantly more than that after the addition of ClO4-. 
The 19F NMR of the mixture suggests that there is not much of the [BF4- ⊂ Pd2(2)4]3+ 
present in the mixture after the addition of ReO4-, since the signal has decreased 
significantly (Figure A2.13). The ratio of free BF4- to encapsulated BF4- has 
increased significantly from 4.00:1.00 to 197.00:1.00 after the addition of ReO4-, 
which suggests that the precipitate which is formed after the addition of ReO4- is 
also likely to be a combination of oligomers of 2, anions and palladium(II), causing 
the decrease in the amount of [BF4- ⊂ Pd2(2)4]3+ present. The ratio of free BF4- to 
encapsulated BF4- after the addition of ReO4- is significantly larger than the ratio 
after the addition of ClO4- (88.00:1.00), suggesting that ReO4- causes more of the 




Figure A2.13. 19F NMR (376 MHz, d6 – DMSO) of the reaction of [BF4- ⊂ Pd2(2)4]3+ 
with 16 equivalents of TBAReO4 showing fluorine assignment. 
 
 
The precipitate was isolated from the mixture, and then washed with water and 
acetone. The precipitate was then placed in a desiccator overnight to dry out. The 
elemental analysis on the precipitate determined that the percentages of C, H and N 
led to an empirical formula which is consistent with the chemical formula of 2, 








Anion exchange calculations 
 
 
Equation (1): [BF4- ⊂ Pd2(1)4]3+ + [X-] ⇌ [X- ⊂ Pd2(1)4]3+ + [BF4-]  
 
[BF4-]i = 0.0629 mol L-1, [BF4- ⊂ Pd2(1)4]3+i = 0.0210 mol L-1, [ClO4-]i = 0.157 mol L-1 
[ClO4- ⊂ Pd2(1)4]3+e = ((0.26 – 0.03) / 0.26) x 0.0210 mol L-1 = 0.0185 mol L-1 
[BF4- ⊂ Pd2(1)4]3+e = 0.0210 mol L-1 – 0.0185 mol L-1 = 0.00242 mol L-1  
[BF4-]e = 0.0629 mol L-1 + 0.0185 mol L-1 = 0.0814 mol L-1  
[ClO4-]e = 0.157 mol L-1 – 0.0185 mol L-1 = 0.138 mol L-1  
 
Table A2.1. Calculated concentrations of species at equilibrium in the reaction of 





































[BF4-]i = 0.0629 mol L-1, [BF4- ⊂ Pd2(1)4]3+i = 0.0210 mol L-1, [ClO4-]i = 0.157 mol L-1 
[ClO4- ⊂ Pd2(1)4]3+e = (82 / (82 + 27 )) x 0.0210 mol L-1 = 0.0158 mol L-1 
[BF4- ⊂ Pd2(1)4]3+e = (27 / (82 + 27 )) x 0.0210 mol L-1 = 0.00519 mol L-1  
[BF4-]e = 0.0629 mol L-1 + 0.0158 mol L-1 = 0.0787 mol L-1  
[ClO4-]e = 0.157 mol L-1 – 0.0158 mol L-1 = 0.141 mol L-1  
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Table A2.2. Calculated concentrations of species at equilibrium in the reaction of 







































Table A2.3. Calculated concentrations of species at equilibrium in the reaction of 





































Table A2.4. Calculated concentrations of species at equilibrium in the reaction of 






































Table A2.5. Calculated concentrations of species at equilibrium in the reaction of 





































Table A2.6. Calculated concentrations of species at equilibrium in the reaction of 






































Table A2.7. Calculated concentrations of species at equilibrium in the reaction of 





































Table A2.8. Calculated concentrations of species at equilibrium in the reaction of 






































Table A2.9. Calculated concentrations of species at equilibrium in the reaction of 





































Table A2.10. Calculated concentrations of species at equilibrium in the reaction of 





































Table A2.11. Calculated concentrations of species at equilibrium in the reaction of 





































Table A2.12. Calculated concentrations of species at equilibrium in the reaction of 





































Initial integrations of atropisomers; 0.4 (A), 0.4 (B), 0.5 (C) 
Final integrations of atropisomers; 0.3 (A), 0.3 (B), 0.2 (C) 
Calculation to determine [BF4- ⊂ Pd2(5)4]i, [BF4- ⊂ Pd2(5)4]e and [ClO4- ⊂ Pd2(5)4]e 
for atropisomer A; 
[BF4- ⊂ Pd2(5)4]i = (0.4 / (0.4 + 0.4 + 0.5)) x 0.0204 mol L-1 = 0.00628 mol L-1  
[ClO4- ⊂ Pd2(1)4]e = ((0.4 – 0.3) / 0.4) x 0.00628 mol L-1 = 0.00157 mol L-1  
[BF4- ⊂ Pd2(1)4]e = 0.00628 mol L-1 – 0.00157 mol L-1 = 0.00471 mol L-1 
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Table A2.13. Calculated concentrations of species at equilibrium in the reaction of 






































Table A2.14. Calculated concentrations of species at equilibrium in the reaction of 





































Table A2.15. Calculated concentrations of species at equilibrium in the reaction of 





































Table A2.16. Calculated concentrations of species at equilibrium in the reaction of 





































Table A2.17. Calculated concentrations of species at equilibrium in the reaction of 







































Initial integrations of atropisomers; 0.4 (A), 0.3 (B), 0.2 (C) 





Table A2.18. Calculated concentrations of species at equilibrium in the reaction of 






































Table A2.19. Calculated concentrations of species at equilibrium in the reaction of 





































Table A2.20. Calculated concentrations of species at equilibrium in the reaction of 





































Table A2.21. Calculated concentrations of species at equilibrium in the reaction of 




































Table A2.22. Calculated concentrations of species at equilibrium in the reaction of 




































Initial integrations of atropisomers; 4.00 (A), 3.84 (B), 4.83 (C) 
Final integrations of atropisomers; 0.77 (A), 0.60 (B), 0.30 (C) 
 
Table A2.23. Calculated concentrations of species at equilibrium in the reaction of 





































Table A2.24. Calculated concentrations of species at equilibrium in the reaction of 






































Table A2.25. Calculated concentrations of species at equilibrium in the reaction of 
















































Synthesis of 1,4-bis(3-pyridyloxy)benzene (1) 
 
Reaction was adapted from McMorran and Steel2. 3-hydroxypyridine (2 eq, 3.00 g, 
32 mmol), 1,4-dibromobenzene (1 eq, 3.70 g, 16 mmol), caesium carbonate (2.6 eq, 
13.50 g, 41 mmol) and activated copper (160 mg) were placed in an oven dried 100 
mL round bottom flask. Anhydrous N,N-dimethylacetamide (99 %, 30 mL) was 
added and the reaction was refluxed under argon for 24 hr at 170oC.  The resulting 
solution was cooled, then diluted with EtOAc (200 mL) and filtered through celite, 
and celite washed with EtOAc until clear. The solution was then washed with dilute 
NaOH (10 %, 100 mL) and the layers were separated, and then the aqueous layer 
was washed with EtOAc (100 mL). The combined organic extracts were then washed 
with brine (100 mL), dried over magnesium sulfate, and solvent was removed in 
vacuo to give an orange/yellow oil (3.90 g). This was chromatographed on silica 
(EtOAc : Pet ether, 1:1) to give yellow/brown solid (1.00 g, 21 %).  
Analysis: C16H12N2O2 requires C 72.72, H 4.58, N 10.60 %; found C 72.93, H 4.91, N 
10.99 %. 1H NMR (400 MHz, CDCl3): δ 8.39 (2H, s, H2’), 8.35 (2H, m, H6’), 7.30 (4H, m, 
H4’ + H5’), 7.03 (4H, s, H2 + H3 + H5 + H6). HR – ESI MS (DCM): m/z 265.09786 [M + 
H]+, calc. for [C16H12N2O2 + H]+ = 265.09715. 
Synthesis of 1,4-bis(3-pyridyloxy)naphthalene (2) 
 
3-hydroxypyridine (3.3 eq, 1.70 g, 12 mmol), 1,4-dibromonapthalene (1 eq, 1.10 g, 
3.8 mmol), caesium carbonate (4.2 eq, 5.20 g, 16 mmol) and activated copper (100 
mg) were placed in an oven dried 50 mL round bottom flask. Anhydrous N,N-
dimethylacetamide (99 %, 10 mL) was added and the reaction was refluxed under 
argon for 72 hrs at 170oC. The resulting solution was cooled, then diluted with EtOAc 
(100 mL), filtered through celite, and celite washed with EtOAc until clear. The 
solution was then washed with dilute NaOH (10 %, 100 mL) and the layers were 
separated, and then the aqueous layer was washed with EtOAc (100 mL). The 
combined organic extracts were then washed with brine (100 mL), dried over 
magnesium sulfate, and solvent was removed in vacuo to give a brown oil (1.10 g). 
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This was chromatographed on silica (EtOAc : Pet ether, 3:2) to give a sticky brown 
oil (380 mg, 32 %).  
Analysis: C20H14N2O2 requires C 76.42, H 4.49, N 8.91 %; found C 66.94, H 5.28, N 
7.33 %. 1H NMR (400 MHz, CDCl3): δ 8.43 (2H, br, H2’), 8.31 (2H, br, H6’) 8.07 (2H, m, 
H4’’), 7.48 (2H, m, H3’’), 7.21 (4H, m, H4’ + H5’), 6.86 (2H, s, H5). HR – ESI MS (DCM): 
m/z 315.11147 [M + H]+, calc. for [C20H14N2O2 + H]+ = 315.11280, m/z 337.09325 [M 
+ Na]+, calc. for [C20H14N2O2 + Na]+ = 337.09475. 
 
 
Synthesis of 1,4-bis(3-pyridyloxy)2,5-difluorobenzene (4) 
 
3-hydroxypyridine (2 eq, 610 mg, 6.4 mmol), 1,4-diiodotetrafluorobenzene (1 eq, 
1.60 g, 3.2 mmol), caesium carbonate (2.6 eq, 2.80 g, 8.4 mmol) and activated copper 
(100 mg) were placed in an oven dried 50 mL round bottom flask. Anhydrous N,N-
dimethylacetamide (99 %, 10 mL) was added and the reaction was refluxed under 
argon for 40 hrs at 170oC.  The resulting solution was cooled, then diluted with 
EtOAc (100 mL), filtered through celite, and celite washed with EtOAc until clear. 
The solution was then washed with dilute NaOH (10 %, 100 mL) and the layers were 
separated, and then the aqueous layer was washed with EtOAc (50 mL). The 
combined organic extracts were then washed with brine (100 mL), dried over 
magnesium sulfate, and solvent was removed in vacuo to give a bright yellow oil 
(813 mg). This was chromatographed on silica (EtOAc : Pet ether, 2:1) to give a light 
yellow solid (200 mg, 28 %).  
Analysis: C16H10F2N2O2 requires C 64.00, H 3.36, N 9.33 %; found C 63.44, H 3.30, N 
9.06 %. 1H NMR (400 MHz, CDCl3): δ 8.43 (4H, br, H2’ + H6’), 7.34 (4H, br, H4’ + H5’), 
7.00 (2H, t, JH-F = 8.8 Hz, H3). 19F-NMR (376 MHz, CDCl3): δ -131.22 (t, JH-F = 8.9 Hz) 






Synthesis of 1,4-bis(3-pyridyloxy)2,5-dimethylbenzene (5) 
 
3-hydroxypyridine (2.5 eq, 1.40 g, 14 mmol), 1,4-diiodo-2,5-dimethylbenzene (1 eq, 
2.10 g, 5.7 mmol), caesium carbonate (3.3 eq, 6.20 g, 19 mmol) and activated copper 
(200 mg) were placed in an oven dried 50 mL round bottom flask. Anhydrous N,N-
dimethylacetamide (99 %, 10 mL) was added and the reaction was refluxed under 
argon for 72 hrs at 170oC.  The resulting solution was cooled, then diluted with 
EtOAc (100 mL), filtered through celite, and celite washed with EtOAc until clear. 
The solution was then washed with dilute NaOH (10 %, 100 mL) and the layers were 
separated, and then the aqueous layer was washed with EtOAc (50 mL). The 
combined organic extracts were then washed with brine (100 mL), dried over 
magnesium sulfate, and solvent was removed in vacuo to give a brown oil (340 mg). 
This was chromatographed on silica (EtOAc : Pet ether, 1:1) to give a dark brown 
solid (130 mg, 8 %).  
Analysis: C18H16N2O2 requires C 73.95, H 5.52, N 9.58 %; found C 71.36, H 6.13, N 
8.12 %. 1H NMR (400 MHz, CDCl3): δ 8.30 (4H, br, H2’ + H6’), 7.23 (2H, m, H5’), 7.15 
(2H, m, H4’), 6.83 (2H, s, H3), 2.13 (6H, s, CH3). HR – ESI MS (DCM): m/z 293.12730 
[M + H]+, calc. for [C18H16N2O2 + H]+ = 293.12845, m/z 315.10916 [M + Na]+, calc. for 
[C18H16N2O2 + Na]+ = 315.11040. 
 
 
Synthesis of 1,4-bis(3-pyridyloxy)tetramethylbenzene (6) 
 
3-hydroxypyridine (2 eq, 740 mg, 7.8 mmol), 1,4-diiodotetramethylbenzene (1 eq, 
1.60 g, 4.1 mmol), caesium carbonate (2.6 eq, 3.30 g, 10 mmol) and activated copper 
bronze (100 mg) were placed in an oven dried 50 mL round bottom flask. Anhydrous 
N,N-dimethylacetamide (99 %, 10 mL) was added and the reaction was refluxed 
under argon for 60 hr at 170oC.  The resulting solution was cooled, then diluted with 
EtOAc (100 mL), filtered through celite, and celite washed with EtOAc until clear. 
The solution was then washed with dilute NaOH (10 %, 100 mL) and the layers were 
separated, and then the aqueous layer was washed with EtOAc (100 mL). The 
combined organic extracts were then washed with brine (100 mL), dried over 
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magnesium sulfate, and solvent was removed in vacuo to give a pale yellow oil (720 
mg). This was chromatographed on silica (EtOAc : Pet ether, 1:1) to give a pale 
yellow solid (230 mg, 18 %).  
Analysis: C20H20N2O2 requires C 74.98, H 6.29, N 8.74 %; found C 70.16, H 6.28, N 
7.78 %. 1H NMR (400 MHz, CDCl3): δ 8.30 (2H, br, H2’), 8.29 (2H, br, H6’), 7.31 (2H, 
br, H5’), 7.12 (2H, br d, H4’), 2.06 (12H, s, CH3). HR – ESI MS (DCM): m/z 321.15905 
[M + H]+, calc. for [C20H20N2O2 + H]+ = 321.15975, m/z 343.14089 [M + Na]+, calc. for 
[C20H20N2O2 + Na]+ = 343.14170. 
 
 
Synthesis of [Pd2(1)4] helicate 
 
Tetrakis(acetonitrile)palladium(II) tetrafluoroborate (1 eq, 14.0 mg, 0.030 mmol) 
and 1 (2 eq, 17.0 mg, 0.060 mmol) were mixed together in d6 – DMSO (0.75 mL) and 
left for three days to equilibrate at room temperature. 
19F NMR (376 MHz, d6 – DMSO): δ -148.29 (BF4-), -148.89 ([BF4- ⊂ Pd2(1)4]3+). 19F 
DOSY (470 MHz, d6 – DMSO): D 4.91 ± 0.01 x 10-10 m2 s-1 (BF4-), 1.34 ± 0.04 x 10-10 
m2 s-1 ([BF4- ⊂ Pd2(1)4]3+). HR – ESI MS (d6 – DMSO): m/z 452.39047 [BF4- ⊂ 
Pd2(1)4]3+, calc. for [C64H48N8O8Pd2BF4]3+ = 452.39054, m/z 696.06998 
[Pd2(1)4BF4Cl]2+, calc. for [C64H48N8O8Pd2(BF4)(Cl)]2+ = 696.07017, m/z 1479.14395 
[Pd2(1)4(BF4)2Cl]+, calc. for [C64H48N8O8Pd2(BF4)2(Cl)]2+ = 1479.14460. 
 
 
Synthesis of [Pd2(2)4] helicate 
 
Tetrakis(acetonitrile)palladium(II) tetrafluoroborate (1 eq, 14.0 mg, 0.030 mmol) 
and 2 (2 eq, 0.3 mL of 0.2 M solution in DCM, solvent removed in vacuo, 0.060 mmol) 




19F NMR (376 MHz, d6 – DMSO): δ -148.29 (BF4-), -150.24 ([BF4- ⊂ Pd2(2)4]3+). 19F 
DOSY (470 MHz, d6 – DMSO): D 5.53 ± 0.04 x 10-10 m2 s-1 (BF4-), 1.53 ± 0.05 x 10-10 
m2 s-1 ([BF4- ⊂ Pd2(2)4]3+). HR – ESI MS (d6 – DMSO): m/z 315.1109 [2 + H]+, calc. for 
[C20H14N2O2 + H]+ = 315.11280, m/z 519.07604 [BF4- ⊂ Pd2(2)4]3+, calc. for 
[C80H56N8O8Pd2BF4]3+ = 519.07827, m/z 796.09870 [Pd2(2)4BF4Cl]2+, calc. for 
[C80H56N8O8Pd2(BF4)(Cl)]2+ = 796.10177, m/z 1679.20080 [Pd2(2)4(BF4)2Cl]+, calc. 
for [C80H56N8O8Pd2(BF4)2(Cl)]2+ = 1679.20782. 
 
 
Attempted synthesis of [Pd2(3)4] helicate 
 
Tetrakis(acetonitrile)palladium(II) tetrafluoroborate (1 eq, 14.0 mg, 0.030 mmol) 
and 3 (2 eq, 23.0 mg, 0.060 mmol) were mixed together in d6 – DMSO (0.75 mL) and 
left for three days to equilibrate at room temperature. 
19F NMR (376 MHz, d6 – DMSO): δ -148.23 (BF4-). HR – ESI MS (d6 – DMSO): m/z 
365.12729 [3 + H]+, calc. for [C24H16N2O2 + H]+ = 365.12845. 
 
 
Synthesis of [Pd2(4)4] helicate 
 
Tetrakis(acetonitrile)palladium(II) tetrafluoroborate (1 eq, 16.0 mg, 0.038 mmol) 
and 4 (2 eq, 19.0 mg, 0.060 mmol) were mixed together in d6 – DMSO (0.75 mL) and 
left for three days to equilibrate at room temperature.  
19F NMR (376 MHz, d6 – DMSO): δ -127.09 (ligand 4), -133.28 (ligand 4), -134.43 
(ligand 4), -148.25 (BF4-), -149.09 (A), -149.20 (B), -149.26 (C), -149.50 (D). 19F 
DOSY (470 MHz, d6 – DMSO): D 5.02 ± 0.02 x 10-10 m2 s-1 (BF4-), 0.83 ± 0.04 x 10-10 
m2 s-1 (A), 0.95 ± 0.02 x 10-10 m2 s-1 (B), 1.13 ± 0.01 x 10-10 m2 s-1 (C), 0.82 ± 0.03 x 
10-10 m2 s-1 (D). HR – ESI MS (d6 – DMSO): m/z 301.07714 [4 + H]+, calc. for 
[C16H10F2N2O2 + H]+ = 301.07831, m/z 500.36459 [BF4- ⊂ Pd2(4)4]3+, calc. for 
[C64H40F8N8O8Pd2BF4]3+ = 500.36541, m/z 768.03073 [Pd2(4)4(BF4)(Cl)]2+, calc. for 
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[C64H40F8N8O8Pd2(BF4)(Cl)]2+ = 768.03248, m/z 794.04838 [Pd2(4)4(BF4)2]2+, calc. 
for [C64H40F8N8O8Pd2(BF4)2]2+ = 794.05025, m/z 1674.10024 [Pd2(4)4(BF4)3]+, calc. 
for [C64H40F8N8O8Pd2(BF4)3]+ = 1674.10498. 
 
 
Synthesis of [Pd2(5)4] helicate 
 
Tetrakis(acetonitrile)palladium(II) tetrafluoroborate (1 eq, 14.0 mg, 0.030 mmol) 
and 5 (2 eq, 18.0 mg, 0.060 mmol) were mixed together in d6 – DMSO (0.75 mL) and 
left for three days to equilibrate at room temperature. 
19F NMR (376 MHz, d6 – DMSO): δ -148.26 (BF4-), -148.64 (A), -148.93 (B), -149.90 
(C). 19F DOSY (470 MHz, d6 – DMSO): D 4.78 ± 0.03 x 10-10 m2 s-1 (BF4-), 1.22 ± 0.04 x 
10-10 m2 s-1 (A), 1.18 ± 0.06 x 10-10 m2 s-1 (B), 1.18 ± 0.06 x 10-10 m2 s-1 (C). HR – ESI 
MS (d6 – DMSO): m/z 489.76602 [BF4- ⊂ Pd2(5)4]3+, calc. for [C72H64N8O8Pd2BF4]3+ = 
489.76571, m/z 778.15015 [Pd2(5)4(BF4)2]2+, calc. for [C72H64N8O8Pd2(BF4)2]2+ = 




Attempted synthesis of [Pd2(6)4] helicate 
 
Tetrakis(acetonitrile)palladium(II) tetrafluoroborate (1 eq, 15.0 mg, 0.030 mmol) 
and 6 (2 eq, 20.0 mg, 0.060 mmol) were mixed together in d6 – DMSO (0.75 mL) and 
left for three days to equilibrate at room temperature. 
19F NMR (376 MHz, d6 – DMSO): δ -148.35 (BF4-). HR – ESI MS (d6 – DMSO): m/z 






Anion exchange on [Pd2(1)4] 
 
Anion exchange with ClO4- 
Tetrabutylammonium perchlorate (16 eq, 40.0 mg, 0.12 mmol) was added to a 
solution of [Pd2(1)4] (as prepared above) in d6 – DMSO (0.75 mL), and was left 
overnight to equilibrate at room temperature. 
19F NMR (376 MHz, d6 – DMSO): δ -148.38 (BF4-), -148.83 ([BF4- ⊂ Pd2(1)4]3+). HR – 
ESI MS (d6 – DMSO): m/z 242.28360 [TBA]+, calc. for [C16H36N]+ = 242.28423, m/z 
452.39021 [BF4- ⊂ Pd2(1)4]3+, calc. for [C64H48N8O8Pd2BF4]3+ = 452.39054, m/z 
456.37164 [ClO4- ⊂ Pd2(1)4]3+, calc. for [C64H48N8O8Pd2ClO4]3+ = 456.37193,   m/z 
696.06920 [Pd2(1)4(BF4)(Cl)]2+, calc. for [C64H48N8O8Pd2(BF4)(Cl)]2+ = 696.07017, 
m/z 702.04143 [Pd2(1)4(ClO4)(Cl)]2+, calc. for [C64H48N8O8Pd2(ClO4)(Cl)]2+ = 
702.04230, m/z 715.55127 [Pd2(1)4(ClO4)(NO3)]2+, calc. for 
[C64H48N8O8Pd2(ClO4)(NO3)]2+ = 715.55209, m/z 728.06161 [Pd2(1)4(BF4)(ClO4)]2+, 
calc. for [C64H48N8O8Pd2(BF4)(ClO4)]2+ = 728.06002, m/z 734.03135 
[Pd2(1)4(ClO4)2]2+, calc. for [C64H48N8O8Pd2(ClO4)2]2+ = 734.03215. 
 
 
Anion exchange with ReO4- 
Tetrabutylammonium perrhenate (16 eq, 59.0 mg, 0.12 mmol) was added to a 
solution of [Pd2(1)4] (as prepared above) in d6 – DMSO (0.75 mL), and was left 
overnight to equilibrate at room temperature. 
19F NMR (376 MHz, d6 – DMSO): δ -148.37 (BF4-), -148.83 ([BF4- ⊂ Pd2(1)4]3+). HR – 
ESI MS (d6 – DMSO): m/z 242.28360 [TBA]+, calc. for [C16H36N]+ = 242.28423, m/z 
452.39024 [BF4- ⊂ Pd2(1)4]3+, calc. for [C64H48N8O8Pd2BF4]3+ = 452.39054, m/z 
506.36689 [ReO4- ⊂ Pd2(1)4]3+, calc. for [C64H48N8O8Pd2ReO4]3+ = 506.36738,   m/z 
696.06923 [Pd2(1)4(BF4)(Cl)]2+, calc. for [C64H48N8O8Pd2(BF4)(Cl)]2+ = 696.07017, 
m/z 722.59296 [Pd2(1)4(BF4)2]2+, calc. for [C64H48N8O8Pd2(BF4)2]2+ = 722.08794, 
m/z 778.03493 [Pd2(1)4(ReO4)(Cl)]2+, calc. for [C64H48N8O8Pd2(ReO4)(Cl)]2+ = 
778.03562, m/z 804.05232 [Pd2(1)4(BF4)(ReO4)]2+, calc. for 
[C64H48N8O8Pd2(BF4)(ReO4)]2+ = 803.05324. 
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Anion exchange with NO3- 
Tetrabutylammonium nitrate (16 eq, 37.0 mg, 0.12 mmol) was added to a solution 
of [Pd2(1)4] (as prepared above) in d6 – DMSO (0.75 mL), and was left overnight to 
equilibrate at room temperature. 
19F NMR (376 MHz, d6 – DMSO): δ -148.40 (BF4-), -148.82 ([BF4- ⊂ Pd2(1)4]3+). HR – 
ESI MS (d6 – DMSO): m/z 242.28360 [TBA]+, calc. for [C16H36N]+ = 242.28423, m/z 
444.05156 [NO3- ⊂ Pd2(1)4]3+, calc. for [C64H48N8O8Pd2NO3]3+ = 444.05191, m/z 
452.39020 [BF4- ⊂ Pd2(1)4]3+, calc. for [C64H48N8O8Pd2BF4]3+ = 452.39054, m/z 
683.56118 [Pd2(1)4(NO3)(Cl)]2+, calc. for [C64H48N8O8Pd2(NO3)(Cl)]2+ = 683.56224, 
m/z 696.06936 [Pd2(1)4(BF4)(Cl)]2+, calc. for [C64H48N8O8Pd2(BF4)(Cl)]2+ = 
696.07017, m/z 709.58044 [Pd2(1)4(NO3)(BF4)]2+, calc. for 
[C64H48N8O8Pd2(NO3)(BF4)]2+ = 709.58000, m/z 722.08996 [Pd2(1)4(BF4)2]2+, calc. 
for [C64H48N8O8Pd2(BF4)2]2+ = 722.08794.  
 
 
Attempted anion exchange on [Pd2(2)4] 
 
Anion exchange with ClO4- 
Tetrabutylammonium perchlorate (16 eq, 41.0 mg, 0.12 mmol) was added to a 
solution of [Pd2(2)4] (as prepared above) in d6 – DMSO (0.75 mL), and was left 
overnight to equilibrate at room temperature, resulting in a white precipitate. 
Analysis: C20H14N2O2 requires C 76.42, H 4.49, N 8.91 %; found C 50.79, H 3.67, N 




Anion exchange with ReO4- 
Tetrabutylammonium perrhenate (16 eq, 59.0 mg, 0.12 mmol) was added to a 
solution of [Pd2(2)4] (as prepared above) in d6 – DMSO (0.75 mL), and was left 
overnight to equilibrate at room temperature, resulting in a white precipitate. 
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Analysis: C20H14N2O2 requires C 76.42, H 4.49, N 8.91 %; found C 43.69, H 2.64, N 




Anion exchange on [Pd2(4)4] 
 
Anion exchange with ClO4- 
Tetrabutylammonium perchlorate (16 eq, 41.0 mg, 0.12 mmol) was added to a 
solution of [Pd2(4)4] (as prepared above) in d6 – DMSO (0.75 mL), and was left 
overnight to equilibrate at room temperature. 
19F NMR (376 MHz, d6 – DMSO): δ -127.23 (ligand 4), -133.23 (ligand 4), -134.25 
(ligand 4), -148.38 (BF4-), -149.07 (A), -149.18 (B), -149.24 (C), -149.48 (D). HR – 
ESI MS (d6 – DMSO): m/z 242.28360 [TBA]+, calc. for [C16H36N]+ = 242.28423, m/z 
500.36169 [BF4- ⊂ Pd2(4)4]3+, calc. for [C64H40F8N8O8Pd2BF4]3+ = 500.36541, m/z 
504.34323 [ClO4- ⊂ Pd2(4)4]3+, calc. for [C64H40F8N8O8Pd2ClO4]3+ = 504.34680, m/z 
768.02697 [Pd2(4)4(BF4)(Cl)]2+, calc. for [C64H40F8N8O8Pd2(BF4)(Cl)]2+ = 768.03248, 
m/z 773.99945 [Pd2(4)4(ClO4)(Cl)]2+, calc. for [C64H40F8N8O8Pd2(ClO4)(Cl)]2+ = 
774.00461, m/z 794.05049 [Pd2(4)4(BF4)2]2+, calc. for [C64H40F8N8O8Pd2(BF4)2]2+ = 
794.05025, m/z 805.98878 [Pd2(4)4(ClO4)2]2+, calc. for [C64H40F8N8O8Pd2(ClO4)2]2+ 
=  805.99446. 
 
 
Anion exchange with ReO4- 
Tetrabutylammonium perrhenate (16 eq, 59.0 mg, 0.12 mmol) was added to a 
solution of [Pd2(4)4] (as prepared above) in d6 – DMSO (0.75 mL), and was left 
overnight to equilibrate at room temperature. 
19F NMR (376 MHz, d6 – DMSO): δ -127.00 (ligand 4), -133.18 (ligand 4), -134.40 
(ligand 4), -148.38 (BF4-), -149.05 (A), -149.16 (B), -149.22 (C), -149.45 (D). HR – 
ESI MS (d6 – DMSO): m/z 242.28360 [TBA]+, calc. for [C16H36N]+ = 242.28423, m/z 
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500.36201 [BF4- ⊂ Pd2(4)4]3+, calc. for [C64H40F8N8O8Pd2BF4]3+ = 500.36541, m/z 
555.00522 [ReO4- ⊂ Pd2(4)4]3+, calc. for [C64H40F8N8O8Pd2ReO4]3+ = 555.00910, m/z 
768.02730 [Pd2(4)4(BF4)(Cl)]2+, calc. for [C64H40F8N8O8Pd2(BF4)(Cl)]2+ = 768.03248, 
m/z 781.53692 [Pd2(4)4(BF4)(NO3)]2+, calc. for [C64H40F8N8O8Pd2(BF4)(NO3)]2+ = 
781.54231, m/z 794.05008 [Pd2(4)4(BF4)2]2+, calc. for [C64H40F8N8O8Pd2(BF4)2]2+ = 
794.05025, m/z 849.99210 [Pd2(4)4(ReO4)(Cl)]2+, calc. for 
[C64H40F8N8O8Pd2(ReO4)(Cl)]2+ = 849.99793, m/z 875.00982 
[Pd2(4)4(BF4)(ReO4)]2+, calc. for [C64H40F8N8O8Pd2(BF4)(ReO4)]2+ = 875.01555, m/z 
956.97475 [Pd2(4)4(ReO4)2]2+, calc. for [C64H40F8N8O8Pd2(ReO4)2]2+ = 956.98095. 
 
 
Anion exchange on [Pd2(5)4] 
 
Anion exchange with ClO4- 
Tetrabutylammonium perchlorate (16 eq, 42.0 mg, 0.12 mmol) was added to a 
solution of [Pd2(5)4] (as prepared above) in d6 – DMSO (0.75 mL), and was left 
overnight to equilibrate at room temperature. 
19F NMR (376 MHz, d6 – DMSO): δ -148.39 (BF4-), -148.61 (A), -148.90 (B), -149.88 
(C). HR – ESI MS (d6 – DMSO): m/z 242.28360 [TBA]+, calc. for [C16H36N]+ = 
242.28423, m/z 489.76550 [BF4- ⊂ Pd2(5)4]3+, calc. for [C72H64N8O8Pd2BF4]3+ = 
489.76571, m/z 493.74687 [ClO4- ⊂ Pd2(5)4]3+, calc. for [C72H64N8O8Pd2ClO4]3+ = 
493.74709, m/z 752.13210 [Pd2(5)4(BF4)(Cl)]2+, calc. for 
[C72H64N8O8Pd2(BF4)(Cl)]2+ = 752.13293, m/z 758.10455 [Pd2(5)4(ClO4)(Cl)]2+, calc. 
for [C72H64N8O8Pd2(ClO4)(Cl)]2+ = 758.10505, m/z 784.12279 
[Pd2(5)4(ClO4)(BF4)]2+, calc. for [C72H64N8O8Pd2(ClO4)(BF4)]2+ = 784.12278, m/z 







Anion exchange with ReO4- 
Tetrabutylammonium perrhenate (16 eq, 62.0 mg, 0.12 mmol) was added to a 
solution of [Pd2(5)4] (as prepared above) in d6 – DMSO (0.75 mL), and was left 
overnight to equilibrate at room temperature. 
19F NMR (376 MHz, d6 – DMSO): δ -148.37 (BF4-), -148.62 (A), -148.90 (B), -149.88 
(C). HR – ESI MS (d6 – DMSO): m/z 242.28360 [TBA]+, calc. for [C16H36N]+ = 
242.28423, m/z 489.76213 [BF4- ⊂ Pd2(5)4]3+, calc. for [C72H64N8O8Pd2BF4]3+ = 
489.76571, m/z 544.40542 [ReO4- ⊂ Pd2(5)4]3+, calc. for [C72H64N8O8Pd2ReO4]3+ = 
544.4940, m/z 752.12777 [Pd2(5)4(BF4)(Cl)]2+, calc. for [C72H64N8O8Pd2(BF4)(Cl)]2+ 
= 752.13293, m/z 778.14746 [Pd2(5)4(BF4)2]2+, calc. for [C72H64N8O8Pd2(BF4)2]2+ = 
778.15070, m/z 834.09275 [Pd2(5)4(ReO4)(Cl)]2+, calc. for 
[C72H64N8O8Pd2(ReO4)(Cl)]2+ = 834.09837, m/z 859.11017 [Pd2(5)4(BF4)(ReO4)]2+, 
calc. for [C72H64N8O8Pd2(BF4)(ReO4)]2+ = 859.11599,  m/z 941.07507 
[Pd2(5)4(ReO4)2]2+, calc. for [C72H64N8O8Pd2(ReO4)2]2+ = 941.08139. 
 
 
Anion exchange with NO3- 
Tetrabutylammonium nitrate (16 eq, 38.0 mg, 0.12 mmol) was added to a solution 
of [Pd2(5)4] (as prepared above) in d6 – DMSO (0.75 mL), and was left overnight to 
equilibrate at room temperature. 
19F NMR (376 MHz, d6 – DMSO): δ -148.40 (BF4-), -148.61 (A), -148.91 (B), -149.89 
(C). HR – ESI MS (d6 – DMSO): m/z 242.28360 [TBA]+, calc. for [C16H36N]+ = 
242.28423, m/z 293.12810 [5 + H]+, calc. for [C20H20N2O2 + H]+ = 293.12845, m/z 
481.42685 [NO3- ⊂ Pd2(5)4]3+, calc. for [C72H64N8O8Pd2NO3]3+ = 481.42707, m/z 
489.76529 [BF4- ⊂ Pd2(5)4]3+, calc. for [C72H64N8O8Pd2BF4]3+ = 489.76571, m/z 
739.62468 [Pd2(5)4(NO3)(Cl)]2+, calc. for [C72H64N8O8Pd2(NO3)(Cl)]2+ = 739.62499, 
m/z 752.13214 [Pd2(5)4(BF4)(Cl)]2+, calc. for [C72H64N8O8Pd2(BF4)(Cl)]2+ = 
752.13293, m/z 765.64196 [Pd2(5)4(NO3)(BF4)]2+, calc. for 
[C72H64N8O8Pd2(NO3)(BF4)]2+ = 765.64276, m/z 778.14967 [Pd2(5)4(BF4)2]2+, calc. 
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A3.1 Synthesis of [Pd2(1)x(L)4-x] helicates 
 
Synthesis of [Pd2(1)x(2)4-x] helicates 
 
[Pd2(1)x(2)4-x]3+ helicates were synthesised from the mixing of [Pd(MeCN)4](BF4)2, 
1, and 2 in a 2 : 2 : 2 ratio in d6 – DMSO at room temperature. The mixture was left 
for three days to equilibrate, and then sent for HR – ESI MS, 1H NMR and 19F NMR 
analysis. 
The HR – ESI MS of the mixture supports the formation of a mixture of [BF4- ⊂ 
Pd2(1)x(2)4-x]3+ helicates (Figure A3.1). There are five main 3+ signals observed at 
m/z 452.3886, 469.06069, 485.73255, 502.40415, and 519.07641. The isotope 
patterns and m/z of the observed signals match that calculated for the heteroleptic 
species [BF4- ⊂ Pd2(1)4]3+, [BF4- ⊂ Pd2(1)3(2)]3+, [BF4- ⊂ Pd2(1)2(2)2]3+, [BF4- ⊂ 
Pd2(1)(2)3]3+, and [BF4- ⊂ Pd2(2)4]3+. 
There were other signals corresponding to 2+ and 1+ helicate species present in the 
spectrum of the mixture. The five 2+ signals observed at m/z 696.06745, 721.07567, 
746.08366, 771.09177, and 796.10069 correspond to the heteroleptic species 
[Pd2(1)4(BF4)(Cl)]2+, [Pd2(1)3(2)(BF4)(Cl)]2+, [Pd2(1)2(2)2(BF4)(Cl)]2+, 
[Pd2(1)(2)3(BF4)(Cl)]2+, and [Pd2(2)4(BF4)(Cl)]2+, respectively.  
Heating of the mixture at 80 oC overnight caused a change in intensities of the [BF4- 
⊂ Pd2(1)x(2)4-x]3+ helicates observed in the HR – ESI MS (Figure A3.2) The largest 
heteroleptic helicate observed is that of [BF4- ⊂ Pd2(1)3(2)]3+, whereas the largest 
before heating was that of [BF4- ⊂ Pd2(1)2(2)2]3+. This suggests that heating the 
mixture leads to the increased formation of the thermodynamic products, whereas 
before heating the kinetic products dominate. Ratios of the HR – ESI MS heights 
before and after heating with respect to the [BF4- ⊂ Pd2(1)4]3+ height are 





Figure A3.1. HR – ESI MS (d6 – DMSO) of synthesised [BF4- ⊂ Pd2(1)x(2)4-x]3+ 




Figure A3.2. HR – ESI MS (d6 – DMSO) of synthesised [BF4- ⊂ Pd2(1)x(2)4-x]3+ 
helicates after heating at 80 oC overnight showing the observed m/z and isotope 
pattern for each helicate. 
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Table A3.1. Normalised ratios of the HR – ESI MS heights before and after heating 
with respect to the [BF4- ⊂ Pd2(1)4]3+ height. 










Initial 1.00 3.42 4.42 2.75 0.83 
After Heating 1.00 1.53 1.00 0.32 0.048 
 
 
The 1H NMR of the mixture also supports the formation of mixed [BF4- ⊂ Pd2(1)x(2)4-
x]3+ helicates as the spectrum is different to the spectra of [BF4- ⊂ Pd2(1)4]3+ and 
[BF4- ⊂ Pd2(2)4]3+ mixtures (Figure A3.3). The spectrum looks like the 1H NMR 
spectrum of [BF4- ⊂ Pd2(1)4]3+, but with lots of small sharp peaks between δ 8.9 – 
6.5 ppm. These peaks are likely due to the different heteroleptic helicates present in 










The 19F NMR of the mixture supports the formation of mixed [BF4- ⊂ Pd2(1)x(2)4-x]3+ 
helicates as the spectrum is different to the spectra of [BF4- ⊂ Pd2(1)4]3+ and [BF4- ⊂ 
Pd2(2)4]3+ mixtures (Figure A3.4). Other than the signal for the free BF4-, there are 
six signals observed in the spectrum at δ -148.89, -148.95 (A), -149.11 (B), -149.22 
(C), -149.65 (D), and -150.25 ppm, and are due to the [BF4- ⊂ helicate]3+ species. 
Comparing the spectrum with the spectra of [BF4- ⊂ Pd2(1)4]3+ and [BF4- ⊂ 
Pd2(2)4]3+, the signal at δ – 148.89 ppm is likely that of the [BF4- ⊂ Pd2(1)4]3+ helicate, 
and the signal at δ – 150.25 is likely that of the [BF4- ⊂ Pd2(2)4]3+ helicate. The other 
four signals are due to the different heteroleptic [BF4- ⊂ Pd2(1)x(2)4-x]3+ helicates 
present, however they are difficult to assign. The signal for [BF4- ⊂ Pd2(1)4]3+ and 
signal A overlap with each other, and so do signals B and C.  Signal D and the signal 
for [BF4- ⊂ Pd2(2)4]3+ are both quite broad, which is similar to what is observed in 
the 19F NMR spectrum of pure [BF4- ⊂ Pd2(2)4]3+. The ratio of free BF4- signal to the 
encapsulated BF4- signals is 3.00:1.00, which shows that all ligand is incorporated 






Figure A3.4. 19F NMR (376 MHz, d6 – DMSO) of mixed [BF4- ⊂ Pd2(1)x(2)4-x]3+ 
helicates showing fluorine assignment. 
 
 
The 19F NMR of the mixture after heating shows an increase in signal intensities for 
the [BF4- ⊂ Pd2(1)4]3+ signal A, whereas there is a decrease in signal intensities for 
signal D and the [BF4- ⊂ Pd2(2)4]3+ signal (Figure A3.5). This reflects what was 
observed in the HR – ESI MS of the heated mixture, as the intensities of the [BF4- ⊂ 
Pd2(1)4]3+ signals in both are increased and the intensities of the [BF4- ⊂ Pd2(2)4]3+ 
signals are decreased. The ratio of the free BF4- signal to encapsulated BF4- signals 
slightly increases to 3.40:1.00 after heating, suggesting some helicate 






Figure A3.5. 19F NMR (376 MHz, d6 – DMSO) of mixed [BF4- ⊂ Pd2(1)x(2)4-x]3+ 
helicates heated at 80 oC overnight showing fluorine assignment. 
 
 
A 19F DOSY spectrum was also performed to determine the diffusion coefficients of 
both free BF4- and [BF4- ⊂ helicate]3+ signals (Figure A3.6). The diffusion coefficient 
for the free BF4- anion signal was recorded as (5.03 ± 0.05) x 10-10 m2 s-1, whereas 
the signals for the encapsulated BF4- anions of [BF4- ⊂ Pd2(1)4]3+, A and B were 
recorded as (1.28 ± 0.07) x 10-10 m2 s-1, (1.31 ± 0.06) x 10-10 m2 s-1, and (1.14 ± 0.13) 
x 10-10 m2 s-1, respectively. The diffusion coefficients for the other signals could not 
be measured due to the weakness of the signals. The diffusion coefficient for the free 
BF4- signal is consistent with what was observed for free BF4- in the other mixtures, 
and the diffusion coefficient for the encapsulated BF4- signal of [BF4- ⊂ Pd2(1)4]3+ is 
also consistent with what was observed for the pure solution of [BF4- ⊂ Pd2(1)4]3+ 
(1.34 ± 0.04 x 10-10 m2 s-1). The diffusion coefficients for signals A and B suggest that 
the A’s apparent size is slightly smaller than the [BF4- ⊂ Pd2(1)4]3+ helicate, whereas 




Figure A3.6. 19F DOSY (470 MHz, d6 – DMSO) of mixed [BF4- ⊂ Pd2(1)x(2)4-x]3+ 
helicates showing diffusion coefficients of free and encapsulated BF4-. 
 
 
Synthesis of [Pd2(1)x(4)4-x] helicates 
 
[Pd2(1)x(4)4-x]3+ helicates were synthesised from the mixing of [Pd(MeCN)4](BF4)2, 
1, and 4 in a 2 : 2 : 2 ratio in d6 – DMSO at room temperature. The mixture was left 
for three days to equilibrate, and then sent for HR – ESI MS and 19F NMR analysis. 
The HR – ESI MS of the mixture supports the formation of a mixture of [BF4- ⊂ 
Pd2(1)x(4)4-x]3+ helicates (Figure A3.7). There are five main 3+ signals observed at 
m/z 452.38992, 464.38357, 476.37729, 488.37097, and 500.36493. The isotope 
patterns and m/z of the observed signals match that calculated for the heteroleptic 
species [BF4- ⊂ Pd2(1)4]3+, [BF4- ⊂ Pd2(1)3(4)]3+, [BF4- ⊂ Pd2(1)2(4)2]3+, [BF4- ⊂ 
Pd2(1)(4)3]3+, and [BF4- ⊂ Pd2(4)4]3+. 
There were several other signals corresponding to 2+ and 1+ helicate species 
present in the spectrum of the mixture. The five largest 2+ signals observed at m/z 
696.07071, 714.06066, 732.05094, 750.04138, and 768.03200 correspond to the 
heteroleptic species [Pd2(1)4(BF4)(Cl)]2+, [Pd2(1)3(4)(BF4)(Cl)]2+, 
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[Pd2(1)2(4)2(BF4)(Cl)]2+, [Pd2(1)(4)3(BF4)(Cl)]2+, and [Pd2(4)4(BF4)(Cl)]2+, 
respectively.  
Heating of the mixture at 80 oC overnight results in the intensity of the [BF4- ⊂ 
Pd2(4)4]3+ helicate decreasing, and the intensities of the [BF4- ⊂ Pd2(1)3(4)]3+, [BF4- 
⊂ Pd2(1)2(4)2]3+ and [BF4- ⊂ Pd2(1)1(4)3]3+ increasing. The intensity of the [BF4- ⊂ 
Pd2(1)4]3+ remains constant (Figure A3.8). Ratios of the HR – ESI MS heights before 






Figure A3.7. HR – ESI MS (d6 – DMSO) of synthesised [BF4- ⊂ Pd2(1)x(4)4-x]3+ 





Figure A3.8. HR – ESI MS (d6 – DMSO) of synthesised [BF4- ⊂ Pd2(1)x(4)4-x]3+ 
helicates after heating at 80 oC overnight showing the observed m/z and isotope 
pattern for each helicate. 
 
 
Table A3.2. Normalised ratios of the HR – ESI MS heights before and after heating 
with respect to the [BF4- ⊂ Pd2(1)4]3+ height. 










Initial 1.00 3.64 4.64 3.14 1.00 
After Heating 1.00 4.70 7.00 4.50 0.90 
 
 
The 19F NMR of the mixture supports the formation of mixed [BF4- ⊂ Pd2(1)x(4)4-x]3+ 
helicates as the spectrum is different to the spectra of [BF4- ⊂ Pd2(1)4]3+ and [BF4- ⊂ 
Pd2(4)4]3+ mixtures (Figure A3.9). Other than the signal for the free BF4-, there are 
six signals observed in the spectrum at δ -148.89, -149.09 (A + E), -149.22 (B + F), -
149.27 (C + G), -149.30 (H) and -149.52 (D) ppm, and are due to the [BF4- ⊂ 
helicate]3+ species. Comparing the spectrum with the spectrum of [BF4- ⊂ Pd2(1)4]3+, 
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the signal at δ – 148.89 ppm is likely that of the [BF4- ⊂ Pd2(1)4]3+ helicate, and 
comparing the spectrum with that of [BF4- ⊂ Pd2(4)4]3+, the signals A, B, C and D are 
likely that of the different atropisomers of [BF4- ⊂ Pd2(4)4]3+. The signals, E, F, G and 
H are due to the different heteroleptic [BF4- ⊂ Pd2(1)x(4)4-x]3+ helicates present, 
however they overlap with the signals due to the [BF4- ⊂ Pd2(4)4]3+ helicates which 
makes them difficult to assign. Comparison of the intensities of the encapsulated 
BF4- signals in the [BF4- ⊂ Pd2(4)4]3+ spectrum and the [BF4- ⊂ Pd2(1)x(4)4-x]3+ 
spectrum, signal B and D have both decreased which suggests that the ratio of  [BF4- 
⊂ Pd2(4)4]3+ atropisomers has changed.  The ratio of free BF4- signal to the 
encapsulated BF4- signals is 4.00:1.00, which suggests that not all of the ligands have 




Figure A3.9. 19F NMR (376 MHz, d6 – DMSO) of mixed [BF4- ⊂ Pd2(1)x(4)4-x]3+ 




The 19F NMR of the mixture after heating shows broadening of the free BF4- and 
encapsulated BF4- signals (Figure A3.10). This suggests that heating causes the 
decomposition of the helicates. The ratio of the free BF4- signal to encapsulated BF4- 
signals slightly decreases to 3.50:1.00 after heating, which can be contributed to the 
accuracy of the experiment as the formation of more [BF4- ⊂ Pd2(1)x(4)4-x]3+ 




Figure A3.10. 19F NMR (376 MHz, d6 – DMSO) of mixed [BF4- ⊂ Pd2(1)x(4)4-x]3+ 
helicates heated at 80 oC overnight showing fluorine assignment. 
 
 
A 19F DOSY spectrum was also performed to determine the diffusion coefficients of 
both free BF4- and [BF4- ⊂ helicate]3+ signals (Figure A3.11). The diffusion 
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coefficient for the free BF4- anion signal was recorded as (5.36 ± 0.006) x 10-10 m2 s-
1, whereas the signals for the encapsulated BF4- anions of [BF4- ⊂ Pd2(1)4]3+, A + E, 
B + F, C + G, and H were recorded as (1.45 ± 0.04) x 10-10 m2 s-1, (1.35 ± 0.03) x 10-
10 m2 s-1, (0.99 ± 0.04) x 10-10 m2 s-1, (1.13 ± 0.02) x 10-10 m2 s-1,  and (1.23 ± 0.03) x 
10-10 m2 s-1, respectively. The diffusion coefficients for signal D could not be 
measured due to the weakness of the signal. The diffusion coefficient for the free 
BF4- signal is consistent with what was observed for free BF4- in the other mixtures, 
and the diffusion coefficient for the encapsulated BF4- signal of [BF4- ⊂ Pd2(1)4]3+ is 
also consistent with what was observed for the pure solution of [BF4- ⊂ Pd2(1)4]3+. 
(1.34 ± 0.04 x 10-10 m2 s-1). The diffusion coefficients for signals A + E, B + F, C + G, 
and H suggest that the helicates have a larger apparent size than that of the [BF4- ⊂ 
Pd2(1)4]3+ helicate, due to the slower diffusion coefficients than the value for the 
[BF4- ⊂ Pd2(1)4]3+ helicate. Assignment of which encapsulated BF4- signal 
corresponds to which [BF4- ⊂ Pd2(1)x(4)4-x]3+ helicate is difficult since the signals 





Figure A3.11. 19F DOSY (470 MHz, d6 – DMSO) of mixed [BF4- ⊂ Pd2(1)x(4)4-x]3+ 




Synthesis of [Pd2(1)x(6)4-x] helicates 
 
[Pd2(1)x(6)4-x]3+ helicates were synthesised from the mixing of [Pd(MeCN)4](BF4)2, 
1, and 6 in a 2 : 2 : 2 ratio in d6 – DMSO at room temperature. The mixture was left 
for three days to equilibrate, and then sent for HR – ESI MS and 19F NMR analysis. 
The HR – ESI MS of the mixture supports the formation of a mixture of [BF4- ⊂ 
Pd2(1)x(6)4-x]3+ helicates (Figure A3.12). There are three main 3+ signals observed 
at m/z 452.39017, 471.07761, and 489.76504. The isotope patterns and m/z of the 
observed signals match that calculated for the heteroleptic species [BF4- ⊂ 
Pd2(1)4]3+, [BF4- ⊂ Pd2(1)3(6)]3+, and [BF4- ⊂ Pd2(1)2(6)2]3+. There is no evidence of 
formation of either the [BF4- ⊂ Pd2(1)(6)3]3+ helicate or the [BF4- ⊂ Pd2(6)4]3+ 
helicate, which suggests that ligand 6 is too bulky to come close enough together to 
form the [BF4- ⊂ Pd2(1)(6)3]3+ helicate, as it is too sterically hindered. This is like 
what was observed with [BF4- ⊂ Pd2(1)x(3)4-x]3+ helicates, where all of the helicates 
were present except for the [BF4- ⊂ Pd2(3)4]3+ helicate. 
There were several other signals corresponding to 2+ and 1+ helicate species 
present in the spectrum of the mixture. The four largest 2+ signals observed at m/z 
696.06931, 724.10029, 750.12095, and 778.13101 correspond to the heteroleptic 
species [Pd2(1)4(BF4)(Cl)]2+, [Pd2(1)3(6)(BF4)(Cl)]2+, [Pd2(1)2(6)3(BF4)2]2+, and 
[Pd2(1)2(6)2(BF4)2]2+, respectively. The ratios of the HR – ESI MS heights with 




Figure A3.12. HR – ESI MS (d6 – DMSO) of synthesised [BF4- ⊂ Pd2(1)x(6)4-x]3+ 
helicates showing the observed m/z and isotope pattern for each helicate. 
 
 
Table A3.3. Normalised ratios of the HR – ESI MS heights with respect to the [BF4- 
⊂ Pd2(1)4]3+ height. 
 [BF4- ⊂ Pd2(1)4]3+ [BF4- ⊂ Pd2(1)3(6)]3+ [BF4- ⊂ Pd2(1)2(6)2]3+ 
Initial 1.00 4.68 1.16 
 
 
The 19F NMR of the mixture supports the formation of mixed [BF4- ⊂ Pd2(1)x(6)4-x]3+ 
helicates as the spectrum is different to the spectra of [BF4- ⊂ Pd2(1)4]3+ and [BF4- ⊂ 
Pd2(6)4]3+ mixtures (Figure A3.13). Other than the signal for the free BF4-, there are 
four signals observed in the spectrum at δ -148.89 ([BF4- ⊂ Pd2(1)4]3+), -149.13 (A), 
-149.27 (B), and -149.95 (C) ppm, and are due to the [BF4- ⊂ helicate]3+ species. 
Comparing the spectrum with that of [BF4- ⊂ Pd2(1)4]3+, the signal at δ – 148.89 is 
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likely due to that of the [BF4- ⊂ Pd2(1)4]3+ helicate, and the signals A, B, and C are 




Figure A3.13. 19F NMR (376 MHz, d6 – DMSO) of mixed [BF4- ⊂ Pd2(1)x(6)4-x]3+ 
helicates showing fluorine assignment. 
 
 
Comparing the 19F NMR spectrum with the observed intensities of the helicates in 
the HR – ESI MS, signal B is likely that of the [BF4- ⊂ Pd2(1)3(6)]3+ helicate as it has 
the largest intensity in the MS, and is also the largest signal in the NMR. Signals A 
and C are likely the cis/trans isomers of the [BF4- ⊂ Pd2(1)2(6)2]3+ helicate. Signal A 
is most likely the trans isomer as it has the largest signal intensity in the NMR, and 
is the least sterically hindered. Signal C is most likely the cis isomer as it is more 
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sterically hindered, and has the smallest signal intensity in the NMR. The ratio of 
free BF4- signal to the encapsulated BF4- signals is 4.00:1.00, which suggests that not 
all of the ligands have been incorporated into helicates.  
The 19F NMR of the mixture after heating shows no change in the signal intensities 
of any of the signals, suggesting that heating has no effect on the distribution of 
helicates. 
A 19F DOSY spectrum was also performed to determine the diffusion coefficients of 
both free BF4- and [BF4- ⊂ helicate]3+ signals (Figure A3.14). The diffusion 
coefficient for the free BF4- anion signal was recorded as (5.14 ± 0.02) x 10-10 m2 s-1, 
whereas the signals for the encapsulated BF4- anions of [BF4- ⊂ Pd2(1)4]3+, A and B 
were recorded as (2.02 ± 0.2) x 10-10 m2 s-1, (1.31 ± 0.05) x 10-10 m2 s-1, and (1.45 ± 
0.05) x 10-10 m2 s-1, respectively. The diffusion coefficients for signal C could not be 
measured due to the weakness of the signal. The diffusion coefficient for the free 
BF4- signal is consistent with what was observed for free BF4- in the other mixtures. 
Comparing the diffusion coefficients for signals A and B, B has a smaller apparent 
size than that of A. This suggests that the assignment that signal B is due to the [BF4- 
⊂ Pd2(1)3(6)]3+ helicate is correct, as it only has one of ligand 6, whereas A must 






Figure A3.14. 19F DOSY (470 MHz, d6 – DMSO) of mixed [BF4- ⊂ Pd2(1)x(6)4-x]3+ 
helicates showing diffusion coefficients of free and encapsulated BF4-. 
 
 
A3.2 Synthesis of [Pd2(2)x(L)4-x] helicates 
 
 
Synthesis of [Pd2(2)x(3)4-x] helicates 
 
[Pd2(2)x(3)4-x]3+ helicates were synthesised from the mixing of [Pd(MeCN)4](BF4)2, 
2, and 3 in a 2 : 2 : 2 ratio in d6 – DMSO at room temperature. The mixture was left 
for three days to equilibrate, and then sent for HR – ESI MS and 19F NMR analysis. 
The HR – ESI MS of the mixture supports the formation of a mixture of [BF4- ⊂ 
Pd2(2)x(3)4-x]3+ helicates (Figure A3.15). There are four main 3+ signals observed 
at m/z 519.08071, 535.75276, 552.42462, and 569.09646. The isotope patterns and 
m/z of the observed signals match that calculated for the heteroleptic species [BF4- 
⊂ Pd2(2)4]3+, [BF4- ⊂ Pd2(2)3(3)]3+, [BF4- ⊂ Pd2(2)2(3)2]3+, and [BF4- ⊂ Pd2(2)(3)3]3+. 
There is no signal observed for [BF4- ⊂ Pd2(3)4]3+, as the helicate is too sterically 
hindered to form. 
There were other signals corresponding to 2+ and 1+ helicate species present in the 
spectrum of the mixture. The four 2+ signals observed at m/z 796.10578, 
821.11427, 846.12607, and 872.13899 correspond to the heteroleptic species 
[Pd2(2)4(BF4)(Cl)]2+, [Pd2(2)3(3)(BF4)(Cl)]2+, [Pd2(2)2(3)2(BF4)(Cl)]2+, and 
[Pd2(2)(3)3(BF4)(Cl)]2+, respectively. The ratios of the HR – ESI MS heights with 




Figure A3.15. HR – ESI MS (d6 – DMSO) of synthesised [BF4- ⊂ Pd2(2)x(3)4-x]3+ 
helicates showing the observed m/z and isotope pattern for each helicate. 
 
 
Table A3.4. Normalised ratios of the HR – ESI MS heights with respect to the [BF4- 
⊂ Pd2(2)4]3+ height. 








Initial 1.00 6.91 7.91 0.91 
 
 
The 19F NMR of the mixture supports the formation of mixed [BF4- ⊂ Pd2(2)x(3)4-x]3+ 
helicates as the spectrum is different to the spectra of [BF4- ⊂ Pd2(2)4]3+ and [BF4- ⊂ 
Pd2(3)4]3+ mixtures (Figure A3.16). Other than the signal for the free BF4-, there are 
four signals observed in the spectrum at δ -149.28 (A), -149.41 (B), -149.57 (C), and 
-150.23 ([BF4- ⊂ Pd2(2)4]3+) ppm, and are due to the [BF4- ⊂ helicate]3+ species. 
Comparing the spectrum with that of [BF4- ⊂ Pd2(2)4]3+, the signal at δ – 150.23  is 
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likely due to that of the [BF4- ⊂ Pd2(2)4]3+ helicate, and signals A, B, and C are due to 
the different heteroleptic [BF4- ⊂ Pd2(2)x(3)4-x]3+ helicates present.  
 
 
Figure A3.16. 19F NMR (376 MHz, d6 – DMSO) of mixed [BF4- ⊂ Pd2(2)x(3)4-x]3+ 
helicates showing fluorine assignment. 
 
 
Comparing the 19F NMR spectrum with the observed intensities of the helicates in 
the HR – ESI MS, signal A is likely that of the [BF4- ⊂ Pd2(2)(3)3]3+ helicate as it has 
a similar intensity to the [BF4- ⊂ Pd2(2)4]3+ helicate in the MS and in the NMR. The 
other signals are harder to assign, however comparing the signal intensities to the 
heights of the helicates observed in the MS can help with the assignment. The most 
abundant species in the MS is that of the [BF4- ⊂ Pd2(2)2(3)2]3+ helicate, which is 
closely followed by the [BF4- ⊂ Pd2(2)3(3)]3+ helicate. Comparing this to the signal 
intensities observed in the NMR, signals B and C could be either the [BF4- ⊂ 
279 
 
Pd2(2)2(3)2]3+ helicate, or the [BF4- ⊂ Pd2(2)3(3)]3+ helicate, since the signal 
intensities of B and C do not differ drastically. The ratio of free BF4- signal to the 
encapsulated BF4- signals is 4.00:1.00, which suggests that not all of the ligands have 
been incorporated into helicates. 
The 19F NMR of the mixture after heating shows an increase in signal intensities for 
signals A, B and C, and a decrease in the signal intensity of [BF4- ⊂ Pd2(2)4]3+. The 
ratio of the free BF4- signal to encapsulated BF4- signals decreases to 3.60:1.00 after 
heating.  
A 19F DOSY spectrum was also performed to determine the diffusion coefficients of 
both free BF4- and [BF4- ⊂ helicate]3+ signals (Figure A3.17). The diffusion 
coefficient for the free BF4- anion signal was recorded as (4.48 ± 0.007) x 10-10 m2 s-
1, whereas the diffusion coefficients for signals A, B and C were recorded as (1.18 ± 
0.03) x 10-10 m2 s-1, (0.94 ± 0.03) x 10-10 m2 s-1, and (0.64 ± 0.07) x 10-10 m2 s-1, 
respectively. The diffusion coefficient for the [BF4- ⊂ Pd2(2)4]3+ helicate could not be 
measured due to the weakness of the signal. The diffusion coefficient for the free 
BF4- signal is consistent with what was observed for free BF4- in the other mixtures. 
Comparing the diffusion coefficients for signals A, B and C, A has the smallest 
apparent size than B and C. This suggests that signal A is likely due to the [BF4- ⊂ 
Pd2(2)3(3)]3+ helicate, as this would be the smallest helicate. From this, B is likely 
that of the [BF4- ⊂ Pd2(2)2(3)2]3+ helicate and C is the [BF4- ⊂ Pd2(2)(3)3]3+ helicate. 
However, it is noted that this is not consistent with the intensities observed for the 





Figure A3.17. 19F DOSY (470 MHz, d6 – DMSO) of mixed [BF4- ⊂ Pd2(2)x(3)4-x]3+ 
helicates showing diffusion coefficients of free and encapsulated BF4-. 
 
 
Synthesis of [Pd2(2)x(4)4-x] helicates 
 
[Pd2(2)x(4)4-x]3+ helicates were synthesised from the mixing of [Pd(MeCN)4](BF4)2, 
2, and 4 in a 2 : 2 : 2 ratio in d6 – DMSO at room temperature. The mixture was left 
for three days to equilibrate, and then sent for HR – ESI MS and 19F NMR analysis. 
The HR – ESI MS of the mixture supports the formation of a mixture of [BF4- ⊂ 
Pd2(2)x(4)4-x]3+ helicates (Figure A3.18). There are five main 3+ signals observed 
at m/z 500.36493, 505.04307, 509.72132, 514.39947, and 519.07767. The isotope 
patterns and m/z of the observed signals match that calculated for the heteroleptic 
species [BF4- ⊂ Pd2(4)4]3+, [BF4- ⊂ Pd2(2)(4)3]3+, [BF4- ⊂ Pd2(2)2(4)2]3+, [BF4- ⊂ 
Pd2(2)3(4)]3+, and [BF4- ⊂ Pd2(2)4]3+.  
There were other signals corresponding to 2+ and 1+ helicate species present in the 
spectrum of the mixture. The five 2+ signals observed at m/z 768.03161, 775.04893, 
782.06620, 789.08326, and 796.10022 correspond to the heteroleptic species 
[Pd2(4)4(BF4)(Cl)]2+, [Pd2(2)(4)3(BF4)(Cl)]2+, [Pd2(2)2(4)2(BF4)(Cl)]2+, 
[Pd2(2)3(4)(BF4)(Cl)]2+,  and [Pd2(2)4(BF4)(Cl)]2+, respectively. The ratios of the HR 
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– ESI MS heights with respect to the [BF4- ⊂ Pd2(2)4]3+ helicate height are 




Figure A3.18. HR – ESI MS (d6 – DMSO) of synthesised [BF4- ⊂ Pd2(2)x(4)4-x]3+ 
helicates showing the observed m/z and isotope pattern for each helicate. 
 
 
Table A3.5. Normalised ratios of the HR – ESI MS heights with respect to the [BF4- 
⊂ Pd2(2)4]3+ height. 















The 19F NMR of the mixture supports the formation of mixed [BF4- ⊂ Pd2(2)x(4)4-x]3+ 
helicates as the spectrum is different to the spectra of [BF4- ⊂ Pd2(2)4]3+ and [BF4- ⊂ 
Pd2(4)4]3+ mixtures (Figure A3.19). There are several more signals for the fluorine 
atoms of 4 in the helicates between δ -126.71 - -134.42 ppm compared to the 
spectrum of pure [BF4- ⊂ Pd2(4)4]3+, supporting that the formation of [BF4- ⊂ 
Pd2(2)x(4)4-x]3+ helicates. Other than the signal for the free BF4-, there are 10 signals 
observed in the spectrum at δ -148.88 (E), -149.00 (F), -149.11 (A + G), -149.21 (B 
+ H), -149.28 (C + I), -149.36 (J), -149.41 (K), -149.52 (D), -149.59 (L), and -150.25 





Figure A3.19. 19F NMR (376 MHz, d6 – DMSO) of mixed [BF4- ⊂ Pd2(2)x(4)4-x]3+ 




Comparing the spectrum with that of [BF4- ⊂ Pd2(2)4]3+, the signal at δ – 150.25 is 
likely due to that of the [BF4- ⊂ Pd2(2)4]3+ helicate, and comparing the spectrum with 
that of [BF4- ⊂ Pd2(4)4]3+, signals A, B, C and D are likely due to the different 
atropisomers of [BF4- ⊂ Pd2(4)4]3+. However, they are hard to assign due to the 
overlapping of all of the new signals due to the heteroleptic [BF4- ⊂ Pd2(2)x(4)4-x]3+ 
helicates (signals E - L). Due to the fact there are different atropisomers of the [BF4- 
⊂ Pd2(4)4]3+ helicate, the heteroleptic [BF4- ⊂ Pd2(2)x(4)4-x]3+ helicates can also have 
different atropisomers. This leads to a large number of signals observed in the 19F 
NMR, and therefore makes the assignment of the signals impossible to determine. 
The ratio of free BF4- signal to the encapsulated BF4- signals is 4.00:1.00, which 
suggests that not all of the ligands have been incorporated into helicates. 
The 19F NMR of the mixture after heating shows no change in the signal intensities 
of any of the signals, suggesting that heating has no effect on the distribution of 
helicates.  
A 19F DOSY spectrum was also performed to determine the diffusion coefficients of 
both free BF4- and [BF4- ⊂ helicate]3+ signals (Figure A3.20). The diffusion 
coefficient for the free BF4- anion signal was recorded as (5.56 ± 0.04) x 10-10 m2 s-1, 
whereas the signals of A + G, B + H, C + I, and J were recorded as (1.10 ± 0.2) x 10-10 
m2 s-1, (1.80 ± 0.2) x 10-10 m2 s-1, (1.68 ± 0.2) x 10-10 m2 s-1, and (1.34 ± 0.2) x 10-10 
m2 s-1, respectively. The diffusion coefficient for signals D, E, F, K, L, and the [BF4- ⊂ 
Pd2(2)4]3+ helicate signal could not be measured due to the weakness of the signals. 
The diffusion coefficient for the free BF4- signal is consistent with what was observed 
for free BF4- in the other mixtures. Comparing the diffusion coefficients for signals A 
+ G, B + H, C + I, and J, B + H has the smallest apparent size than the other signals. 
However, the assignment of which mixed helicate belongs to which signal cannot be 






Figure A3.20. 19F DOSY (470 MHz, d6 – DMSO) of mixed [BF4- ⊂ Pd2(2)x(4)4-x]3+ 
helicates showing diffusion coefficients of free and encapsulated BF4-. 
 
 
Synthesis of [Pd2(2)x(5)4-x] helicates 
 
[Pd2(2)x(5)4-x]3+ helicates were synthesised from the mixing of [Pd(MeCN)4](BF4)2, 
2, and 5 in a 2 : 2 : 2 ratio in d6 – DMSO at room temperature. The mixture was left 
for three days to equilibrate, and then sent for HR – ESI MS and 19F NMR analysis. 
The HR – ESI MS of the mixture supports the formation of a mixture of [BF4- ⊂ 
Pd2(2)x(5)4-x]3+ helicates (Figure A3.21). There are five main 3+ signals observed 
at m/z 489.76529, 497.09331, 504.42147, 511.74950, and 519.07771. The isotope 
patterns and m/z of the observed signals match that calculated for the heteroleptic 
species [BF4- ⊂ Pd2(5)4]3+, [BF4- ⊂ Pd2(2)(5)3]3+, [BF4- ⊂ Pd2(2)2(5)2]3+, [BF4- ⊂ 
Pd2(2)3(5)]3+, and [BF4- ⊂ Pd2(2)4]3+.  
There were other signals corresponding to 2+ and 1+ helicate species present in the 
spectrum of the mixture. The five 2+ signals observed at m/z 752.13190, 763.12418, 
774.11639, 785.10858, and 796.10087 correspond to the heteroleptic species 
[Pd2(5)4(BF4)(Cl)]2+, [Pd2(2)(5)3(BF4)(Cl)]2+, [Pd2(2)2(5)2(BF4)(Cl)]2+, 
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[Pd2(2)3(5)(BF4)(Cl)]2+,  and [Pd2(5)4(BF4)(Cl)]2+, respectively. The ratios of the HR 
– ESI MS heights with respect to the [BF4- ⊂ Pd2(2)4]3+ helicate height are 




Figure A3.21. HR – ESI MS (d6 – DMSO) of synthesised [BF4- ⊂ Pd2(2)x(5)4-x]3+ 
helicates showing the observed m/z and isotope pattern for each helicate. 
 
 
Table A3.6. Normalised ratios of the HR – ESI MS heights with respect to the [BF4- 
⊂ Pd2(2)4]3+ height. 















The 19F NMR of the mixture supports the formation of mixed [BF4- ⊂ Pd2(2)x(5)4-x]3+ 
helicates as the spectrum is different to the spectra of [BF4- ⊂ Pd2(2)4]3+ and [BF4- ⊂ 
Pd2(5)4]3+ mixtures (Figure A3.22). Other than the signal for the free BF4-, there are 
six signals observed in the spectrum at δ -148.65 (A), -148.93 (B), -149.29 (D), -
149.39 (E), -149.91 (C), and -150.25 ([BF4- ⊂ Pd2(2)4]3+) ppm, and are due to the 




Figure A3.22. 19F NMR (376 MHz, d6 – DMSO) of mixed [BF4- ⊂ Pd2(2)x(5)4-x]3+ 
helicates showing fluorine assignment. 
 
 
Comparing the spectrum with that of [BF4- ⊂ Pd2(2)4]3+, the signal at δ – 150.25 is 
likely due to that of the [BF4- ⊂ Pd2(2)4]3+ helicate, and comparing the spectrum with 
that of [BF4- ⊂ Pd2(5)4]3+, signals A, B, and C are likely due to the different 
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atropisomers of [BF4- ⊂ Pd2(5)4]3+. Signals D and E are due to the different 
heteroleptic [BF4- ⊂ Pd2(2)x(5)4-x]3+ helicates present. Interestingly, the two signals 
which incorporate ligand 2 are quite broad, which suggests that this broadness 
observed is possibly characteristic of a helicate containing ligand 2. This broadness 
has been observed in previous [BF4- ⊂ Pd2(2)x(L)4-x]3+ solutions. Because of this, the 
assignment of signals D and E to their corresponding heteroleptic helicate is 
difficult. The intensity of the [BF4- ⊂ Pd2(5)4]3+ signal in the HR – ESI MS agrees with 
the observed intensities of the atropisomers of [BF4- ⊂ Pd2(5)4]3+ in the 19F NMR. 
The ratio of free BF4- signal to the encapsulated BF4- signals is 4.00:1.00, which 
suggests that not all of the ligands have been incorporated into helicates. 
The 19F NMR of the mixture after heating shows no change in the signal intensities 
of any of the signals, suggesting that heating has no effect on the distribution of 
helicates.  
A 19F DOSY spectrum was also performed to determine the diffusion coefficients of 
both free BF4- and [BF4- ⊂ helicate]3+ signals (Figure A3.23). The diffusion 
coefficient for the free BF4- anion signal was recorded as (5.25 ± 0.04) x 10-10 m2 s-1, 
whereas the signals of A, B, D, E, C and the [BF4- ⊂ Pd2(2)4]3+ helicate were recorded 
as (1.43 ± 0.2) x 10-10 m2 s-1, (1.48 ± 0.2) x 10-10 m2 s-1, (1.47 ± 0.08) x 10-10 m2 s-1, 
(1.20 ± 0.2) x 10-10 m2 s-1, (1.46 ± 0.1) x 10-10 m2 s-1, and  (1.01 ± 0.1) x 10-10 m2 s-1, 
respectively. The diffusion coefficient for the free BF4- signal is consistent with what 
was observed for free BF4- in the other mixtures. Comparing the diffusion 
coefficients for the encapsulated BF4- signals, the [BF4- ⊂ Pd2(2)4]3+ helicate has the 
largest apparent size. Signal E has the second largest apparent size compared to the 
other signals, which suggests that this signal may be due to the [BF4- ⊂ Pd2(2)(5)3]3+ 
helicate. However, for the rest of the signals, the diffusion coefficients overlap which 




Figure A3.23. 19F DOSY (470 MHz, d6 – DMSO) of mixed [BF4- ⊂ Pd2(2)x(5)4-x]3+ 
helicates showing diffusion coefficients of free and encapsulated BF4-. 
 
 
Synthesis of [Pd2(2)x(6)4-x] helicates 
 
[Pd2(2)x(6)4-x]3+ helicates were synthesised from the mixing of [Pd(MeCN)4](BF4)2, 
2, and 6 in a 2 : 2 : 2 ratio in d6 – DMSO at room temperature. The mixture was left 
for three days to equilibrate, and then sent for HR – ESI MS and 19F NMR analysis. 
The HR – ESI MS of the mixture supports the formation of a mixture of [BF4- ⊂ 
Pd2(2)x(6)4-x]3+ helicates (Figure A3.24). There are two main 3+ signals observed 
at m/z 519.07822 and 521.09241, which overlap with each other due to the small 
difference in m/z. The isotope patterns and m/z of the observed signals match that 
calculated for the heteroleptic species [BF4- ⊂ Pd2(2)4]3+ and [BF4- ⊂ Pd2(2)3(6)]3+. 
There is no signal observed for the heteroleptic [BF4- ⊂ Pd2(2)2(6)2]3+, [BF4- ⊂ 
Pd2(2)(6)3]3+, or [BF4- ⊂ Pd2(6)4]3+ helicate species. This suggests that ligand 6 is too 
bulky to come close enough to itself or ligand 2 to form the [BF4- ⊂ Pd2(2)2(6)2]3+, 
[BF4- ⊂ Pd2(2)(6)3]3+, and [BF4- ⊂ Pd2(6)4]3+ helicate species. Less heteroleptic 
species are formed when mixing ligands 2 and 6 together compared to the mixing 




There were other signals corresponding to 2+ and 1+ helicate species present in the 
spectrum of the mixture. The two 2+ signals observed at m/z 796.10112 and 
799.11991 correspond to the heteroleptic species [Pd2(2)4(BF4)(Cl)]2+ and 
[Pd2(2)3(6)(BF4)(Cl)]2+, respectively. Like the 3+ species, these two signals overlap 





Figure A3.24. HR – ESI MS (d6 – DMSO of synthesised [BF4- ⊂ Pd2(2)x(6)4-x]3+ 




The 19F NMR of the mixture supports the formation of mixed [BF4- ⊂ Pd2(2)x(6)4-x]3+ 
helicates as the spectrum is different to the spectra of [BF4- ⊂ Pd2(2)4]3+ and [BF4- ⊂ 
Pd2(6)4]3+ mixtures (Figure A3.25). Other than the signal for the free BF4-, there are 
two signals observed in the spectrum at δ -149.41 (A) and -150.25 ([BF4- ⊂ 
Pd2(2)4]3+) ppm, and are due to the [BF4- ⊂ helicate]3+ species. Both [BF4- ⊂ 





Figure A3.25. 19F NMR (376 MHz, d6 – DMSO) of mixed [BF4- ⊂ Pd2(2)x(6)4-x]3+ 





Comparing the spectrum with that of [BF4- ⊂ Pd2(2)4]3+, the signal at δ – 150.25 is 
likely due to that of the [BF4- ⊂ Pd2(2)4]3+ helicate. Signal A must be that of the [BF4- 
⊂ Pd2(2)3(6)]3+ helicate as this is the only other helicate observed in the HR – ESI 
MS. The ratio of free BF4- signal to the encapsulated BF4- signals is 9.00:1.00, which 
suggests that not all of the ligands have been incorporated into helicates. 
The 19F NMR of the mixture after heating shows an increase in signal intensity for 
signal A, and the formation of new signals at δ -148.50 (B), -149.72 (C), and -150.41 
(D) ppm (Figure A3.26). These new signals could be due to either atropisomers of 
the [BF4- ⊂ Pd2(2)3(6)]3+ helicate since ligand 2 can have two different orientations 
when coordinated in the helicate, similar to what is observed for ligand 4 and 5. The 
other scenario could be the formation of the cis/trans isomers of the [BF4- ⊂ 
Pd2(2)2(6)2]3+ helicates, where they can both possess atropisomers. The sample was 




Figure A3.26. 19F NMR (376 MHz, d6 – DMSO) of mixed [BF4- ⊂ Pd2(2)x(6)4-x]3+ 
helicates after heating, showing fluorine assignment. 
292 
 
A 19F DOSY spectrum was also performed to determine the diffusion coefficients of 
both free BF4- and [BF4- ⊂ helicate]3+ signals (Figure A3.27). The diffusion 
coefficient for the free BF4- anion signal was recorded as (5.25 ± 0.04) x 10-10 m2 s-1, 
whereas the signals of A and the [BF4- ⊂ Pd2(2)4]3+ helicate were recorded as (1.19 
± 0.1) x 10-10 m2 s-1 and (1.38 ± 0.05) x 10-10 m2 s-1, respectively. The diffusion 
coefficient for the free BF4- signal is consistent with what was observed for free BF4- 
in the other mixtures. Comparing the diffusion coefficients for the encapsulated 
BF4- signals, the [BF4- ⊂ Pd2(2)4]3+ helicate has the smallest apparent size, which is 
expected as ligand 2 is smaller than ligand 6. Signal A has the largest apparent size, 





Figure A3.27. 19F DOSY (470 MHz, d6 – DMSO) of mixed [BF4- ⊂ Pd2(2)x(6)4-x]3+ 






A3.3 Synthesis of [Pd2(3)x(L)4-x] helicates 
 
 
Synthesis of [Pd2(3)x(4)4-x] helicates 
 
[Pd2(3)x(4)4-x]3+ helicates were synthesised from the mixing of [Pd(MeCN)4](BF4)2, 
3, and 4 in a 2 : 2 : 2 ratio in d6 – DMSO at room temperature. The mixture was left 
for three days to equilibrate, and then sent for HR – ESI MS and 19F NMR analysis. 
The HR – ESI MS of the mixture supports the formation of a mixture of [BF4- ⊂ 
Pd2(3)x(4)4-x]3+ helicates (Figure A3.28). There are three main 3+ signals observed 
at m/z 521.71476, 543.06497, and 564.41502. The isotope patterns and m/z of the 
observed signals match that calculated for the heteroleptic species [BF4- ⊂ 
Pd2(3)(4)3]3+, [BF4- ⊂ Pd2(3)2(4)2]3+, and [BF4- ⊂ Pd2(3)3(4)]3+. There are no signals 
observed for the homoleptic [BF4- ⊂ Pd2(3)4]3+ helicate and the [BF4- ⊂ Pd2(4)4]3+ 
helicate. 
There were other signals corresponding to 2+ and 1+ helicate species present in the 
spectrum of the mixture. The three 2+ signals observed at m/z 800.05683, 
832.08205, and 864.10690 correspond to the heteroleptic species 
[Pd2(3)(4)3(BF4)(Cl)]2+, [Pd2(3)2(4)2(BF4)(Cl)]2+, and [Pd2(3)3(4)(BF4)(Cl)]2+, 
respectively. The ratios of the HR – ESI MS heights with respect to the [BF4- ⊂ 




Figure A3.28. HR – ESI MS (d6 – DMSO) of synthesised [BF4- ⊂ Pd2(3)x(4)4-x]3+ 
helicates showing the observed m/z and isotope pattern for each helicate. 
 
 
Table A3.7. Normalised ratios of the HR – ESI MS heights with respect to the [BF4- 
⊂ Pd2(3)3(4)]3+ height. 
 [BF4- ⊂ Pd2(3)3(4)]3+ [BF4- ⊂ Pd2(3)2(4)2]3+ [BF4- ⊂ Pd2(3)(4)3]3+ 
Initial 1.00 14.57 12.57 
 
 
The 19F NMR of the mixture supports the formation of mixed [BF4- ⊂ Pd2(3)x(4)4-x]3+ 
helicates as the spectrum is different to the spectra of [BF4- ⊂ Pd2(3)4]3+ and [BF4- ⊂ 
Pd2(4)4]3+ mixtures (Figure A3.29). There are several more signals for the fluorine 
atoms of 4 in the helicates between δ -126.70 - -128.79 ppm, and signals at δ -130.76, 
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-131.29, and -134.15 ppm, compared to the spectrum of pure [BF4- ⊂ Pd2(4)4]3+. 
Other than the signal for the free BF4-, there are 13 signals observed in the spectrum 
at δ -148.83 (E), -149.11 (A + F), -149.22 (B), -149.28 (C), -149.52 (D + G), -149.68 
(H), -149.78 (I), -149.92 (J), -150.01 (K), -150.12 (L), -150.17 (M), -150.21 (N), and 




Figure A3.29. 19F NMR (376 MHz, d6 – DMSO) of mixed [BF4- ⊂ Pd2(3)x(4)4-x]3+ 
helicates showing fluorine assignment. 
 
 
Comparing the spectrum with that of [BF4- ⊂ Pd2(4)4]3+, signals A, B, C and D are 
likely due to the different atropisomers of [BF4- ⊂ Pd2(4)4]3+. However, they are hard 
to assign due to the overlapping of new signals due to the heteroleptic [BF4- ⊂ 
Pd2(3)x(4)4-x]3+ helicates (signals F and G). Signals E and H - O are due to the new 
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formed [BF4- ⊂ Pd2(3)x(4)4-x]3+ helicates. Due to the fact there are different 
atropisomers of the [BF4- ⊂ Pd2(4)4]3+ helicate, the heteroleptic [BF4- ⊂ Pd2(3)x(4)4-
x]3+ helicates can also have different atropisomers. This leads to a large number of 
signals observed in the 19F NMR, and therefore makes the assignment of the signals 
impossible to determine. The ratio of free BF4- signal to the encapsulated BF4- signals 
is 3.00:1.00, which suggests that all of the ligands have been incorporated into 
helicates. 
The 19F NMR of the mixture after heating shows a decrease in signal intensities for 
signals E, A + F, B, C, D + G, I, J, L and M, and an increase in signal intensities for 
signals H, K, N and O. The ratio of the free BF4- signal to encapsulated BF4- signals 
stays constant after heating.  
A 19F DOSY spectrum was also performed to determine the diffusion coefficients of 
both free BF4- and [BF4- ⊂ helicate]3+ signals (Figure A3.30). The diffusion 
coefficient for the free BF4- anion signal was recorded as (4.96 ± 0.02) x 10-10 m2 s-1, 
whereas the diffusion coefficients for signals H - O were recorded as (1.47 ± 0.1) x 
10-10 m2 s-1, (1.41 ± 0.05) x 10-10 m2 s-1, (1.27 ± 0.05) x 10-10 m2 s-1, (1.18 ± 0.05) x 
10-10 m2 s-1, (0.93 ± 0.06) x 10-10 m2 s-1, (1.04 ± 0.04) x 10-10 m2 s-1, (1.08 ± 0.03) x 
10-10 m2 s-1, and (1.09 ± 0.03) x 10-10 m2 s-1,  respectively.  
The diffusion coefficients for signals E, A + F, B, C and D + G could not be measured 
due to the weakness of the signals. The diffusion coefficient for the free BF4- signal 
is consistent with what was observed for free BF4- in the other mixtures. Comparing 
the diffusion coefficients for signals H - O, the values measured for signals H and I 
are similar to each other, so are signals J and K, and signals L - O. This suggests that 
the similar signals belong to different atropisomers of the same mixed helicate. Since 
the rate of diffusion is related to the apparent size of the mixed helicate, signals L - 
O must correspond to the heavier mixed helicate, [BF4- ⊂ Pd2(3)3(4)]3+, since ligand 
3 is heavier than ligand 4. Therefore, signals J and K must correspond to [BF4- ⊂ 
Pd2(3)2(4)2]3+, and signals H and I to [BF4- ⊂ Pd2(3)(4)3]3+. However, comparison of 
the intensities of these signals in the 19F NMR to those observed in the HR – ESI MS, 





Figure A3.30. 19F DOSY (470 MHz, d6 – DMSO) of mixed [BF4- ⊂ Pd2(3)x(4)4-x]3+ 
helicates showing diffusion coefficients of free and encapsulated BF4-. 
 
 
Attempted synthesis of [Pd2(3)4(6)4-x] helicates 
 
[Pd2(3)x(6)4-x]3+ helicates were attempted to be synthesised from the mixing of 
[Pd(MeCN)4](BF4)2, 3, and 6 in a 2 : 2 : 2 ratio in d6 – DMSO at room temperature. 
The mixture was left for three days to equilibrate, and then sent for 19F NMR 
analysis. 
The 19F NMR of the mixture shows no formation of mixed [BF4- ⊂ Pd2(3)x(6)4-x]3+ 
helicates as the spectrum is the same as the spectra of [BF4- ⊂ Pd2(3)4]3+ and [BF4- 
⊂ Pd2(6)4]3+ mixtures (Figure A3.31). Only one signal is observed in 2 : 2 : 2 mixture 
of [Pd(MeCN)4](BF4)2 : 3 : 6, which is that of free BF4- at δ -148.29 ppm. This result 
is unsurprising as both of the [BF4- ⊂ Pd2(3)4]3+ and [BF4- ⊂ Pd2(6)4]3+ helicates are 
unable to form from their respective mixtures. This suggests that both ligand 3 and 
6 are too sterically hindered to coordinate to palladium(II) to form homoleptic and 





Figure A3.31. 19F NMR (376 MHz, d6 – DMSO) of a 2 : 2 : 2 mixture of 
[Pd(MeCN)4](BF4)2 : 3 : 6, showing fluorine assignment. 
 
 
A3.4 Synthesis of [Pd2(4)x(L)4-x] helicates 
 
 
Synthesis of [Pd2(4)x(5)4-x] helicates 
 
[Pd2(4)x(5)4-x]3+ helicates were synthesised from the mixing of [Pd(MeCN)4](BF4)2, 
4, and 5 in a 2 : 2 : 2 ratio in d6 – DMSO at room temperature. The mixture was left 
for three days to equilibrate, and then sent for HR – ESI MS and 19F NMR analysis. 
The HR – ESI MS of the mixture supports the formation of a mixture of [BF4- ⊂ 
Pd2(4)x(5)4-x]3+ helicates (Figure A3.32). There are five main 3+ signals observed 
at m/z 489.76391, 492.41437, 495.06422, 497.71432, and 500.36433, which 
overlap with each other due to the small difference in m/z. The isotope patterns and 
m/z of the observed signals match that calculated for the heteroleptic species [BF4- 
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⊂ Pd2(5)4]3+, [BF4- ⊂ Pd2(4)(5)3]3+, [BF4- ⊂ Pd2(4)2(5)2]3+, [BF4- ⊂ Pd2(4)3(5)]3+, and 
[BF4- ⊂ Pd2(4)4(5)]3+.  
There were other signals corresponding to 2+ and 1+ helicate species present in the 
spectrum of the mixture. The five 2+ signals observed at m/z 752.12981, 756.10618, 
760.08109, 764.05630, and 768.03183 correspond to the heteroleptic species 
[Pd2(5)4(BF4)(Cl)]2+, [Pd2(4)(5)3(BF4)(Cl)]2+, [Pd2(4)2(5)2(BF4)(Cl)]2+, 
[Pd2(4)3(5)(BF4)(Cl)]2+, and [Pd2(4)4(BF4)(Cl)]2+, respectively. Similarly, to the 3+ 




Figure A3.32. HR – ESI MS (d6 – DMSO) of synthesised [BF4- ⊂ Pd2(4)x(5)4-x]3+ 
helicates showing the observed m/z and isotope pattern for each helicate. 
 
 
The 19F NMR of the mixture supports the formation of mixed [BF4- ⊂ Pd2(4)x(5)4-x]3+ 
helicates as the spectrum is different to the spectra of [BF4- ⊂ Pd2(4)4]3+ and [BF4- ⊂ 
Pd2(5)4]3+ mixtures (Figure A3.33). There are several more signals for the fluorine 
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atoms of 4 in the helicates between δ -126.67 - -127.51 ppm, and signals at δ -131.47 
and -134.43 ppm, compared to that observed for the [BF4- ⊂ Pd2(4)4]3+ solution. 
Other than the signal for the free BF4-, there are 12 signals observed in the spectrum 
at δ -148.65 (A’), -148.90 (A + B’), -149.01 (E), -149.07 (F), -149.14 (G), -149.18 (H), 
-149.23 (B + I), -149.27 (C + J), -149.53 (D), -149.91 (C’), -150.33 (K), and -150.70 




Figure A3.33. 19F NMR (376 MHz, d6 – DMSO) of mixed [BF4- ⊂ Pd2(4)x(5)4-x]3+ 
helicates showing fluorine assignment. 
 
 
Comparing the spectrum with that of [BF4- ⊂ Pd2(4)4]3+, signals A, B, C and D are 
likely due to the different atropisomers of [BF4- ⊂ Pd2(4)4]3+, and comparing the 
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spectrum with that of [BF4- ⊂ Pd2(5)4]3+, signals A’, B’ and C’ are likely due to the 
different atropisomers of [BF4- ⊂ Pd2(5)4]3+. However, these signals are hard to 
assign due to the overlapping of new signals due to the heteroleptic [BF4- ⊂ 
Pd2(4)x(5)4-x]3+ helicates (signals I and J). Signals E - H, I, and L are due to the new 
formed [BF4- ⊂ Pd2(4)x(5)4-x]3+ helicates. Due to the fact there are different 
atropisomers of the [BF4- ⊂ Pd2(4)4]3+ and [BF4- ⊂ Pd2(5)4]3+ helicates, the 
heteroleptic [BF4- ⊂ Pd2(4)x(5)4-x]3+ helicates can also have different atropisomers. 
This leads to a large number of signals observed in the 19F NMR, and therefore makes 
the assignment of the signals impossible. The ratio of free BF4- signal to the 
encapsulated BF4- signals is 5.00:1.00, which suggests that not all of the ligands have 
been incorporated into helicates.  
The 19F NMR of the mixture after heating shows no change in the signal intensities 
of any of the signals, suggesting that heating has no effect on the distribution of 
helicates.  
A 19F DOSY spectrum was also performed to determine the diffusion coefficients of 
both free BF4- and [BF4- ⊂ helicate]3+ signals (Figure A3.34). The diffusion 
coefficient for the free BF4- signal was recorded as (5.33 ± 0.02) x 10-10 m2 s-1, 
whereas the diffusion coefficients of signals A + B’, E - H, B + I, C + J, D and C’ were 
recorded as (1.30 ± 0.03) x 10-10 m2 s-1, (1.27 ± 0.1) x 10-10 m2 s-1, (1.21 ± 0.05) x 10-
10 m2 s-1, (1.20 ± 0.03) x 10-10 m2 s-1, (1.13 ± 0.04) x 10-10 m2 s-1, (1.33 ± 0.02) x 10-10 
m2 s-1, (1.32 ± 0.06) x 10-10 m2 s-1, (1.28 ± 0.08) x 10-10 m2 s-1, and (1.18 ± 0.09) x 10-
10 m2 s-1, respectively.  
The diffusion coefficients for signals E, K and L could not be measured due to the 
weakness of the signals. The diffusion coefficient for the free BF4- signal is consistent 
with what was observed for free BF4- in the other mixtures. Comparison of signals 
C’ to that measured for signal C in the [BF4- ⊂ Pd2(5)4]3+ spectrum, the value for C’ 
matches that of C (1.18 ± 0.06 x 10-10 m2 s-1), comparison of the signal D to that 
measured for D in the [BF4- ⊂ Pd2(4)4]3+ spectrum, the value for D is inconsistent 
(0.80 ± 0.03 x 10-10 m2 s-1). Comparing the diffusion coefficients for signals A + B’, B 
+ I, and C + J, the values measured are similar to each other, so are signals E - G, and 
signals H and D. This suggests that the similar signals belong to different 
atropisomers of the same mixed helicate. Due to the complexity of the signals and 
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Figure A3.34. 19F DOSY (470 MHz, d6 – DMSO) of mixed [BF4- ⊂ Pd2(4)x(5)4-x]3+ 
helicates showing diffusion coefficients of free and encapsulated BF4-. 
 
 
Synthesis of [Pd2(4)x(6)4-x] helicates 
 
[Pd2(4)x(6)4-x]3+ helicates were synthesised from the mixing of [Pd(MeCN)4](BF4)2, 
4, and 6 in a 2 : 2 : 2 ratio in d6 – DMSO at room temperature. The mixture was left 
for three days to equilibrate, and then sent for HR – ESI MS and 19F NMR analysis. 
The HR – ESI MS of the mixture supports the formation of a mixture of [BF4- ⊂ 
Pd2(4)x(6)4-x]3+ helicates (Figure A3.35). There are three main 3+ signals observed 
at m/z 500.36483, 507.5863, and 513.75248. The isotope patterns and m/z of the 
observed signals match that calculated for the heteroleptic species [BF4- ⊂ 
Pd2(4)4]3+, [BF4- ⊂ Pd2(4)3(6)]3+, and [BF4- ⊂ Pd2(4)2(6)2]3+. 
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There were other signals corresponding to 2+ and 1+ helicate species present in the 
spectrum of the mixture. The three 2+ signals observed at m/z 768.03191, 
778.07257, and 788.11308 correspond to the heteroleptic species 
[Pd2(4)4(BF4)(Cl)]2+, [Pd2(4)3(6)(BF4)(Cl)]2+, and [Pd2(4)2(6)2(BF4)(Cl)]2+, 
respectively. The ratios of the HR – ESI MS heights with respect to the [BF4- ⊂ 
Pd2(4)4]3+ helicate height are summarised in Table A3.8. 
 
 
Figure A3.35. HR – ESI MS (d6 – DMSO) of synthesised [BF4- ⊂ Pd2(4)x(6)4-x]3+ 
helicates showing the observed m/z and isotope pattern for each helicate. 
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Table A3.8. Normalised ratios of the HR – ESI MS heights with respect to the [BF4- 
⊂ Pd2(4)4]3+ height. 
 [BF4- ⊂ Pd2(4)4]3+ [BF4- ⊂ Pd2(4)3(6)]3+ [BF4- ⊂ Pd2(4)2(6)2]3+ 
Initial 1.00 7.63 2.52 
 
 
The 19F NMR of the mixture supports the formation of mixed [BF4- ⊂ Pd2(4)x(6)4-x]3+ 
helicates as the spectrum is different to the spectra of [BF4- ⊂ Pd2(4)4]3+ and [BF4- ⊂ 
Pd2(6)4]3+ mixtures (Figure A3.36). There are several more signals for the fluorine 
atoms of 4 in the helicates between δ -126.07 - -127.23 ppm, and signals at δ -132.03, 
-133.74 and -134.43 ppm, compared to that observed for the [BF4- ⊂ Pd2(4)4]3+ 
solution. Other than the signal for the free BF4-, there are 10 signals observed in the 
spectrum at δ -148.84 (E), -148.93 (F), -149.11 (A + G), -149.15 (H), -149.20 (B + I), 
-149.27 (C + J), -149.32 (K), -149.47 (L), -149.52 (D + M), and -149.58 (N) ppm, and 





Figure A3.36. 19F NMR (376 MHz, d6 – DMSO) of mixed [BF4- ⊂ Pd2(4)x(6)4-x]3+ 
helicates showing fluorine assignment. 
 
 
Comparing the spectrum with that of [BF4- ⊂ Pd2(4)4]3+, signals A, B, C and D are 
likely due to the different atropisomers of [BF4- ⊂ Pd2(4)4]3+, however, these signals 
are hard to assign due to the overlapping of new signals due to the heteroleptic [BF4- 
⊂ Pd2(4)x(6)4-x]3+ helicates (signals G, I, J and M). Signals E, F, H, K, L and N are due 
to the new formed [BF4- ⊂ Pd2(4)x(6)4-x]3+ helicates. Due to the fact there are 
different atropisomers of the [BF4- ⊂ Pd2(4)4]3+ helicate, the heteroleptic [BF4- ⊂ 
Pd2(4)x(6)4-x]3+ helicates can also have different atropisomers. This leads to a large 
number of signals observed in the 19F NMR, and therefore makes the assignment of 
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the signals impossible. The ratio of free BF4- signal to the encapsulated BF4- signals 
is 6.00:1.00, which suggests that not all of the ligands have been incorporated into 
helicates. 
The 19F NMR of the mixture after heating shows a decrease in signal intensity for 
signal D + M, and an increase in the signal intensities for signals F, L and N. There is 
also a new signal which has appeared at δ -150.39 (O) ppm (Figure A3.37). This 
new signal could be due to either an atropisomer of the [BF4- ⊂ Pd2(4)3(6)]3+ 
helicate or the [BF4- ⊂ Pd2(4)2(6)2]3+ helicate, or due to the formation of the [BF4- ⊂ 
Pd2(4)3(6)]3+ helicate. The sample was submitted for HR – ESI MS, however due to 




Figure A3.37. 19F NMR (376 MHz, d6 – DMSO) of mixed [BF4- ⊂ Pd2(4)x(6)4-x]3+ 




A 19F DOSY spectrum was also performed to determine the diffusion coefficients of 
both free BF4- and [BF4- ⊂ helicate]3+ signals (Figure A3.38). The diffusion 
coefficient for the free BF4- signal was recorded as (5.45 ± 0.02) x 10-10 m2 s-1, 
whereas the diffusion coefficients signals of signals H, B + I, C + J, and K were 
recorded as (0.86 ± 0.3) x 10-10 m2 s-1, (1.11 ± 0.1) x 10-10 m2 s-1, (1.56 ± 0.2) x 10-10 
m2 s-1, and (1.27 ± 0.1) x 10-10 m2 s-1, respectively.  
The diffusion coefficients for signals E, F, A + G, L, D + M and N could not be measured 
due to the weakness of the signals. The diffusion coefficient for the free BF4- signal 
is consistent with what was observed for free BF4- in the other mixtures. Comparing 
signals H and K, H has a larger apparent size than that of K, since it diffuses slower 
through d6 – DMSO. However, due to the complexity of the signals and the possibility 




Figure A3.38. 19F DOSY (470 MHz, d6 – DMSO) of mixed [BF4- ⊂ Pd2(4)x(6)4-x]3+ 





A3.5 Synthesis of [Pd2(5)x(L)4-x] helicates 
 
 
Synthesis of [Pd2(5)x(6)4-x] helicates 
 
[Pd2(5)x(6)4-x]3+ helicates were synthesised from the mixing of [Pd(MeCN)4](BF4)2, 
5, and 6 in a 2 : 2 : 2 ratio in d6 – DMSO at room temperature. The mixture was left 
for three days to equilibrate, and then sent for HR – ESI MS and 19F NMR analysis. 
The HR – ESI MS of the mixture supports the formation of a mixture of [BF4- ⊂ 
Pd2(5)x(6)4-x]3+ helicates (Figure A3.39). There are three main 3+ signals observed 
at m/z 489.76448, 499.10795, and 508.45227. The isotope patterns and m/z of the 
observed signals match that calculated for the heteroleptic species [BF4- ⊂ 
Pd2(5)4]3+, [BF4- ⊂ Pd2(5)3(6)]3+, and [BF4- ⊂ Pd2(5)2(6)2]3+. 
There were other signals corresponding to 2+ and 1+ helicate species present in the 
spectrum of the mixture. The two 2+ signals observed at m/z 752.13132 and 
766.14709 correspond to the heteroleptic species [Pd2(5)4(BF4)(Cl)]2+, and 
[Pd2(5)3(6)(BF4)(Cl)]2+, respectively. The ratios of the HR – ESI MS heights with 







Figure A3.39. HR – ESI MS (d6 – DMSO) of synthesised [BF4- ⊂ Pd2(5)x(6)4-x]3+ 
helicates showing the observed m/z and isotope pattern for each helicate. 
 
 
Table A3.9. Normalised ratios of the HR – ESI MS heights with respect to the [BF4- 
⊂ Pd2(5)2(6)2]3+ height. 
 [BF4- ⊂ Pd2(5)4]3+ [BF4- ⊂ Pd2(5)3(6)]3+ [BF4- ⊂ Pd2(5)2(6)2]3+ 
Initial 10.36 7.18 1.00 
 
 
The 19F NMR of the mixture supports the formation of mixed [BF4- ⊂ Pd2(5)x(6)4-x]3+ 
helicates as the spectrum is different to the spectra of [BF4- ⊂ Pd2(5)4]3+ (Figure 
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A3.40). Other than the signal for the free BF4-, there are five signals observed in the 
spectrum at δ -148.29 (A), -148.93 (B), -149.36 (D), -149.46 (E), and -149.91 (C) 




Figure A3.40. 19F NMR (376 MHz, d6 – DMSO) of mixed [BF4- ⊂ Pd2(5)x(6)4-x]3+ 
helicates showing fluorine assignment. 
 
 
Comparing the spectrum with that of [BF4- ⊂ Pd2(5)4]3+, signals A, B, and C are likely 
due to the different atropisomers of [BF4- ⊂ Pd2(5)4]3+, and signals D and E are due 
to the new formed [BF4- ⊂ Pd2(5)x(6)4-x]3+ helicates. The ratio of free BF4- signal to 
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the encapsulated BF4- signals is 23.00:1.00, which suggests that most of the ligands 
have not been incorporated into helicates. 
After letting the mixture sit for one month, the 19F NMR spectrum was run again. 
Surprisingly the size of signals D and E had slightly increased, and were now larger 
than that of signals A, B and C. More interesting is the fact that four new signals had 
appeared in the spectrum at δ -150.06 (F), -150.52 (G), -150.66 (H), and -150.72 (I) 
ppm (Figure A3.41). These new signals are likely to be the thermodynamic 
heteroleptic [BF4- ⊂ Pd2(5)x(6)4-x]3+ helicates, and are most likely atropisomers of 
[BF4- ⊂ Pd2(5)3(6)]3+ and [BF4- ⊂ Pd2(5)2(6)2]3+. The ratio of free BF4- signal to the 
encapsulated BF4- signals after sitting for a month was measured as 10.00:1.00, 





Figure A3.41. 19F NMR (376 MHz, d6 – DMSO) of mixed [BF4- ⊂ Pd2(5)x(6)4-x]3+ 
helicates after sitting for a month, showing fluorine assignment. 
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The 19F NMR of the mixture after heating showed no change in the signal intensities 
of any of the signals, suggesting that heating had no effect on the distribution of 
helicates. This might be due to the fact that the mixture was left to sit for a month, 
therefore all of the thermodynamic products had already formed. 
A 19F DOSY spectrum was performed on the month-old mixture to determine the 
diffusion coefficients of both free BF4- and [BF4- ⊂ helicate]3+ signals (Figure A3.42). 
The diffusion coefficient for the free BF4- anion signal was recorded as (5.03 ± 0.02) 
x 10-10 m2 s-1, whereas the diffusion coefficients of signals A, B, D, E, C, and F - I were 
recorded as (1.26 ± 0.06) x 10-10 m2 s-1, (1.24 ± 0.07) x 10-10 m2 s-1, (1.22 ± 0.02) x 
10-10 m2 s-1, (1.02 ± 0.05) x 10-10 m2 s-1, (1.17 ± 0.05) x 10-10 m2 s-1, (1.03 ± 0.05) x 
10-10 m2 s-1, (1.01 ± 0.08) x 10-10 m2 s-1, (1.13 ± 0.07) x 10-10 m2 s-1, and (1.21 ± 0.04) 
x 10-10 m2 s-1, respectively.  
The diffusion coefficient for the free BF4- signal is consistent with what was observed 
for free BF4- in the other mixtures. Comparing signals A, B and C, they all have a 
similar diffusion coefficient, which supports that they are likely atropisomers of the 
same helicate. The value of the diffusion coefficient supports that the signals have 
the smallest apparent size, and confirms that they are the atropisomers of the 
homoleptic [BF4- ⊂ Pd2(5)4]3+ helicate. Signals D and I have similar diffusion 
coefficients, and so do signals E, F and G, which suggests that they are also 
atropisomers of the same helicate. Signals D and I have a larger diffusion coefficient 
than that of signals E, F and G, which suggests that they have a smaller apparent size 
than atropisomers E, F and G. Therefore, signals D and I are likely to be atropisomers 








Figure A3.42. 19F DOSY (470 MHz, d6 – DMSO) of mixed [BF4- ⊂ Pd2(5)x(6)4-x]3+ 




A3.6 Anion exchange on [Pd2(1)x(L)4-x] helicates 
 
 
Attempted anion exchange on [Pd2(1)x(2)4-x] 
 
16 equivalents of tetrabutylammonium perchlorate (TBAClO4) were added to a 
solution of [BF4- ⊂ Pd2(1)x(2)4-x]3+ in d6 – DMSO. The mixture was then left overnight 
to equilibrate. 
A couple of minutes after the addition of ClO4- to the [BF4- ⊂ Pd2(1)x(2)4-x]3+ solution, 
a white precipitate started to form. When the solution was analysed after being left 
overnight, the amount of the white precipitate produced had increased. Therefore, 
it was assumed that what happened when the anion was added to the solution of 




The same observation was made when 16 equivalents of TBAReO4 and 16 




Anion exchange on [Pd2(1)x(3)4-x]3+ 
 
Addition of tetrabutylammonium nitrate  
 
16 equivalents of tetrabutylammonium nitrate (TBANO3) were added to a solution 
of [BF4- ⊂ Pd2(1)4(3)4-x]3+ in d6 – DMSO. The mixture was then left for two days to 
equilibrate, and then analysed by HR – ESI MS and 19F NMR. 
The HR – ESI MS of the mixture confirms that anion exchange on the [BF4- ⊂ 
Pd2(1)4(3)4-x]3+ helicates has occurred with the addition of TBANO3 (Figure A3.43). 
There are three main 3+ signals observed which match the m/z values calculated for 
the heteroleptic species [NO3- ⊂ Pd2(1)3(3)]3+, [NO3- ⊂ Pd2(1)2(3)2]3+ and [NO3- ⊂ 
Pd2(1)(3)3]3+. There are no signals observed for the BF4- encapsulated helicates of 
[Pd2(1)4(3)4-x]3+, or the NO3- encapsulated helicates of [Pd2(1)4] and [Pd2(3)4]. This 
suggests that when NO3- is added, the equilibrium mixture of [BF4- ⊂ Pd2(1)4(3)4-
x]3+ helicates rearranges to produce only helicates which prefer to encapsulate NO3-
. The 1+ ion signals which occur at a m/z of 519.53796, 546.55688 and 571.57266 






Figure A3.43. HR – ESI MS (d6 – DMSO) of [BF4- ⊂ Pd2(1)x(3)4-x]3+ after addition of 
16 equivalents of TBANO3, showing observed signals for BF4- and 
NO3- encapsulated helicates. 
 
 
The 19F NMR spectrum of the mixture supports the formation of NO3- encapsulated 
helicates from the anion exchange of BF4- for NO3- in [BF4- ⊂ Pd2(1)x(3)4-x]3+ (Figure 
A3.44). Comparing this spectrum to the spectrum of the initial [BF4- ⊂ Pd2(1)x(3)4-
x]3+ solution, only the signals of A, B, C and D are observed: there is no signal 
observed for the [BF4- ⊂ Pd2(1)4]3+ helicate. The intensity of signals A, B, C and D are 
very small compared to the free BF4- signal, which supports why no signal for the 
[BF4- ⊂ Pd2(1)x(3)4-x]3+ helicates were observed in the HR – ESI MS of the mixture. 
The ratio of the free BF4- signal to the encapsulated BF4- signals also increases from 
3.00:1.00 to 111:1.00, after the addition of 16 equivalents of NO3-. This suggests that 
there is a large amount of free BF4- in the solution after the addition of NO3-, which 
is due to the anion exchange of NO3- for BF4- to form the [NO3- ⊂ Pd2(1)2(3)]3+, [NO3- 




Figure A3.44. 19F NMR (470 MHz, d6 – DMSO) of the reaction of [BF4- ⊂ 
Pd2(1)x(3)4-x]3+ with 16 equivalents of TBANO3 showing fluorine assignment. 
 
 
Anion exchange of [Pd2(1)x(4)4-x]3+ 
 
Addition of tetrabutylammonium nitrate  
 
16 equivalents of tetrabutylammonium nitrate (TBANO3) were added to a solution 
of [BF4- ⊂ Pd2(1)x(4)4-x]3+ in d6 – DMSO. The mixture was then for two days to 
equilibrate, and then analysed by HR – ESI MS and 19F NMR. 
The HR – ESI MS of the mixture confirms that anion exchange on the [BF4- ⊂ 
Pd2(1)x(4)4-x]3+ helicates has occurred with the addition of TBANO3 (Figure A3.45). 
There are six main 3+ signals observed which match the m/z values calculated for 
the heteroleptic species [BF4- ⊂ Pd2(1)4]3+, [NO3- ⊂ Pd2(1)4]3+, [BF4- ⊂ Pd2(1)3(4)]3+, 
[NO3- ⊂ Pd2(1)3(4)]3+, [BF4- ⊂ Pd2(1)2(4)2]3+ and [NO3- ⊂ Pd2(1)2(4)2]3+. This 
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suggests that when NO3- is added, the equilibrium mixture of [BF4- ⊂ Pd2(1)x(4)4-x]3+ 
helicates rearranges to produce more of the helicates which prefer to encapsulate 
NO3-. The relative heights of the [BF4- ⊂ Pd2(1)x(4)4-x]3+ helicates remain the same 




Figure A3.45. HR – ESI MS (d6 – DMSO) of [BF4- ⊂ Pd2(1)x(4)4-x]3+ after addition of 
16 equivalents of TBANO3, showing observed signals for BF4- and 
NO3- encapsulated helicates. 
 
 
The ratio of heights of the [BF4- ⊂ Pd2(1)x(4)4-x]3+ signals to the corresponding 
[NO3- ⊂ Pd2(1)x(4)4-x]3+ signals are summarised in Table A3.10. For helicates 
[Pd2(1)4] and [Pd2(1)3(4)], the NO3- encapsulated helicate is larger than that of the 
corresponding BF4- helicate, indicating that these helicates prefer to bind NO3- over 
BF4-. However, for helicate [Pd2(1)2(4)2], the BF4- and NO3- signals are about the 





Table A3.10. Ratio of MS heights of BF4- encapsulated helicates to corresponding 
NO3- helicates. 
 [Pd2(1)4]3+ [Pd2(1)3(4)]3+ [Pd2(1)2(4)2]3+ 
Ratio of BF4- : NO3- 9:13 9:19 40:39 
 
 
The 19F NMR spectrum of the mixture supports the formation of NO3- encapsulated 
helicates from the anion exchange of BF4- for NO3- in [BF4- ⊂ Pd2(1)x(4)4-x]3+ (Figure 
A3.46). Comparing this spectrum to that of the initial [BF4- ⊂ Pd2(1)x(4)4-x]3+ 
solution, there are no signal observed for BF4- encapsulated helicates. This is 
different to the observations made in the HR – ESI MS of the mixture, as there were 
[BF4- ⊂ Pd2(1)x(4)4-x]3+ signals observed. The 19F NMR suggests that NO3- has 
exchanged with all of the encapsulated BF4- helicates to form                                                




Figure A3.46. 19F NMR (470 MHz, d6 – DMSO) of the reaction of [BF4- ⊂ 
Pd2(1)x(4)4-x]3+ with 16 equivalents of TBANO3 showing fluorine assignment. 
 
 
Anion exchange on [Pd2(1)x(5)4-x]3+ 
 
Addition of tetrabutylammonium nitrate  
 
16 equivalents of tetrabutylammonium nitrate (TBANO3) were added to a solution 
of [BF4- ⊂ Pd2(1)x(5)4-x]3+ in d6 – DMSO. The mixture was then left for two days to 
equilibrate, and then analysed by HR – ESI MS and 19F NMR. 
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The HR – ESI MS of the mixture confirms that anion exchange on the [BF4- ⊂ 
Pd2(1)x(5)4-x]3+ helicates has occurred with the addition of TBANO3 (Figure A3.47). 
There are two main 3+ signals observed which match the m/z values calculated for 
the heteroleptic species [NO3- ⊂ Pd2(1)4]3+ and [NO3- ⊂ Pd2(1)3(5)]3+. This suggests 
that when NO3- is added, the equilibrium mixture of the [BF4- ⊂ Pd2(1)x(5)4-x]3+ 
helicates rearranges to produce more of the helicates which prefer to encapsulate 
NO3-. Since there are no BF4- encapsulated helicates observed, it suggests that the 




Figure A3.47. HR – ESI MS (d6 – DMSO) of [BF4- ⊂ Pd2(1)x(5)4-x]3+ after addition of 





The 19F NMR spectrum of the mixture supports the formation of NO3- encapsulated 
helicates from the anion exchange of BF4- for NO3- in [BF4- ⊂ Pd2(1)x(5)4-x]3+ (Figure 
A3.48). Comparing this spectrum to that of the initial [BF4- ⊂ Pd2(1)x(5)4-x]3+ 
solution, no encapsulated BF4- signals are observed.  This suggests that NO3- has fully 
exchanged with the [BF4- ⊂ Pd2(1)x(5)4-x]3+ helicates to form the [NO3- ⊂ Pd2(1)4]3+ 
and [NO3- ⊂ Pd2(1)3(5)]3+ helicates. The assignment of the 1+ ion signals at a m/z of 





Figure A3.48. 19F NMR (470 MHz, d6 – DMSO) of the reaction of [BF4- ⊂ 





Anion exchange on [Pd2(1)x(6)4-x] 
 
Addition of tetrabutylammonium perchlorate 
 
16 equivalents of tetrabutylammonium perchlorate (TBAClO4) were added to a 
solution of [BF4- ⊂ Pd2(1)x(6)4-x]3+ in d6 – DMSO. The mixture was then left for two 
days to equilibrate, and then analysed by HR – ESI MS and 19F NMR. 
The HR – ESI MS of the mixture confirms that anion exchange on the [BF4- ⊂ 
Pd2(1)x(6)4-x]3+ helicates has occurred with the addition of TBAClO4 (Figure A3.49). 
There are five main 3+ signals observed which match the m/z values calculated for 
the heteroleptic species [ClO4- ⊂ Pd2(1)4]3+, [BF4- ⊂ Pd2(1)3(6)]3+, [ClO4- ⊂ 
Pd2(1)3(6)]3+, [BF4- ⊂ Pd2(1)2(6)2]3+ and [ClO4- ⊂ Pd2(1)2(6)2]3+. This suggests that 
when ClO4- is added, the equilibrium mixture of                                           [BF4- ⊂ 
Pd2(1)x(6)4-x]3+ helicates rearranges to produce more of the helicates which prefer 
to encapsulated ClO4-. The ratio of heights of the [BF4- ⊂ Pd2(1)x(6)4-x]3+ signals to 
the corresponding [ClO4- ⊂ Pd2(1)x(6)4-x]3+ signals are summarised in Table A3.11. 
For each helicate, the ClO4- encapsulated helicate is larger than that of the 






Figure A3.49. HR – ESI MS (d6 – DMSO) of [BF4- ⊂ Pd2(1)x(6)4-x]3+ after addition of 
16 equivalents of TBAClO4, showing observed signals for BF4- and 
ClO4- encapsulated helicates. 
 
 
Table A3.11. Ratio of MS heights of BF4- encapsulated helicates to corresponding 
ClO4- helicates. 
 [Pd2(1)3(6)]3+ [Pd2(1)2(6)2]3+ 
Ratio of BF4- : ClO4- 5:22 13:62 
 
 
The 19F NMR spectrum of the mixture supports the formation of ClO4- encapsulated 
helicates from the anion exchange of BF4- for ClO4- in [BF4- ⊂ Pd2(1)x(6)4-x]3+ (Figure 
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A3.50). Comparing this spectrum to that of the initial [BF4- ⊂ Pd2(1)x(6)4-x]3+ 
solution, only signals A and B are observed. The ratio of the free BF4- signal to the 
encapsulated BF4- signals also increases from 4.00:1.00 to 72:1.00, after the addition 
of 16 equivalents of ClO4-. This suggests that there is more free BF4- in the solution 
after the addition of ClO4-, which is due the anion exchange of ClO4- for BF4- to form 





Figure A3.50. 19F NMR (470 MHz, d6 – DMSO) of the reaction of [BF4- ⊂ 






Addition of tetrabutylammonium perrhenate  
 
16 equivalents of tetrabutylammonium perrhenate (TBAReO4) were added to a 
solution of [BF4- ⊂ Pd2(1)x(6)4-x]3+ in d6 – DMSO. The mixture was then left for two 
days to equilibrate, and then analysed by HR – ESI MS and 19F NMR. 
The HR – ESI MS of the mixture confirms that anion exchange on the [BF4- ⊂ 
Pd2(1)x(6)4-x]3+ helicates has occurred with the addition of TBAReO4 (Figure 
A3.51). There are four main 3+ signals observed which match the m/z values 
calculated for the heteroleptic species [BF4- ⊂ Pd2(1)3(6)]3+, [ReO4- ⊂ Pd2(1)3(6)]3+, 
[BF4- ⊂ Pd2(1)2(6)2]3+ and [ReO4- ⊂ Pd2(1)2(6)2]3+. This suggests that when ReO4- is 
added, the equilibrium mixture of [BF4- ⊂ Pd2(1)x(6)4-x]3+ helicates rearranges to 
produce more of the helicates which prefer to encapsulate ReO4-. The 1+ ion which 
occurs at a m/z of 519.53787 corresponds to [(TBA)2(Cl)]+. The ratio of heights of 
the [BF4- ⊂ Pd2(1)x(6)4-x]3+ signals to the corresponding [ReO4- ⊂ Pd2(1)x(6)4-x]3+ 
signals are summarised in Table A3.12. For each helicate, the BF4- encapsulated 
helicate is larger than that of the corresponding ReO4- helicate, indicating that the 




Figure A3.51. HR – ESI MS (d6 – DMSO) of [BF4- ⊂ Pd2(1)x(6)4-x]3+ after addition of 
16 equivalents of TBAReO4, showing observed signals for BF4- and 




Table A3.12. Ratio of MS heights of BF4- encapsulated helicates to corresponding 
ReO4- helicates. 
 [Pd2(1)3(6)]3+ [Pd2(1)2(6)2]3+ 
Ratio of BF4- : ReO4- 42:17 40:11 
 
 
The 19F NMR spectrum of the mixture supports the formation of ReO4- encapsulated 
helicates from the anion exchange of BF4- for ReO4- in [BF4- ⊂ Pd2(1)x(6)4-x]3+ 
(Figure A3.52). Comparing this spectrum to that of the initial                                               
[BF4- ⊂ Pd2(1)x(6)4-x]3+ solution, all signals are observed, including a small amount 
of the [BF4- ⊂ Pd2(1)4]3+, even though it is not observed in the HR – ESI MS of the 
mixture. The ratio of the free BF4- signal to the encapsulated BF4- signals also 
increases from 4.00:1.00 to 9.00:1.00, after the addition of 16 equivalents of ReO4-. 
This suggests that there is more free BF4- in the solution after the addition of ReO4-, 
which is due to the anion exchange of ReO4- for BF4- to form the [ReO4- ⊂ 





Figure A3.52. 19F NMR (470 MHz, d6 – DMSO) of the reaction of [BF4- ⊂ 
Pd2(1)x(6)4-x]3+ with 16 equivalents of TBAReO4 showing fluorine assignment. 
 
 
Addition of tetrabutylammonium nitrate  
 
16 equivalents of tetrabutylammonium nitrate (TBANO3) were added to a solution 
of [BF4- ⊂ Pd2(1)x(6)4-x]3+ in d6 – DMSO. The mixture was then left for two days to 
equilibrate, and then analysed by HR – ESI MS and 19F NMR. 
The HR – ESI MS of the mixture confirms that anion exchange on the [BF4- ⊂ 
Pd2(1)x(6)4-x]3+ helicates has occurred with the addition of TBANO3 (Figure A3.53). 
There are three main 3+ signals observed which match the m/z values calculated for 
the heteroleptic species [NO3- ⊂ Pd2(1)3(6)]3+, [BF4- ⊂ Pd2(1)2(6)2]3+ and [NO3- ⊂ 
Pd2(1)2(6)2]3+. This suggests that when NO3- is added, the equilibrium mixture of the 
[BF4- ⊂ Pd2(1)x(6)4-x]3+ helicates rearranges to produce more of the helicates which 
prefer to encapsulate NO3-. Comparing the relative MS heights of the observed 
signals, the largest is that of the [NO3- ⊂ Pd2(1)3(6)]3+ helicate (60), followed by [BF4- 
328 
 
⊂ Pd2(1)2(6)2]3+ (36), and then [NO3- ⊂ Pd2(1)2(6)2]3+ (32). From this, the helicates 




Figure A3.53. HR – ESI MS (d6 – DMSO) of [BF4- ⊂ Pd2(1)x(6)4-x]3+ after addition of 
16 equivalents of TBANO3, showing observed signals for BF4- and 
NO3- encapsulated helicates. 
 
 
The 19F NMR spectrum of the mixture supports the formation of NO3- encapsulated 
helicates from the anion exchange of BF4- for NO3- in [BF4- ⊂ Pd2(1)x(6)4-x]3+ (Figure 
A3.54). Comparing this spectrum to that of the initial [BF4- ⊂ Pd2(1)x(6)4-x]3+ 
solution, only signal B is observed. The ratio of the free BF4- signal to the 
encapsulated BF4- signals also increases from 4.00:1.00 to 313:1.00, after the 
addition of 16 equivalents of NO3-. This suggests that there is a large amount of free 
BF4- in the solution after the addition of NO3-, which is due to the anion exchange of 










Figure A3.54. 19F NMR (470 MHz, d6 – DMSO) of the reaction of [BF4- ⊂ 











Synthesis of [Pd2(1)x(2)4-x] helicates 
 
Tetrakis(acetonitrile)palladium(II) tetrafluoroborate (2 eq, 6.70 mg, 0.015 mmol), 
1 (2 eq, 4.00 mg, 0.015 mmol), and 2 (2 eq, 0.08 mL of 0.2 M solution in DCM, solvent 
removed in vacuo, 0.015 mmol)  were mixed together in d6 – DMSO (0.75 mL) and 
left for three days to equilibrate at room temperature. 
19F NMR (376 MHz, d6 – DMSO): δ -148.30 (BF4-), -148.89 ([BF4- ⊂ Pd2(1)4]3+), -
148.95 (A), - 149.11 (B), - 149.22 (C), -149.64 (D), -150.29 ([BF4- ⊂ Pd2(2)4]3+). 19F 
DOSY (470 MHz, d6 – DMSO): D 5.03 ± 0.04 x 10-10 m2 s-1 (BF4-), 1.28 ± 0.07 x 10-10 
m2 s-1 ([BF4- ⊂ Pd2(1)4]3+), 1.31 ± 0.06 x 10-10 m2 s-1 (A), 1.14 ± 0.13 x 10-10 m2 s-1 (C). 
HR – ESI MS (d6 – DMSO): m/z 452.3886 [BF4- ⊂ Pd2(1)4]3+, calc. for 
[C64H48N8O8Pd2BF4]3+ = 452.39054, m/z 469.06069 [BF4- ⊂ Pd2(1)3(2)]3+, calc. for 
[C68H50N8O8Pd2BF4]3+ = 469.06247, m/z 485.73255 [BF4- ⊂ Pd2(1)2(2)2]3+, calc. for 
[C72H52N8O8Pd2BF4]3+ = 485.73441, m/z 502.40415 [BF4- ⊂ Pd2(1)(2)3]3+, calc. for 
[C76H54N8O8Pd2BF4]3+ = 502.40634, m/z 519.07641 [BF4- ⊂ Pd2(2)4]3+, calc. for 
[C80H56N8O8Pd2BF4]3+ = 519.07827, m/z 696.06745 [Pd2(1)4(BF4)(Cl)]2+, calc. for 
[C64H48N8O8Pd2(BF4)(Cl)]2+ = 696.07017, m/z 721.07567 [Pd2(1)3(2)(BF4)(Cl)]2+, 
calc. for [C68H50N8O8Pd2(BF4)(Cl)]2+ = 721.07808, m/z 746.08366 
[Pd2(1)2(2)2(BF4)(Cl)]2+, calc. for [C72H50N8O8Pd2(BF4)(Cl)]2+ = 746.08598, m/z 
771.09177 [Pd2(1)(2)3(BF4)(Cl)]2+, calc. for [C76H54N8O8Pd2(BF4)(Cl)]2+ = 
771.09388, m/z 796.09177 [Pd2(2)4(BF4)(Cl)]2+, calc. for 
[C80H56N8O8Pd2(BF4)(Cl)]2+ = 796.10177. 
 
 
Synthesis of [Pd2(1)x(3)4-x] helicates 
 
Tetrakis(acetonitrile)palladium(II) tetrafluoroborate (2 eq, 7.30 mg, 0.015 mmol), 
1 (2 eq, 4.60 mg, 0.015 mmol), and 3 (2 eq, 5.50 mg, 0.015 mmol)  were mixed 
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together in d6 – DMSO (0.75 mL) and left for three days to equilibrate at room 
temperature. 
19F NMR (376 MHz, d6 – DMSO): δ -148.30 (BF4-), -148.89 ([BF4- ⊂ Pd2(1)4]3+), -
149.86 (A), - 150.08 (B), -150.26 (C), -150.81 (D). 19F DOSY (470 MHz, d6 – DMSO): 
D 3.30 ± 0.1 x 10-10 m2 s-1 (BF4-), 1.56 ± 0.1 x 10-10 m2 s-1 (A), 1.09 ± 0.2 x 10-10 m2 s-1 
(B), 1.34 ± 0.1 x 10-10 m2 s-1 (C), 1.28 ± 0.05 x 10-10 m2 s-1 (D). HR – ESI MS (d6 – 
DMSO): m/z 452.38982 [BF4- ⊂ Pd2(1)4]3+, calc. for [C64H48N8O8Pd2BF4]3+ = 
452.39054, m/z 485.73368 [BF4- ⊂ Pd2(1)3(3)]3+, calc. for [C72H52N8O8Pd2BF4]3+ = 
485.73441, m/z 519.07747 [BF4- ⊂ Pd2(1)2(3)2]3+, calc. for [C80H56N8O8Pd2BF4]3+ = 
519.07827, m/z 552.42127 [BF4- ⊂ Pd2(1)(3)3]3+, calc. for [C88H60N8O8Pd2BF4]3+ = 
552.42214, m/z 696.06968 [Pd2(1)4(BF4)(Cl)]2+, calc. for 
[C64H48N8O8Pd2(BF4)(Cl)]2+ = 696.07017, m/z 746.08537 [Pd2(1)3(3)(BF4)(Cl)]2+, 
calc. for [C72H52N8O8Pd2(BF4)(Cl)]2+ = 746.08598, m/z 796.10111 
[Pd2(1)2(3)2(BF4)(Cl)]2+, calc. for [C80H60N8O8Pd2(BF4)(Cl)]2+ = 796.10177. 
 
3 : 1 mixture  
Tetrakis(acetonitrile)palladium(II) tetrafluoroborate (2 eq, 13.00 mg, 0.030 mmol), 
1 (3 eq, 12.00 mg, 0.0460 mmol), and 3 (1 eq, 5.60 mg, 0.015 mmol)  were mixed 
together in d6 – DMSO (0.75 mL) and left for three days to equilibrate at room 
temperature. 
19F NMR (376 MHz, d6 – DMSO): δ -148.31 (BF4-), -148.96 ([BF4- ⊂ Pd2(1)4]3+), -
149.91 (A), -150.32 (C), -150.86 (D). 
 
2 : 2 mixture 
Tetrakis(acetonitrile)palladium(II) tetrafluoroborate (2 eq, 13.00 mg, 0.030 mmol), 
1 (1 eq, 4.00 mg, 0.015 mmol), and 3 (3 eq, 17.00 mg, 0.046 mmol)  were mixed 




19F NMR (376 MHz, d6 – DMSO): δ -148.31 (BF4-), -149.95 (A), - 150.17 (B), -150.35 
(C), -150.90 (D). 
 
 
Synthesis of [Pd2(1)x(4)4-x] helicates 
 
Tetrakis(acetonitrile)palladium(II) tetrafluoroborate (2 eq, 7.60 mg, 0.015 mmol), 
1 (2 eq, 4.30 mg, 0.015 mmol), and 4 (2 eq, 5.00 mg, 0.015 mmol)  were mixed 
together in d6 – DMSO (0.75 mL) and left for three days to equilibrate at room 
temperature. 
19F NMR (376 MHz, d6 – DMSO): δ -148.28 (BF4-), -148.89 ([BF4- ⊂ Pd2(1)4]3+), -
149.09 (A + E), - 149.22 (B + F), -149.27 (C + G), -149.30 (H), -149.52 (D). 19F DOSY 
(470 MHz, d6 – DMSO): D 5.36 ± 0.006 x 10-10 m2 s-1 (BF4-), 1.45 ± 0.04 x 10-10 m2 s-1 
([BF4- ⊂ Pd2(1)4]3+), 1.35 ± 0.03 x 10-10 m2 s-1 (A + E), 0.99 ± 0.04 x 10-10 m2 s-1 (B + 
F), 1.13 ± 0.02 x 10-10 m2 s-1 (C + G), 1.23 ± 0.03 x 10-10 m2 s-1 (H). HR – ESI MS (d6 – 
DMSO): m/z 452.38992 [BF4- ⊂ Pd2(1)4]3+, calc. for [C64H48N8O8Pd2BF4]3+ = 
452.39054, m/z 464.38357 [BF4- ⊂ Pd2(1)3(4)]3+, calc. for [C64H46F2N8O8Pd2BF4]3+ = 
464.38425, m/z 476.37729 [BF4- ⊂ Pd2(1)2(4)2]3+, calc. for [C64H44F4N8O8Pd2BF4]3+ 
= 476.37797, m/z 488.37097 [BF4- ⊂ Pd2(1)(4)3]3+, calc. for [C64H42F6N8O8Pd2BF4]3+ 
= 488.37169, m/z 500.36493 [BF4- ⊂ Pd2(4)4]3+, calc. for [C64H40F8N8O8Pd2BF4]3+ = 
500.36541, m/z 696.07071 [Pd2(1)4(BF4)(Cl)]2+, calc. for 
[C64H48N8O8Pd2(BF4)(Cl)]2+ = 696.07017, m/z 714.06066 [Pd2(1)3(4)(BF4)(Cl)]2+, 
calc. for [C64H46F2N8O8Pd2(BF4)(Cl)]2+ = 714.06075, m/z 732.05094 
[Pd2(1)2(4)2(BF4)(Cl)]2+, calc. for [C64H44F4N8O8Pd2(BF4)(Cl)]2+ = 732.05133, m/z 
750.04138 [Pd2(1)(4)3(BF4)(Cl)]2+, calc. for [C64H42F6N8O8Pd2(BF4)(Cl)]2+ = 
750.04191, m/z 768.03200 [Pd2(4)4(BF4)(Cl)]2+, calc. for 






Synthesis of [Pd2(1)x(5)4-x] helicates 
 
Tetrakis(acetonitrile)palladium(II) tetrafluoroborate (2 eq, 7.00 mg, 0.015 mmol), 
1 (2 eq, 4.30 mg, 0.015 mmol), and 5 (2 eq, 4.70 mg, 0.015 mmol)  were mixed 
together in d6 – DMSO (0.75 mL) and left for three days to equilibrate at room 
temperature. 
19F NMR (376 MHz, d6 – DMSO): δ -148.29 (BF4-), -148.65 (A), -148.79 (D), - 148.84 
([BF4- ⊂ Pd2(1)4]3+ + B), -148.90 ([BF4- ⊂ Pd2(1)4]3+ + B), -149.01 (E), -149.13 (F), -
149.28 (G), -149.38 (H), -149.90 (C). 19F DOSY (470 MHz, d6 – DMSO): D 4.73 ± 0.2 x 
10-10 m2 s-1 (BF4-), 1.22 ± 0.2 x 10-10 m2 s-1 (D), 1.32 ± 0.2 x 10-10 m2 s-1 ([BF4- ⊂ 
Pd2(1)4]3+ + B), 1.30 ± 0.2 x 10-10 m2 s-1 ([BF4- ⊂ Pd2(1)4]3+ + B), 1.21 ± 0.2 x 10-10 m2 
s-1 (F). HR – ESI MS (d6 – DMSO): m/z 452.39038 [BF4- ⊂ Pd2(1)4]3+, calc. for 
[C64H48N8O8Pd2BF4]3+ = 452.39054, m/z 461.73418 [BF4- ⊂ Pd2(1)3(5)]3+, calc. for 
[C66H52N8O8Pd2BF4]3+ = 461.73433, m/z 471.07781 [BF4- ⊂ Pd2(1)2(5)2]3+, calc. for 
[C68H56N8O8Pd2BF4]3+ = 471.07812, m/z 480.42143 [BF4- ⊂ Pd2(1)(5)3]3+, calc. for 
[C70H60N8O8Pd2BF4]3+ = 480.42192, m/z 489.76503 [BF4- ⊂ Pd2(5)4]3+, calc. for 
[C72H64N8O8Pd2BF4]3+ = 489.76571. 
 
 
Synthesis of [Pd2(1)x(6)4-x] helicates 
 
Tetrakis(acetonitrile)palladium(II) tetrafluoroborate (2 eq, 7.70 mg, 0.015 mmol), 
1 (2 eq, 4.30 mg, 0.015 mmol), and 6 (2 eq, 4.80 mg, 0.015 mmol)  were mixed 
together in d6 – DMSO (0.75 mL) and left for three days to equilibrate at room 
temperature. 
19F NMR (376 MHz, d6 – DMSO): δ -148.30 (BF4-), -148.89 ([BF4- ⊂ Pd2(1)4]3+), -
149.13 (A), - 149.27 (B), -149.95 (C). 19F DOSY (470 MHz, d6 – DMSO): D 5.14 ± 0.02 
x 10-10 m2 s-1 (BF4-), 2.02 ± 0.02 x 10-10 m2 s-1 ([BF4- ⊂ Pd2(1)4]3+), 1.31 ± 0.05 x 10-10 
m2 s-1 (A), 1.45 ± 0.05 x 10-10 m2 s-1 (B). HR – ESI MS (d6 – DMSO): m/z 452.39017 
[BF4- ⊂ Pd2(1)4]3+, calc. for [C64H48N8O8Pd2BF4]3+ = 452.39054, m/z 471.07761 [BF4- 
⊂ Pd2(1)3(6)]3+, calc. for [C68H56N8O8Pd2BF4]3+ = 471.07812, m/z 489.76509 [BF4- ⊂ 
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Pd2(1)2(6)2]3+, calc. for [C72H64N8O8Pd2BF4]3+ = 489.76571, m/z 696.06931 
[Pd2(1)4(BF4)(Cl)]2+, calc. for [C64H48N8O8Pd2(BF4)(Cl)]2+ = 696.07017, m/z 
724.10029 [Pd2(1)3(6)(BF4)(Cl)]2+, calc. for [C68H56N8O8Pd2(BF4)(Cl)]2+ = 
724.10155, m/z 750.12095 [Pd2(1)3(6)(BF4)2]2+, calc. for [C68H56N8O8Pd2(BF4)2]2+ = 




Synthesis of [Pd2(2)x(3)4-x] helicates 
 
Tetrakis(acetonitrile)palladium(II) tetrafluoroborate (2 eq, 6.70 mg, 0.015 mmol), 
2 (2 eq, 0.08 mL of 0.2 M solution in DCM, solvent removed in vacuo, 0.015 mmol), 
and 3 (2 eq, 6.00 mg, 0.015 mmol)  were mixed together in d6 – DMSO (0.75 mL) and 
left for three days to equilibrate at room temperature. 
19F NMR (376 MHz, d6 – DMSO): δ -148.27 (BF4-), -149.28 (A), - 149.41 (B), -149.57 
(C), -150.23 ([BF4- ⊂ Pd2(2)4]3+). 19F DOSY (470 MHz, d6 – DMSO): D 4.48 ± 0.007 x 
10-10 m2 s-1 (BF4-), 1.18 ± 0.03 x 10-10 m2 s-1 (A), 0.94 ± 0.03 x 10-10 m2 s-1 (B), 0.64 ± 
0.07 x 10-10 m2 s-1 (C). HR – ESI MS (d6 – DMSO): m/z 519.08071 [BF4- ⊂ Pd2(2)4]3+, 
calc. for [C80H56N8O8Pd2BF4]3+ = 519.07827, m/z 535.75276 [BF4- ⊂ Pd2(2)3(3)]3+, 
calc. for [C84H58N8O8Pd2BF4]3+ = 535.75021, m/z 552.42462 [BF4- ⊂ Pd2(2)2(3)2]3+, 
calc. for [C88H60N8O8Pd2BF4]3+ = 552.42214, m/z 569.09646 [BF4- ⊂ Pd2(2)(3)3]3+, 
calc. for [C92H62N8O8Pd2BF4]3+ = 569.09407, m/z 796.10578 [Pd2(2)4(BF4)(Cl)]2+, 
calc. for [C80H56N8O8Pd2(BF4)(Cl)]2+ = 796.10177, m/z 
821.11427[Pd2(2)3(3)(BF4)(Cl)]2+, calc. for [C84H58N8O8Pd2(BF4)(Cl)]2+ = 
821.10967, m/z 846.12607 [Pd2(2)2(3)2(BF4)(Cl)]2+, calc. for 
[C88H60N8O8Pd2(BF4)(Cl)]2+ = 846.11757, m/z 872.13899 [Pd2(2)(3)3(BF4)(Cl)]2+, 






Synthesis of [Pd2(2)x(4)4-x] helicates 
 
Tetrakis(acetonitrile)palladium(II) tetrafluoroborate (2 eq, 6.70 mg, 0.015 mmol), 
2 (2 eq, 0.08 mL of 0.2 M solution in DCM, solvent removed in vacuo, 0.015 mmol), 
and 4 (2 eq, 4.20 mg, 0.015 mmol)  were mixed together in d6 – DMSO (0.75 mL) and 
left for three days to equilibrate at room temperature. 
19F NMR (376 MHz, d6 – DMSO): δ -127.10 (ligand 4), -127.26 (ligand 4), -127.53 
(ligand 4), -127.79 (ligand 4), -134.42 (ligand 4), -148.29 (BF4-), -148.88 (E), -149.00 
(F), -149.11 (A + G), -149.21 (B + H), -149.28 (C + I), -149.36 (J), -149.41 (K), -149.52 
(D), -149.59 (L), -150.23 ([BF4- ⊂ Pd2(2)4]3+). 19F DOSY (470 MHz, d6 – DMSO): D 
5.56 ± 0.04 x 10-10 m2 s-1 (BF4-), 1.10 ± 0.2 x 10-10 m2 s-1 (A + G), 1.80 ± 0.2 x 10-10 m2 
s-1 (B + H), 1.68 ± 0.2 x 10-10 m2 s-1 (C + I), 1.34 ± 0.2 x 10-10 m2 s-1 (J). HR – ESI MS 
(d6 – DMSO): m/z 500.36493 [BF4- ⊂ Pd2(4)4]3+, calc. for [C64H40F8N8O8Pd2BF4]3+ = 
500.36541, m/z 505.04307 [BF4- ⊂ Pd2(2)(4)3]3+, calc. for [C68H44F6N8O8Pd2BF4]3+ = 
505.04363, m/z 509.72132 [BF4- ⊂ Pd2(2)2(4)2]3+, calc. for [C72H48F4N8O8Pd2BF4]3+ 
= 509.72184, m/z 514.39947 [BF4- ⊂ Pd2(2)3(4)]3+, calc. for [C76H52F2N8O8Pd2BF4]3+ 
= 514.40006, m/z 519.07767 [BF4- ⊂ Pd2(2)4]3+, calc. for [C80H56N8O8Pd2BF4]3+ = 
519.07827, m/z 768.03161 [Pd2(4)4(BF4)(Cl)]2+, calc. for 
[C64H40F8N8O8Pd2(BF4)(Cl)]2+ = 768.03248, m/z 775.04893 [Pd2(2)(4)3(BF4)(Cl)]2+, 
calc. for [C68H44F6N8O8Pd2(BF4)(Cl)]2+ = 775.04981, m/z 782.06620 
[Pd2(2)2(4)2(BF4)(Cl)]2+, calc. for [C72H48F4N8O8Pd2(BF4)(Cl)]2+ = 782.06713, m/z 
789.08326 [Pd2(2)3(4)(BF4)(Cl)]2+, calc. for [C76H52F2N8O8Pd2(BF4)(Cl)]2+ = 
789.08445, m/z 796.10022 [Pd2(2)4(BF4)(Cl)]2+, calc. for 
[C80H56N8O8Pd2(BF4)(Cl)]2+ = 796.10177. 
 
 
Synthesis of [Pd2(2)x(5)4-x] helicates 
 
Tetrakis(acetonitrile)palladium(II) tetrafluoroborate (2 eq, 6.90 mg, 0.015 mmol), 
2 (2 eq, 0.08 mL of 0.2 M solution in DCM, solvent removed in vacuo, 0.015 mmol), 
and 5 (2 eq, 4.70 mg, 0.015 mmol)  were mixed together in d6 – DMSO (0.75 mL) and 
left for three days to equilibrate at room temperature. 
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19F NMR (376 MHz, d6 – DMSO): δ -148.29 (BF4-), -148.65 (A), -148.93 (B), -149.29 
(D), -149.39 (E), -149.91 (C), -150.25 ([BF4- ⊂ Pd2(2)4]3+). 19F DOSY (470 MHz, d6 – 
DMSO): D 5.25 ± 0.04 x 10-10 m2 s-1 (BF4-), 1.43 ± 0.2 x 10-10 m2 s-1 (A), 1.48 ± 0.2 x 
10-10 m2 s-1 (B), 1.47 ± 0.08 x 10-10 m2 s-1 (D), 1.20 ± 0.2 x 10-10 m2 s-1 (E), 1.46 ± 0.1 
x 10-10 m2 s-1 (C), 1.01 ± 0.1 x 10-10 m2 s-1 ([BF4- ⊂ Pd2(2)4]3+). HR – ESI MS (d6 – 
DMSO): m/z 489.76529 [BF4- ⊂ Pd2(5)4]3+, calc. for [C72H64N8O8Pd2BF4]3+ = 
489.76571, m/z 497.09331 [BF4- ⊂ Pd2(2)(5)3]3+, calc. for [C74H62N8O8Pd2BF4]3+ = 
497.09385, m/z 504.42147 [BF4- ⊂ Pd2(2)2(5)2]3+, calc. for [C76H60N8O8Pd2BF4]3+ = 
504.42199, m/z 511.74950 [BF4- ⊂ Pd2(2)3(5)]3+, calc. for [C78H58N8O8Pd2BF4]3+ = 
511.75013, m/z 519.07771 [BF4- ⊂ Pd2(2)4]3+, calc. for [C80H56N8O8Pd2BF4]3+ = 
519.07827, m/z 752.13190 [Pd2(5)4(BF4)(Cl)]2+, calc. for 
[C72H64N8O8Pd2(BF4)(Cl)]2+ = 752.13293, m/z 763.12418 [Pd2(2)(5)3(BF4)(Cl)]2+, 
calc. for [C74H62N8O8Pd2(BF4)(Cl)]2+ = 763.12514, m/z 774.11639 
[Pd2(2)2(5)2(BF4)(Cl)]2+, calc. for [C76H60N8O8Pd2(BF4)(Cl)]2+ = 774.11735, m/z 
785.10858 [Pd2(2)3(5)(BF4)(Cl)]2+, calc. for [C78H58N8O8Pd2(BF4)(Cl)]2+ = 
785.10956, m/z 796.10087 [Pd2(2)4(BF4)(Cl)]2+, calc. for 
[C80H56N8O8Pd2(BF4)(Cl)]2+ = 796.10177. 
 
 
Synthesis of [Pd2(2)x(6)4-x] helicates 
 
Tetrakis(acetonitrile)palladium(II) tetrafluoroborate (2 eq, 7.20 mg, 0.015 mmol), 
2 (2 eq, 0.08 mL of 0.2 M solution in DCM, solvent removed in vacuo, 0.015 mmol), 
and 6 (2 eq, 5.40 mg, 0.015 mmol)  were mixed together in d6 – DMSO (0.75 mL) and 
left for three days to equilibrate at room temperature. 
19F NMR (376 MHz, d6 – DMSO): δ -148.30 (BF4-), -149.41 (A), -150.25 ([BF4- ⊂ 
Pd2(2)4]3+). 19F DOSY (470 MHz, d6 – DMSO): D 5.25 ± 0.04 x 10-10 m2 s-1 (BF4-), 1.19 
± 0.1 x 10-10 m2 s-1 (A), 1.38 ± 0.05 x 10-10 m2 s-1 ([BF4- ⊂ Pd2(2)4]3+). HR – ESI MS (d6 
– DMSO): m/z 519.07822 [BF4- ⊂ Pd2(2)4]3+, calc. for [C80H56N8O8Pd2BF4]3+ = 
519.07827, m/z 521.09241 [BF4- ⊂ Pd2(2)3(6)]3+, calc. for [C80H62N8O8Pd2BF4]3+ = 
521.09393, m/z 796.10112 [Pd2(2)4(BF4)(Cl)]2+, calc. for 
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[C80H56N8O8Pd2(BF4)(Cl)]2+ = 796.10177, m/z 799.11991 [Pd2(2)3(6)(BF4)(Cl)]2+, 
calc. for [C80H62N8O8Pd2(BF4)(Cl)]2+ = 799.12525. 
The mixture was then heated at 80 oC overnight and sent for 19F NMR analysis. 
19F NMR (376 MHz, d6 – DMSO): δ -148.30 (BF4-), -148.50 (B), -149.41 (A), -149.72 
(C), -150.25 ([BF4- ⊂ Pd2(2)4]3+), -150.41 (D). 
 
 
Synthesis of [Pd2(3)x(4)4-x] helicates 
 
Tetrakis(acetonitrile)palladium(II) tetrafluoroborate (2 eq, 7.20 mg, 0.015 mmol), 
3 (2 eq, 5.60 mg, 0.015 mmol), and 4 (2 eq, 4.40 mg, 0.015 mmol)  were mixed 
together in d6 – DMSO (0.75 mL) and left for three days to equilibrate at room 
temperature. 
19F NMR (376 MHz, d6 – DMSO): δ -126.70 (ligand 4), -127.07 (ligand 4), -127.30 
(ligand 4), -127.78 (ligand 4), -128.25 (ligand 4), -128.79 (ligand 4), -130.76 (ligand 
4), -131.29 (ligand 4), -134.15 (ligand 4), -148.30 (BF4-), -148.83 (E), -149.11 (A + 
F), -149.22 (B), -149.28 (C), -149.52 (D + G), -149.68 (H), -149.78 (I), -149.92 (J), -
150.01 (K), -150.12 (L), -150.17 (M), -150.21 (N), -150.86 (O). 19F DOSY (470 MHz, 
d6 – DMSO): D 4.96 ± 0.02 x 10-10 m2 s-1 (BF4-), 1.47 ± 0.1 x 10-10 m2 s-1 (H), 1.41 ± 
0.05 x 10-10 m2 s-1 (I), 1.27 ± 0.05 x 10-10 m2 s-1 (J), 1.18 ± 0.05 x 10-10 m2 s-1 (K), 0.93 
± 0.06 x 10-10 m2 s-1 (L), 1.04 ± 0.04 x 10-10 m2 s-1 (M), 1.08 ± 0.03 x 10-10 m2 s-1 (N), 
1.09 ± 0.03 x 10-10 m2 s-1 (O). HR – ESI MS (d6 – DMSO): m/z 521.71476 [BF4- ⊂ 
Pd2(3)(4)3]3+, calc. for [C72H46F6N8O8Pd2BF4]3+ = 521.71556, m/z 543.06497 [BF4- ⊂ 
Pd2(3)2(4)2]3+, calc. for [C80H52F4N8O8Pd2BF4]3+ = 543.06571, m/z 564.41502 [BF4- 
⊂ Pd2(3)3(4)]3+, calc. for [C88H58F2N8O8Pd2BF4]3+ = 564.41586, m/z 800.05683 
[Pd2(3)(4)3(BF4)(Cl)]2+, calc. for [C72H46F6N8O8Pd2(BF4)(Cl)]2+ = 800.05771, m/z 
832.08205 [Pd2(3)2(4)2(BF4)(Cl)]2+, calc. for [C80H52F4N8O8Pd2(BF4)(Cl)]2+ = 
832.08293, m/z 864.10690 [Pd2(3)3(4)(BF4)(Cl)]2+, calc. for 




Synthesis of [Pd2(3)x(5)4-x] helicates 
 
Tetrakis(acetonitrile)palladium(II) tetrafluoroborate (2 eq, 8.00 mg, 0.015 mmol), 
3 (2 eq, 7.00 mg, 0.015 mmol), and 5 (2 eq, 4.80 mg, 0.015 mmol)  were mixed 
together in d6 – DMSO (0.75 mL) and left for three days to equilibrate at room 
temperature. 
19F NMR (376 MHz, d6 – DMSO): δ -148.29 (BF4-), -148.57 (D), -148.67 (A + E), -
148.83 (F), -148.91 (G), -148.96 (B + H), -149.10 (I), -149.25 (J), -149.41 (K), -149.89 
(C), -150.07 (L), -150.51 (M), -151.16 (N). 19F DOSY (470 MHz, d6 – DMSO): D 5.22 ± 
0.02 x 10-10 m2 s-1 (BF4-), 1.57 ± 0.1 x 10-10 m2 s-1 (F), 1.53 ± 0.1 x 10-10 m2 s-1 (G), 1.93 
± 0.07 x 10-10 m2 s-1 (B + H), 1.63 ± 0.03 x 10-10 m2 s-1 (J), 1.82 ± 0.03 x 10-10 m2 s-1 
(K), 1.66 ± 0.02 x 10-10 m2 s-1 (C), 1.79 ± 0.02 x 10-10 m2 s-1 (L). HR – ESI MS (d6 – 
DMSO): m/z 489.76413 [BF4- ⊂ Pd2(5)4]3+, calc. for [C72H64N8O8Pd2BF4]3+ = 
489.76571, m/z 513.76438 [BF4- ⊂ Pd2(3)(5)3]3+, calc. for [C78H64N8O8Pd2BF4]3+ = 
513.76578, m/z 537.76438 [BF4- ⊂ Pd2(3)2(5)2]3+, calc. for [C84H64N8O8Pd2BF4]3+ = 
537.76583, m/z 788.13127 [Pd2(3)(5)3(BF4)(Cl)]2+, calc. for 
[C78H64N8O8Pd2(BF4)(Cl)]2+ = 788.13304, m/z 824.13126 [Pd2(3)2(5)2(BF4)(Cl)]2+, 
calc. for [C84H64N8O8Pd2(BF4)(Cl)]2+ = 824.13315. 
The mixture was then heated at 80 oC overnight and sent for 19F NMR analysis. 
19F NMR (376 MHz, d6 – DMSO): δ -148.29 (BF4-), -148.57 (D), -148.67 (A + E), -
148.83 (F), -148.91 (G), -148.96 (B + H), -149.10 (I), -149.25 (J), -149.41 (K), -149.89 
(C), -150.07 (L), -150.38 (O), -150.51 (M), -151.16 (N), -151.36 (P), -151.50 (Q). 
 
 
Attempted synthesis of [Pd2(3)x(6)4-x] helicates 
 
Tetrakis(acetonitrile)palladium(II) tetrafluoroborate (2 eq, 6.80 mg, 0.015 mmol), 
3 (2 eq, 5.70 mg, 0.015 mmol), and 6 (2 eq, 5.00 mg, 0.015 mmol)  were mixed 
together in d6 – DMSO (0.75 mL) and left for three days to equilibrate at room 
temperature. 
19F NMR (376 MHz, d6 – DMSO): δ -148.29 (BF4-). 
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Synthesis of [Pd2(4)x(5)4-x] helicates 
 
Tetrakis(acetonitrile)palladium(II) tetrafluoroborate (2 eq, 7.40 mg, 0.015 mmol), 
4 (2 eq, 4.50 mg, 0.015 mmol), and 5 (2 eq, 4.60 mg, 0.015 mmol)  were mixed 
together in d6 – DMSO (0.75 mL) and left for three days to equilibrate at room 
temperature. 
19F NMR (376 MHz, d6 – DMSO): δ -126.67 (ligand 4), -127.10 (ligand 4), -127.51 
(ligand 4), -131.47 (ligand 4), -134.43 (ligand 4), -148.29 (BF4-), -148.65 (A’), -
148.90 (A + B’), -149.01 (E), -149.07 (F), -149.14 (G), -149.18 (H), -149.23 (B + I), -
149.27 (C + J), -149.53 (D), -149.91 (C’), -150.33 (K), -150.70 (L). 19F DOSY (470 
MHz, d6 – DMSO): D 5.33 ± 0.02 x 10-10 m2 s-1 (BF4-), 1.30 ± 0.03 x 10-10 m2 s-1 (A + 
B’), 1.27 ± 0.1 x 10-10 m2 s-1 (E), 1.21 ± 0.05 x 10-10 m2 s-1 (F), 1.20 ± 0.03 x 10-10 m2 
s-1 (G), 1.13 ± 0.04 x 10-10 m2 s-1 (H), 1.33 ± 0.02 x 10-10 m2 s-1 (B + I), 1.32 ± 0.06 x 
10-10 m2 s-1 (C + J), 1.28 ± 0.08 x 10-10 m2 s-1 (D), 1.18 ± 0.09 x 10-10 m2 s-1 (C’). HR – 
ESI MS (d6 – DMSO): m/z 489.76391 [BF4- ⊂ Pd2(5)4]3+, calc. for 
[C72H64N8O8Pd2BF4]3+ = 489.76571, m/z 492.41437 [BF4- ⊂ Pd2(4)(5)3]3+, calc. for 
[C70H58F2N8O8Pd2BF4]3+ = 492.41563, m/z 495.06422 [BF4- ⊂ Pd2(4)2(5)2]3+, calc. 
for [C68H52F4N8O8Pd2BF4]3+ = 495.06556, m/z 497.71432 [BF4- ⊂ Pd2(4)3(5)]3+, calc. 
for [C66H46F6N8O8Pd2BF4]3+ = 497.71548, m/z 500.36433 [BF4- ⊂ Pd2(4)]3+, calc. for 
[C64H40F8N8O8Pd2BF4]3+ = 500.36541, m/z 752.12951 [Pd2(5)4(BF4)(Cl)]2+, calc. for 
[C72H64N8O8Pd2(BF4)(Cl)]2+ = 752.13293, m/z 756.10618 [Pd2(4)(5)3(BF4)(Cl)]2+, 
calc. for [C70H58F2N8O8Pd2(BF4)(Cl)]2+ = 756.10782, m/z 760.08109 
[Pd2(4)2(5)2(BF4)(Cl)]2+, calc. for [C68H52F4N8O8Pd2(BF4)(Cl)]2+ = 760.08271, m/z 
764.05630 [Pd2(4)3(5)(BF4)(Cl)]2+, calc. for [C66H46F6N8O8Pd2(BF4)(Cl)]2+ = 
764.05760, m/z 768.03183 [Pd2(4)4(BF4)(Cl)]2+, calc. for 
[C64H40F8N8O8Pd2(BF4)(Cl)]2+ = 768.03248. 
 
 
Synthesis of [Pd2(4)x(6)4-x] helicates 
 
Tetrakis(acetonitrile)palladium(II) tetrafluoroborate (2 eq, 6.90 mg, 0.015 mmol), 
4 (2 eq, 4.00 mg, 0.015 mmol), and 6 (2 eq, 5.00 mg, 0.015 mmol)  were mixed 
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together in d6 – DMSO (0.75 mL) and left for three days to equilibrate at room 
temperature. 
19F NMR (376 MHz, d6 – DMSO): δ -126.07 (ligand 4), -126.53 (ligand 4), -126.75 
(ligand 4), -127.06 (ligand 4), -127.03 (ligand 4), -132.03 (ligand 4), -133.74 (ligand 
4), -134.43 (ligand 4), -148.30 (BF4-), -148.84 (E), -148.93 (F), -149.11 (A + G), -
149.15 (H), -149.20 (B + I), -149.27 (C + J), -149.32 (K), -149.47 (L), -149.52 (D + 
M), -149.58 (N). 19F DOSY (470 MHz, d6 – DMSO): D 5.45 ± 0.02 x 10-10 m2 s-1 (BF4-), 
0.86 ± 0.3 x 10-10 m2 s-1 (H), 1.11 ± 0.1 x 10-10 m2 s-1 (B + I), 1.56 ± 0.2 x 10-10 m2 s-1 
(C + J), 1.27 ± 0.1 x 10-10 m2 s-1 (K). HR – ESI MS (d6 – DMSO): m/z 500.36483 [BF4- 
⊂ Pd2(4)4]3+, calc. for [C64H40F8N8O8Pd2BF4]3+ = 500.36541, m/z 507.05863 [BF4- ⊂ 
Pd2(4)3(6)]3+, calc. for [C68H50F6N8O8Pd2BF4]3+ = 507.05928, m/z 513.75248 [BF4- ⊂ 
Pd2(4)2(6)2]3+, calc. for [C72H60F4N8O8Pd2BF4]3+ = 513.75314, m/z 768.03191 
[Pd2(4)4(BF4)(Cl)]2+, calc. for [C64H40F8N8O8Pd2(BF4)(Cl)]2+ = 768.03248, m/z 
778.07257 [Pd2(4)3(6)(BF4)(Cl)]2+, calc. for [C68H50F6N8O8Pd2(BF4)(Cl)]2+ = 
778.07328, m/z 788.11308 [Pd2(4)2(6)2(BF4)(Cl)]2+, calc. for 
[C72H60F4N8O8Pd2(BF4)(Cl)]2+ = 788.11408. 
The mixture was then heated at 80 oC overnight and sent for 19F NMR analysis. 
19F NMR (376 MHz, d6 – DMSO): δ -126.07 (ligand 4), -126.53 (ligand 4), -126.75 
(ligand 4), -127.06 (ligand 4), -127.03 (ligand 4), -132.03 (ligand 4), -133.74 (ligand 
4), -134.43 (ligand 4), -148.30 (BF4-), -148.84 (E), -148.93 (F), -149.11 (A + G), -
149.15 (H), -149.20 (B + I), -149.27 (C + J), -149.32 (K), -149.47 (L), -149.52 (D + 
M), -149.58 (N), -150.39 (O). 
 
 
Synthesis of [Pd2(5)x(6)4-x] helicates 
 
Tetrakis(acetonitrile)palladium(II) tetrafluoroborate (2 eq, 7.80 mg, 0.015 mmol), 
5 (2 eq, 5.10 mg, 0.015 mmol), and 6 (2 eq, 5.40 mg, 0.015 mmol)  were mixed 




19F NMR (376 MHz, d6 – DMSO): δ -148.29 (BF4-), -148.65 (A), -148.93 (B), -149.36 
(D), -149.46 (E), -149.91 (C). HR – ESI MS (d6 – DMSO): m/z 489.76448 [BF4- ⊂ 
Pd2(5)4]3+, calc. for [C72H64N8O8Pd2BF4]3+ = 489.76571, m/z 499.10795 [BF4- ⊂ 
Pd2(5)3(6)]3+, calc. for [C74H68N8O8Pd2BF4]3+ = 499.10950, m/z 508.45227 [BF4- ⊂ 
Pd2(5)2(6)2]3+, calc. for [C76H72N8O8Pd2BF4]3+ = 508.45329, m/z 752.13132 
[Pd2(5)4(BF4)(Cl)]2+, calc. for [C72H64N8O8Pd2(BF4)(Cl)]2+ = 752.13293, m/z 
766.14709 [Pd2(5)3(6)(BF4)(Cl)]2+, calc. for [C74H68N8O8Pd2(BF4)(Cl)]2+ = 
766.14862. 
After leaving the mixture for a month, it was sent for 19F NMR and 19F DOSY analysis. 
19F NMR (376 MHz, d6 – DMSO): δ -148.29 (BF4-), -148.65 (A), -148.93 (B), -149.36 
(D), -149.46 (E), -149.91 (C), -150.06 (F), -150.52 (G), -150.66 (H), -150.72 (I). 19F 
DOSY (470 MHz, d6 – DMSO): D 5.03 ± 0.02 x 10-10 m2 s-1 (BF4-), 1.26 ± 0.06 x 10-10 
m2 s-1 (A), 1.24 ± 0.07 x 10-10 m2 s-1 (B), 1.22 ± 0.02 x 10-10 m2 s-1 (D), 1.02 ± 0.05 x 
10-10 m2 s-1 (E), 1.17 ± 0.05 x 10-10 m2 s-1 (C), 1.03 ± 0.05 x 10-10 m2 s-1 (F), 1.01 ± 0.08 
x 10-10 m2 s-1 (G), 1.13 ± 0.07 x 10-10 m2 s-1 (H), 1.21 ± 0.04 x 10-10 m2 s-1 (I). 
 
 
Synthesis of [Pd2(1)x(3)4-x] by ligand exchange on [Pd2(1)4] 
 
Tetrakis(acetonitrile)palladium(II) tetrafluoroborate (1 eq, 14.00 mg, 0.030 mmol) 
and 1 (2 eq, 16.00 mg, 0.060 mmol)  were mixed together in d6 – DMSO (0.75 mL) 
and left for three days to equilibrate at room temperature. After three days, 3 (1 eq, 
16.00 mg, 0.030 mmol) was added to the solution, and was left for three days to 
equilibrate at room temperature. 
19F NMR (376 MHz, d6 – DMSO): δ -148.29 (BF4-), -148.89 ([BF4- ⊂ Pd2(1)4]3+), -






Synthesis of [Pd2(1)x(3)4-x] by ligand exchange on a mixture of Pd(II) : 3 
 
Tetrakis(acetonitrile)palladium(II) tetrafluoroborate (1 eq, 14.00 mg, 0.030 mmol) 
and 3 (2 eq, 22.00 mg, 0.060 mmol)  were mixed together in d6 – DMSO (0.75 mL) 
and left for three days to equilibrate at room temperature. After three days, 1 (1 eq, 
7.90 mg, 0.030 mmol) was added to the solution, and was left for three days to 
equilibrate at room temperature. 
19F NMR (376 MHz, d6 – DMSO): δ -148.29 (BF4-), -148.93 ([BF4- ⊂ Pd2(1)4]3+), -
149.89 (A), - 150.12 (B), -150.29 (C), -150.84 (D). 
 
 
Attempted anion exchange on [Pd2(1)x(2)4-x] 
 
Anion exchange with ClO4- 
Tetrabutylammonium perchlorate (16 eq, 22.00 mg, 0.060 mmol) was added to a 
solution of [Pd2(1)x(2)4-x] (as prepared above) in d6 – DMSO (0.75 mL), and was left 
for two days to equilibrate at room temperature, resulting in a white precipitate. 
 
 
Anion exchange with ReO4- 
Tetrabutylammonium perrhenate (16 eq, 29.00 mg, 0.060 mmol) was added to a 
solution of [Pd2(1)x(2)4-x] (as prepared above) in d6 – DMSO (0.75 mL), and was left 
for two days to equilibrate at room temperature, resulting in a white precipitate. 
 
 
Anion exchange with NO3- 
Tetrabutylammonium nitrate (16 eq, 19.00 mg, 0.060 mmol) was added to a 
solution of [Pd2(1)x(2)4-x] (as prepared above) in d6 – DMSO (0.75 mL), and was left 
for two days to equilibrate at room temperature, resulting in a white precipitate. 
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Anion exchange on [Pd2(1)x(3)4-x] 
 
Anion exchange with ClO4- 
Tetrabutylammonium perchlorate (16 eq, 23.00 mg, 0.060 mmol) was added to a 
solution of [Pd2(1)x(3)4-x] (as prepared above) in d6 – DMSO (0.75 mL), and was left 
for two days to equilibrate at room temperature. 
19F NMR (376 MHz, d6 – DMSO): δ -148.35 (BF4-), -149.80 (A), -150.22 (C), -150.77 
(D). HR – ESI MS (d6 – DMSO): m/z 242.28451 [TBA]+, calc. for [C16H36N]+ = 
242.28423, m/z 485.73476 [BF4- ⊂ Pd2(1)3(3)]3+, calc. for [C72H52N8O8Pd2BF4]3+ = 
485.73441, m/z 489.71685 [ClO4- ⊂ Pd2(1)3(3)]3+, calc. for [C72H52N8O8Pd2ClO4]3+ = 
456.37193, m/z 519.07981 [BF4- ⊂ Pd2(1)2(3)2]3+, calc. for [C80H56N8O8Pd2BF4]3+ = 
519.07827, m/z 523.06171 [ClO4- ⊂ Pd2(1)2(3)2]3+, calc. for [C80H56N8O8Pd2ClO4]3+ 
= 456.37193,  m/z 746.08722 [Pd2(1)3(3)(BF4)(Cl)]2+, calc. for 
[C72H52N8O8Pd2(BF4)(Cl)]2+ = 746.08598, m/z 752.05952 [Pd2(1)3(3)(ClO4)(Cl)]2+, 
calc. for [C72H52N8O8Pd2(ClO4)(Cl)]2+ = 752.05809, m/z 796.10401 
[Pd2(1)2(3)2(BF4)(Cl)]2+, calc. for [C80H56N8O8Pd2(BF4)(Cl)]2+ = 796.10177, m/z 




Anion exchange with ReO4- 
Tetrabutylammonium perrhenate (16 eq, 29.00 mg, 0.060 mmol) was added to a 
solution of [Pd2(1)x(3)4-x] (as prepared above) in d6 – DMSO (0.75 mL), and was left 
for two days to equilibrate at room temperature. 
19F NMR (376 MHz, d6 – DMSO): δ -148.34 (BF4-), -149.81 (A), -150.05 (B), -150.22 
(C), -150.77 (D). HR – ESI MS (d6 – DMSO): m/z 242.28335 [TBA]+, calc. for 
[C16H36N]+ = 242.28423, m/z 485.73495 [BF4- ⊂ Pd2(1)3(3)]3+, calc. for 
[C72H52N8O8Pd2BF4]3+ = 485.73441, m/z 519.07893 [BF4- ⊂ Pd2(1)2(3)2]3+, calc. for 
[C80H56N8O8Pd2BF4]3+ = 519.07827, m/z 540.37857 [ReO4- ⊂ Pd2(1)3(3)]3+, calc. for 
[C72H52N8O8Pd2ReO4]3+ = 540.37809, m/z 552.42243 [BF4- ⊂ Pd2(1)(3)3]3+, calc. for 
[C88H60N8O8Pd2BF4]3+ = 552.42214, m/z 573.72275 [ReO4- ⊂ Pd2(1)2(3)2]3+, calc. for 
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[C80H56N8O8Pd2ReO4]3+ = 573.72196, m/z 607.06635 [ReO4- ⊂ Pd2(1)(3)3]3+, calc. 
for [C88H60N8O8Pd2ReO4]3+ = 607.06583, m/z 746.08672 [Pd2(1)3(3)(BF4)(Cl)]2+, 
calc. for [C72H52N8O8Pd2(BF4)(Cl)]2+ = 746.08598, m/z 796.10259 
[Pd2(1)2(3)2(BF4)(Cl)]2+, calc. for [C80H56N8O8Pd2(BF4)(Cl)]2+ = 796.10177, m/z 
828.05255 [Pd2(1)3(3)(ReO4)(Cl)]2+, calc. for [C72H52N8O8Pd2(ReO4)(Cl)]2+ = 
828.05142, m/z 846.12031 [Pd2(1)(3)3(BF4)(Cl)]2+, calc. for 
[C88H60N8O8Pd2(BF4)(Cl)]2+ = 846.11757, m/z 878.06802 [Pd2(1)2(3)2(ReO4)(Cl)]2+, 
calc. for [C80H56N8O8Pd2(ReO4)(Cl)]2+ = 878.06722. 
 
 
Anion exchange with NO3- 
Tetrabutylammonium nitrate (16 eq, 19.00 mg, 0.060 mmol) was added to a 
solution of [Pd2(1)x(3)4-x] (as prepared above) in d6 – DMSO (0.75 mL), and was left 
for two days to equilibrate at room temperature. 
19F NMR (376 MHz, d6 – DMSO): δ -148.34 (BF4-), -149.82 (A), -150.06 (B), -150.23 
(C), -150.77 (D). HR – ESI MS (d6 – DMSO): m/z 242.28347 [TBA]+, calc. for 
[C16H36N]+ = 242.28423, m/z 477.39593 [NO3- ⊂ Pd2(1)3(3)]3+, calc. for 
[C72H52N8O8Pd2NO3]3+ = 477.39577, m/z 510.74035 [NO3- ⊂ Pd2(1)2(3)2]3+, calc. for 
[C80H56N8O8Pd2NO3]3+ = 510.73964, m/z 544.08403 [NO3- ⊂ Pd2(1)3(3)]3+, calc. for 
[C72H52N8O8Pd2NO3]3+ = 544.08350, m/z 733.57468 [Pd2(1)3(3)(NO3)(Cl)]2+, calc. 
for [C72H52N8O8Pd2(NO3)(Cl)]2+ = 733.57803, m/z 783.59479 
[Pd2(1)2(3)2(NO3)(Cl)]2+, calc. for [C80H56N8O8Pd2(NO3)(Cl)]2+ = 783.59383. 
 
 
Anion exchange on [Pd2(1)x(4)4-x] 
 
Anion exchange with ClO4- 
Tetrabutylammonium perchlorate (16 eq, 22.00 mg, 0.060 mmol) was added to a 
solution of [Pd2(1)x(4)4-x] (as prepared above) in d6 – DMSO (0.75 mL), and was left 
for two days to equilibrate at room temperature. 
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19F NMR (376 MHz, d6 – DMSO): δ -127.26 (ligand 4), -134.39 (ligand 4), -148.34 
(BF4-). HR – ESI MS (d6 – DMSO): m/z 242.28348 [TBA]+, calc. for [C16H36N]+ = 
242.28423, m/z 456.37262 [ClO4- ⊂ Pd2(1)4]3+, calc. for [C64H48N8O8Pd2ClO4]3+ = 
456.37193, m/z 468.36646 [ClO4- ⊂ Pd2(1)3(4)]3+, calc. for [C64H46F2N8O8Pd2ClO4]3+ 
= 486.36565, m/z 480.36014 [ClO4- ⊂ Pd2(1)2(4)2]3+, calc. for 
[C64H44F4N8O8Pd2ClO4]3+ = 480.35937, m/z 492.35371 [ClO4- ⊂ Pd2(1)(4)3]3+, calc. 
for [C64H42F6N8O8Pd2ClO4]3+ = 492.35308, m/z 504.34283 [ClO4- ⊂ Pd2(4)4]3+, calc. 
for [C64H40F8N8O8Pd2ClO4]3+ = 504.34680, m/z 720.03415 [Pd2(1)3(4)(ClO4)(Cl)]2+, 
calc. for [C64H46F2N8O8Pd2(ClO4)(Cl)]2+ = 720.03288, m/z 738.02457 
[Pd2(1)2(4)2(ClO4)(Cl)]2+, calc. for [C64H44F4N8O8Pd2(ClO4)(Cl)]2+ = 738.02346, m/z 
756.01517 [Pd2(1)(4)3(ClO4)(Cl)]2+, calc. for [C64H42F6N8O8Pd2(ClO4)(Cl)]2+ = 
756.01403, m/z 774.00549 [Pd2(4)4(ClO4)(Cl)]2+, calc. for 
[C64H40F8N8O8Pd2(ClO4)(Cl)]2+ = 774.00461. 
 
 
Anion exchange with ReO4- 
Tetrabutylammonium perrhenate (16 eq, 32.00 mg, 0.060 mmol) was added to a 
solution of [Pd2(1)x(4)4-x] (as prepared above) in d6 – DMSO (0.75 mL), and was left 
for two days to equilibrate at room temperature. 
19F NMR (376 MHz, d6 – DMSO): δ -127.02 (ligand 4), -127.58 (ligand 4), -131.42 
(ligand 4), -132.01 (ligand 4), -134.39 (ligand 4), -148.33 (BF4-), -148.83 ([BF4- ⊂ 
Pd2(1)4]3+), -149.04 (A + E), -149.16 (B + F), -149.22 (C + G), -149.25 (H), -149.46 
(D). HR – ESI MS (d6 – DMSO): m/z 242.28350 [TBA]+, calc. for [C16H36N]+ = 
242.28423, m/z 464.38401 [BF4- ⊂ Pd2(1)3(4)]3+, calc. for [C64H46F2N8O8Pd2BF4]3+ = 
464.38425, m/z 476.37973 [BF4- ⊂ Pd2(1)2(4)2]3+, calc. for [C64H44F4N8O8Pd2BF4]3+ 
= 476.37797, m/z 488.37284 [BF4- ⊂ Pd2(1)(4)3]3+, calc. for [C64H42F6N8O8Pd2BF4]3+ 
= 488.37169, m/z 500.36627 [BF4- ⊂ Pd2(4)4]3+, calc. for [C64H40F8N8O8Pd2BF4]3+ = 
500.36627, m/z 714.06188 [Pd2(1)3(4)(BF4)(Cl)]2+, calc. for 
[C64H46F2N8O8Pd2(BF4)(Cl)]2+ = 714.06075, m/z 732.05299 
[Pd2(1)2(4)2(BF4)(Cl)]2+, calc. for [C64H44F4N8O8Pd2(BF4)(Cl)]2+ = 732.05133, m/z 
750.04342 [Pd2(1)(4)3(BF4)(Cl)]2+, calc. for [C64H42F6N8O8Pd2(BF4)(Cl)]2+ = 
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750.04191, m/z 768.03309 [Pd2(4)4(BF4)(Cl)]2+, calc. for 
[C64H40F8N8O8Pd2(BF4)(Cl)]2+ = 768.03248. 
 
 
Anion exchange with NO3- 
Tetrabutylammonium nitrate (16 eq, 19.00 mg, 0.060 mmol) was added to a 
solution of [Pd2(1)x(4)4-x] (as prepared above) in d6 – DMSO (0.75 mL), and was left 
for two days to equilibrate at room temperature. 
19F NMR (376 MHz, d6 – DMSO): δ -126.27 (ligand 4), -126.69 (ligand 4), -131.43 
(ligand 4), -132.01 (ligand 4), -134.22 (ligand 4), -134.60 (ligand 4), -148.34 (BF4-). 
HR – ESI MS (d6 – DMSO): m/z 242.28358 [TBA]+, calc. for [C16H36N]+ = 242.28423, 
m/z 444.05209 [NO3- ⊂ Pd2(1)4]3+, calc. for [C64H48N8O8Pd2NO3]3+ = 444.05191, m/z 
452.38984 [BF4- ⊂ Pd2(1)4]3+, calc. for [C64H48N8O8Pd2BF4]3+ = 452.30954, m/z 
456.04531 [NO3- ⊂ Pd2(1)3(4)]3+, calc. for [C64H46F2N8O8Pd2NO3]3+ = 456.04563, 
m/z 464.38459 [BF4- ⊂ Pd2(1)3(4)]3+, calc. for [C64H46F2N8O8Pd2BF4]3+ = 464.38425, 
m/z 468.03697 [NO3- ⊂ Pd2(1)2(4)2]3+, calc. for [C64H44F4N8O8Pd2NO3]3+ = 
468.03934, m/z 476.37908 [BF4- ⊂ Pd2(1)2(4)2]3+, calc. for [C64H44F4N8O8Pd2BF4]3+ 
= 476.37797, m/z 683.56258 [Pd2(1)4(NO3)(Cl)]2+, calc. for 
[C64H48N8O8Pd2(NO3)(Cl)]2+ = 683.56224, m/z 701.55151 [Pd2(1)3(4)(NO3)(Cl)]2+, 
calc. for [C64H46F2N8O8Pd2(NO3)(Cl)]2+ = 701.55282. 
 
 
Anion exchange on [Pd2(1)x(5)4-x] 
 
Anion exchange with ClO4- 
Tetrabutylammonium perchlorate (16 eq, 21.00 mg, 0.060 mmol) was added to a 
solution of [Pd2(1)x(5)4-x] (as prepared above) in d6 – DMSO (0.75 mL), and was left 
for two days to equilibrate at room temperature. 
19F NMR (376 MHz, d6 – DMSO): δ -148.34 (BF4-), -148.75 (D), -148.80 (B). HR – ESI 
MS (d6 – DMSO): m/z 242.28362 [TBA]+, calc. for [C16H36N]+ = 242.28423, m/z 
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461.73487 [BF4- ⊂ Pd2(1)3(5)]3+, calc. for [C66H52N8O8Pd2BF4]3+ = 461.73433, m/z 
465.71687 [ClO4- ⊂ Pd2(1)3(5)]3+, calc. for [C66H52N8O8Pd2ClO4]3+ = 465.71572, m/z 
471.07877 [BF4- ⊂ Pd2(1)2(5)2]3+, calc. for [C68H56N8O8Pd2BF4]3+ = 471.07812, m/z 
475.05547 [ClO4- ⊂ Pd2(1)2(5)2]3+, calc. for [C68H56N8O8Pd2ClO4]3+ = 475.05951, m/z 
484.40305 [ClO4- ⊂ Pd2(1)(5)3]3+, calc. for [C70H60N8O8Pd2ClO4]3+ = 484.40330, m/z 
716.06016 [Pd2(1)3(5)(ClO4)(Cl)]2+, calc. for [C66H52N8O8Pd2(ClO4)(Cl)]2+ = 
716.05799, m/z 724.10052 [Pd2(1)2(5)2(BF4)(Cl)]2+, calc. for 
[C68H56N8O8Pd2(BF4)(Cl)]2+ = 724.10155, m/z 730.06845 [Pd2(1)2(5)2(ClO4)(Cl)]2+, 
calc. for [C68H56N8O8Pd2(ClO4)(Cl)]2+ = 730.07367. 
 
 
Anion exchange with ReO4- 
Tetrabutylammonium perrhenate (16 eq, 30.00 mg, 0.060 mmol) was added to a 
solution of [Pd2(1)x(5)4-x] (as prepared above) in d6 – DMSO (0.75 mL), and was left 
for two days to equilibrate at room temperature. 
19F NMR (376 MHz, d6 – DMSO): δ -148.33 (BF4-), -148.79 (D), -148.84 (B), -149.08 
(E). HR – ESI MS (d6 – DMSO): m/z 242.28334 [TBA]+, calc. for [C16H36N]+ = 
242.28423, m/z 461.73479 [BF4- ⊂ Pd2(1)3(5)]3+, calc. for [C66H52N8O8Pd2BF4]3+ = 
461.73433, m/z 471.07875 [BF4- ⊂ Pd2(1)2(5)2]3+, calc. for [C68H56N8O8Pd2BF4]3+ = 
471.07812, m/z 516.37795 [ReO4- ⊂ Pd2(1)3(5)]3+, calc. for [C66H52N8O8Pd2ReO4]3+ 
= 516.37802, m/z 525.05577 [ReO4- ⊂ Pd2(1)2(5)2]3+, calc. for 
[C68H56N8O8Pd2ReO4]3+ = 525.05496, m/z 710.08649 [Pd2(1)3(5)(BF4)(Cl)]2+, calc. 
for [C66H52N8O8Pd2(BF4)(Cl)]2+ = 710.08586, m/z 724.09960 
[Pd2(1)2(5)2(BF4)(Cl)]2+, calc. for [C68H56N8O8Pd2(BF4)(Cl)]2+ = 724.10155, m/z 
792.05292 [Pd2(1)3(5)(ReO4)(Cl)]2+, calc. for [C66H52N8O8Pd2(ReO4)(Cl)]2+ = 
792.05131, m/z 806.06732 [Pd2(1)2(5)2(ReO4)(Cl)]2+, calc. for 






Anion exchange with NO3- 
Tetrabutylammonium nitrate (16 eq, 19.00 mg, 0.060 mmol) was added to a 
solution of [Pd2(1)x(5)4-x] (as prepared above) in d6 – DMSO (0.75 mL), and was left 
for two days to equilibrate at room temperature. 
19F NMR (376 MHz, d6 – DMSO): δ -148.34 (BF4-). HR – ESI MS (d6 – DMSO): m/z 
242.28355 [TBA]+, calc. for [C16H36N]+ = 242.28423, m/z 444.05224 [NO3- ⊂ 
Pd2(1)4]3+, calc. for [C64H48N8O8Pd2NO3]3+ = 444.05191, m/z 453.39428 [NO3- ⊂ 
Pd2(1)3(5)]3+, calc. for [C66H52N8O8Pd2NO3]3+ = 453.39570, m/z 697.57477 
[Pd2(1)3(5)(NO3)(Cl)]2+, calc. for [C66H52N8O8Pd2(NO3)(Cl)]2+ = 697.57793. 
 
 
Anion exchange on [Pd2(1)x(6)4-x] 
 
Anion exchange with ClO4- 
Tetrabutylammonium perchlorate (16 eq, 21.00 mg, 0.060 mmol) was added to a 
solution of [Pd2(1)x(6)4-x] (as prepared above) in d6 – DMSO (0.75 mL), and was left 
for two days to equilibrate at room temperature. 
19F NMR (376 MHz, d6 – DMSO): δ -148.34 (BF4-), -149.01 (A), -149.23 (B). HR – ESI 
MS (d6 – DMSO): m/z 242.28356 [TBA]+, calc. for [C16H36N]+ = 242.28423, m/z 
456.37448 [ClO4- ⊂ Pd2(1)4]3+, calc. for [C64H48N8O8Pd2ClO4]3+ = 456.37193, m/z 
471.07936 [BF4- ⊂ Pd2(1)3(6)]3+, calc. for [C68H56N8O8Pd2BF4]3+ = 471.07812, m/z 
475.05966 [ClO4- ⊂ Pd2(1)3(6)]3+, calc. for [C68H56N8O8Pd2ClO4]3+ = 475.05951, m/z 
489.76639 [BF4- ⊂ Pd2(1)2(6)2]3+, calc. for [C72H64N8O8Pd2BF4]3+ = 489.76571, m/z 
493.74771 [ClO4- ⊂ Pd2(1)2(6)2]3+, calc. for [C72H64N8O8Pd2ClO4]3+ = 493.74709, m/z 
724.10052 [Pd2(1)3(6)(BF4)(Cl)]2+, calc. for [C68H56N8O8Pd2(BF4)(Cl)]2+ = 
724.10155, m/z 730.07399 [Pd2(1)3(6)(ClO4)(Cl)]2+, calc. for 
[C68H56N8O8Pd2(ClO4)(Cl)]2+ = 730.07367, m/z 752.13341 [Pd2(1)2(6)2(BF4)(Cl)]2+, 
calc. for [C72H64N8O8Pd2(BF4)(Cl)]2+ = 752.13293, m/z 758.10572 




Anion exchange with ReO4- 
Tetrabutylammonium perrhenate (16 eq, 29.00 mg, 0.060 mmol) was added to a 
solution of [Pd2(1)x(6)4-x] (as prepared above) in d6 – DMSO (0.75 mL), and was left 
for two days to equilibrate at room temperature. 
19F NMR (376 MHz, d6 – DMSO): δ -148.34 (BF4-), -148.84 ([BF4- ⊂ Pd2(1)4]3+), -
149.10 (A), -149.22 (B), -149.90 (C). HR – ESI MS (d6 – DMSO): m/z 242.28338 
[TBA]+, calc. for [C16H36N]+ = 242.28423, m/z 471.07998 [BF4- ⊂ Pd2(1)3(6)]3+, calc. 
for [C68H56N8O8Pd2BF4]3+ = 471.07812, m/z 489.76642 [BF4- ⊂ Pd2(1)2(6)2]3+, calc. 
for [C72H64N8O8Pd2BF4]3+ = 489.76571, m/z 525.72263 [ReO4- ⊂ Pd2(1)3(6)]3+, calc. 
for [C68H56N8O8Pd2ReO4]3+ = 525.72181, m/z 544.41020 [ReO4- ⊂ Pd2(1)2(6)2]3+, 
calc. for [C72H64N8O8Pd2ReO4]3+ = 544.40940, m/z 724.10242 
[Pd2(1)3(6)(BF4)(Cl)]2+, calc. for [C68H56N8O8Pd2(BF4)(Cl)]2+ = 724.10155, m/z 
752.13352 [Pd2(1)2(6)2(BF4)(Cl)]2+, calc. for [C72H64N8O8Pd2(BF4)(Cl)]2+ = 
752.13293, m/z 806.06815 [Pd2(1)3(6)(ReO4)(Cl)]2+, calc. for 
[C68H56N8O8Pd2(ReO4)(Cl)]2+ = 806.06699, m/z 834.09937 
[Pd2(1)2(6)2(ReO4)(Cl)]2+, calc. for [C72H64N8O8Pd2(ReO4)(Cl)]2+ = 834.09837.  
 
 
Anion exchange with NO3- 
Tetrabutylammonium nitrate (16 eq, 23.00 mg, 0.060 mmol) was added to a 
solution of [Pd2(1)x(6)4-x] (as prepared above) in d6 – DMSO (0.75 mL), and was left 
for two days to equilibrate at room temperature. 
19F NMR (376 MHz, d6 – DMSO): δ -148.34 (BF4-), -149.23 (B). HR – ESI MS (d6 – 
DMSO): m/z 242.28362 [TBA]+, calc. for [C16H36N]+ = 242.28423, m/z 462.73931 
[NO3- ⊂ Pd2(1)3(6)]3+, calc. for [C68H56N8O8Pd2NO3]3+ = 462.73949, m/z 481.42580 
[NO3- ⊂ Pd2(1)2(6)2]3+, calc. for [C72H64N8O8Pd2NO3]3+ = 481.42707,  m/z 489.76638 
[BF4- ⊂ Pd2(1)2(6)2]3+, calc. for [C72H64N8O8Pd2BF4]3+ = 489.76571, m/z 711.59058 
[Pd2(1)3(6)(NO3)(Cl)]2+, calc. for [C68H56N8O8Pd2(NO3)(Cl)]2+ = 711.59361, m/z 
739.62124 [Pd2(1)2(6)2(NO3)(Cl)]2+, calc. for [C72H64N8O8Pd2(NO3)(Cl)]2+ = 
739.62499,  m/z 752.13359 [Pd2(1)2(6)2(BF4)(Cl)]2+, calc. for 








Synthesis of [Pd2(1)x(2)y(3)z] helicates 
 
Tetrakis(acetonitrile)palladium(II) tetrafluoroborate (2 eq, 6.60 mg, 0.015 mmol), 
1 (2 eq, 4.30 mg, 0.015 mmol), 2 (2 eq, 0.08 mL of 0.2 M solution in DCM, solvent 
removed in vacuo, 0.015 mmol), and 3 (2 eq, 6.30 mg, 0.015 mmol)  were mixed 
together in d6 – DMSO (0.75 mL) and left for three days to equilibrate at room 
temperature. 
19F NMR (376 MHz, d6 – DMSO): δ -148.30 (BF4-), -148.88 ([BF4- ⊂ Pd2(1)4]3+), -
148.94 (BF4- ⊂ helicate), -149.11 (BF4- ⊂ helicate), -149.22 (BF4- ⊂ helicate), -149.57 
(BF4- ⊂ helicate), -149.65 (BF4- ⊂ helicate), -149.79 (BF4- ⊂ helicate), -149.85 (BF4- 
⊂ helicate), -149.88 (a), -150.80 (BF4- ⊂ helicate). HR – ESI MS (d6 – DMSO): m/z 
452.38964 [BF4- ⊂ Pd2(1)4]3+, calc. for [C64H48N8O8Pd2BF4]3+ = 452.39054, m/z 
469.06146 [BF4- ⊂ Pd2(1)3(2)]3+, calc. for [C68H50N8O8Pd2BF4]3+ = 469.06247, m/z 
485.73335 [BF4- ⊂ Pd2(1)3(3)]3+ or [BF4- ⊂ Pd2(1)2(2)2]3+, calc. for 
[C72H52N8O8Pd2BF4]3+ = 485.73441, m/z 502.40526 [BF4- ⊂ Pd2(1)(2)3]3+ or [BF4- ⊂ 
Pd2(1)2(2)(3)]3+, calc. for [C76H54N8O8Pd2BF4]3+ = 502.406342, m/z 519.07710 [BF4- 
⊂ Pd2(1)2(3)2]3+, [BF4- ⊂ Pd2(2)4]3+ or [BF4- ⊂ Pd2(1)(2)2(3)]3+, calc. for 
[C80H56N8O8Pd2BF4]3+ = 519.07827, m/z 535.74907 [BF4- ⊂ Pd2(2)3(3)]3+ or [BF4- ⊂ 
Pd2(1)(2)(3)2]3+, calc. for [C84H58N8O8Pd2BF4]3+ = 535.75021, m/z 552.42141 [BF4- 
⊂ Pd2(1)(3)3]3+ or [BF4- ⊂ Pd2(2)2(3)2]3+, calc. for [C88H60N8O8Pd2BF4]3+ = 
552.42214, m/z 696.06926 [Pd2(1)4(BF4)(Cl)]2+, calc. for 
[C64H48N8O8Pd2(BF4)(Cl)]2+ = 696.07017, m/z 721.07830 [Pd2(1)3(2)(BF4)(Cl)]2+, 
calc. for [C68H50N8O8Pd2(BF4)(Cl)]2+ = 721.07808, m/z 746.08572 
[Pd2(1)3(3)(BF4)(Cl)]2+ or [Pd2(1)2(2)2(BF4)(Cl)]2+, calc. for 
[C72H52N8O8Pd2(BF4)(Cl)]3+ = 746.08598, m/z 771.09538 [Pd2(1)(2)3(BF4)(Cl)]2+ or 
[Pd2(1)2(2)(3)(BF4)(Cl)]2+, calc. for [C76H54N8O8Pd2(BF4)(Cl)]2+ = 771.09388, m/z 
796.10432 [Pd2(1)2(3)2(BF4)(Cl)]2+, [Pd2(2)4(BF4)(Cl)]2+ or 
[Pd2(1)(2)2(3)(BF4)(Cl)]2+, calc. for [C80H56N8O8Pd2(BF4)(Cl)]2+ = 796.10177, m/z 
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821.11525 [Pd2(2)3(3)(BF4)(Cl)]2+ or [Pd2(1)(2)(3)2(BF4)(Cl)]2+, calc. for 
[C84H58N8O8Pd2(BF4)(Cl)]2+ = 821.10967, m/z 846.12448 [Pd2(1)(3)3(BF4)(Cl)]2+ or 
[Pd2(2)2(3)2(BF4)(Cl)]2+, calc. for [C88H60N8O8Pd2(BF4)(Cl)]2+ = 846.11757. 
The mixture was then heated at 80 oC overnight and sent for 19F NMR analysis. 
19F NMR (376 MHz, d6 – DMSO): δ -148.30 (BF4-), -148.88 ([BF4- ⊂ Pd2(1)4]3+), -
148.94 (BF4- ⊂ helicate), -149.11 (BF4- ⊂ helicate), -149.22 (BF4- ⊂ helicate), -149.57 
(BF4- ⊂ helicate), -149.65 (BF4- ⊂ helicate), -149.79 (BF4- ⊂ helicate), -149.85 (BF4- 
⊂ helicate), -149.88 (a), -150.11 (b), -150.80 (BF4- ⊂ helicate). 
 
 
Synthesis of [Pd2(1)x(3)y(6)z] helicates 
 
Tetrakis(acetonitrile)palladium(II) tetrafluoroborate (2 eq, 6.80 mg, 0.015 mmol), 
1 (2 eq, 4.50 mg, 0.015 mmol), 3 (2 eq, 5.70 mg, 0.015 mmol), and 6 (2 eq, 5.00 mg, 
0.015 mmol)  were mixed together in d6 – DMSO (0.75 mL) and left for three days to 
equilibrate at room temperature. 
19F NMR (376 MHz, d6 – DMSO): δ -148.30 (BF4-), -148.89 ([BF4- ⊂ Pd2(1)4]3+), -
149.13 (BF4- ⊂ helicate), -149.26 (BF4- ⊂ helicate), -149.84 (BF4- ⊂ helicate),  -149.92 
(a), -149.95 (BF4- ⊂ helicate), -150.00 (BF4- ⊂ helicate), -150.07 (BF4- ⊂ helicate), -
150.25 (BF4- ⊂ helicate), -150.80 (BF4- ⊂ helicate). HR – ESI MS (d6 – DMSO): m/z 
452.39238 [BF4- ⊂ Pd2(1)4]3+, calc. for [C64H48N8O8Pd2BF4]3+ = 452.39054, m/z 
471.08003 [BF4- ⊂ Pd2(1)3(6)]3+, calc. for [C68H56N8O8Pd2BF4]3+ = 471.07812, m/z 
485.73649 [BF4- ⊂ Pd2(1)3(3)]3+, calc. for [C72H52N8O8Pd2BF4]3+ = 485.73441, m/z 
489.76759 [BF4- ⊂ Pd2(1)2(6)2]3+, calc. for [C72H64N8O8Pd2BF4]3+ = 489.76571, m/z 
504.42410 [BF4- ⊂ Pd2(1)2(3)(6)]3+, calc. for [C76H60N8O8Pd2BF4]3+ = 504.42199, 
m/z 519.08043 [BF4- ⊂ Pd2(1)2(3)2]3+, calc. for [C80H56N8O8Pd2BF4]3+ = 519.07827, 
m/z 537.76797 [BF4- ⊂ Pd2(1)(3)2(6)]3+, calc. for [C84H64N8O8Pd2BF4]3+ = 
537.76586, m/z 552.42410 [BF4- ⊂ Pd2(1)(3)3]3+, calc. for [C88H60N8O8Pd2BF4]3+ = 
552.42214, m/z 724.10424 [Pd2(1)3(6)(BF4)(Cl)]2+, calc. for 
[C68H56N8O8Pd2(BF4)(Cl)]2+ = 724.10155, m/z 746.08954 [Pd2(1)3(3)(BF4)(Cl)]2+, 
calc. for [C72H52N8O8Pd2(BF4)(Cl)]3+ = 746.08598, m/z 752.12576 
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[Pd2(1)2(6)2(BF4)(Cl)]2+, calc. for [C72H64N8O8Pd2(BF4)(Cl)]2+ = 752.13293, m/z 
774.11515 [Pd2(1)2(3)(6)(BF4)(Cl)]2+, calc. for [C76H60N8O8Pd2(BF4)(Cl)]2+ = 
774.11735, m/z 796.10566 [Pd2(1)2(3)2(BF4)(Cl)]2+, calc. for 
[C80H56N8O8Pd2(BF4)(Cl)]2+ = 796.10177, m/z 824.12581 
[Pd2(1)(3)2(6)(BF4)(Cl)]2+, calc. for [C84H64N8O8Pd2(BF4)(Cl)]2+ = 824.13315, m/z 
846.12284 [Pd2(1)(3)3(BF4)(Cl)]2+, calc. for [C88H60N8O8Pd2(BF4)(Cl)]2+ = 
846.11757.  
The mixture was then heated at 80 oC overnight and sent for 19F NMR analysis. 
19F NMR (376 MHz, d6 – DMSO): δ -148.30 (BF4-), -148.89 ([BF4- ⊂ Pd2(1)4]3+), -
149.13 (BF4- ⊂ helicate), -149.26 (BF4- ⊂ helicate), -149.56 (b), -149.84 (BF4- ⊂ 
helicate), -149.92 (a), -149.95 (BF4- ⊂ helicate), -150.00 (BF4- ⊂ helicate), -150.07 
(BF4- ⊂ helicate), -150.25 (BF4- ⊂ helicate), -150.80 (BF4- ⊂ helicate). 
 
 
Synthesis of [Pd2(1)x(4)y(5)z] helicates 
 
Tetrakis(acetonitrile)palladium(II) tetrafluoroborate (2 eq, 7.00 mg, 0.015 mmol), 
1 (2 eq, 4.50 mg, 0.015 mmol), 4 (2 eq, 5.90 mg, 0.015 mmol), and 5 (2 eq, 4.50 mg, 
0.015 mmol)  were mixed together in d6 – DMSO (0.75 mL) and left for three days to 
equilibrate at room temperature. 
19F NMR (376 MHz, d6 – DMSO): δ -126.71 (ligand 4), -126.95 (ligand 4), -127.12 
(ligand 4), -127.66 (ligand 4), -131.46 (ligand 4), -132.02 (ligand 4), -133.30 (ligand 
4), -134.43 (ligand 4), -148.31 (BF4-), -148.79 (BF4- ⊂ helicate), -148.85 (BF4- ⊂ 
helicate), -148.89 ([BF4- ⊂ Pd2(1)4]3+), -148.97 (a), -149.04 (BF4- ⊂ helicate), -149.09 
(BF4- ⊂ helicate), -149.17 (BF4- ⊂ helicate), -149.23 (BF4- ⊂ helicate), -149.28 (BF4- ⊂ 
helicate), -149.52 (BF4- ⊂ helicate). HR – ESI MS (d6 – DMSO): m/z 452.38743 [BF4- 
⊂ Pd2(1)4]3+, calc. for [C64H48N8O8Pd2BF4]3+ = 452.39054, m/z 461.73091 [BF4- ⊂ 
Pd2(1)3(5)]3+, calc. for [C66H52N8O8Pd2BF4]3+ = 461.73433, m/z 464.38084 [BF4- ⊂ 
Pd2(1)3(4)]3+, calc. for [C64H46F2N8O8Pd2BF4]3+ = 464.38425, m/z 471.07431 [BF4- ⊂ 
Pd2(1)2(5)2]3+, calc. for [C68H56N8O8Pd2BF4]3+ = 471.07812, m/z 473.72452 [BF4- ⊂ 
Pd2(1)2(4)(5)]3+, calc. for [C66H50F2N8O8Pd2BF4]3+ = 473.72805, m/z 476.37441 
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[BF4- ⊂ Pd2(1)2(4)2]3+, calc. for [C64H46F4N8O8Pd2BF4]3+ = 476.37797, m/z 
480.41806 [BF4- ⊂ Pd2(1)(5)3]3+, calc. for [C70H60N8O8Pd2BF4]3+ = 480.42192, m/z 
483.06810 [BF4- ⊂ Pd2(1)(4)(5)2]3+, calc. for [C68H54F2N8O8Pd2BF4]3+ = 483.07184, 
m/z 485.71805 [BF4- ⊂ Pd2(1)(4)2(5)]3+, calc. for [C66H48F4N8O8Pd2BF4]3+ = 
485.72177, m/z 488.36799 [BF4- ⊂ Pd2(1)(4)3]3+, calc. for [C64H42F6N8O8Pd2BF4]3+ = 
488.37169, m/z 489.76326 [BF4- ⊂ Pd2(5)4]3+, calc. for [C72H64N8O8Pd2BF4]3+ = 
489.76571, m/z 492.41180 [BF4- ⊂ Pd2(4)(5)3]3+, calc. for [C70H58F2N8O8Pd2BF4]3+ = 
492.41563, m/z 495.06157 [BF4- ⊂ Pd2(4)2(5)2]3+, calc. for [C68H52F4N8O8Pd2BF4]3+ 
= 495.06556, m/z 497.71168 [BF4- ⊂ Pd2(4)3(5)]3+, calc. for [C66H46F6N8O8Pd2BF4]3+ 
= 497.71548, m/z 696.06567 [Pd2(1)4(BF4)(Cl)]2+, calc. for 
[C64H48N8O8Pd2(BF4)(Cl)]2+ = 696.07017, m/z 710.08098 [Pd2(1)3(5)(BF4)(Cl)]2+, 
calc. for [C66H52N8O8Pd2(BF4)(Cl)]2+ = 710.08586, m/z 714.05587 
[Pd2(1)3(4)(BF4)(Cl)]2+, calc. for [C64H46F2N8O8Pd2(BF4)(Cl)]3+ = 714.06075, m/z 
724.09562 [Pd2(1)2(5)2(BF4)(Cl)]2+, calc. for [C68H56N8O8Pd2(BF4)(Cl)]2+ = 
724.10155, m/z 728.07137 [Pd2(1)2(4)(5)(BF4)(Cl)]2+, calc. for 
[C66H50F2N8O8Pd2(BF4)(Cl)]2+ = 728.07644, m/z 732.04638 
[Pd2(1)2(4)2(BF4)(Cl)]2+, calc. for [C64H46F4N8O8Pd2(BF4)(Cl)]2+ = 732.05133, m/z 
738.10968 [Pd2(1)(5)3(BF4)(Cl)]2+, calc. for [C70H60N8O8Pd2(BF4)(Cl)]2+ = 
738.11724, m/z 742.08568 [Pd2(1)(4)(5)2(BF4)(Cl)]2+, calc. for 
[C68H54F2N8O8Pd2(BF4)(Cl)]2+ = 742.09213, m/z 746.06155 
[Pd2(1)(4)2(5)(BF4)(Cl)]2+, calc. for [C66H48F4N8O8Pd2(BF4)(Cl)]2+ = 746.06702, m/z 
750.03731 [Pd2(1)(4)3(BF4)(Cl)]2+, calc. for [C64H42F6N8O8Pd2(BF4)(Cl)]2+ = 
750.04191, m/z 760.07307 [Pd2(4)2(5)2(BF4)(Cl)]2+, calc. for 
[C68H52F4N8O8Pd2(BF4)(Cl)]2+ = 760.88271, m/z 764.05176 [Pd2(4)3(5)(BF4)(Cl)]2+, 
calc. for [C66H46F6N8O8Pd2(BF4)(Cl)]2+ = 764.05760. 
Mixture was then heated at 80 oC overnight and then sent for 19F NMR analysis. 
19F NMR (376 MHz, d6 – DMSO): δ -126.71 (ligand 4), -126.95 (ligand 4), -127.12 
(ligand 4), -127.66 (ligand 4), -131.46 (ligand 4), -132.02 (ligand 4), -133.30 (ligand 
4), -134.43 (ligand 4), -148.31 (BF4-), -148.79 (BF4- ⊂ helicate), -148.85 (BF4- ⊂ 
helicate), -148.89 ([BF4- ⊂ Pd2(1)4]3+), -148.97 (a), -149.01 (BF4- ⊂ helicate), -149.04 
(BF4- ⊂ helicate), -149.09 (BF4- ⊂ helicate), -149.17 (BF4- ⊂ helicate), -149.23 (BF4- ⊂ 
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Synthesis of [Pd2(2)x(3)y(6)z] helicates 
 
Tetrakis(acetonitrile)palladium(II) tetrafluoroborate (2 eq, 6.60 mg, 0.015 mmol), 
2 (2 eq, 0.08 mL of 0.2 M solution in DCM, solvent removed in vacuo, 0.015 mmol), 
3 (2 eq, 6.20 mg, 0.015 mmol), and 6 (2 eq, 5.10 mg, 0.015 mmol)  were mixed 
together in d6 – DMSO (0.75 mL) and left for three days to equilibrate at room 
temperature. 
19F NMR (376 MHz, d6 – DMSO): δ -148.31 (BF4-), -149.04 (a), -149.39 (BF4- ⊂ 
helicate), -149.44 (BF4- ⊂ helicate), -149.59 (BF4- ⊂ helicate), -150.25 ([BF4- ⊂ 
Pd2(2)4]3+), -151.02 (b). HR – ESI MS (d6 – DMSO): m/z 519.07821 [BF4- ⊂ Pd2(2)4]3+, 
calc. for [C80H56N8O8Pd2BF4]3+ = 519.07827, m/z 521.09246 [BF4- ⊂ Pd2(2)3(6)]3+, 
calc. for [C80H62N8O8Pd2BF4]3+ = 521.09393, m/z 535.74973 [BF4- ⊂ Pd2(2)3(3)]3+, 
calc. for [C84H58N8O8Pd2BF4]3+ = 535.75021, m/z 537.76173 [BF4- ⊂ 
Pd2(2)2(3)(6)]3+, calc. for [C84H64N8O8Pd2BF4]3+ = 537.76586, m/z 552.42151 [BF4- 
⊂ Pd2(2)2(3)2]3+, calc. for [C88H60N8O8Pd2BF4]3+ = 552.42214, m/z 554.42555 [BF4- 
⊂ Pd2(2)(3)2(6)]3+, calc. for [C88H66N8O8Pd2BF4]3+ = 554.43779, m/z 569.09334 
[BF4- ⊂ Pd2(2)(3)3]3+, calc. for [C92H62N8O8Pd2BF4]3+ = 569.09407, m/z 796.10179 
[Pd2(2)4(BF4)(Cl)]2+, calc. for [C80H56N8O8Pd2(BF4)(Cl)]2+ = 796.10177, m/z 
798.61542 [Pd2(2)3(6)(BF4)(Cl)]2+, calc. for [C80H62N8O8Pd2(BF4)(Cl)]3+ = 
798.62543, m/z 821.10981 [Pd2(2)3(3)(BF4)(Cl)]2+, calc. for 
[C84H58N8O8Pd2(BF4)(Cl)]2+ = 821.10967, m/z 824.12479 
[Pd2(2)2(3)(6)(BF4)(Cl)]2+, calc. for [C84H64N8O8Pd2(BF4)(Cl)]2+ = 824.13315, m/z 
846.11993 [Pd2(2)2(3)2(BF4)(Cl)]2+, calc. for [C88H60N8O8Pd2(BF4)(Cl)]2+ = 
846.11757, m/z 849.12966 [Pd2(2)(3)2(6)(BF4)(Cl)]2+, calc. for 
[C88H66N8O8Pd2(BF4)(Cl)]2+ = 849.14105, m/z 871.13258 [Pd2(2)(3)3(BF4)(Cl)]2+, 
calc. for [C92H62N8O8Pd2(BF4)(Cl)]2+ = 871.12547.  
The mixture was then heated at 80 oC overnight and sent for 19F NMR analysis. 
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19F NMR (376 MHz, d6 – DMSO): δ -148.31 (BF4-), -148.98 (c), -149.04 (a), -149.26 
(BF4- ⊂ helicate), -149.31 (BF4- ⊂ helicate), -149.39 (BF4- ⊂ helicate), -149.44 (BF4- ⊂ 
helicate), -149.95 (BF4- ⊂ helicate), -150.25 ([BF4- ⊂ Pd2(2)4]3+), -151.02 (b). 
 
 
Synthesis of [Pd2(3)x(5)y(6)z] helicates 
 
Tetrakis(acetonitrile)palladium(II) tetrafluoroborate (2 eq, 7.10 mg, 0.015 mmol), 
3 (2 eq, 6.50 mg, 0.015 mmol), 5 (2 eq, 5.20 mg, 0.015 mmol), and 6 (2 eq, 4.80 mg, 
0.015 mmol)  were mixed together in d6 – DMSO (0.75 mL) and left for three days to 
equilibrate at room temperature. 
19F NMR (376 MHz, d6 – DMSO): δ -148.30 (BF4-), -148.65 (BF4- ⊂ helicate), -148.93 
(BF4- ⊂ helicate), -149.16 (BF4- ⊂ helicate), -149.37 (BF4- ⊂ helicate), -149.41 (BF4- 
⊂ helicate), -149.89 (BF4- ⊂ helicate), -150.08 (BF4- ⊂ helicate), -150.99 (a). HR – ESI 
MS (d6 – DMSO): m/z 489.76284 [BF4- ⊂ Pd2(5)4]3+, calc. for [C72H64N8O8Pd2BF4]3+ = 
489.76571, m/z 499.10870 [BF4- ⊂ Pd2(5)3(6)]3+, calc. for [C74H68N8O8Pd2BF4]3+ = 
499.10950, m/z 508.42567 [BF4- ⊂ Pd2(5)2(6)2]3+, calc. for [C76H72N8O8Pd2BF4]3+ = 
508.45329, m/z 513.76512 [BF4- ⊂ Pd2(3)(5)3]3+, calc. for [C78H64N8O8Pd2BF4]3+ = 
513.76578, m/z 523.10891 [BF4- ⊂ Pd2(3)(5)2(6)]3+, calc. for [C80H68N8O8Pd2BF4]3+ 
= 523.10958, m/z 532.45276 [BF4- ⊂ Pd2(3)(5)(6)2]3+, calc. for 
[C82H72N8O8Pd2BF4]3+ = 532.45337, m/z 537.76510 [BF4- ⊂ Pd2(3)2(5)2]3+, calc. for 
[C84H64N8O8Pd2BF4]3+ = 537.76586, m/z 547.10896 [BF4- ⊂ Pd2(3)2(5)(6)]3+, calc. 
for [C86H68N8O8Pd2BF4]3+ = 547.10965, m/z 561.76512 [BF4- ⊂ Pd2(3)3(5)]3+, calc. 
for [C90H64N8O8Pd2BF4]3+ = 561.76593, m/z 766.14461 [Pd2(5)3(6)(BF4)(Cl)]2+, calc. 
for [C74H68N8O8Pd2(BF4)(Cl)]2+ = 766.14862, m/z 780.15686 
[Pd2(5)2(6)2(BF4)(Cl)]2+, calc. for [C76H72N8O8Pd2(BF4)(Cl)]3+ = 780.16431, m/z 
788.13204 [Pd2(3)(5)3(BF4)(Cl)]2+, calc. for [C78H64N8O8Pd2(BF4)(Cl)]2+ = 
788.13304, m/z 802.14734 [Pd2(3)(5)2(6)(BF4)(Cl)]2+, calc. for 
[C80H68N8O8Pd2(BF4)(Cl)]2+ = 802.14873, m/z 824.13235 [Pd2(3)2(5)2(BF4)(Cl)]2+, 
calc. for [C84H64N8O8Pd2(BF4)(Cl)]2+ = 824.13315, m/z 838.14776 
[Pd2(3)2(5)(6)(BF4)(Cl)]2+, calc. for [C86H68N8O8Pd2(BF4)(Cl)]2+ = 838.14884, m/z 
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860.13349 [Pd2(3)3(5)(BF4)(Cl)]2+, calc. for [C90H64N8O8Pd2(BF4)(Cl)]2+ = 
860.13326.  
The mixture was then heated at 80 oC overnight and sent for 19F NMR analysis. 
19F NMR (376 MHz, d6 – DMSO): δ -148.30 (BF4-), -149.16 (BF4- ⊂ helicate), -149.26 
(BF4- ⊂ helicate), -149.37 (BF4- ⊂ helicate), -149.41 (BF4- ⊂ helicate), -149.47 (BF4- ⊂ 
helicate), -149.84 (BF4- ⊂ helicate), -149.89 (BF4- ⊂ helicate), -150.02 (BF4- ⊂ 
helicate), - 150.08 (BF4- ⊂ helicate), -150.33 (b), -150.38 (c), -150.84 (d), -151.16 
(e), -151.37 (f), -151.50 (g).  
 
 
 
 
 
 
